data_2ep8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ep8 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.818 0.342 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 1.9 tt -67.54 -35.14 78.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -112.94 37.28 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -59.81 112.66 1.92 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 83.61 -49.19 4.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.453 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 329' ' ' GLY . 12.5 mt -35.41 129.72 0.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 110.946 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -103.07 130.15 50.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.864 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -121.53 164.46 17.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -143.02 139.22 30.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.43 HD13 ' CB ' ' A' ' 340' ' ' ARG . 3.5 mt -116.22 146.21 42.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -104.94 169.67 8.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -71.46 -13.28 61.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.837 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -82.97 -45.77 13.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.3 m -84.36 150.6 57.75 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.618 0.723 . . . . 0.0 111.102 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 120.7 7.44 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.658 2.239 . . . . 0.0 112.382 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 0.43 ' CB ' HD13 ' A' ' 334' ' ' LEU . 5.9 ptt180 -93.78 -38.4 11.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -45.44 -37.59 5.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -86.25 -57.43 3.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.08 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 89.3 mt -54.2 -60.42 3.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -42.11 -64.8 0.53 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.092 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -47.79 -40.69 21.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 16.6 mt -66.41 -72.42 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.13 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 22.4 mt -40.48 -38.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -67.2 -53.67 28.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 11.0 p -55.03 -36.27 65.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -80.72 11.35 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.857 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 65.96 48.83 62.64 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.536 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -122.13 160.77 16.49 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.476 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -93.57 131.11 39.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.906 0.384 . . . . 0.0 110.886 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 14.1 p -147.82 134.21 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.144 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' SER . . . . . 0.505 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 23.1 t -137.82 158.23 44.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 29.0 p90 -130.44 168.24 17.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.938 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . 0.435 ' CB ' HD12 ' A' ' 360' ' ' LEU . 3.1 t70 -56.57 122.03 11.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.819 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -51.7 -48.44 63.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 40.2 t -57.73 -48.48 79.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.435 HD12 ' CB ' ' A' ' 357' ' ' ASP . 32.6 mt -50.45 -51.18 49.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.93 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 4.7 m -160.23 139.23 10.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 12.6 pt -66.66 156.55 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.131 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 108.49 14.72 15.31 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.486 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -97.82 162.42 13.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.916 0.389 . . . . 0.0 111.067 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 19.5 p -116.22 -68.41 0.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.159 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' TYR . . . . . 0.505 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 9.6 p90 -99.99 147.28 25.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.906 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.97 175.86 9.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.842 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' A' ' 368' ' ' VAL . 7.9 p -75.26 3.24 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.09 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 74.6 p -112.15 27.54 9.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.121 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -104.69 101.55 11.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 9.7 m -42.66 -35.13 1.03 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.819 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -40.9 -43.68 2.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.817 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 66.1 mt -44.17 125.33 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.148 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 43.0 p -92.84 -45.05 8.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.133 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -127.41 135.84 51.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' GLN . . . . . 0.576 ' NE2' ' CE2' ' A' ' 392' ' ' TYR . 40.6 tt0 -120.33 123.84 44.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 33.0 mm -92.32 133.75 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.153 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 19.4 m -149.99 153.03 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -76.16 -28.94 57.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -134.73 80.85 48.79 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.592 0.711 . . . . 0.0 110.87 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -18.25 37.27 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.678 2.252 . . . . 0.0 112.299 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -77.52 -64.32 2.09 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.488 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -42.3 -57.72 2.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.797 0.332 . . . . 0.0 110.909 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -79.86 129.04 34.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.943 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 70.6 p -63.1 -179.85 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.121 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 25.3 p -110.98 178.87 4.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . 0.43 HG11 ' N ' ' A' ' 388' ' ' ILE . 49.0 t -125.29 137.97 55.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.107 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.43 ' N ' HG11 ' A' ' 387' ' ' VAL . 3.0 mt -44.12 123.34 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.106 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 89.26 -44.29 3.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.561 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -82.16 137.41 34.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.827 0.346 . . . . 0.0 110.889 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 23.5 m -120.61 117.38 27.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . 0.576 ' CE2' ' NE2' ' A' ' 376' ' ' GLN . 9.7 m-85 -80.79 145.64 31.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.942 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 31.3 m -150.56 165.33 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.115 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -78.39 158.18 76.84 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.6 0.715 . . . . 0.0 110.894 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -4.36 13.91 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.675 2.25 . . . . 0.0 112.351 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -86.74 -23.85 25.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -59.82 -33.37 71.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 75.4 t -76.16 -47.2 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.138 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -58.35 -36.5 73.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.866 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.85 -27.38 60.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 40.4 m -76.13 -51.27 12.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 14.8 m -53.5 -41.98 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.157 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -69.27 -34.78 75.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -93.07 3.28 56.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 42.58 44.72 3.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' A' ' 407' ' ' LEU . 18.6 tp -160.86 154.84 22.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.906 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . 0.437 ' N ' ' HG ' ' A' ' 406' ' ' LEU . 97.3 mt -84.9 99.68 11.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.01 154.97 91.43 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.597 0.713 . . . . 0.0 110.902 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 105.73 1.54 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.711 2.274 . . . . 0.0 112.33 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.2 m -53.9 -16.62 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -58.27 -23.85 57.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.103 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -86.0 -31.65 21.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.908 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -102.6 39.85 1.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 43.2 t80 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.825 0.345 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -54.26 -41.76 69.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -112.89 47.86 1.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -72.87 138.09 46.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.885 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 49.03 60.0 6.44 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.5 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 90.6 mt -150.17 121.39 7.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.823 0.344 . . . . 0.0 110.935 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -99.5 123.36 43.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -115.12 164.09 14.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -138.2 117.03 12.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.864 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.448 ' HG ' ' CG2' ' A' ' 354' ' ' VAL . 4.7 mt -93.02 141.38 28.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.92 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -95.81 -177.18 3.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -85.66 -20.84 28.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.831 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -78.6 -18.32 54.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 6.0 m -108.12 150.61 40.66 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.595 0.712 . . . . 0.0 111.126 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 119.22 6.2 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.685 2.257 . . . . 0.0 112.346 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 341' ' ' GLU . 34.3 ttp180 -85.41 -56.78 3.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 340' ' ' ARG . 6.8 pt-20 -36.84 -39.58 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.909 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -79.0 -64.55 1.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.092 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . 0.424 HD23 ' CE2' ' A' ' 399' ' ' PHE . 52.6 mt -57.2 -61.67 2.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.894 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.406 ' HB1' ' CG ' ' A' ' 340' ' ' ARG . . . -41.54 -48.65 3.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.125 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -63.59 -48.97 75.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 16.8 mt -55.25 -64.82 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.159 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 32.7 mt -50.42 -47.66 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -64.6 -24.22 67.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 23.2 t -84.52 -29.7 25.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -83.53 -8.99 59.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 93.1 42.63 4.29 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.486 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -122.97 164.34 15.97 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.501 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -93.29 135.04 34.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 110.949 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.448 ' CG2' ' HG ' ' A' ' 334' ' ' LEU . 12.6 p -149.88 125.84 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.158 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 2.0 t -128.24 161.18 29.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 41.0 p90 -138.7 171.92 13.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.951 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -67.73 111.17 4.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -42.58 -54.26 4.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.4 t -41.47 -59.61 1.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 9.0 mt -51.65 -50.71 59.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 4.8 m -154.39 141.88 19.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 20.7 pt -73.92 -175.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.15 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 86.43 -15.39 50.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.451 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -63.73 166.3 7.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 0.0 111.105 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 41.0 p -117.32 -70.51 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.169 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -109.52 139.06 44.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.939 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.56 169.76 15.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.83 -19.48 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.153 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 62.7 p -84.44 26.3 0.8 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.14 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -115.05 121.09 42.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.7 t -58.41 -36.12 73.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -38.92 -40.42 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.928 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 374' ' ' THR . 49.8 mt -46.34 138.32 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.414 ' N ' HG22 ' A' ' 373' ' ' ILE . 26.5 p -113.57 -22.85 10.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.15 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -150.26 155.33 39.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -135.79 111.88 9.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.95 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . 0.426 ' CG2' ' HA ' ' A' ' 395' ' ' PRO . 46.8 mm -82.75 113.74 22.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.155 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . 0.464 ' CG2' ' HB3' ' A' ' 381' ' ' PRO . 29.2 m -131.34 148.08 32.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.11 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -62.25 -42.93 99.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -131.93 82.19 60.42 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.593 0.711 . . . . 0.0 110.931 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . 0.464 ' HB3' ' CG2' ' A' ' 378' ' ' VAL . 53.5 Cg_endo -69.76 -13.86 35.26 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.686 2.257 . . . . 0.0 112.352 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -73.92 -44.83 29.25 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.522 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . 0.413 ' HG3' ' N ' ' A' ' 384' ' ' GLN . 3.1 pt20 -62.27 -37.34 85.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.737 0.303 . . . . 0.0 110.885 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.413 ' N ' ' HG3' ' A' ' 383' ' ' GLN . 7.8 pt20 -98.34 118.07 34.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 44.7 p -50.49 175.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' SER . . . . . 0.506 ' HA ' ' CE1' ' A' ' 392' ' ' TYR . 1.9 t -104.81 178.66 4.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 74.4 t -119.56 136.23 57.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.149 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 5.9 mm -51.21 103.97 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 109.44 -28.34 11.02 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.497 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -105.96 148.77 27.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.787 0.327 . . . . 0.0 110.858 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 63.7 m -125.17 131.29 53.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . 0.506 ' CE1' ' HA ' ' A' ' 386' ' ' SER . 24.9 m-85 -91.43 131.74 36.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 11.3 m -130.0 166.99 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.107 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -86.73 161.36 47.92 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.603 0.716 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . 0.426 ' HA ' ' CG2' ' A' ' 377' ' ' ILE . 54.0 Cg_endo -69.75 -7.42 21.01 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.684 2.256 . . . . 0.0 112.328 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -80.86 -24.4 38.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.885 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 41.5 t90 -59.1 -42.14 89.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 96.1 t -67.68 -58.37 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.156 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.424 ' CE2' HD23 ' A' ' 343' ' ' LEU . 59.7 m-85 -52.31 -26.53 12.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . 0.429 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 24.2 t0 -85.07 -49.97 7.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.861 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 15.4 m -56.75 -51.25 69.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.859 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 27.7 m -55.53 -40.31 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.147 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -80.21 -9.14 59.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -113.14 8.6 18.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 404' ' ' ALA . 1.3 mpt_? 34.42 42.64 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 7.5 tp -162.8 144.28 10.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.868 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 12.4 mt -72.6 89.49 1.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.933 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.429 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 35.9 mt -56.62 154.34 17.86 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.569 0.699 . . . . 0.0 110.971 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 108.76 2.15 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.705 2.27 . . . . 0.0 112.348 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.3 m -57.19 -21.71 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.115 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -58.11 -12.0 3.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.105 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.39 -27.89 14.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -108.65 37.01 2.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 5.5 t80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.877 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.84 0.352 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 13.8 tp -49.23 -53.46 21.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.894 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -96.75 41.86 1.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -71.93 138.01 47.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 47.24 51.43 14.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.482 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 58.0 mt -139.43 122.18 16.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 0.0 110.924 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -93.98 129.25 40.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.891 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -125.81 152.19 45.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.878 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -131.91 136.01 47.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 8.0 mt -112.46 137.53 50.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -85.7 -178.23 6.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -81.68 -23.4 36.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -77.48 -44.49 28.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.6 m -75.33 149.53 84.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.644 0.735 . . . . 0.0 111.103 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 124.74 11.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.65 2.234 . . . . 0.0 112.334 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 19.2 ttp180 -89.82 -60.12 2.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -38.07 -39.57 0.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.46 -60.11 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.084 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 49.4 mt -60.28 -63.42 1.3 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -39.84 -55.07 2.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.129 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -55.63 -44.53 77.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.868 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 18.5 mt -63.13 -67.92 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.129 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 33.5 mt -46.88 -42.42 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.108 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -68.95 -30.2 68.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 29.2 t -78.2 -34.05 49.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.892 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . 0.426 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 14.9 m-85 -83.42 7.62 16.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.857 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 76.36 63.96 2.27 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.55 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -145.42 154.75 26.13 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.516 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -92.57 125.66 37.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.879 0.371 . . . . 0.0 110.883 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 7.0 p -131.66 140.95 46.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.111 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 32.5 t -132.39 159.29 39.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.847 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' TRP . . . . . 0.562 ' CD1' ' SG ' ' A' ' 361' ' ' CYS . 48.8 p90 -149.48 165.89 30.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.921 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -55.06 110.01 0.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.855 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.407 ' CD ' ' HB2' ' A' ' 364' ' ' ALA . 14.2 mmmt -54.86 -35.53 64.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 5.4 t -55.73 -54.96 37.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 14.7 mt -56.11 -45.3 79.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' CYS . . . . . 0.562 ' SG ' ' CD1' ' A' ' 356' ' ' TRP . 0.8 OUTLIER -151.98 135.37 16.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.874 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.89 143.26 12.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 133.06 -29.68 3.17 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.476 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.407 ' HB2' ' CD ' ' A' ' 358' ' ' LYS . . . -46.66 171.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 111.025 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' THR . . . . . 0.421 ' OG1' ' CD2' ' A' ' 366' ' ' TYR . 68.3 p -101.04 -69.81 0.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.138 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' TYR . . . . . 0.421 ' CD2' ' OG1' ' A' ' 365' ' ' THR . 1.1 p90 -112.27 173.18 6.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -86.36 164.91 16.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.56 -23.44 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.147 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 42.0 p -84.03 25.07 0.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.132 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.12 100.49 12.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.835 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 372' ' ' ARG . 56.0 m -51.72 -41.03 61.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 371' ' ' SER . 23.6 mmt180 -37.7 -40.61 0.43 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.893 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 95.4 mt -41.77 121.35 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.13 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 39.2 p -81.25 -40.31 23.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.191 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -132.77 148.79 52.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' GLN . . . . . 0.485 ' OE1' ' NE ' ' A' ' 390' ' ' ARG . 56.8 tt0 -130.37 115.66 17.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.863 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 47.0 mm -83.04 127.95 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.114 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 31.0 m -148.69 159.69 6.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.134 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.01 -38.73 35.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . 0.477 ' NH2' ' NE2' ' A' ' 383' ' ' GLN . 42.8 mtp180 -130.26 80.8 69.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.632 0.729 . . . . 0.0 110.917 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -15.55 37.2 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.701 2.267 . . . . 0.0 112.349 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -64.47 -53.85 32.98 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.45 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . 0.477 ' NE2' ' NH2' ' A' ' 380' ' ' ARG . 3.3 pt20 -89.19 30.56 0.96 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.714 0.292 . . . . 0.0 110.89 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -109.05 121.98 46.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.926 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 39.8 m -58.33 87.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 53.3 p -52.22 159.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 96.1 t -129.01 141.27 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.6 mt -51.35 115.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 101.51 -46.34 1.29 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.539 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' ARG . . . . . 0.485 ' NE ' ' OE1' ' A' ' 376' ' ' GLN . 15.4 ttp180 -80.68 144.87 31.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 110.852 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 10.3 m -124.4 134.26 53.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . 0.433 ' CZ ' ' OE1' ' A' ' 376' ' ' GLN . 3.0 m-85 -96.74 116.53 29.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.918 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 21.0 m -123.93 158.69 29.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.126 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -75.99 158.28 82.5 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.602 0.715 . . . . 0.0 110.919 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -4.16 13.45 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.665 2.244 . . . . 0.0 112.345 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -84.6 -16.33 42.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.962 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 69.1 t90 -65.34 -39.21 92.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.938 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 73.6 t -72.54 -52.76 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -51.2 -37.13 44.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . 0.463 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 1.1 m-20 -73.49 -45.61 52.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 69.2 m -56.67 -58.03 9.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.852 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . 0.426 ' HB ' ' CZ ' ' A' ' 350' ' ' PHE . 30.9 m -47.94 -43.58 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.104 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -66.13 -43.67 86.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -86.53 10.53 15.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.086 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' A' ' 404' ' ' ALA . 3.2 mpt_? 36.56 37.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 15.1 tp -151.49 145.01 24.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 17.6 mt -74.91 89.37 2.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.94 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.463 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 34.8 mt -60.52 154.91 52.57 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.626 0.727 . . . . 0.0 110.913 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 113.47 3.38 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.731 2.287 . . . . 0.0 112.344 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 19.5 m -55.17 -28.25 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.137 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -48.09 -30.33 4.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.136 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -77.76 -35.65 51.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.855 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -106.05 49.66 0.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 42.1 t80 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.838 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.824 0.345 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 12.2 tp -68.79 -50.55 49.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -87.49 31.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -66.09 118.22 9.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.832 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 66.28 49.32 57.94 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 67.9 mt -141.21 122.14 14.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.904 0.383 . . . . 0.0 110.914 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -95.54 139.8 31.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.49 ' CD1' ' HB2' ' A' ' 375' ' ' HIS . 80.7 m-85 -133.79 153.57 51.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' PHE . . . . . 0.468 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 9.4 t80 -129.56 117.6 20.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.848 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.426 ' HG ' ' CG2' ' A' ' 354' ' ' VAL . 12.7 mt -94.68 132.2 39.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.926 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -90.63 165.68 13.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.466 ' HG2' ' N ' ' A' ' 337' ' ' GLU . 0.1 OUTLIER -65.15 -30.07 70.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.828 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . 0.466 ' N ' ' HG2' ' A' ' 336' ' ' ARG . 9.1 pt-20 -65.56 -37.41 86.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.0 m -91.01 150.7 42.26 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.633 0.73 . . . . 0.0 111.106 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 128.46 16.04 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.683 2.255 . . . . 0.0 112.324 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -92.0 -49.3 6.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.866 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -42.68 -39.61 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -79.97 -65.74 0.97 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.052 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 68.6 mt -51.79 -62.53 1.57 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -40.74 -59.81 1.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -51.62 -49.14 62.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.843 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 349' ' ' SER . 31.1 mt -57.74 -70.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.136 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 28.0 mt -42.26 -52.19 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.105 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 26.5 mtt-85 -64.5 -25.66 68.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.882 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 346' ' ' ILE . 43.4 t -80.12 -30.21 39.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . 0.54 ' CZ ' HG13 ' A' ' 402' ' ' VAL . 16.3 m-85 -92.04 14.0 17.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.893 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 70.93 57.47 6.31 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.508 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -135.22 161.04 24.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.512 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -94.81 135.06 36.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.874 0.368 . . . . 0.0 110.869 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.426 ' CG2' ' HG ' ' A' ' 334' ' ' LEU . 8.1 p -148.37 133.98 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.169 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 17.3 t -132.42 162.84 30.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' TRP . . . . . 0.534 ' CZ2' ' O ' ' A' ' 363' ' ' GLY . 20.2 p90 -137.4 -176.39 4.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.944 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.38 118.92 18.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.822 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -58.89 -15.7 13.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 4.5 p -83.04 -27.66 30.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 22.7 mt -76.94 -49.65 15.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.96 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 8.2 m -157.86 139.55 13.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 24.3 pt -56.53 155.75 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.534 ' O ' ' CZ2' ' A' ' 356' ' ' TRP . . . 100.52 38.17 3.55 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.486 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -105.47 117.23 33.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 0.0 111.079 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 45.3 p -69.65 -61.0 1.96 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.153 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -126.53 158.37 36.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.22 169.9 11.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . 0.468 ' HB ' ' CZ ' ' A' ' 333' ' ' PHE . 11.5 p -68.01 -10.6 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.106 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 73.4 p -95.6 14.16 23.85 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.12 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . 0.48 ' OD1' ' CG ' ' A' ' 372' ' ' ARG . 4.6 t70 -87.54 107.54 18.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 64.1 p -50.74 -28.47 9.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.842 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . 0.48 ' CG ' ' OD1' ' A' ' 370' ' ' ASP . 17.0 mmm180 -54.03 -30.46 47.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.872 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 87.2 mt -51.53 126.64 6.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.105 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 47.4 p -95.53 -43.0 8.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . 0.49 ' HB2' ' CD1' ' A' ' 332' ' ' PHE . 20.0 m80 -130.11 155.04 46.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' GLN . . . . . 0.577 ' CD ' ' CE2' ' A' ' 392' ' ' TYR . 59.6 tt0 -136.18 115.0 12.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.9 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . 0.411 ' O ' ' CG1' ' A' ' 378' ' ' VAL . 45.3 mm -80.65 136.43 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . 0.411 ' CG1' ' O ' ' A' ' 377' ' ' ILE . 35.4 m -158.01 142.2 7.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.125 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -60.1 -32.67 71.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -128.55 80.92 71.67 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.617 0.722 . . . . 0.0 110.882 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -3.51 12.16 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.674 2.249 . . . . 0.0 112.358 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -106.52 -49.19 0.92 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.487 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -52.93 -73.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.783 0.325 . . . . 0.0 110.915 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -55.38 130.21 41.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.894 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 20.3 p -63.55 131.28 47.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 54.7 p -85.28 149.53 25.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.828 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 388' ' ' ILE . 63.2 t -75.82 114.8 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.104 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' A' ' 387' ' ' VAL . 2.1 mp -36.17 104.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.134 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 122.26 -45.11 1.24 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 11.1 ttm-85 -76.55 159.45 30.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.8 0.333 . . . . 0.0 110.83 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 19.0 m -122.31 134.85 54.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.937 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . 0.577 ' CE2' ' CD ' ' A' ' 376' ' ' GLN . 2.4 m-85 -112.85 147.55 36.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.944 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 20.8 m -151.25 145.69 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.135 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -61.35 158.36 38.39 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.557 0.694 . . . . 0.0 110.938 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -4.63 14.39 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.378 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -85.95 -19.0 31.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -64.63 -34.03 77.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 80.7 t -71.23 -32.82 48.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.182 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.41 ' CE1' ' CD1' ' A' ' 346' ' ' ILE . 38.4 m-85 -74.85 -60.03 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.873 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -52.93 -17.9 1.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 16.9 m -82.33 -53.21 6.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . 0.54 HG13 ' CZ ' ' A' ' 350' ' ' PHE . 6.2 m -58.01 -37.54 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.158 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -72.56 -34.66 67.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.957 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 406' ' ' LEU . . . -94.31 9.23 38.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.095 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 404' ' ' ALA . 0.9 OUTLIER 36.95 31.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . 0.458 HD21 ' N ' ' A' ' 407' ' ' LEU . 0.0 OUTLIER -147.27 130.98 16.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . 0.458 ' N ' HD21 ' A' ' 406' ' ' LEU . 98.1 mt -66.67 85.66 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.946 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 32.0 mt -51.24 155.38 2.37 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.633 0.73 . . . . 0.0 110.882 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 118.82 5.91 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.691 2.261 . . . . 0.0 112.359 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.1 m -64.74 -25.51 38.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.088 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -54.55 -15.32 1.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.103 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -94.42 -30.97 14.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -96.06 33.34 1.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.95 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 16.5 t80 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.85 0.357 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 18.8 tp -59.75 -54.92 40.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -95.18 37.5 1.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -73.03 139.35 46.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 53.72 47.98 62.91 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.493 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 71.9 mt -142.45 122.26 13.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.913 0.387 . . . . 0.0 110.878 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -96.13 126.76 41.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -119.34 152.81 36.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' PHE . . . . . 0.419 ' CD1' ' O ' ' A' ' 355' ' ' SER . 59.0 t80 -131.88 124.85 30.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.914 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 7.2 mt -101.78 133.15 46.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.969 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -88.74 163.99 15.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.444 ' HB3' ' CD1' ' A' ' 360' ' ' LEU . 2.0 ptp85 -65.2 -13.36 58.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -85.84 -46.76 10.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 4.1 m -77.94 151.1 78.93 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.652 0.739 . . . . 0.0 111.142 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 127.64 14.93 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.676 2.251 . . . . 0.0 112.36 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 0.444 ' O ' ' N ' ' A' ' 344' ' ' ALA . 0.5 OUTLIER -95.51 -55.05 3.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -39.15 -42.07 0.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -77.5 -51.12 11.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.121 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . 0.557 HD22 ' CE1' ' A' ' 399' ' ' PHE . 87.8 mt -65.16 -64.11 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -38.72 -53.14 1.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -57.54 -47.95 80.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 38.0 mt -62.59 -67.95 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.117 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 32.2 mt -44.26 -37.33 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.085 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -77.99 -35.0 50.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 46.7 t -67.62 -29.65 69.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.858 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . 0.42 ' CE2' HG13 ' A' ' 402' ' ' VAL . 25.4 m-85 -94.99 20.45 8.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 64.46 63.56 4.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.519 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -136.72 164.48 25.18 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.512 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -104.15 129.29 51.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.884 0.374 . . . . 0.0 110.868 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.86 138.91 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.12 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' SER . . . . . 0.419 ' O ' ' CD1' ' A' ' 333' ' ' PHE . 8.4 t -140.56 149.82 42.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 40.6 p90 -131.7 175.89 8.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -62.17 114.95 3.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -44.88 -46.3 10.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.3 m -53.26 -51.83 60.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.855 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.444 ' CD1' ' HB3' ' A' ' 336' ' ' ARG . 21.4 mt -46.56 -49.84 18.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.921 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 1.8 t -168.19 153.33 6.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 36.2 pt -63.32 177.08 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.119 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 94.42 -37.22 3.47 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -44.63 152.11 0.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.821 0.343 . . . . 0.0 111.121 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 5.1 p -116.2 -65.28 1.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.156 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -111.22 144.93 39.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.943 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -88.7 171.66 9.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.12 -17.35 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 22.6 p -79.24 12.09 2.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.166 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -101.43 140.56 35.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.854 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 372' ' ' ARG . 4.9 t -80.5 -40.52 25.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 371' ' ' SER . 9.0 ptp180 -36.69 -42.68 0.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.922 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.4 HG23 ' N ' ' A' ' 374' ' ' THR . 73.4 mt -40.11 136.89 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.146 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.4 ' N ' HG23 ' A' ' 373' ' ' ILE . 58.1 p -115.22 -24.72 8.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -139.91 143.03 36.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.868 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' GLN . . . . . 0.5 ' OE1' ' N ' ' A' ' 377' ' ' ILE . 0.7 OUTLIER -137.13 108.98 7.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . 0.5 ' N ' ' OE1' ' A' ' 376' ' ' GLN . 5.5 mm -79.39 127.0 39.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.127 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 30.6 m -139.98 155.94 24.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.158 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -81.51 -23.34 37.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . 0.407 ' O ' ' CG ' ' A' ' 383' ' ' GLN . 75.7 mtt180 -130.75 83.0 62.96 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.583 0.706 . . . . 0.0 110.852 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -18.41 36.99 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.651 2.234 . . . . 0.0 112.335 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -67.53 -55.25 15.67 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.468 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . 0.407 ' CG ' ' O ' ' A' ' 380' ' ' ARG . 3.7 pt20 -46.26 -33.85 4.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.763 0.316 . . . . 0.0 110.92 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -84.3 149.97 25.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.36 -70.7 0.71 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.119 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 96.7 p -175.13 164.23 3.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . 0.512 HG22 ' CZ ' ' A' ' 392' ' ' TYR . 74.6 t -133.05 153.73 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.145 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.5 mm -68.66 99.41 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.176 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 92.95 -35.01 4.25 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.482 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' ARG . . . . . 0.424 ' HG2' ' N ' ' A' ' 391' ' ' CYS . 8.3 ttm180 -93.0 151.36 19.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.762 0.315 . . . . 0.0 110.888 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' CYS . . . . . 0.424 ' N ' ' HG2' ' A' ' 390' ' ' ARG . 83.3 m -134.18 139.6 45.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . 0.512 ' CZ ' HG22 ' A' ' 387' ' ' VAL . 68.0 m-85 -81.38 140.67 34.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . 0.406 ' CG1' ' HB ' ' A' ' 410' ' ' VAL . 12.0 m -150.62 166.66 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.115 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -89.42 159.32 44.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.596 0.712 . . . . 0.0 110.878 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . 0.425 ' HA ' ' CG2' ' A' ' 377' ' ' ILE . 54.2 Cg_endo -69.7 -3.73 12.56 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.717 2.278 . . . . 0.0 112.379 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -84.91 -31.25 23.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.923 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' TRP . . . . . 0.519 ' CE2' HG13 ' A' ' 410' ' ' VAL . 69.1 t90 -50.5 -38.44 44.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.93 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.08 -61.21 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.074 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.557 ' CE1' HD22 ' A' ' 343' ' ' LEU . 12.3 m-30 -51.7 -29.63 19.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -73.32 -52.03 15.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 405' ' ' ARG . 14.6 m -58.47 -47.36 84.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.844 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . 0.433 HG21 ' N ' ' A' ' 403' ' ' ASN . 27.3 m -61.24 -46.27 96.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.119 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . 0.433 ' N ' HG21 ' A' ' 402' ' ' VAL . 41.2 t30 -70.07 -8.08 46.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -122.93 0.48 9.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.097 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' A' ' 401' ' ' SER . 0.2 OUTLIER 44.53 32.12 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -141.94 140.69 32.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 12.4 mt -71.77 81.63 0.88 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 43.0 mt -55.22 155.64 8.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.599 0.714 . . . . 0.0 110.929 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 115.67 4.21 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.685 2.256 . . . . 0.0 112.325 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . 0.519 HG13 ' CE2' ' A' ' 397' ' ' TRP . 32.6 m -65.56 -21.39 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.144 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . 0.542 ' HA ' ' CE2' ' A' ' 414' ' ' PHE . . . -64.1 -33.8 76.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.171 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -75.93 1.07 16.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -126.06 41.56 3.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.967 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' PHE . . . . . 0.542 ' CE2' ' HA ' ' A' ' 411' ' ' ALA . 2.5 m-85 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.918 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.759 0.314 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.407 ' C ' HD23 ' A' ' 326' ' ' LEU . 2.4 tt -59.25 -54.86 42.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.906 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -91.5 39.37 1.0 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -80.96 106.7 13.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 88.08 43.54 5.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.458 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 83.5 mt -143.1 124.09 14.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.912 0.387 . . . . 0.0 110.909 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.418 ' HE3' ' CE2' ' A' ' 366' ' ' TYR . 28.3 mtpt -95.41 139.09 32.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 375' ' ' HIS . 88.5 m-85 -135.2 147.32 49.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -130.01 115.31 16.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 2.6 mt -90.77 148.08 22.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -107.14 176.93 5.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.944 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -74.79 -22.08 58.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -72.46 -35.97 68.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.897 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.2 m -95.54 150.87 38.09 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.622 0.725 . . . . 0.0 111.127 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 120.94 7.66 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.664 2.243 . . . . 0.0 112.41 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 0.411 ' HD2' ' CE3' ' A' ' 356' ' ' TRP . 27.7 ttp85 -87.19 -49.87 6.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.863 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -42.4 -36.77 1.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -83.05 -63.83 1.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.059 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 53.3 mt -53.95 -59.45 4.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -42.74 -60.51 1.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -51.15 -43.07 61.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.842 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' ILE . . . . . 0.481 ' O ' ' N ' ' A' ' 349' ' ' SER . 11.8 mt -63.64 -72.58 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 29.8 mt -39.16 -43.6 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.15 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 67.6 mtt-85 -68.51 -36.07 78.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.863 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' SER . . . . . 0.481 ' N ' ' O ' ' A' ' 346' ' ' ILE . 29.8 t -69.95 -43.34 71.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . 0.516 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 11.4 m-85 -73.17 -11.23 60.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 91.2 56.58 1.68 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.427 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -132.16 160.55 23.68 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -91.26 125.39 36.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.909 0.385 . . . . 0.0 110.886 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 12.4 p -137.85 139.56 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.132 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' SER . . . . . 0.544 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 42.7 t -136.74 149.34 47.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' TRP . . . . . 0.411 ' CE3' ' HD2' ' A' ' 340' ' ' ARG . 15.1 p90 -129.39 -175.86 3.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.962 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -76.97 105.76 8.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.82 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -38.89 -43.32 0.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.912 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 14.2 t -53.64 -58.73 6.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 18.8 mt -50.53 -48.94 57.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.912 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 4.2 m -158.39 130.0 6.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.902 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 14.9 pt -61.14 176.34 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.14 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 107.37 -39.65 2.81 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.45 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -38.72 158.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.877 0.37 . . . . 0.0 111.084 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 1.2 p -113.46 -45.67 3.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' TYR . . . . . 0.544 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 33.4 p90 -125.43 173.92 8.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.956 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.96 169.34 8.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.863 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 14.0 p -58.85 -31.36 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.111 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 68.1 p -63.6 -16.21 60.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -65.7 99.3 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 372' ' ' ARG . 22.2 t -47.5 -42.11 22.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 371' ' ' SER . 29.9 mmt180 -35.58 -45.25 0.35 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.826 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.436 ' C ' ' O ' ' A' ' 372' ' ' ARG . 77.8 mt -34.45 120.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.131 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 26.7 p -92.32 -44.26 8.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . 0.436 ' HB2' ' CD1' ' A' ' 332' ' ' PHE . 20.1 m80 -129.8 146.25 51.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.799 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -131.1 94.57 3.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.918 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 49.5 mm -58.61 132.44 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . 0.471 HG11 ' NE2' ' A' ' 384' ' ' GLN . 30.6 m -151.94 156.18 6.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.145 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -68.25 -38.74 82.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -122.71 84.17 49.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.57 0.7 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 94.46 0.53 Allowed 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.7 2.267 . . . . 0.0 112.346 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 152.44 -39.92 0.74 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.516 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -118.26 76.75 1.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.738 0.304 . . . . 0.0 110.923 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.597 ' OE1' ' CD1' ' A' ' 392' ' ' TYR . 0.0 OUTLIER -171.49 105.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' THR . . . . . 0.466 ' C ' ' O ' ' A' ' 384' ' ' GLN . 10.5 m 32.9 46.68 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 13.7 p -41.5 149.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 53.8 t -134.14 110.05 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.3 mt -50.0 100.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.127 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 126.09 -42.75 1.45 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -80.25 157.82 26.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.849 0.357 . . . . 0.0 110.862 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 1.8 m -122.73 145.37 48.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.85 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . 0.597 ' CD1' ' OE1' ' A' ' 384' ' ' GLN . 37.7 m-85 -117.98 131.58 56.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 17.3 m -129.6 155.3 41.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.082 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -72.39 161.37 79.4 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.576 0.703 . . . . 0.0 110.922 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -4.24 13.63 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.702 2.268 . . . . 0.0 112.371 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 -86.26 -16.35 37.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 79.7 t90 -65.72 -34.86 79.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 88.9 t -81.09 -49.81 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.106 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -51.13 -30.1 15.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -85.48 -47.3 10.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 63.7 m -56.45 -47.08 79.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.85 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . 0.516 ' HB ' ' CZ ' ' A' ' 350' ' ' PHE . 23.5 m -50.44 -43.8 23.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.152 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -74.35 -40.34 62.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -76.86 0.72 19.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.121 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 41.96 44.74 3.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 25.4 tp -165.42 143.71 6.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.955 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 40.3 mt -69.6 93.94 0.74 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.941 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 65.7 mt -60.4 153.18 61.15 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.6 0.714 . . . . 0.0 110.924 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 114.48 3.72 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.677 2.251 . . . . 0.0 112.347 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 18.7 m -58.89 -27.4 35.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.09 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -50.17 -29.46 9.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.125 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -78.48 -24.98 45.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -106.6 38.03 2.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.944 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 53.1 t80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 -179.969 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.824 0.345 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 22.4 tp -44.01 -54.06 5.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -98.0 36.78 1.5 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -60.94 116.85 4.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.864 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 76.17 -46.72 2.19 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 329' ' ' GLY . 24.3 mt -37.31 125.94 1.02 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.879 0.371 . . . . 0.0 110.95 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -95.24 144.76 25.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -135.06 153.26 52.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.919 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -140.17 117.11 11.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 2.8 mt -97.83 149.95 21.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.924 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -107.54 164.01 12.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.9 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -61.48 -31.1 71.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -41.59 97.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 10.1 m -91.03 150.81 42.43 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.628 0.728 . . . . 0.0 111.116 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 118.61 5.78 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.726 2.284 . . . . 0.0 112.301 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 24.3 ptt85 -89.29 -37.25 15.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.84 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -49.82 -42.75 47.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.851 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -74.8 -62.3 1.59 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.061 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 344' ' ' ALA . 30.9 mt -53.1 -60.36 3.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.908 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 343' ' ' LEU . . . -37.02 -58.9 0.75 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -53.14 -45.84 68.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 23.0 mt -59.23 -69.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.147 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 20.9 mt -40.1 -57.35 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.097 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -58.41 -45.78 87.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 40.2 t -55.04 -34.81 63.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -98.4 29.26 3.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.894 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 54.98 52.17 48.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.515 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -119.62 154.97 16.27 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.437 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -92.8 138.93 31.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.888 0.375 . . . . 0.0 110.864 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.78 140.33 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.118 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 42.0 t -140.04 144.23 36.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.815 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 40.5 p90 -121.13 174.84 6.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 358' ' ' LYS . 19.9 m-20 -65.0 104.15 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 357' ' ' ASP . 12.1 ptpt -36.65 -44.87 0.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 11.3 t -51.93 -48.74 64.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 8.8 mt -53.03 -47.48 68.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.894 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 45.5 t -162.33 156.73 21.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 21.2 tt -73.24 160.21 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.112 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 112.8 -27.64 9.58 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.508 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -41.59 148.26 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.85 0.357 . . . . 0.0 111.118 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 26.0 p -108.76 -64.82 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.151 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -117.2 144.42 44.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.871 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.03 174.15 8.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.887 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 7.1 p -69.62 -22.38 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.094 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 82.6 p -86.14 24.52 1.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.137 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -98.36 102.3 14.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.3 t -46.54 -29.31 1.73 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.824 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -47.43 -40.11 17.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.88 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 58.5 mt -40.06 147.48 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.135 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 55.3 p -125.8 -30.71 2.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -147.59 110.22 4.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.868 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -96.68 100.98 12.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 19.1 mm -68.79 113.48 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 18.7 m -126.65 -178.93 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.136 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.55 -40.5 10.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -128.69 80.9 71.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.657 0.742 . . . . 0.0 110.891 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -10.84 29.55 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.657 2.238 . . . . 0.0 112.33 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -85.4 -20.06 57.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.517 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -102.68 -43.8 5.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.778 0.323 . . . . 0.0 110.898 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -44.82 163.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.937 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 71.4 p -87.4 121.52 29.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.178 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 56.2 p -70.54 151.88 44.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.801 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 87.3 t -129.82 114.38 30.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.142 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 8.8 mt -38.08 116.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.118 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 102.68 -44.79 1.44 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.474 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -77.62 158.03 29.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.819 0.343 . . . . 0.0 110.888 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 82.4 m -133.63 132.73 41.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.861 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -106.68 124.65 49.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 19.2 m -135.44 156.86 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.118 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -71.0 158.86 87.26 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.607 0.718 . . . . 0.0 110.898 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -7.74 21.83 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.684 2.256 . . . . 0.0 112.332 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -79.19 -25.37 42.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.936 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' TRP . . . . . 0.51 ' HB2' ' CD2' ' A' ' 413' ' ' TYR . 92.0 t90 -59.44 -28.11 66.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 39.7 t -72.09 -57.55 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.137 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -50.0 -53.8 24.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . 0.43 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 0.8 OUTLIER -54.85 -45.56 74.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 21.5 m -56.58 -66.7 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 403' ' ' ASN . 26.8 m -47.43 -40.48 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.101 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . 0.429 ' N ' HG23 ' A' ' 402' ' ' VAL . 14.4 m-20 -69.89 -35.07 74.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -92.08 11.65 24.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 404' ' ' ALA . 2.8 mmm180 38.11 44.24 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.839 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 8.1 tp -165.07 150.59 9.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.929 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 97.1 mt -81.16 80.11 7.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.43 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 49.3 mt -46.04 156.45 0.46 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.562 0.696 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 119.01 6.02 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.653 2.235 . . . . 0.0 112.322 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.88 -23.77 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.088 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -53.17 -18.58 2.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -88.73 -33.46 17.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.51 ' CD2' ' HB2' ' A' ' 397' ' ' TRP . 6.4 m-85 -95.3 36.03 1.27 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.902 179.983 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . 0.416 ' HD2' ' C ' ' A' ' 350' ' ' PHE . 9.9 mmtp . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.841 0.353 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.76 -40.45 72.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.933 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -118.06 40.71 3.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -56.94 114.78 2.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 75.23 -47.41 1.98 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.477 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 329' ' ' GLY . 33.0 mt -35.78 125.16 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.884 0.373 . . . . 0.0 110.929 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -101.96 151.13 22.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.928 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -141.94 154.48 45.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' PHE . . . . . 0.509 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 18.8 t80 -130.87 116.6 18.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.416 ' HG ' ' CG2' ' A' ' 354' ' ' VAL . 6.6 mt -91.09 146.76 23.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -101.72 164.49 11.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.912 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -66.58 -17.3 64.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -78.33 -47.62 17.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.892 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 2.1 m -84.32 148.98 54.16 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.615 0.722 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 138.04 36.99 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.706 2.271 . . . . 0.0 112.35 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 341' ' ' GLU . 16.9 ptt85 -102.23 -48.09 4.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.865 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 340' ' ' ARG . 4.9 pt-20 -35.29 -46.71 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -75.31 -59.05 2.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.072 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 79.4 mt -55.9 -63.64 1.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.93 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -39.42 -54.35 1.91 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.1 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -55.71 -44.78 77.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 21.7 mt -65.8 -67.79 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.135 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . 0.491 ' O ' ' N ' ' A' ' 352' ' ' GLY . 25.5 mt -41.4 -35.21 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 44.4 mtp85 -79.95 -45.65 18.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 32.3 t -56.08 -30.58 62.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . 0.416 ' C ' ' HD2' ' A' ' 325' ' ' LYS . 58.7 m-85 -98.58 26.67 5.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 58.91 58.96 11.8 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.479 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 347' ' ' ILE . . . -129.73 150.37 19.0 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.483 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -96.52 133.28 41.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.894 0.378 . . . . 0.0 110.914 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.416 ' CG2' ' HG ' ' A' ' 334' ' ' LEU . 7.4 p -143.49 143.39 24.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.119 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' SER . . . . . 0.556 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 1.5 t -141.07 156.8 45.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 23.9 p90 -138.09 140.79 40.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -42.77 115.99 0.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -44.7 -57.28 3.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.875 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 78.3 p -41.32 -47.87 3.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.853 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 86.7 mt -61.61 -50.92 70.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 23.3 m -154.95 140.55 17.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.3 pt -69.77 162.39 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.119 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 93.43 39.41 5.05 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.452 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -113.56 149.47 34.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 0.0 111.109 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 41.4 p -98.59 -72.4 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.096 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' TYR . . . . . 0.556 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 18.5 p90 -103.43 161.79 13.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.911 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.01 168.62 11.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.834 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . 0.509 ' HB ' ' CZ ' ' A' ' 333' ' ' PHE . 7.6 p -70.69 -6.65 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.161 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 24.3 p -100.3 18.71 18.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -95.19 118.69 32.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.821 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.2 m -51.17 -43.78 61.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.843 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 21.4 mtt85 -38.93 -40.1 0.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.82 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 57.0 mt -48.55 115.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.103 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 74.8 p -85.25 -43.61 13.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -128.84 158.97 37.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.81 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' GLN . . . . . 0.54 ' CD ' ' CE2' ' A' ' 392' ' ' TYR . 25.9 tt0 -140.62 108.97 5.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 44.6 mm -76.09 139.12 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.192 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 379' ' ' ASP . 18.7 m -154.7 139.59 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . 0.439 ' O ' ' CG ' ' A' ' 380' ' ' ARG . 5.7 t0 -35.95 -45.74 0.43 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . 0.439 ' CG ' ' O ' ' A' ' 379' ' ' ASP . 62.7 mtt180 -161.07 121.6 1.6 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.65 0.738 . . . . 0.0 110.86 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 2.67 3.3 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.673 2.248 . . . . 0.0 112.373 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -96.89 -31.41 7.0 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.48 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -91.84 31.73 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.882 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -174.14 144.07 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.871 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 9.9 t -79.62 158.15 27.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.6 p -110.97 166.64 10.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 56.5 t -98.97 128.39 50.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.4 mt -44.22 110.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.151 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 113.67 -41.25 2.25 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.468 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' ARG . . . . . 0.514 ' HD2' ' CE1' ' A' ' 392' ' ' TYR . 13.2 ttm-85 -79.52 152.39 30.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.778 0.323 . . . . 0.0 110.9 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 40.5 m -120.27 115.67 24.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . 0.54 ' CE2' ' CD ' ' A' ' 376' ' ' GLN . 7.0 m-85 -92.51 130.4 38.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.919 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 25.1 m -134.97 167.98 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.143 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -83.78 160.56 58.2 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.576 0.703 . . . . 0.0 110.935 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -7.99 22.48 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.708 2.272 . . . . 0.0 112.328 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 12.6 tp-100 -79.18 -12.76 59.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 92.4 t90 -79.79 -13.03 59.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.65 -33.81 6.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.163 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -76.33 -28.75 57.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -81.04 -53.09 6.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.875 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 39.3 m -48.74 -46.44 40.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 18.9 m -64.25 -43.1 97.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.126 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -64.28 -32.31 73.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -97.04 8.84 43.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.094 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 39.77 40.46 0.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 6.9 tp -156.93 149.41 23.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 90.7 mt -78.08 90.59 4.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 84.4 mt -56.35 151.63 27.34 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.581 0.705 . . . . 0.0 110.908 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 107.44 1.86 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.635 2.223 . . . . 0.0 112.37 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.2 m -54.21 -19.03 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.147 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -58.31 -14.52 7.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.107 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -98.43 -16.63 19.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -114.57 28.34 8.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 26.1 t80 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.807 0.337 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.46 ' CD2' HD22 ' A' ' 407' ' ' LEU . 4.8 tp -71.47 -51.59 22.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.916 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . 0.464 ' HB2' ' CA ' ' A' ' 352' ' ' GLY . 22.8 m-85 -86.3 31.7 0.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -66.54 119.83 12.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.862 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 82.7 -53.07 4.79 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.467 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 329' ' ' GLY . 29.7 mt -36.69 124.84 0.86 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.847 0.356 . . . . 0.0 110.87 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -99.82 115.08 28.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -104.32 167.54 9.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' PHE . . . . . 0.41 ' CD1' ' O ' ' A' ' 355' ' ' SER . 34.6 t80 -152.58 115.56 4.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.466 ' HG ' ' CG2' ' A' ' 354' ' ' VAL . 4.1 mt -89.77 128.22 36.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.934 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -83.23 145.99 28.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.03 -20.03 1.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -78.75 -42.49 27.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 13.3 m -82.39 151.21 65.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.623 0.725 . . . . 0.0 111.144 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 124.82 11.47 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.715 2.277 . . . . 0.0 112.366 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 0.438 ' O ' ' C ' ' A' ' 341' ' ' GLU . 15.6 mtm105 -89.42 -55.45 3.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.875 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 340' ' ' ARG . 7.5 pt-20 -35.26 -45.85 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -71.58 -63.76 1.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.099 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 344' ' ' ALA . 35.3 mt -55.46 -63.59 1.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.916 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -37.07 -57.65 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -52.83 -46.21 67.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 14.6 mt -61.18 -62.05 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.129 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 20.3 mt -48.63 -53.03 7.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.155 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -62.07 -40.32 95.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 4.5 m -60.21 -34.88 74.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.821 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . 0.543 ' CD1' HG11 ' A' ' 402' ' ' VAL . 62.2 m-85 -98.79 29.04 3.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 53.8 59.17 10.19 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.477 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . 0.464 ' CA ' ' HB2' ' A' ' 327' ' ' PHE . . . -125.39 156.31 19.16 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.467 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -91.27 142.47 27.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.951 0.405 . . . . 0.0 110.838 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.466 ' CG2' ' HG ' ' A' ' 334' ' ' LEU . 7.5 p -159.11 141.03 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.149 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' SER . . . . . 0.41 ' O ' ' CD1' ' A' ' 333' ' ' PHE . 32.7 t -140.9 157.47 45.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.828 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -136.35 -177.89 4.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.13 119.78 13.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 22.8 mttp -53.52 -55.43 25.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 26.5 t -48.18 -58.94 3.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.87 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 5.9 mt -49.97 -40.54 44.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 3.8 m -160.68 144.72 13.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 7.3 pt -82.27 151.33 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.1 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 109.79 26.94 4.82 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.451 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -99.98 155.87 17.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 111.139 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 23.8 p -108.12 -57.82 2.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.14 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -128.27 136.7 51.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.9 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.92 169.8 14.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.839 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . 0.447 ' HA ' ' CD1' ' A' ' 373' ' ' ILE . 11.3 p -55.54 -29.35 24.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.137 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 75.8 p -65.88 -25.6 67.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.145 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -62.21 98.88 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 60.5 p -49.49 -29.62 6.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -45.99 -40.45 10.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.859 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.447 ' CD1' ' HA ' ' A' ' 368' ' ' VAL . 60.0 mt -38.16 145.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.103 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 75.7 p -117.55 -30.81 5.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.164 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -141.75 124.37 15.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.827 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' GLN . . . . . 0.529 ' NE2' ' CG1' ' A' ' 378' ' ' VAL . 0.2 OUTLIER -106.09 95.04 5.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 48.2 mm -58.62 97.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.108 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . 0.529 ' CG1' ' NE2' ' A' ' 376' ' ' GLN . 27.4 m -118.58 163.3 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.137 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.96 -34.77 64.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -134.64 80.9 49.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.602 0.715 . . . . 0.0 110.906 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 3.05 2.99 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.665 2.244 . . . . 0.0 112.381 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -113.43 -21.56 5.78 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.484 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . 0.421 ' HG3' ' N ' ' A' ' 384' ' ' GLN . 1.0 OUTLIER -92.64 -61.07 1.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.78 0.324 . . . . 0.0 110.888 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.421 ' N ' ' HG3' ' A' ' 383' ' ' GLN . 2.4 pt20 -54.56 138.82 39.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 7.8 t -48.93 146.8 3.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.14 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 25.2 p -118.87 152.71 35.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.848 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.39 119.22 49.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.112 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 5.0 mp -42.57 111.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.17 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 115.18 -38.58 3.07 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.52 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' ARG . . . . . 0.483 ' HD2' ' CZ ' ' A' ' 392' ' ' TYR . 6.7 ttm180 -83.55 146.81 28.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.765 0.317 . . . . 0.0 110.898 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 43.8 m -114.53 143.61 44.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . 0.483 ' CZ ' ' HD2' ' A' ' 390' ' ' ARG . 3.7 m-85 -123.29 129.33 51.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . 0.447 ' CG1' ' HB ' ' A' ' 410' ' ' VAL . 33.8 m -132.99 152.21 35.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.197 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -71.05 160.91 81.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.576 0.703 . . . . 0.0 110.936 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -4.58 14.3 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.709 2.273 . . . . 0.0 112.315 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . 0.525 ' HA ' ' CD2' ' A' ' 399' ' ' PHE . 14.0 tt0 -85.36 -31.77 22.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -53.78 -30.32 44.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.468 ' O ' ' CG2' ' A' ' 402' ' ' VAL . 21.4 t -72.52 -38.33 59.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.106 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.525 ' CD2' ' HA ' ' A' ' 396' ' ' GLN . 17.3 m-85 -63.19 -52.24 63.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.25 -26.92 67.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 45.8 m -75.81 -59.81 2.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.837 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . 0.543 HG11 ' CD1' ' A' ' 350' ' ' PHE . 5.8 m -55.6 -33.99 34.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.083 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -76.3 -38.74 55.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -85.37 12.34 8.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.085 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 40.04 36.07 0.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 49.7 tp -151.48 151.39 31.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.978 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . 0.46 HD22 ' CD2' ' A' ' 326' ' ' LEU . 46.9 mt -86.83 71.9 10.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.924 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 407' ' ' LEU . 43.6 mt -38.04 156.41 0.1 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.621 0.724 . . . . 0.0 110.906 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 113.6 3.42 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.345 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . 0.447 ' HB ' ' CG1' ' A' ' 393' ' ' VAL . 16.4 m -61.83 -31.22 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -45.21 -44.39 10.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.47 -27.16 67.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -98.35 38.33 1.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.889 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.801 0.334 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 22.7 tp -53.25 -53.07 56.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . 0.413 ' HB2' ' CA ' ' A' ' 352' ' ' GLY . 24.5 m-85 -95.24 35.52 1.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -60.68 113.08 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 80.51 -41.88 2.56 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.5 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 34.9 mt -44.8 124.75 4.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.903 0.382 . . . . 0.0 110.894 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -95.81 147.39 23.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -137.82 155.77 48.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -139.55 116.3 10.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.434 ' HG ' ' CG2' ' A' ' 354' ' ' VAL . 2.8 mt -94.64 152.65 18.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -114.54 147.88 38.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.453 ' HD2' ' N ' ' A' ' 336' ' ' ARG . 0.5 OUTLIER -46.86 -27.78 1.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -63.87 -48.59 76.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.7 m -86.89 151.14 51.73 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.675 0.75 . . . . 0.0 111.121 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 116.06 4.38 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.67 2.247 . . . . 0.0 112.328 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 0.434 ' HG2' ' N ' ' A' ' 341' ' ' GLU . 0.0 OUTLIER -87.4 -29.98 21.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.884 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.434 ' N ' ' HG2' ' A' ' 340' ' ' ARG . 11.2 pt-20 -50.96 -49.75 59.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -74.3 -57.59 3.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.089 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . 0.443 HD21 ' CZ ' ' A' ' 399' ' ' PHE . 27.6 mt -53.14 -65.33 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 343' ' ' LEU . . . -35.03 -62.66 0.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.059 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . 0.585 ' N ' HH21 ' A' ' 348' ' ' ARG . 19.8 t80 -48.27 -49.73 32.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 349' ' ' SER . 44.4 mt -56.55 -71.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.16 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 352' ' ' GLY . 20.9 mt -37.99 -50.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.138 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . 0.585 HH21 ' N ' ' A' ' 345' ' ' PHE . 75.0 mtm180 -65.21 -37.71 88.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 346' ' ' ILE . 29.6 t -61.2 -42.83 99.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . 0.435 ' CD1' HG13 ' A' ' 402' ' ' VAL . 51.7 m-85 -88.54 23.05 2.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.869 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 60.67 57.2 20.12 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.452 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 347' ' ' ILE . . . -123.01 164.22 16.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.471 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -103.75 130.12 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.924 0.392 . . . . 0.0 110.893 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.434 ' CG2' ' HG ' ' A' ' 334' ' ' LEU . 5.7 p -141.51 142.76 28.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.123 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' SER . . . . . 0.442 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 4.6 t -140.48 162.46 35.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' TRP . . . . . 0.441 ' O ' ' CB ' ' A' ' 364' ' ' ALA . 20.4 p90 -139.32 153.92 47.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.913 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 360' ' ' LEU . 3.9 t70 -45.07 104.87 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 357' ' ' ASP . 7.3 mtpm? -35.92 -36.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.2 t -64.0 -48.35 76.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 357' ' ' ASP . 36.8 mt -55.44 -39.35 70.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 3.7 t -172.23 146.7 1.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.6 pt -66.34 173.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.102 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 104.42 -38.96 3.0 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.499 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 356' ' ' TRP . . . -50.34 140.3 13.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.822 0.344 . . . . 0.0 111.13 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 23.6 p -101.49 -50.94 3.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.186 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' TYR . . . . . 0.442 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 29.9 p90 -112.49 149.64 32.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.52 167.56 19.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.86 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 12.8 p -69.73 -22.56 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.155 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 77.3 p -84.02 13.55 4.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.61 110.49 17.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 22.6 p -55.35 -23.8 25.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -60.94 -36.8 80.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.85 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 66.6 mt -40.55 130.38 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.121 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 69.6 p -97.52 -24.72 15.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.169 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -154.55 149.36 26.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' GLN . . . . . 0.541 ' OE1' ' CE2' ' A' ' 392' ' ' TYR . 52.8 tt0 -134.37 111.56 10.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 19.1 mm -80.0 115.0 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.129 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 29.5 m -131.97 168.98 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.55 -34.59 31.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . 0.438 ' CZ ' ' HG3' ' A' ' 383' ' ' GLN . 81.3 mtp180 -132.23 80.81 62.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.612 0.72 . . . . 0.0 110.872 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -18.6 37.04 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.689 2.259 . . . . 0.0 112.358 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -73.92 -32.45 58.84 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.526 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . 0.438 ' HG3' ' CZ ' ' A' ' 380' ' ' ARG . 21.1 mm-40 -76.12 -49.3 17.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.756 0.312 . . . . 0.0 110.898 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -53.17 178.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 72.4 p -122.2 121.93 38.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 81.3 p -56.88 157.54 5.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 97.3 t -125.43 140.16 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.131 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.1 mt -37.82 111.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.093 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 92.13 -49.07 2.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.489 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' ARG . . . . . 0.463 ' HD2' ' N ' ' A' ' 391' ' ' CYS . 6.9 tmm_? -84.43 146.28 27.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.806 0.336 . . . . 0.0 110.863 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' CYS . . . . . 0.463 ' N ' ' HD2' ' A' ' 390' ' ' ARG . 88.3 m -134.8 147.55 49.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . 0.541 ' CE2' ' OE1' ' A' ' 376' ' ' GLN . 5.2 m-85 -94.62 132.87 38.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 4.2 m -138.26 158.13 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.116 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -78.7 161.32 69.67 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.608 0.718 . . . . 0.0 110.913 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -6.19 18.02 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.643 2.229 . . . . 0.0 112.341 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -80.96 -23.74 38.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.946 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 92.5 t90 -63.73 -27.97 69.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 48.0 t -75.0 -70.27 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.443 ' CZ ' HD21 ' A' ' 343' ' ' LEU . 5.4 m-30 -42.07 -36.95 1.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.88 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -72.44 -44.31 62.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 75.8 m -63.55 -54.47 35.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.81 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . 0.435 HG13 ' CD1' ' A' ' 350' ' ' PHE . 2.5 m -56.74 -33.88 41.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.089 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -79.48 -29.48 41.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -94.5 9.17 39.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.071 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? 40.19 32.71 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.62 137.4 17.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.93 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 48.1 mt -74.1 85.37 1.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 45.5 mt -51.57 154.15 3.48 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.552 0.691 . . . . 0.0 110.977 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 107.93 1.96 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.711 2.274 . . . . 0.0 112.326 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.1 m -54.84 -16.78 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.141 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -62.16 -19.16 62.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -90.74 -24.24 20.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -104.96 38.27 1.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.905 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 6.0 t80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.813 0.34 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 15.9 tp -57.69 -52.57 64.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -92.41 38.39 1.01 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -71.69 141.15 49.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.919 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 45.49 43.45 10.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.451 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 42.1 mt -132.23 126.81 34.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.86 0.362 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.53 ' HE3' ' CE2' ' A' ' 366' ' ' TYR . 37.1 mtpt -99.32 141.38 32.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.909 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -133.18 156.16 47.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' PHE . . . . . 0.461 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 8.9 t80 -138.36 115.63 11.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.86 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 2.9 mt -94.47 151.96 18.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.933 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -104.45 177.12 4.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -77.48 -27.51 51.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.855 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -72.13 -26.04 61.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.1 m -102.15 148.39 35.31 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.603 0.716 . . . . 0.0 111.122 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 122.31 8.97 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.633 2.222 . . . . 0.0 112.343 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 0.49 ' O ' ' CB ' ' A' ' 344' ' ' ALA . 6.3 ppt_? -95.08 -30.67 13.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.463 ' N ' ' HD2' ' A' ' 340' ' ' ARG . 8.1 pt-20 -52.07 -37.82 55.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -86.26 -60.67 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.112 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . 0.53 HD22 ' CE2' ' A' ' 399' ' ' PHE . 54.9 mt -52.7 -55.58 21.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' A' ' 340' ' ' ARG . . . -45.35 -58.6 3.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.07 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . 0.407 ' O ' ' N ' ' A' ' 349' ' ' SER . 4.8 t80 -56.38 -46.93 79.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' ILE . . . . . 0.412 ' CD1' ' CE1' ' A' ' 399' ' ' PHE . 29.2 mt -55.83 -67.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.147 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 17.0 mt -45.77 -37.94 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.167 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -78.97 -26.72 43.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 345' ' ' PHE . 16.7 t -82.53 -21.9 35.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.837 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -101.18 15.56 28.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 72.31 73.37 0.85 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.501 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -158.1 169.03 34.69 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.455 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -106.03 143.47 34.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.832 0.349 . . . . 0.0 110.947 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 11.7 p -157.82 128.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.151 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' SER . . . . . 0.54 ' HB2' ' CE1' ' A' ' 366' ' ' TYR . 1.9 m -133.7 154.15 51.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' TRP . . . . . 0.466 ' CD1' ' O ' ' A' ' 361' ' ' CYS . 14.3 p90 -122.16 -178.5 3.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.884 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 358' ' ' LYS . 10.9 t70 -73.83 111.75 9.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.854 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 357' ' ' ASP . 27.4 mttt -35.0 -51.47 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 7.9 t -57.97 -49.11 77.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 28.1 mt -51.31 -51.12 57.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' CYS . . . . . 0.466 ' O ' ' CD1' ' A' ' 356' ' ' TRP . 1.8 m -160.91 143.28 12.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 45.0 pt -66.22 160.08 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.41 ' O ' ' CZ2' ' A' ' 356' ' ' TRP . . . 96.91 36.21 5.08 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.464 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -117.33 147.17 42.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.816 0.341 . . . . 0.0 111.116 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 21.9 p -105.18 -71.06 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.146 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' TYR . . . . . 0.54 ' CE1' ' HB2' ' A' ' 355' ' ' SER . 13.6 p90 -96.34 146.59 24.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.934 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.76 170.66 11.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . 0.461 ' HB ' ' CZ ' ' A' ' 333' ' ' PHE . 7.3 p -64.55 -18.05 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.134 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 70.1 p -85.37 22.85 1.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.181 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -104.73 103.83 13.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 30.0 m -50.35 -37.09 35.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 30.6 mtt180 -40.59 -39.84 1.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.86 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 70.6 mt -45.65 117.64 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.158 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 48.9 p -81.64 -44.93 16.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -126.32 138.87 53.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.861 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' GLN . . . . . 0.46 ' OE1' ' CZ ' ' A' ' 390' ' ' ARG . 37.6 tt0 -122.32 99.05 6.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.914 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . 0.424 ' N ' ' O ' ' A' ' 333' ' ' PHE . 25.8 mm -65.87 129.46 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 35.4 m -152.27 146.67 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.139 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -68.21 -34.54 76.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.827 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.2 mtp85 -132.7 89.86 34.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.612 0.72 . . . . 0.0 110.878 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -27.06 27.17 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.668 2.245 . . . . 0.0 112.337 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -72.58 -59.2 4.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.528 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . 0.457 ' HG3' ' N ' ' A' ' 384' ' ' GLN . 12.1 pt20 -43.03 -36.96 1.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.808 0.337 . . . . 0.0 110.921 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.457 ' N ' ' HG3' ' A' ' 383' ' ' GLN . 10.4 pt20 -104.32 114.67 29.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.95 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 16.2 m -51.37 153.11 2.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.159 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 6.9 t -91.51 173.18 8.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.858 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.9 t -127.77 130.91 70.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.111 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 29.3 mm -42.37 125.95 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.143 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 94.68 -33.52 5.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.487 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' ARG . . . . . 0.46 ' CZ ' ' OE1' ' A' ' 376' ' ' GLN . 19.8 ttp180 -93.97 146.11 24.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.782 0.325 . . . . 0.0 110.881 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 62.5 m -129.22 127.8 42.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -96.61 133.64 40.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 17.0 m -143.21 142.76 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.123 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -57.85 158.45 12.48 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.607 0.718 . . . . 0.0 110.93 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -7.25 20.6 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.709 2.273 . . . . 0.0 112.294 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.31 -33.75 42.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' TRP . . . . . 0.442 ' CE2' HG12 ' A' ' 410' ' ' VAL . 69.1 t90 -48.49 -31.16 6.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.926 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 65.7 t -80.22 -55.03 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.53 ' CE2' HD22 ' A' ' 343' ' ' LEU . 68.1 m-85 -54.23 -22.02 10.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -85.45 -41.39 15.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 405' ' ' ARG . 20.3 m -66.53 -51.92 51.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 15.3 m -49.77 -38.12 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.141 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -78.12 -44.18 26.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -83.08 8.28 13.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.138 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 404' ' ' ALA . 7.9 mmm180 35.57 46.0 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 12.6 tp -156.18 148.18 23.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.932 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 13.5 mt -80.0 84.14 5.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 33.1 mt -55.53 154.36 12.63 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.598 0.714 . . . . 0.0 110.886 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 114.13 3.61 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.707 2.271 . . . . 0.0 112.293 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . 0.442 HG12 ' CE2' ' A' ' 397' ' ' TRP . 35.2 m -60.57 -21.27 22.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.123 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -55.54 -40.05 71.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.085 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.38 -9.99 59.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -121.34 38.41 4.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.887 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 10.4 t80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 -179.976 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.795 0.331 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 11.6 tp -44.37 -50.58 9.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.866 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -93.01 42.59 1.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -74.56 133.86 42.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 52.32 55.29 22.75 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.486 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 88.0 mt -147.55 118.1 7.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.88 0.371 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -93.43 126.26 38.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.948 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.499 ' CD1' ' HB2' ' A' ' 375' ' ' HIS . 74.5 m-85 -120.29 160.36 23.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' PHE . . . . . 0.523 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 36.8 t80 -141.11 117.01 10.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 7.4 mt -93.67 142.84 26.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' ASN . . . . . 0.454 ' ND2' HG11 ' A' ' 378' ' ' VAL . 2.7 m-80 -101.22 158.25 16.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.422 ' HB3' ' CD1' ' A' ' 360' ' ' LEU . 12.9 ptt180 -58.78 -29.53 66.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.846 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . 0.462 ' CG ' ' OD2' ' A' ' 379' ' ' ASP . 11.6 tp10 -66.19 -48.0 72.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 5.1 m -80.82 150.64 69.66 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.582 0.706 . . . . 0.0 111.184 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 110.34 2.53 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.677 2.251 . . . . 0.0 112.3 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -86.53 -38.67 16.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -44.69 -41.33 6.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -82.42 -58.49 2.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.075 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 71.4 mt -53.99 -61.23 2.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -39.66 -55.55 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.068 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -58.81 -44.54 90.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 47.8 mt -59.65 -62.33 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.151 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 20.1 mt -51.97 -55.88 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -56.43 -40.26 74.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 29.5 t -64.92 -43.96 91.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . 0.464 ' CZ ' HG22 ' A' ' 402' ' ' VAL . 14.0 m-85 -73.44 -9.16 58.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 90.83 54.55 2.03 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.497 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -128.91 161.95 22.46 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.492 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -92.06 129.07 38.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.912 0.387 . . . . 0.0 110.851 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 10.8 p -148.06 143.2 19.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.155 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' SER . . . . . 0.528 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 5.1 t -147.39 152.26 37.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.868 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' TRP . . . . . 0.492 ' CD1' ' HB3' ' A' ' 361' ' ' CYS . 31.7 p90 -128.45 173.15 10.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.59 109.28 1.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.821 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -46.45 -34.34 4.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 28.4 t -69.41 -55.18 11.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.814 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.422 ' CD1' ' HB3' ' A' ' 336' ' ' ARG . 18.5 mt -54.91 -44.14 73.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.894 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' CYS . . . . . 0.492 ' HB3' ' CD1' ' A' ' 356' ' ' TRP . 2.1 t -147.21 159.97 43.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 15.7 tt -86.55 162.26 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.149 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 85.98 43.1 6.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.508 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -107.04 165.8 11.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.878 0.37 . . . . 0.0 111.09 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 20.9 p -129.78 -64.05 0.89 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.143 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' TYR . . . . . 0.528 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 8.3 p90 -112.31 145.91 39.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.953 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.13 167.17 22.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.88 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . 0.523 ' HB ' ' CZ ' ' A' ' 333' ' ' PHE . 7.5 p -63.62 -20.49 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.107 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 79.1 p -93.65 26.62 3.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.142 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -93.87 113.58 25.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 372' ' ' ARG . 11.9 t -53.62 -45.76 70.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.871 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 371' ' ' SER . 18.5 mmt180 -37.15 -42.42 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.917 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 34.0 mt -47.75 129.95 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.096 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 41.6 p -94.73 -43.1 8.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.106 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . 0.499 ' HB2' ' CD1' ' A' ' 332' ' ' PHE . 37.3 m80 -128.82 148.47 50.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -128.74 115.42 17.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.927 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 27.0 mm -82.72 116.17 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.167 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . 0.454 HG11 ' ND2' ' A' ' 335' ' ' ASN . 30.9 m -141.05 158.19 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . 0.462 ' OD2' ' CG ' ' A' ' 337' ' ' GLU . 2.8 m-20 -71.48 -37.7 71.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -127.69 81.98 69.19 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.578 0.704 . . . . 0.0 110.892 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -23.07 31.34 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.715 2.277 . . . . 0.0 112.373 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -68.64 -47.16 58.13 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.476 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -63.11 -48.9 76.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.775 0.321 . . . . 0.0 110.88 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -45.81 164.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.91 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 51.6 m -95.87 126.68 41.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.117 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 72.4 m -67.21 139.78 57.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 90.5 t -129.78 119.36 47.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.112 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 5.0 mp -39.94 134.41 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 88.76 -40.8 3.05 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.455 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' ARG . . . . . 0.428 ' NH1' ' O ' ' A' ' 368' ' ' VAL . 14.5 ttp180 -95.65 145.79 25.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.756 0.312 . . . . 0.0 110.871 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 84.0 m -132.85 124.33 27.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -90.89 128.07 36.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.954 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 19.7 m -135.99 151.11 28.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.088 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -66.55 158.12 80.1 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.602 0.715 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -5.5 16.34 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.662 2.241 . . . . 0.0 112.362 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -80.68 -14.77 57.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -73.12 -49.77 26.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 51.7 t -55.5 -41.75 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.12 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -65.03 -64.53 0.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . 0.462 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 2.4 m-20 -50.42 -33.42 20.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.836 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 69.6 m -70.49 -26.24 63.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . 0.464 HG22 ' CZ ' ' A' ' 350' ' ' PHE . 2.2 t -89.23 -45.73 15.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.096 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -67.73 -31.68 71.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -88.08 5.99 38.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.087 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? 40.08 44.4 1.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 43.0 tp -165.13 144.24 6.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 16.4 mt -74.95 99.31 3.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.462 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 52.2 mt -71.55 153.62 93.56 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.634 0.731 . . . . 0.0 110.924 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 119.57 6.49 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.702 2.268 . . . . 0.0 112.35 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.09 -28.6 44.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.136 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -52.9 -21.82 4.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -84.52 -32.65 23.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -104.96 42.51 1.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.923 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 3.7 t80 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.88 179.966 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.809 0.338 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.409 ' CD2' HD23 ' A' ' 407' ' ' LEU . 2.5 tt -57.26 -52.6 64.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.936 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -92.15 38.54 1.0 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -77.21 124.37 27.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 69.01 49.2 42.71 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.544 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 88.9 mt -148.19 124.46 10.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.854 0.359 . . . . 0.0 110.935 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.464 ' HE2' ' CE2' ' A' ' 366' ' ' TYR . 45.3 mttt -95.54 133.11 39.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -119.26 152.8 36.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.909 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -130.98 119.04 21.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.879 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 7.3 mt -97.95 140.89 31.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -98.34 -175.14 3.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.872 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -82.46 -33.74 28.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -69.81 -36.6 75.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.1 m -87.16 145.28 37.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.658 0.742 . . . . 0.0 111.107 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 127.32 14.44 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.664 2.242 . . . . 0.0 112.33 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 0.406 ' C ' ' HD2' ' A' ' 340' ' ' ARG . 0.0 OUTLIER -96.86 -40.19 9.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -45.65 -41.36 10.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -78.9 -66.91 0.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.139 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . 0.535 HD21 ' CE1' ' A' ' 399' ' ' PHE . 60.2 mt -44.57 -58.26 3.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -43.3 -54.79 4.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -55.39 -40.61 71.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 15.6 mt -68.64 -72.91 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.145 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 26.1 mt -37.33 -37.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.122 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -75.18 -47.99 25.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 47.5 t -55.52 -31.18 61.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.804 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . 0.414 ' CE2' ' HB ' ' A' ' 402' ' ' VAL . 20.7 m-85 -98.72 26.22 5.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 53.02 71.44 0.69 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.521 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -136.87 173.07 22.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.49 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -109.17 128.23 54.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 110.902 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.06 131.58 17.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.119 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' SER . . . . . 0.556 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 10.4 t -136.2 163.86 29.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' TRP . . . . . 0.493 ' CD1' ' HB2' ' A' ' 361' ' ' CYS . 34.0 p90 -142.35 159.07 42.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.905 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . 0.444 ' HB2' ' CD1' ' A' ' 360' ' ' LEU . 7.0 m-20 -55.65 120.88 7.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -45.08 -59.38 2.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 14.7 t -45.4 -48.88 13.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.824 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.444 ' CD1' ' HB2' ' A' ' 357' ' ' ASP . 32.3 mt -55.97 -49.62 73.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.973 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' CYS . . . . . 0.493 ' HB2' ' CD1' ' A' ' 356' ' ' TRP . 62.1 m -154.03 157.4 38.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.2 tt -84.9 158.48 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.117 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 91.73 36.38 6.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.486 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -105.52 158.2 16.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 0.0 111.087 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' THR . . . . . 0.434 ' OG1' ' CD2' ' A' ' 366' ' ' TYR . 22.3 p -111.99 -64.14 1.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.124 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' TYR . . . . . 0.556 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 16.0 p90 -110.18 139.43 45.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -76.74 171.46 14.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 13.6 p -64.12 -11.77 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.175 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 25.3 p -96.89 15.66 21.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.147 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . 0.427 ' CB ' ' HB2' ' A' ' 366' ' ' TYR . 0.9 OUTLIER -96.03 107.2 19.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.886 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 59.0 p -52.24 -33.34 41.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . 0.406 ' HB3' ' NZ ' ' A' ' 331' ' ' LYS . 26.1 mmm-85 -40.05 -45.14 1.88 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.877 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.428 HG12 ' CE1' ' A' ' 366' ' ' TYR . 20.7 mt -41.24 136.16 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.192 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 50.6 p -112.12 -23.87 10.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.114 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -134.47 134.16 41.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.847 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' GLN . . . . . 0.425 ' HG2' ' CE2' ' A' ' 392' ' ' TYR . 2.0 tp-100 -124.59 105.5 9.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.896 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 6.0 mm -84.38 126.38 40.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.09 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 13.5 m -139.11 152.36 23.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.12 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -67.19 -42.49 84.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . 0.414 ' NH1' ' HB3' ' A' ' 380' ' ' ARG . 0.0 OUTLIER -132.12 90.42 35.0 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 0.0 110.866 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -19.45 36.3 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.668 2.246 . . . . 0.0 112.352 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -65.48 -47.03 82.41 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.531 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -80.92 -42.22 21.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.756 0.312 . . . . 0.0 110.894 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -51.93 153.49 2.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.0 149.67 23.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.139 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 26.1 p -108.86 153.11 23.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.839 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 26.1 t -119.65 128.43 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.14 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.3 mt -40.4 117.67 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.167 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 103.88 -43.14 1.73 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.466 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -87.67 148.7 24.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 0.0 110.867 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 4.0 t -123.58 145.51 48.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . 0.425 ' CE2' ' HG2' ' A' ' 376' ' ' GLN . 2.9 m-85 -107.28 118.05 35.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.942 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 31.4 m -124.85 160.32 30.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.135 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -76.02 159.59 80.29 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.57 0.7 . . . . 0.0 110.887 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -6.69 19.18 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.669 2.246 . . . . 0.0 112.357 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -83.55 -15.9 47.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.947 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -66.09 -26.55 67.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 85.9 t -76.43 -51.34 19.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.161 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.535 ' CE1' HD21 ' A' ' 343' ' ' LEU . 11.1 m-30 -60.18 -30.67 69.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . 0.445 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 1.0 OUTLIER -80.55 -36.45 33.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.904 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 71.8 m -69.27 -49.47 55.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . 0.414 ' HB ' ' CE2' ' A' ' 350' ' ' PHE . 34.9 m -60.43 -45.29 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.117 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -65.08 -39.04 92.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -87.16 9.49 19.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.128 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' A' ' 404' ' ' ALA . 12.6 mmm-85 34.71 45.31 0.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -165.32 136.1 3.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . 0.409 HD23 ' CD2' ' A' ' 326' ' ' LEU . 15.6 mt -66.1 95.99 0.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.955 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.445 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 45.6 mt -64.75 156.1 80.07 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.607 0.718 . . . . 0.0 110.941 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 116.04 4.37 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.701 2.267 . . . . 0.0 112.361 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.9 m -58.02 -26.15 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.133 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -50.94 -34.3 28.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.072 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -75.72 -26.12 57.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -108.77 42.67 1.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 43.4 t80 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.898 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.802 0.334 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 2.0 tt -60.91 -48.62 80.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.939 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -93.48 38.87 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.848 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . 0.488 ' CD ' ' N ' ' A' ' 329' ' ' GLY . 3.9 tp10 -72.41 133.12 44.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . 0.488 ' N ' ' CD ' ' A' ' 328' ' ' GLU . . . 58.31 53.19 47.78 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.484 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 89.8 mt -148.14 132.6 17.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.884 0.373 . . . . 0.0 110.941 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -109.62 132.99 53.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.959 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -126.05 140.82 52.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.852 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -119.97 115.36 23.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.889 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 8.1 mt -89.08 145.57 25.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -98.87 -179.65 4.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -81.96 -17.96 45.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -79.3 -45.07 20.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.845 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 2.0 m -83.95 150.16 57.99 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.617 0.722 . . . . 0.0 111.18 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 137.69 35.96 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.712 2.275 . . . . 0.0 112.342 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 344' ' ' ALA . 0.0 OUTLIER -105.62 -34.73 7.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.905 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -50.91 -41.61 58.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -81.5 -48.41 11.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.083 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 75.7 mt -67.15 -65.67 0.65 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -38.09 -45.23 0.9 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.08 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -68.33 -44.77 74.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 25.8 mt -61.8 -63.03 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.104 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 28.1 mt -51.4 -43.01 29.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -67.63 -33.99 76.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 17.7 t -72.23 -44.05 63.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . 0.516 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 14.2 m-85 -72.68 1.16 8.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 81.42 54.78 3.4 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.499 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -129.19 153.42 19.83 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.461 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -91.81 126.36 36.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.926 0.393 . . . . 0.0 110.846 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 6.5 p -139.99 137.92 38.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.046 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' SER . . . . . 0.525 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 29.4 t -136.18 160.77 37.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 31.8 p90 -135.41 -175.37 3.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.925 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 358' ' ' LYS . 12.5 m-20 -78.08 113.22 15.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.416 ' NZ ' ' OD1' ' A' ' 367' ' ' ASP . 1.3 mppt? -38.31 -56.2 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 17.7 t -44.88 -50.11 10.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 29.1 mt -57.02 -35.68 69.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.944 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 1.9 t -174.64 156.61 2.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 10.6 tt -81.36 163.23 3.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 111.16 -33.57 5.79 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.467 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -40.47 147.14 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 0.0 111.143 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 42.8 p -110.92 -58.97 2.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.094 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' TYR . . . . . 0.525 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 18.7 p90 -111.51 146.36 37.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.905 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -86.47 165.51 16.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.838 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 13.7 p -56.73 -30.83 33.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.125 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 73.2 p -67.15 -25.84 66.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.211 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -56.69 103.65 0.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 53.9 m -54.7 -26.85 36.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -46.13 -40.11 10.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 68.4 mt -44.92 120.98 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 71.2 p -89.17 -50.58 6.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.142 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -120.7 146.69 46.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.829 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -131.44 102.7 6.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 31.8 mm -71.59 130.18 35.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.147 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 22.1 m -143.01 164.2 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.157 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 380' ' ' ARG . 0.4 OUTLIER -57.95 -48.45 79.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . 0.472 ' N ' ' OD1' ' A' ' 379' ' ' ASP . 53.4 mtm-85 -145.78 104.96 4.22 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.637 0.732 . . . . 0.0 110.861 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -0.05 6.31 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.694 2.262 . . . . 0.0 112.377 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -103.67 -34.78 3.71 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.528 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -71.23 -71.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.726 0.298 . . . . 0.0 110.861 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -61.85 143.6 56.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 96.5 m -69.05 128.95 38.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 9.2 p -80.9 166.02 21.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 388' ' ' ILE . 97.5 t -94.73 108.7 21.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.401 ' C ' ' O ' ' A' ' 387' ' ' VAL . 5.3 mp -36.32 102.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.148 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 125.2 -44.84 1.22 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.463 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 11.6 ttm-85 -78.9 160.51 27.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 110.852 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 73.6 m -119.21 115.81 24.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -96.0 136.04 36.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 17.8 m -139.47 153.11 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.13 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -68.81 159.24 83.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.57 0.7 . . . . 0.0 110.912 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -8.02 22.54 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.677 2.251 . . . . 0.0 112.398 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -81.22 -20.8 40.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 70.3 t90 -60.55 -43.05 97.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.99 -55.9 20.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.161 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -51.8 -35.62 44.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -76.4 -38.99 54.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.829 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 36.8 m -64.3 -48.23 76.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.815 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . 0.516 ' HB ' ' CZ ' ' A' ' 350' ' ' PHE . 22.3 m -61.11 -46.22 97.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.104 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . 0.438 ' N ' HG23 ' A' ' 402' ' ' VAL . 41.5 t30 -62.13 -42.76 99.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -83.38 0.39 46.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 44.07 41.94 4.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -163.3 131.53 3.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 71.4 mt -61.15 103.13 0.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 35.0 mt -70.4 154.2 94.62 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.592 0.71 . . . . 0.0 110.878 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 105.28 1.45 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.711 2.274 . . . . 0.0 112.343 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 32.7 m -51.58 -23.97 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.157 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -49.41 -34.52 16.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.094 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -74.37 -40.53 62.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -91.07 40.1 1.01 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 34.2 t80 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.88 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 59.5 mmtt . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.793 0.33 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 2.4 tt -39.65 -48.08 2.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -96.87 42.0 1.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -80.53 107.12 13.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 90.31 43.82 4.85 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.493 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 96.6 mt -144.43 129.27 18.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.83 0.348 . . . . 0.0 110.959 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.41 ' CE ' ' HB3' ' A' ' 372' ' ' ARG . 19.7 mttm -96.79 143.57 27.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -134.33 144.09 48.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -129.57 116.72 19.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 5.4 mt -97.33 147.68 23.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.969 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -110.35 154.52 23.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -52.48 -36.63 55.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -56.62 -47.8 78.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.0 m -88.94 148.61 41.62 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.575 0.703 . . . . 0.0 111.142 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 125.04 11.68 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.713 2.276 . . . . 0.0 112.343 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 344' ' ' ALA . 0.3 OUTLIER -95.07 -40.99 9.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.857 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 342' ' ' ALA . 8.1 pt-20 -42.37 -42.89 3.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.424 ' N ' ' HG3' ' A' ' 341' ' ' GLU . . . -76.64 -46.7 24.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . 0.506 HD21 ' CZ ' ' A' ' 399' ' ' PHE . 24.2 mt -71.02 -66.34 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.939 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -34.65 -46.08 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.117 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -65.2 -43.33 91.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.926 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 343' ' ' LEU . 15.9 mt -62.7 -67.23 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.121 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 17.6 mt -42.34 -40.26 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 -72.77 -41.83 64.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 33.7 t -60.28 -33.18 71.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . 0.558 ' CZ ' HG11 ' A' ' 402' ' ' VAL . 22.8 m-85 -92.55 14.85 15.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.907 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 63.61 55.81 23.0 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.439 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -120.98 179.72 16.27 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.499 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -113.8 125.01 53.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 0.0 110.913 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 6.9 p -141.79 134.18 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 16.3 t -131.26 158.44 40.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.835 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 41.3 p90 -136.13 178.46 7.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.945 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 358' ' ' LYS . 0.6 OUTLIER -72.24 106.68 4.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.869 179.888 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 357' ' ' ASP . 0.1 OUTLIER -37.84 -45.61 0.86 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.918 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 58.8 m -42.09 -46.39 4.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 31.4 mt -60.01 -50.7 72.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 6.2 t -166.43 161.78 16.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 34.8 pt -64.21 175.34 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 364' ' ' ALA . . . 103.51 -35.07 5.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.508 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 363' ' ' GLY . . . -35.63 139.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.364 . . . . 0.0 111.087 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 37.2 p -113.37 -52.87 2.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.16 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -128.3 145.9 50.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.947 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -74.28 172.58 11.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.879 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 14.0 p -73.36 -14.12 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.135 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 41.3 p -96.94 19.65 12.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.144 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -95.79 105.95 18.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.832 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 8.4 t -47.05 -32.98 4.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . 0.41 ' HB3' ' CE ' ' A' ' 331' ' ' LYS . 9.0 mmt180 -41.95 -43.43 3.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.862 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.41 HG21 ' N ' ' A' ' 374' ' ' THR . 94.0 mt -49.62 135.9 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.112 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.41 ' N ' HG21 ' A' ' 373' ' ' ILE . 77.2 p -106.21 -39.43 5.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.123 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -128.83 122.11 29.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.81 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -105.2 112.69 25.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 49.6 mm -86.13 117.56 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.121 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 29.3 m -136.29 178.2 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.195 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -82.34 -43.91 16.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -125.51 82.2 63.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.573 0.702 . . . . 0.0 110.917 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -14.83 36.71 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.648 2.232 . . . . 0.0 112.354 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -72.78 -54.19 7.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.455 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -99.04 41.48 1.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.74 0.305 . . . . 0.0 110.893 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 385' ' ' THR . 4.3 tp-100 -122.76 100.86 7.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.969 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' THR . . . . . 0.415 ' C ' ' O ' ' A' ' 384' ' ' GLN . 31.3 m -36.59 122.77 0.79 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.114 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 34.4 p -102.73 -179.64 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 59.7 t -130.93 141.05 47.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.093 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.6 mt -42.2 113.89 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.133 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 104.27 -44.72 1.42 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.503 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 25.2 ttp180 -81.11 139.81 35.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.817 0.341 . . . . 0.0 110.861 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 61.8 m -127.38 125.6 40.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -85.86 137.19 32.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.932 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 23.4 m -142.34 164.46 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.119 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -79.04 160.79 70.49 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.567 0.699 . . . . 0.0 110.93 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 -4.83 14.79 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.669 2.246 . . . . 0.0 112.383 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -79.27 -34.22 42.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -50.7 -35.69 32.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.923 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 44.1 t -65.66 -51.57 61.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.107 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.506 ' CZ ' HD21 ' A' ' 343' ' ' LEU . 17.3 m-85 -57.27 -36.92 71.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.882 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . 0.433 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 11.2 m-20 -73.8 -40.39 63.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.853 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 1.9 m -72.55 -23.28 60.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.831 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . 0.558 HG11 ' CZ ' ' A' ' 350' ' ' PHE . 2.2 t -87.25 -31.13 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.14 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -85.37 -24.76 27.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -95.52 8.97 41.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.066 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 404' ' ' ALA . 10.2 mmt85 37.15 42.72 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.877 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 21.2 tp -166.69 142.22 4.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.94 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 13.0 mt -69.19 102.87 1.78 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 17.8 mt -73.68 154.29 89.42 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.593 0.711 . . . . 0.0 110.912 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 108.4 2.06 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.714 2.276 . . . . 0.0 112.319 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.0 m -53.52 -25.36 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.164 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -53.45 -16.16 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.074 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -95.03 -22.4 17.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.868 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -111.81 36.0 3.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.935 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 2.2 t80 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.921 -179.977 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.786 0.327 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 7.5 tp -65.15 -38.65 91.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -105.87 30.16 6.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -54.1 113.84 1.39 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 78.73 -45.35 2.68 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.517 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 15.8 mt -39.6 130.34 1.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.872 0.368 . . . . 0.0 110.912 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -98.97 152.14 20.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -144.65 148.38 34.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -135.59 116.69 14.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.915 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 2.6 mt -94.42 139.97 30.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -88.97 171.15 10.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -77.47 -9.89 59.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.845 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -87.31 -42.84 12.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 5.7 m -84.92 150.97 56.86 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.637 0.732 . . . . 0.0 111.105 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 115.34 4.05 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.681 2.254 . . . . 0.0 112.307 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -94.56 -39.7 10.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -40.2 -36.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -86.66 -49.22 7.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.106 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 30.8 mt -60.29 -61.78 2.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.945 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -38.73 -62.64 0.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.098 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -48.85 -42.01 34.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 23.3 mt -65.81 -72.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.122 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 27.5 mt -38.95 -44.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.153 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -66.78 -42.68 85.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 8.9 t -65.74 -28.48 69.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.849 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -88.6 12.85 13.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.835 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 68.93 50.65 33.6 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.488 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -132.35 156.55 22.08 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.434 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -91.52 132.39 36.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.909 0.385 . . . . 0.0 110.911 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.24 142.8 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.157 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 26.3 t -137.05 159.85 40.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -139.65 174.42 10.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.5 119.13 4.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.887 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.43 -8.72 14.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 4.3 t -88.64 -23.41 23.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.836 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 12.5 mt -75.38 -51.02 14.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 2.7 t -162.48 164.66 26.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.865 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.6 pt -62.47 172.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.137 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 364' ' ' ALA . . . 105.95 -42.87 1.8 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.49 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 363' ' ' GLY . . . -35.3 124.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.893 0.378 . . . . 0.0 111.106 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 41.5 p -97.15 -65.17 0.98 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.152 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -109.61 158.74 17.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 370' ' ' ASP . 3.0 m-20 -83.23 167.97 17.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.914 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.08 -28.77 37.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.108 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 60.8 p -83.0 20.42 1.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.167 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 367' ' ' ASP . 2.8 m-20 -92.36 98.92 11.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 372' ' ' ARG . 16.6 t -43.16 -42.65 4.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.841 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 371' ' ' SER . 48.2 mtp180 -37.45 -41.46 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 78.4 mt -45.92 123.72 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 70.4 p -84.69 -45.1 12.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.14 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . 0.524 ' CD2' ' SG ' ' A' ' 391' ' ' CYS . 51.5 m80 -133.05 141.58 48.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.911 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -123.62 116.71 23.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 49.6 mm -82.42 127.78 39.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.144 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 15.4 m -140.24 172.65 11.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.103 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -90.47 -42.97 10.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.798 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 11.5 ptt-85 -121.22 81.2 36.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.568 0.699 . . . . 0.0 110.846 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 3.07 3.01 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.661 2.241 . . . . 0.0 112.325 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -97.3 -28.14 8.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.477 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -77.28 -71.33 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.787 0.327 . . . . 0.0 110.896 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.574 ' OE1' ' CE2' ' A' ' 392' ' ' TYR . 3.2 pp0? -57.34 120.78 8.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 66.5 p -58.85 140.67 54.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.156 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 27.8 p -68.32 161.12 28.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 388' ' ' ILE . 42.0 t -120.96 121.44 65.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.082 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.422 ' C ' ' O ' ' A' ' 387' ' ' VAL . 10.0 mt -36.17 132.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.124 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 86.48 -48.65 3.94 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.457 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -85.88 138.49 31.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.324 . . . . 0.0 110.901 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' CYS . . . . . 0.524 ' SG ' ' CD2' ' A' ' 375' ' ' HIS . 6.3 p -118.65 129.73 55.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . 0.574 ' CE2' ' OE1' ' A' ' 384' ' ' GLN . 7.8 m-85 -98.23 126.76 43.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . 0.443 ' CG1' ' HB ' ' A' ' 410' ' ' VAL . 34.4 m -136.08 146.92 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.075 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -61.67 161.14 22.11 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.632 0.729 . . . . 0.0 110.859 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -10.47 28.66 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.705 2.27 . . . . 0.0 112.335 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -76.02 -26.42 56.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 85.6 t90 -56.82 -23.58 44.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 3.9 t -87.83 -53.87 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -50.24 -33.54 19.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -79.56 -51.21 9.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 69.9 m -54.4 -51.45 64.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 5.3 m -54.79 -44.24 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.13 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -69.84 -35.26 74.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.848 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -87.98 9.01 23.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 39.13 38.3 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.936 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . 0.414 ' C ' HD23 ' A' ' 406' ' ' LEU . 1.0 OUTLIER -153.68 153.5 32.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.941 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 29.1 mt -85.78 93.59 8.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.11 152.88 76.62 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.73 . . . . 0.0 110.896 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 116.28 4.49 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.642 2.228 . . . . 0.0 112.356 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . 0.443 ' HB ' ' CG1' ' A' ' 393' ' ' VAL . 32.2 m -60.19 -19.74 18.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -63.01 -21.38 66.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.066 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -86.98 -17.27 33.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.937 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -115.49 42.68 2.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 41.7 t80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.812 -179.963 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.821 0.343 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.448 ' CD1' ' HA ' ' A' ' 405' ' ' ARG . 2.1 tt -53.03 -40.92 64.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.934 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -101.63 40.53 1.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -79.14 123.76 27.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.935 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 70.8 50.41 24.53 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.497 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 72.5 mt -142.91 162.28 35.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.86 0.362 . . . . 0.0 110.934 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -131.07 123.16 28.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.93 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.52 ' CD1' ' HB2' ' A' ' 375' ' ' HIS . 78.6 m-85 -119.42 147.49 44.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -132.31 119.91 21.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 3.6 mt -99.13 148.46 24.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' ASN . . . . . 0.469 ' ND2' HG11 ' A' ' 378' ' ' VAL . 2.6 m-80 -104.28 175.51 5.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -71.27 -31.86 68.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.842 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -63.58 -45.42 90.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 2.9 m -82.17 149.61 62.7 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.642 0.735 . . . . 0.0 111.135 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 111.82 2.91 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.688 2.259 . . . . 0.0 112.363 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 0.448 ' O ' ' C ' ' A' ' 341' ' ' GLU . 26.1 ttp85 -78.45 -49.13 14.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 340' ' ' ARG . 1.2 mt-10 -33.59 -69.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.894 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -57.76 -64.04 1.04 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.128 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . 0.529 HD23 ' CE1' ' A' ' 399' ' ' PHE . 29.2 mt -42.08 -70.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 343' ' ' LEU . . . -36.98 -66.53 0.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.096 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -44.01 -49.18 8.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 28.7 mt -57.76 -67.67 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.123 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 29.2 mt -42.48 -44.64 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.164 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 10.3 mtp-105 -65.1 -49.23 70.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 13.2 t -57.26 -21.08 31.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -102.2 22.75 12.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 55.96 50.29 62.23 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.513 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -122.39 163.12 15.91 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.523 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -101.96 126.5 48.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 110.895 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 6.7 p -138.94 138.64 41.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.119 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' SER . . . . . 0.424 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 7.4 t -131.23 161.63 31.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -139.34 174.64 10.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -64.24 107.55 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.852 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -42.39 -44.21 3.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 5.4 t -53.57 -52.34 60.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 41.7 mt -48.63 -51.09 29.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 2.7 m -158.41 166.08 33.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 20.9 tt -80.54 151.97 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 125.41 -36.61 2.74 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -40.81 145.88 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.868 0.366 . . . . 0.0 111.097 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' THR . . . . . 0.532 ' OG1' ' CD2' ' A' ' 366' ' ' TYR . 80.8 p -110.16 -64.25 1.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' TYR . . . . . 0.532 ' CD2' ' OG1' ' A' ' 365' ' ' THR . 2.2 p90 -106.55 159.07 16.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.17 168.22 19.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.892 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 8.2 p -76.26 -3.17 4.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.163 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 73.7 p -108.08 19.76 19.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.17 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -92.94 105.9 17.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.84 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 372' ' ' ARG . 75.3 m -41.12 -42.3 1.98 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.814 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 371' ' ' SER . 62.4 mtt180 -35.75 -44.0 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 85.6 mt -44.54 130.66 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 33.6 p -103.6 -33.1 9.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.126 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . 0.52 ' HB2' ' CD1' ' A' ' 332' ' ' PHE . 24.7 m80 -138.58 124.13 19.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.806 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -112.73 94.6 4.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 16.1 mm -63.45 120.64 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . 0.469 HG11 ' ND2' ' A' ' 335' ' ' ASN . 27.5 m -136.19 164.58 31.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.158 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -77.08 -44.77 29.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 27.3 mmm-85 -124.07 82.79 56.22 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.63 0.729 . . . . 0.0 110.847 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -14.0 35.55 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.676 2.25 . . . . 0.0 112.341 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -79.58 -32.89 36.22 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.515 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 384' ' ' GLN . 7.1 mm100 -84.98 -55.22 4.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.786 0.327 . . . . 0.0 110.91 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 383' ' ' GLN . 30.5 mm-40 -37.47 140.0 0.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 23.5 m -78.0 91.07 4.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.142 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 94.1 p -44.18 156.4 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.84 127.08 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.134 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 18.7 mm -39.99 129.27 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.12 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 91.97 -40.22 2.93 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.549 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -91.27 146.53 23.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.792 0.33 . . . . 0.0 110.881 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 18.4 m -124.17 124.06 41.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -90.22 125.49 35.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 15.2 m -130.59 167.41 25.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.127 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -88.21 161.05 44.44 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.614 0.721 . . . . 0.0 110.876 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -5.33 15.98 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.646 2.231 . . . . 0.0 112.353 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 -81.03 -23.68 38.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -62.53 -35.65 80.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.917 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.68 -61.6 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.132 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.529 ' CE1' HD23 ' A' ' 343' ' ' LEU . 7.9 m-30 -48.14 -31.64 5.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . 0.432 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 3.0 m-20 -76.85 -41.97 41.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 50.6 m -65.9 -52.37 50.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.824 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 4.5 m -54.59 -33.43 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.174 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -87.43 -18.29 30.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.849 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -102.93 9.26 38.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.108 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . 0.448 ' HA ' ' CD1' ' A' ' 326' ' ' LEU . 9.7 mpt_? 39.59 30.38 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 13.0 tp -149.19 164.2 35.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 408' ' ' LEU . 94.2 mt -97.61 68.12 2.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.432 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 27.9 mt -35.41 153.33 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.564 0.697 . . . . 0.0 110.94 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 114.84 3.83 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.701 2.267 . . . . 0.0 112.399 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.8 m -53.5 -22.17 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.124 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -54.22 -42.96 70.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.086 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -70.09 -8.15 47.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -127.32 43.91 3.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.988 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 91.6 t80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.864 -179.936 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.834 0.349 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.02 -44.12 94.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -103.46 40.0 1.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -76.06 130.32 38.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 62.84 50.46 63.62 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.502 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 82.5 mt -146.08 120.27 9.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.842 0.353 . . . . 0.0 110.905 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -95.1 120.62 35.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -112.43 159.42 18.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' PHE . . . . . 0.459 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 35.4 t80 -141.69 116.71 9.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.872 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 3.8 mt -94.05 148.77 21.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.927 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -96.16 179.25 5.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 18.4 ptt85 -73.69 -39.88 64.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.4 -49.3 76.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.1 m -69.24 150.39 97.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.65 0.738 . . . . 0.0 111.14 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 122.16 8.85 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.701 2.268 . . . . 0.0 112.341 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' A' ' 344' ' ' ALA . 5.5 tmm_? -89.6 -37.4 14.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -60.02 -38.55 83.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.934 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.82 -59.65 2.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.087 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 51.5 mt -56.44 -59.2 5.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 340' ' ' ARG . . . -43.96 -56.89 3.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -54.11 -42.9 69.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.832 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 17.1 mt -66.92 -70.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.117 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 37.7 mt -43.69 -37.25 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.153 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -73.2 -37.2 66.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 7.4 m -72.57 -30.2 64.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . 0.514 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 15.3 m-85 -85.87 7.0 25.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.858 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 72.58 59.07 4.63 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.495 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -138.85 156.36 24.24 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.513 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -92.16 133.38 35.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.92 0.39 . . . . 0.0 110.871 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.6 138.7 25.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.126 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' SER . . . . . 0.52 ' CB ' ' CE1' ' A' ' 366' ' ' TYR . 5.1 t -134.05 157.28 46.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.863 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 22.6 p90 -141.03 177.14 8.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.39 111.31 4.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -50.33 -39.7 46.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 28.1 t -48.61 -47.96 39.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 76.0 mt -60.5 -47.03 87.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.904 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 1.8 m -166.64 137.37 3.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 26.1 pt -60.53 168.6 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 113.19 -36.96 3.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.501 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -45.45 166.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.853 0.358 . . . . 0.0 111.109 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' THR . . . . . 0.482 ' OG1' ' CD2' ' A' ' 366' ' ' TYR . 71.6 p -116.8 -68.94 0.88 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.12 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' TYR . . . . . 0.52 ' CE1' ' CB ' ' A' ' 355' ' ' SER . 0.9 OUTLIER -101.54 159.96 14.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.957 -179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -86.94 167.26 14.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.866 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . 0.459 ' HB ' ' CZ ' ' A' ' 333' ' ' PHE . 11.7 p -69.68 -30.3 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.109 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.5 p -83.49 20.61 1.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.139 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -95.06 121.76 37.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 99.0 p -69.78 -18.68 63.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 27.5 mtt-85 -57.33 -33.32 67.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.865 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.454 HG21 ' N ' ' A' ' 374' ' ' THR . 71.4 mt -54.64 144.26 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.454 ' N ' HG21 ' A' ' 373' ' ' ILE . 25.7 p -104.48 -42.04 5.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.145 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -128.54 133.0 48.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.847 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' GLN . . . . . 0.41 ' CD ' ' CZ ' ' A' ' 392' ' ' TYR . 24.9 tt0 -113.56 104.71 12.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 9.2 mm -77.56 123.04 33.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . 0.428 HG13 ' NE2' ' A' ' 384' ' ' GLN . 18.3 m -135.79 148.48 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.113 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -56.33 -39.01 72.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -148.14 104.98 3.59 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.591 0.71 . . . . 0.0 110.855 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.73 -6.38 18.44 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.69 2.26 . . . . 0.0 112.38 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 383' ' ' GLN . . . -83.21 -68.69 1.41 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 382' ' ' GLY . 12.3 mm100 -36.43 -49.64 0.73 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.696 0.284 . . . . 0.0 110.885 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.428 ' NE2' HG13 ' A' ' 378' ' ' VAL . 14.3 pt20 -98.62 143.43 29.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 69.3 p -90.09 127.48 36.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.141 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' SER . . . . . 0.431 ' HB2' ' CD1' ' A' ' 392' ' ' TYR . 90.4 p -62.81 159.25 16.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 88.0 t -90.3 148.52 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.111 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 6.4 mm -54.81 129.42 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.148 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 92.06 -42.44 2.75 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.498 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -85.59 146.04 27.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.765 0.317 . . . . 0.0 110.829 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 81.6 m -113.39 132.06 55.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . 0.431 ' CD1' ' HB2' ' A' ' 386' ' ' SER . 3.3 m-85 -104.13 125.3 50.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . 0.425 ' CG1' ' HB ' ' A' ' 410' ' ' VAL . 6.0 m -131.64 149.7 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -63.49 158.91 55.29 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.656 0.741 . . . . 0.0 110.859 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -6.95 19.85 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.706 2.271 . . . . 0.0 112.342 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -81.39 -26.17 35.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 81.8 t90 -54.13 -43.53 70.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 85.5 t -65.24 -47.67 86.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.114 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -58.93 -33.19 70.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . 0.538 ' CB ' ' CD1' ' A' ' 408' ' ' LEU . 61.6 m-20 -75.95 -31.24 58.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 26.2 m -72.84 -51.65 17.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.847 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . 0.514 ' HB ' ' CZ ' ' A' ' 350' ' ' PHE . 12.5 m -56.13 -40.5 64.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.094 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -67.36 -40.78 85.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -92.15 14.32 16.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 404' ' ' ALA . 1.2 mpp_? 34.3 40.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.859 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.63 149.3 23.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 50.0 mt -75.69 103.45 5.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.538 ' CD1' ' CB ' ' A' ' 400' ' ' ASP . 12.4 mt -70.8 155.35 93.51 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.587 0.708 . . . . 0.0 110.934 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 105.3 1.46 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.658 2.239 . . . . 0.0 112.362 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . 0.425 ' HB ' ' CG1' ' A' ' 393' ' ' VAL . 34.5 m -56.07 -16.63 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.135 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.11 93.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -71.18 -12.31 61.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.869 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -119.62 30.31 7.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.888 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 81.2 t80 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.892 179.995 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 36.8 mmtt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.824 0.345 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.414 HD22 ' C ' ' A' ' 326' ' ' LEU . 2.1 tt -70.01 -49.23 53.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.982 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -106.59 37.82 2.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -57.15 116.07 3.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 77.68 -50.81 3.31 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.494 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 329' ' ' GLY . 19.3 mt -34.65 127.66 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.886 0.374 . . . . 0.0 110.943 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -104.11 146.77 28.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -138.72 155.12 48.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -137.37 116.61 12.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.855 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 3.0 mt -92.52 144.86 24.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.931 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -89.4 -177.67 5.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 14.0 ptt-85 -80.7 -34.79 34.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -67.16 -42.56 84.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 4.3 m -78.89 150.02 74.68 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.61 0.719 . . . . 0.0 111.145 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 110.95 2.67 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.671 2.248 . . . . 0.0 112.39 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 0.459 ' HD2' ' N ' ' A' ' 341' ' ' GLU . 6.2 ppt_? -85.57 -36.11 20.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.459 ' N ' ' HD2' ' A' ' 340' ' ' ARG . 9.3 pt-20 -54.0 -39.41 66.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -79.51 -64.67 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.084 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 32.0 mt -50.07 -60.04 3.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.922 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 340' ' ' ARG . . . -42.4 -56.28 3.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.08 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -54.79 -45.98 74.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.914 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 19.8 mt -60.63 -62.35 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.123 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 23.9 mt -51.9 -43.85 36.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.118 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 70.1 mtp85 -67.01 -32.36 73.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.859 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 26.3 t -74.41 -39.58 62.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . 0.535 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 20.5 m-85 -75.15 -5.59 45.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.905 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 89.0 55.21 2.16 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.462 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -134.34 163.64 24.61 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.512 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -95.69 126.51 41.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.91 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 12.0 p -142.37 141.13 28.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.15 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 18.2 t -143.99 151.95 40.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 31.7 p90 -129.04 172.92 10.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.919 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -59.29 111.26 1.29 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -44.58 -36.77 3.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.4 t -58.1 -50.9 71.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 38.6 mt -48.55 -47.7 39.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.911 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 5.0 t -171.69 145.8 2.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.86 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.3 pt -59.87 166.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.091 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 114.63 -35.21 4.52 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.475 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -51.99 158.77 0.99 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.872 0.367 . . . . 0.0 111.101 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 6.1 p -115.14 -65.7 1.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.166 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -107.56 152.36 24.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.423 ' N ' ' OD2' ' A' ' 370' ' ' ASP . 64.0 m-20 -81.35 173.27 12.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.826 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 12.2 p -69.29 -21.19 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.086 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.6 p -87.34 25.22 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.095 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . 0.423 ' OD2' ' N ' ' A' ' 367' ' ' ASP . 6.6 m-20 -103.27 104.36 14.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 372' ' ' ARG . 11.8 t -39.92 -42.13 1.29 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 371' ' ' SER . 24.8 mmt180 -35.67 -45.54 0.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.873 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.403 ' HB ' ' NH1' ' A' ' 390' ' ' ARG . 41.1 mt -46.6 124.97 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.08 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 44.3 p -97.17 -46.61 6.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.165 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -124.32 141.04 52.39 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.881 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -120.8 111.02 17.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 39.6 mm -76.27 124.9 35.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.083 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 34.5 m -145.08 152.33 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.133 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.37 -37.37 66.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -127.29 86.03 59.62 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.653 0.74 . . . . 0.0 110.891 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 3.22 2.86 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.692 2.261 . . . . 0.0 112.348 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -100.74 -42.8 2.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.52 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -55.13 -68.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.776 0.322 . . . . 0.0 110.956 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.429 ' NE2' ' CD2' ' A' ' 392' ' ' TYR . 4.2 pp0? -63.53 151.67 40.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 98.9 m -89.8 119.87 30.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.185 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 60.6 p -55.15 161.48 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.836 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 71.0 t -108.46 120.36 59.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.141 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 5.0 mt -39.31 104.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.156 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 119.07 -43.18 1.63 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.48 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' ARG . . . . . 0.403 ' NH1' ' HB ' ' A' ' 373' ' ' ILE . 11.8 ttm-85 -80.53 158.19 25.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.741 0.305 . . . . 0.0 110.907 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 55.8 m -126.06 128.88 48.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.891 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . 0.429 ' CD2' ' NE2' ' A' ' 384' ' ' GLN . 3.0 m-85 -105.65 132.47 51.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.907 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . 0.442 HG11 ' CG1' ' A' ' 410' ' ' VAL . 14.2 m -143.39 147.38 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.127 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -55.12 156.21 7.71 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.59 0.709 . . . . 0.0 110.952 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -3.93 12.98 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.359 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 41.5 tp60 -85.13 -28.98 25.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.937 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -48.74 -28.14 3.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.467 ' O ' ' CG2' ' A' ' 402' ' ' VAL . 56.3 t -85.44 -29.58 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.105 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -72.73 -37.2 67.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.906 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . 0.471 ' OD2' ' CZ ' ' A' ' 413' ' ' TYR . 0.8 OUTLIER -84.34 -23.2 30.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.927 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 3.2 m -81.09 -47.85 12.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . 0.535 ' HB ' ' CZ ' ' A' ' 350' ' ' PHE . 13.2 m -57.5 -36.88 55.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.156 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -69.9 -34.39 73.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -95.66 15.08 20.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.081 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 404' ' ' ALA . 9.9 mmt85 35.89 39.73 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.892 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 27.5 tp -147.89 163.29 37.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 42.1 mt -95.0 81.02 3.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 62.7 mt -47.71 155.67 0.77 Allowed Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.605 0.716 . . . . 0.0 110.916 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 118.07 5.46 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.668 2.245 . . . . 0.0 112.326 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . 0.442 ' CG1' HG11 ' A' ' 393' ' ' VAL . 23.2 m -58.54 -31.28 43.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.144 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -42.88 -52.55 5.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.128 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -59.07 -39.68 82.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.471 ' CZ ' ' OD2' ' A' ' 400' ' ' ASP . 68.6 m-85 -95.21 45.76 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 31.8 t80 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.823 0.344 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 14.3 tp -42.4 -37.7 1.65 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.888 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -116.96 50.02 1.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -87.87 137.72 32.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 58.11 41.73 94.77 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.491 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 72.5 mt -141.38 120.22 12.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.902 0.382 . . . . 0.0 110.945 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -93.94 117.25 29.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -105.86 158.44 16.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -141.1 119.86 12.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.883 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.466 ' HG ' ' CG2' ' A' ' 354' ' ' VAL . 14.6 mt -95.53 142.67 27.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.916 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -100.9 179.32 4.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.867 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.448 ' HG2' ' N ' ' A' ' 337' ' ' GLU . 0.0 OUTLIER -78.24 -29.21 48.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.847 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . 0.448 ' N ' ' HG2' ' A' ' 336' ' ' ARG . 20.8 tt0 -72.48 -15.69 61.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 10.6 m -110.02 150.98 42.18 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.636 0.731 . . . . 0.0 111.109 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 115.49 4.11 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.695 2.263 . . . . 0.0 112.354 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 341' ' ' GLU . 19.5 ttp-105 -77.04 -69.69 0.51 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 340' ' ' ARG . 8.3 pt-20 -35.07 -44.58 0.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.17 -64.14 0.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.099 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 346' ' ' ILE . 36.6 mt -59.35 -63.16 1.4 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.903 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 343' ' ' LEU . . . -36.84 -51.86 0.91 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.073 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -59.14 -40.05 84.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' ILE . . . . . 0.64 ' CD1' ' CE1' ' A' ' 399' ' ' PHE . 27.5 mt -67.24 -64.21 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 24.9 mt -48.08 -41.73 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -68.4 -39.25 81.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 12.1 t -68.17 -22.99 64.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -105.48 22.52 15.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 57.46 63.75 5.01 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.471 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -133.81 155.79 21.97 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.503 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -92.25 130.98 37.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.861 0.362 . . . . 0.0 110.908 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.466 ' CG2' ' HG ' ' A' ' 334' ' ' LEU . 7.4 p -146.39 132.2 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 9.6 t -130.06 163.46 26.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -135.04 178.69 6.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.865 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 358' ' ' LYS . 7.7 t70 -70.94 105.89 3.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 357' ' ' ASP . 70.3 mttt -35.47 -44.15 0.28 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.896 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 28.7 t -58.69 -52.95 63.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.834 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 18.5 mt -50.87 -49.44 59.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 3.0 m -160.35 145.35 14.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.3 pt -72.22 176.72 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 92.82 -15.85 61.7 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.48 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -56.75 -177.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.908 0.385 . . . . 0.0 111.099 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 72.7 p -131.47 -66.72 0.72 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -117.53 157.0 27.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.64 168.97 11.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' VAL . . . . . 0.427 ' HA ' ' CD1' ' A' ' 373' ' ' ILE . 9.9 p -66.24 -22.46 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 61.1 p -84.68 26.27 0.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -110.75 109.44 19.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 67.7 m -47.2 -38.23 11.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -40.15 -41.86 1.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' ILE . . . . . 0.427 ' CD1' ' HA ' ' A' ' 368' ' ' VAL . 86.8 mt -41.94 138.65 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.137 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 42.2 p -108.48 -26.82 10.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.15 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -153.44 133.07 13.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.853 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' GLN . . . . . 0.565 ' NE2' ' CG1' ' A' ' 378' ' ' VAL . 1.0 OUTLIER -112.33 94.06 4.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 30.2 mm -55.78 98.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.121 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . 0.565 ' CG1' ' NE2' ' A' ' 376' ' ' GLN . 26.8 m -122.02 140.32 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.138 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . 0.433 ' OD1' ' C ' ' A' ' 379' ' ' ASP . 4.3 t0 -48.04 -43.39 30.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.901 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -129.45 86.93 54.7 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.635 0.731 . . . . 0.0 110.823 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . 0.415 ' N ' HG23 ' A' ' 378' ' ' VAL . 54.2 Cg_endo -69.78 -9.74 26.83 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.687 2.258 . . . . 0.0 112.365 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -85.4 -39.41 8.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.504 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -73.31 -52.52 13.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.712 0.292 . . . . 0.0 110.91 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -45.51 142.01 2.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 57.9 m -71.15 101.17 2.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.106 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 24.9 p -53.56 167.71 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.817 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 389' ' ' GLY . 81.9 t -130.64 134.58 61.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.131 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.401 ' N ' HG12 ' A' ' 387' ' ' VAL . 15.3 mm -56.98 86.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.09 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 387' ' ' VAL . . . 135.06 -27.36 3.16 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.506 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -99.96 156.66 17.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.851 0.357 . . . . 0.0 110.855 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 72.3 m -129.73 123.87 32.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -97.37 121.58 39.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 21.8 m -126.83 164.01 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.144 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -87.49 161.36 45.66 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.606 0.717 . . . . 0.0 110.902 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -4.64 14.42 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.706 2.271 . . . . 0.0 112.348 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -82.99 -14.17 54.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -77.73 -13.77 59.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.439 ' O ' ' CG2' ' A' ' 402' ' ' VAL . 42.1 t -89.18 -41.15 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.154 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.64 ' CE1' ' CD1' ' A' ' 346' ' ' ILE . 47.8 m-85 -71.8 -34.37 69.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.859 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.32 -45.7 53.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.884 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 2.6 m -62.6 -56.25 19.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 398' ' ' VAL . 15.4 m -50.64 -42.54 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -70.62 -37.96 73.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.928 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -89.87 10.73 22.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 404' ' ' ALA . 46.8 mmm-85 37.21 44.05 0.4 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 28.7 tp -153.69 142.68 21.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 20.4 mt -80.73 73.95 7.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 75.4 mt -40.69 152.35 0.24 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.605 0.717 . . . . 0.0 110.91 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 105.6 1.51 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.688 2.259 . . . . 0.0 112.353 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.8 m -50.78 -22.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.111 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -50.94 -35.83 35.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.122 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -69.39 -38.28 77.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.942 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -90.81 41.57 1.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.908 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 16.5 t80 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.944 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 48.0 m -128.21 138.03 52.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.812 0.339 . . . . 0.0 110.885 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 16.6 m -110.89 166.91 10.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.857 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 154.88 152.1 6.04 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.459 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 4.9 t -93.38 159.33 15.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.861 0.362 . . . . 0.0 110.873 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 96.7 p -104.94 -45.96 4.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.822 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 166.61 -70.05 0.18 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.468 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 29.6 mmtm -130.0 175.9 8.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.769 0.319 . . . . 0.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -102.73 52.07 0.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.834 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -128.33 92.1 3.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -132.38 145.94 51.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 1.9 tt -67.54 -35.14 78.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -112.94 37.28 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -59.81 112.66 1.92 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 83.61 -49.19 4.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.453 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 329' ' ' GLY . 12.5 mt -35.41 129.72 0.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 110.946 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -103.07 130.15 50.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.864 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -121.53 164.46 17.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -143.02 139.22 30.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.43 HD13 ' CB ' ' A' ' 340' ' ' ARG . 3.5 mt -116.22 146.21 42.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -104.94 169.67 8.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -71.46 -13.28 61.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.837 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -82.97 -45.77 13.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.3 m -84.36 150.6 57.75 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.618 0.723 . . . . 0.0 111.102 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 120.7 7.44 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.658 2.239 . . . . 0.0 112.382 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 0.43 ' CB ' HD13 ' A' ' 334' ' ' LEU . 5.9 ptt180 -93.78 -38.4 11.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -45.44 -37.59 5.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -86.25 -57.43 3.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.08 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 89.3 mt -54.2 -60.42 3.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -42.11 -64.8 0.53 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.092 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -47.79 -40.69 21.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 16.6 mt -66.41 -72.42 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.13 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 22.4 mt -40.48 -38.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -67.2 -53.67 28.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 11.0 p -55.03 -36.27 65.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -80.72 11.35 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.857 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 65.96 48.83 62.64 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.536 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -122.13 160.77 16.49 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.476 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -93.57 131.11 39.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.906 0.384 . . . . 0.0 110.886 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 14.1 p -147.82 134.21 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.144 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' SER . . . . . 0.505 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 23.1 t -137.82 158.23 44.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 29.0 p90 -130.44 168.24 17.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.938 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . 0.435 ' CB ' HD12 ' A' ' 360' ' ' LEU . 3.1 t70 -56.57 122.03 11.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.819 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -51.7 -48.44 63.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 40.2 t -57.73 -48.48 79.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.435 HD12 ' CB ' ' A' ' 357' ' ' ASP . 32.6 mt -50.45 -51.18 49.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.93 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 4.7 m -160.23 139.23 10.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 12.6 pt -66.66 156.55 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.131 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 108.49 14.72 15.31 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.486 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -97.82 162.42 13.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.916 0.389 . . . . 0.0 111.067 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 19.5 p -116.22 -68.41 0.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.159 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' TYR . . . . . 0.505 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 9.6 p90 -99.99 147.28 25.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.906 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.97 175.86 9.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.842 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' A' ' 368' ' ' VAL . 7.9 p -75.26 3.24 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.09 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 74.6 p -112.15 27.54 9.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.121 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -104.69 101.55 11.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 9.7 m -42.66 -35.13 1.03 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.819 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -40.9 -43.68 2.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.817 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 66.1 mt -44.17 125.33 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.148 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 43.0 p -92.84 -45.05 8.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.133 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -127.41 135.84 51.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' GLN . . . . . 0.576 ' NE2' ' CE2' ' A' ' 392' ' ' TYR . 40.6 tt0 -120.33 123.84 44.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 33.0 mm -92.32 133.75 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.153 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 19.4 m -149.99 153.03 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -76.16 -28.94 57.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -134.73 80.85 48.79 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.592 0.711 . . . . 0.0 110.87 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -18.25 37.27 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.678 2.252 . . . . 0.0 112.299 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -77.52 -64.32 2.09 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.488 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -42.3 -57.72 2.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.797 0.332 . . . . 0.0 110.909 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -79.86 129.04 34.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.943 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 70.6 p -63.1 -179.85 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.121 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 25.3 p -110.98 178.87 4.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . 0.43 HG11 ' N ' ' A' ' 388' ' ' ILE . 49.0 t -125.29 137.97 55.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.107 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.43 ' N ' HG11 ' A' ' 387' ' ' VAL . 3.0 mt -44.12 123.34 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.106 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 89.26 -44.29 3.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.561 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -82.16 137.41 34.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.827 0.346 . . . . 0.0 110.889 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 23.5 m -120.61 117.38 27.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . 0.576 ' CE2' ' NE2' ' A' ' 376' ' ' GLN . 9.7 m-85 -80.79 145.64 31.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.942 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 31.3 m -150.56 165.33 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.115 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -78.39 158.18 76.84 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.6 0.715 . . . . 0.0 110.894 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -4.36 13.91 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.675 2.25 . . . . 0.0 112.351 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -86.74 -23.85 25.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -59.82 -33.37 71.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 75.4 t -76.16 -47.2 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.138 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -58.35 -36.5 73.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.866 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.85 -27.38 60.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 40.4 m -76.13 -51.27 12.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 14.8 m -53.5 -41.98 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.157 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -69.27 -34.78 75.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -93.07 3.28 56.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 42.58 44.72 3.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' A' ' 407' ' ' LEU . 18.6 tp -160.86 154.84 22.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.906 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . 0.437 ' N ' ' HG ' ' A' ' 406' ' ' LEU . 97.3 mt -84.9 99.68 11.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.01 154.97 91.43 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.597 0.713 . . . . 0.0 110.902 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 105.73 1.54 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.711 2.274 . . . . 0.0 112.33 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.2 m -53.9 -16.62 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -58.27 -23.85 57.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.103 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -86.0 -31.65 21.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.908 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -102.6 39.85 1.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 43.2 t80 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 82.9 p -170.31 133.6 1.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.862 0.363 . . . . 0.0 110.911 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 47.5 t -88.88 160.55 17.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.888 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 125.3 134.57 4.17 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.524 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 77.2 p -42.47 143.44 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.882 0.373 . . . . 0.0 110.911 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 62.9 m -117.82 135.53 54.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.824 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -121.34 -77.43 0.46 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.535 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt -73.19 161.0 31.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.855 0.36 . . . . 0.0 110.883 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -118.43 40.85 3.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -146.17 146.05 30.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -134.53 142.9 47.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.88 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -54.26 -41.76 69.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -112.89 47.86 1.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -72.87 138.09 46.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.885 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 49.03 60.0 6.44 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.5 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 90.6 mt -150.17 121.39 7.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.823 0.344 . . . . 0.0 110.935 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -99.5 123.36 43.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -115.12 164.09 14.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -138.2 117.03 12.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.864 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.448 ' HG ' ' CG2' ' A' ' 354' ' ' VAL . 4.7 mt -93.02 141.38 28.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.92 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -95.81 -177.18 3.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -85.66 -20.84 28.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.831 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -78.6 -18.32 54.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 6.0 m -108.12 150.61 40.66 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.595 0.712 . . . . 0.0 111.126 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 119.22 6.2 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.685 2.257 . . . . 0.0 112.346 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 341' ' ' GLU . 34.3 ttp180 -85.41 -56.78 3.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 340' ' ' ARG . 6.8 pt-20 -36.84 -39.58 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.909 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -79.0 -64.55 1.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.092 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . 0.424 HD23 ' CE2' ' A' ' 399' ' ' PHE . 52.6 mt -57.2 -61.67 2.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.894 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.406 ' HB1' ' CG ' ' A' ' 340' ' ' ARG . . . -41.54 -48.65 3.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.125 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -63.59 -48.97 75.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 16.8 mt -55.25 -64.82 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.159 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 32.7 mt -50.42 -47.66 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -64.6 -24.22 67.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 23.2 t -84.52 -29.7 25.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -83.53 -8.99 59.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 93.1 42.63 4.29 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.486 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -122.97 164.34 15.97 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.501 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -93.29 135.04 34.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 110.949 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.448 ' CG2' ' HG ' ' A' ' 334' ' ' LEU . 12.6 p -149.88 125.84 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.158 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 2.0 t -128.24 161.18 29.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 41.0 p90 -138.7 171.92 13.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.951 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -67.73 111.17 4.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -42.58 -54.26 4.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.4 t -41.47 -59.61 1.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 9.0 mt -51.65 -50.71 59.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 4.8 m -154.39 141.88 19.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 20.7 pt -73.92 -175.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.15 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 86.43 -15.39 50.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.451 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -63.73 166.3 7.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 0.0 111.105 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 41.0 p -117.32 -70.51 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.169 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -109.52 139.06 44.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.939 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.56 169.76 15.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.83 -19.48 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.153 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 62.7 p -84.44 26.3 0.8 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.14 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -115.05 121.09 42.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.7 t -58.41 -36.12 73.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -38.92 -40.42 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.928 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 374' ' ' THR . 49.8 mt -46.34 138.32 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.414 ' N ' HG22 ' A' ' 373' ' ' ILE . 26.5 p -113.57 -22.85 10.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.15 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -150.26 155.33 39.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -135.79 111.88 9.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.95 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . 0.426 ' CG2' ' HA ' ' A' ' 395' ' ' PRO . 46.8 mm -82.75 113.74 22.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.155 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . 0.464 ' CG2' ' HB3' ' A' ' 381' ' ' PRO . 29.2 m -131.34 148.08 32.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.11 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -62.25 -42.93 99.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -131.93 82.19 60.42 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.593 0.711 . . . . 0.0 110.931 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . 0.464 ' HB3' ' CG2' ' A' ' 378' ' ' VAL . 53.5 Cg_endo -69.76 -13.86 35.26 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.686 2.257 . . . . 0.0 112.352 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -73.92 -44.83 29.25 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.522 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . 0.413 ' HG3' ' N ' ' A' ' 384' ' ' GLN . 3.1 pt20 -62.27 -37.34 85.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.737 0.303 . . . . 0.0 110.885 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.413 ' N ' ' HG3' ' A' ' 383' ' ' GLN . 7.8 pt20 -98.34 118.07 34.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 44.7 p -50.49 175.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' SER . . . . . 0.506 ' HA ' ' CE1' ' A' ' 392' ' ' TYR . 1.9 t -104.81 178.66 4.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 74.4 t -119.56 136.23 57.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.149 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 5.9 mm -51.21 103.97 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 109.44 -28.34 11.02 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.497 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -105.96 148.77 27.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.787 0.327 . . . . 0.0 110.858 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 63.7 m -125.17 131.29 53.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . 0.506 ' CE1' ' HA ' ' A' ' 386' ' ' SER . 24.9 m-85 -91.43 131.74 36.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 11.3 m -130.0 166.99 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.107 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -86.73 161.36 47.92 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.603 0.716 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . 0.426 ' HA ' ' CG2' ' A' ' 377' ' ' ILE . 54.0 Cg_endo -69.75 -7.42 21.01 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.684 2.256 . . . . 0.0 112.328 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -80.86 -24.4 38.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.885 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 41.5 t90 -59.1 -42.14 89.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 96.1 t -67.68 -58.37 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.156 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.424 ' CE2' HD23 ' A' ' 343' ' ' LEU . 59.7 m-85 -52.31 -26.53 12.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.429 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 24.2 t0 -85.07 -49.97 7.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.861 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 15.4 m -56.75 -51.25 69.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.859 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 27.7 m -55.53 -40.31 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.147 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -80.21 -9.14 59.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -113.14 8.6 18.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 404' ' ' ALA . 1.3 mpt_? 34.42 42.64 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 7.5 tp -162.8 144.28 10.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.868 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 12.4 mt -72.6 89.49 1.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.933 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.429 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 35.9 mt -56.62 154.34 17.86 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.569 0.699 . . . . 0.0 110.971 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 108.76 2.15 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.705 2.27 . . . . 0.0 112.348 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.3 m -57.19 -21.71 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.115 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -58.11 -12.0 3.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.105 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.39 -27.89 14.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -108.65 37.01 2.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 5.5 t80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.877 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 68.8 m 41.69 48.29 3.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.895 0.379 . . . . 0.0 110.868 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 20.7 m -104.3 -49.97 3.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.846 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 59.36 170.59 0.37 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.468 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 1.2 t -108.97 170.67 7.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.837 0.351 . . . . 0.0 110.879 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.1 t -110.47 41.77 1.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 69.18 -100.79 0.74 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.469 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -138.87 119.6 14.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 0.0 110.908 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -125.57 171.59 10.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.869 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -125.72 115.67 20.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -110.9 129.88 55.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 13.8 tp -49.23 -53.46 21.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.894 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -96.75 41.86 1.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -71.93 138.01 47.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 47.24 51.43 14.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.482 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 58.0 mt -139.43 122.18 16.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 0.0 110.924 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -93.98 129.25 40.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.891 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -125.81 152.19 45.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.878 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -131.91 136.01 47.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 8.0 mt -112.46 137.53 50.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -85.7 -178.23 6.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -81.68 -23.4 36.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -77.48 -44.49 28.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.6 m -75.33 149.53 84.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.644 0.735 . . . . 0.0 111.103 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 124.74 11.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.65 2.234 . . . . 0.0 112.334 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 19.2 ttp180 -89.82 -60.12 2.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -38.07 -39.57 0.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.46 -60.11 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.084 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 49.4 mt -60.28 -63.42 1.3 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -39.84 -55.07 2.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.129 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -55.63 -44.53 77.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.868 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 18.5 mt -63.13 -67.92 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.129 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 33.5 mt -46.88 -42.42 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.108 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -68.95 -30.2 68.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 29.2 t -78.2 -34.05 49.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.892 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . 0.426 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 14.9 m-85 -83.42 7.62 16.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.857 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 76.36 63.96 2.27 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.55 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -145.42 154.75 26.13 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.516 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -92.57 125.66 37.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.879 0.371 . . . . 0.0 110.883 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 7.0 p -131.66 140.95 46.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.111 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 32.5 t -132.39 159.29 39.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.847 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' TRP . . . . . 0.562 ' CD1' ' SG ' ' A' ' 361' ' ' CYS . 48.8 p90 -149.48 165.89 30.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.921 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -55.06 110.01 0.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.855 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.407 ' CD ' ' HB2' ' A' ' 364' ' ' ALA . 14.2 mmmt -54.86 -35.53 64.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 5.4 t -55.73 -54.96 37.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 14.7 mt -56.11 -45.3 79.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' CYS . . . . . 0.562 ' SG ' ' CD1' ' A' ' 356' ' ' TRP . 0.8 OUTLIER -151.98 135.37 16.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.874 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.89 143.26 12.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 133.06 -29.68 3.17 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.476 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.407 ' HB2' ' CD ' ' A' ' 358' ' ' LYS . . . -46.66 171.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 111.025 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' THR . . . . . 0.421 ' OG1' ' CD2' ' A' ' 366' ' ' TYR . 68.3 p -101.04 -69.81 0.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.138 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' TYR . . . . . 0.421 ' CD2' ' OG1' ' A' ' 365' ' ' THR . 1.1 p90 -112.27 173.18 6.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -86.36 164.91 16.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.56 -23.44 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.147 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 42.0 p -84.03 25.07 0.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.132 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.12 100.49 12.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.835 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 372' ' ' ARG . 56.0 m -51.72 -41.03 61.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 371' ' ' SER . 23.6 mmt180 -37.7 -40.61 0.43 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.893 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 95.4 mt -41.77 121.35 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.13 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 39.2 p -81.25 -40.31 23.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.191 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -132.77 148.79 52.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' GLN . . . . . 0.485 ' OE1' ' NE ' ' A' ' 390' ' ' ARG . 56.8 tt0 -130.37 115.66 17.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.863 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 47.0 mm -83.04 127.95 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.114 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 31.0 m -148.69 159.69 6.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.134 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.01 -38.73 35.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . 0.477 ' NH2' ' NE2' ' A' ' 383' ' ' GLN . 42.8 mtp180 -130.26 80.8 69.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.632 0.729 . . . . 0.0 110.917 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -15.55 37.2 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.701 2.267 . . . . 0.0 112.349 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -64.47 -53.85 32.98 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.45 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . 0.477 ' NE2' ' NH2' ' A' ' 380' ' ' ARG . 3.3 pt20 -89.19 30.56 0.96 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.714 0.292 . . . . 0.0 110.89 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -109.05 121.98 46.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.926 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 39.8 m -58.33 87.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 53.3 p -52.22 159.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 96.1 t -129.01 141.27 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.6 mt -51.35 115.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 101.51 -46.34 1.29 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.539 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . 0.485 ' NE ' ' OE1' ' A' ' 376' ' ' GLN . 15.4 ttp180 -80.68 144.87 31.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 110.852 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 10.3 m -124.4 134.26 53.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . 0.433 ' CZ ' ' OE1' ' A' ' 376' ' ' GLN . 3.0 m-85 -96.74 116.53 29.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.918 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 21.0 m -123.93 158.69 29.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.126 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -75.99 158.28 82.5 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.602 0.715 . . . . 0.0 110.919 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -4.16 13.45 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.665 2.244 . . . . 0.0 112.345 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -84.6 -16.33 42.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.962 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 69.1 t90 -65.34 -39.21 92.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.938 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 73.6 t -72.54 -52.76 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -51.2 -37.13 44.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.463 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 1.1 m-20 -73.49 -45.61 52.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 69.2 m -56.67 -58.03 9.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.852 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.426 ' HB ' ' CZ ' ' A' ' 350' ' ' PHE . 30.9 m -47.94 -43.58 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.104 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -66.13 -43.67 86.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -86.53 10.53 15.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.086 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' A' ' 404' ' ' ALA . 3.2 mpt_? 36.56 37.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 15.1 tp -151.49 145.01 24.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 17.6 mt -74.91 89.37 2.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.94 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.463 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 34.8 mt -60.52 154.91 52.57 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.626 0.727 . . . . 0.0 110.913 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 113.47 3.38 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.731 2.287 . . . . 0.0 112.344 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 19.5 m -55.17 -28.25 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.137 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -48.09 -30.33 4.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.136 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -77.76 -35.65 51.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.855 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -106.05 49.66 0.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 42.1 t80 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.838 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.519 -0.233 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 1.4 t -143.16 151.85 41.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.849 0.356 . . . . 0.0 110.846 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 31.3 t -58.51 147.46 31.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.15 -73.99 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.529 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 63.2 p -147.52 134.26 20.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 110.879 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 7.4 m -88.5 102.54 15.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.831 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -81.96 89.7 1.44 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.467 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -74.1 103.3 4.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.786 0.327 . . . . 0.0 110.861 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -119.77 172.11 7.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.808 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.46 107.85 2.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -108.15 152.05 25.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.868 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 12.2 tp -68.79 -50.55 49.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -87.49 31.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -66.09 118.22 9.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.832 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 66.28 49.32 57.94 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 67.9 mt -141.21 122.14 14.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.904 0.383 . . . . 0.0 110.914 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -95.54 139.8 31.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.49 ' CD1' ' HB2' ' A' ' 375' ' ' HIS . 80.7 m-85 -133.79 153.57 51.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' PHE . . . . . 0.468 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 9.4 t80 -129.56 117.6 20.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.848 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.426 ' HG ' ' CG2' ' A' ' 354' ' ' VAL . 12.7 mt -94.68 132.2 39.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.926 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -90.63 165.68 13.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.466 ' HG2' ' N ' ' A' ' 337' ' ' GLU . 0.1 OUTLIER -65.15 -30.07 70.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.828 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . 0.466 ' N ' ' HG2' ' A' ' 336' ' ' ARG . 9.1 pt-20 -65.56 -37.41 86.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.0 m -91.01 150.7 42.26 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.633 0.73 . . . . 0.0 111.106 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 128.46 16.04 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.683 2.255 . . . . 0.0 112.324 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -92.0 -49.3 6.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.866 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -42.68 -39.61 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -79.97 -65.74 0.97 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.052 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 68.6 mt -51.79 -62.53 1.57 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -40.74 -59.81 1.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -51.62 -49.14 62.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.843 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 349' ' ' SER . 31.1 mt -57.74 -70.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.136 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 28.0 mt -42.26 -52.19 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.105 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 26.5 mtt-85 -64.5 -25.66 68.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.882 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 346' ' ' ILE . 43.4 t -80.12 -30.21 39.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . 0.54 ' CZ ' HG13 ' A' ' 402' ' ' VAL . 16.3 m-85 -92.04 14.0 17.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.893 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 70.93 57.47 6.31 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.508 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -135.22 161.04 24.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.512 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -94.81 135.06 36.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.874 0.368 . . . . 0.0 110.869 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.426 ' CG2' ' HG ' ' A' ' 334' ' ' LEU . 8.1 p -148.37 133.98 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.169 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 17.3 t -132.42 162.84 30.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' TRP . . . . . 0.534 ' CZ2' ' O ' ' A' ' 363' ' ' GLY . 20.2 p90 -137.4 -176.39 4.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.944 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.38 118.92 18.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.822 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -58.89 -15.7 13.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 4.5 p -83.04 -27.66 30.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 22.7 mt -76.94 -49.65 15.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.96 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 8.2 m -157.86 139.55 13.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 24.3 pt -56.53 155.75 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.534 ' O ' ' CZ2' ' A' ' 356' ' ' TRP . . . 100.52 38.17 3.55 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.486 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -105.47 117.23 33.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 0.0 111.079 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 45.3 p -69.65 -61.0 1.96 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.153 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -126.53 158.37 36.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.22 169.9 11.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . 0.468 ' HB ' ' CZ ' ' A' ' 333' ' ' PHE . 11.5 p -68.01 -10.6 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.106 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 73.4 p -95.6 14.16 23.85 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.12 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . 0.48 ' OD1' ' CG ' ' A' ' 372' ' ' ARG . 4.6 t70 -87.54 107.54 18.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 64.1 p -50.74 -28.47 9.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.842 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . 0.48 ' CG ' ' OD1' ' A' ' 370' ' ' ASP . 17.0 mmm180 -54.03 -30.46 47.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.872 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 87.2 mt -51.53 126.64 6.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.105 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 47.4 p -95.53 -43.0 8.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . 0.49 ' HB2' ' CD1' ' A' ' 332' ' ' PHE . 20.0 m80 -130.11 155.04 46.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' GLN . . . . . 0.577 ' CD ' ' CE2' ' A' ' 392' ' ' TYR . 59.6 tt0 -136.18 115.0 12.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.9 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . 0.411 ' O ' ' CG1' ' A' ' 378' ' ' VAL . 45.3 mm -80.65 136.43 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . 0.411 ' CG1' ' O ' ' A' ' 377' ' ' ILE . 35.4 m -158.01 142.2 7.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.125 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -60.1 -32.67 71.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -128.55 80.92 71.67 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.617 0.722 . . . . 0.0 110.882 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -3.51 12.16 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.674 2.249 . . . . 0.0 112.358 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -106.52 -49.19 0.92 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.487 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -52.93 -73.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.783 0.325 . . . . 0.0 110.915 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -55.38 130.21 41.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.894 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 20.3 p -63.55 131.28 47.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 54.7 p -85.28 149.53 25.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.828 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 388' ' ' ILE . 63.2 t -75.82 114.8 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.104 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' A' ' 387' ' ' VAL . 2.1 mp -36.17 104.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.134 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 122.26 -45.11 1.24 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 11.1 ttm-85 -76.55 159.45 30.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.8 0.333 . . . . 0.0 110.83 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 19.0 m -122.31 134.85 54.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.937 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . 0.577 ' CE2' ' CD ' ' A' ' 376' ' ' GLN . 2.4 m-85 -112.85 147.55 36.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.944 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 20.8 m -151.25 145.69 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.135 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -61.35 158.36 38.39 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.557 0.694 . . . . 0.0 110.938 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -4.63 14.39 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.378 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -85.95 -19.0 31.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -64.63 -34.03 77.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 80.7 t -71.23 -32.82 48.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.182 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.41 ' CE1' ' CD1' ' A' ' 346' ' ' ILE . 38.4 m-85 -74.85 -60.03 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.873 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -52.93 -17.9 1.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 16.9 m -82.33 -53.21 6.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.54 HG13 ' CZ ' ' A' ' 350' ' ' PHE . 6.2 m -58.01 -37.54 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.158 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -72.56 -34.66 67.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.957 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 406' ' ' LEU . . . -94.31 9.23 38.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.095 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 404' ' ' ALA . 0.9 OUTLIER 36.95 31.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . 0.458 HD21 ' N ' ' A' ' 407' ' ' LEU . 0.0 OUTLIER -147.27 130.98 16.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . 0.458 ' N ' HD21 ' A' ' 406' ' ' LEU . 98.1 mt -66.67 85.66 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.946 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 32.0 mt -51.24 155.38 2.37 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.633 0.73 . . . . 0.0 110.882 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 118.82 5.91 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.691 2.261 . . . . 0.0 112.359 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.1 m -64.74 -25.51 38.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.088 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -54.55 -15.32 1.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.103 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -94.42 -30.97 14.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -96.06 33.34 1.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.95 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 16.5 t80 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 33.6 p -99.29 42.07 1.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.874 0.368 . . . . 0.0 110.882 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 41.4 t -44.0 -48.66 8.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 154.95 -141.5 8.2 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.503 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 50.6 p -96.38 85.61 3.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.903 0.382 . . . . 0.0 110.88 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 45.3 t -157.02 138.33 13.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.882 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -103.9 79.86 0.31 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.488 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -80.05 -52.69 7.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.831 0.348 . . . . 0.0 110.885 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 21.3 m170 47.85 45.72 18.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.36 109.9 3.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -117.91 153.44 33.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 18.8 tp -59.75 -54.92 40.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -95.18 37.5 1.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -73.03 139.35 46.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 53.72 47.98 62.91 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.493 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 71.9 mt -142.45 122.26 13.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.913 0.387 . . . . 0.0 110.878 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -96.13 126.76 41.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -119.34 152.81 36.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' PHE . . . . . 0.419 ' CD1' ' O ' ' A' ' 355' ' ' SER . 59.0 t80 -131.88 124.85 30.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.914 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 7.2 mt -101.78 133.15 46.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.969 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -88.74 163.99 15.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.444 ' HB3' ' CD1' ' A' ' 360' ' ' LEU . 2.0 ptp85 -65.2 -13.36 58.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -85.84 -46.76 10.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 4.1 m -77.94 151.1 78.93 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.652 0.739 . . . . 0.0 111.142 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 127.64 14.93 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.676 2.251 . . . . 0.0 112.36 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 0.444 ' O ' ' N ' ' A' ' 344' ' ' ALA . 0.5 OUTLIER -95.51 -55.05 3.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -39.15 -42.07 0.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -77.5 -51.12 11.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.121 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . 0.557 HD22 ' CE1' ' A' ' 399' ' ' PHE . 87.8 mt -65.16 -64.11 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -38.72 -53.14 1.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -57.54 -47.95 80.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 38.0 mt -62.59 -67.95 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.117 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 32.2 mt -44.26 -37.33 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.085 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -77.99 -35.0 50.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 46.7 t -67.62 -29.65 69.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.858 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . 0.42 ' CE2' HG13 ' A' ' 402' ' ' VAL . 25.4 m-85 -94.99 20.45 8.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 64.46 63.56 4.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.519 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -136.72 164.48 25.18 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.512 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -104.15 129.29 51.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.884 0.374 . . . . 0.0 110.868 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.86 138.91 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.12 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' SER . . . . . 0.419 ' O ' ' CD1' ' A' ' 333' ' ' PHE . 8.4 t -140.56 149.82 42.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 40.6 p90 -131.7 175.89 8.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -62.17 114.95 3.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -44.88 -46.3 10.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.3 m -53.26 -51.83 60.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.855 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.444 ' CD1' ' HB3' ' A' ' 336' ' ' ARG . 21.4 mt -46.56 -49.84 18.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.921 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 1.8 t -168.19 153.33 6.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 36.2 pt -63.32 177.08 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.119 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 94.42 -37.22 3.47 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -44.63 152.11 0.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.821 0.343 . . . . 0.0 111.121 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 5.1 p -116.2 -65.28 1.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.156 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -111.22 144.93 39.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.943 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -88.7 171.66 9.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.12 -17.35 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 22.6 p -79.24 12.09 2.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.166 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -101.43 140.56 35.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.854 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 372' ' ' ARG . 4.9 t -80.5 -40.52 25.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 371' ' ' SER . 9.0 ptp180 -36.69 -42.68 0.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.922 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.4 HG23 ' N ' ' A' ' 374' ' ' THR . 73.4 mt -40.11 136.89 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.146 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.4 ' N ' HG23 ' A' ' 373' ' ' ILE . 58.1 p -115.22 -24.72 8.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -139.91 143.03 36.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.868 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' GLN . . . . . 0.5 ' OE1' ' N ' ' A' ' 377' ' ' ILE . 0.7 OUTLIER -137.13 108.98 7.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . 0.5 ' N ' ' OE1' ' A' ' 376' ' ' GLN . 5.5 mm -79.39 127.0 39.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.127 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 30.6 m -139.98 155.94 24.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.158 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -81.51 -23.34 37.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . 0.407 ' O ' ' CG ' ' A' ' 383' ' ' GLN . 75.7 mtt180 -130.75 83.0 62.96 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.583 0.706 . . . . 0.0 110.852 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -18.41 36.99 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.651 2.234 . . . . 0.0 112.335 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -67.53 -55.25 15.67 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.468 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . 0.407 ' CG ' ' O ' ' A' ' 380' ' ' ARG . 3.7 pt20 -46.26 -33.85 4.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.763 0.316 . . . . 0.0 110.92 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -84.3 149.97 25.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.36 -70.7 0.71 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.119 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 96.7 p -175.13 164.23 3.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . 0.512 HG22 ' CZ ' ' A' ' 392' ' ' TYR . 74.6 t -133.05 153.73 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.145 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.5 mm -68.66 99.41 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.176 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 92.95 -35.01 4.25 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.482 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . 0.424 ' HG2' ' N ' ' A' ' 391' ' ' CYS . 8.3 ttm180 -93.0 151.36 19.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.762 0.315 . . . . 0.0 110.888 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' CYS . . . . . 0.424 ' N ' ' HG2' ' A' ' 390' ' ' ARG . 83.3 m -134.18 139.6 45.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . 0.512 ' CZ ' HG22 ' A' ' 387' ' ' VAL . 68.0 m-85 -81.38 140.67 34.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . 0.406 ' CG1' ' HB ' ' A' ' 410' ' ' VAL . 12.0 m -150.62 166.66 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.115 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -89.42 159.32 44.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.596 0.712 . . . . 0.0 110.878 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . 0.425 ' HA ' ' CG2' ' A' ' 377' ' ' ILE . 54.2 Cg_endo -69.7 -3.73 12.56 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.717 2.278 . . . . 0.0 112.379 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -84.91 -31.25 23.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.923 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' TRP . . . . . 0.519 ' CE2' HG13 ' A' ' 410' ' ' VAL . 69.1 t90 -50.5 -38.44 44.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.93 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.08 -61.21 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.074 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.557 ' CE1' HD22 ' A' ' 343' ' ' LEU . 12.3 m-30 -51.7 -29.63 19.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -73.32 -52.03 15.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 405' ' ' ARG . 14.6 m -58.47 -47.36 84.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.844 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.433 HG21 ' N ' ' A' ' 403' ' ' ASN . 27.3 m -61.24 -46.27 96.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.119 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . 0.433 ' N ' HG21 ' A' ' 402' ' ' VAL . 41.2 t30 -70.07 -8.08 46.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -122.93 0.48 9.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.097 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' A' ' 401' ' ' SER . 0.2 OUTLIER 44.53 32.12 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -141.94 140.69 32.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 12.4 mt -71.77 81.63 0.88 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 43.0 mt -55.22 155.64 8.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.599 0.714 . . . . 0.0 110.929 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 115.67 4.21 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.685 2.256 . . . . 0.0 112.325 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . 0.519 HG13 ' CE2' ' A' ' 397' ' ' TRP . 32.6 m -65.56 -21.39 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.144 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . 0.542 ' HA ' ' CE2' ' A' ' 414' ' ' PHE . . . -64.1 -33.8 76.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.171 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -75.93 1.07 16.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -126.06 41.56 3.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.967 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' PHE . . . . . 0.542 ' CE2' ' HA ' ' A' ' 411' ' ' ALA . 2.5 m-85 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.918 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.254 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 68.0 m 42.78 48.06 4.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.877 0.37 . . . . 0.0 110.888 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 33.3 t -124.6 100.65 6.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.844 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 68.75 -161.44 51.41 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.482 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 30.2 t -148.7 153.76 38.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.821 0.343 . . . . 0.0 110.865 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 14.4 t -104.91 162.51 13.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.871 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 103.74 148.57 19.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.479 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 32.1 tttp 66.06 44.42 2.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.826 0.346 . . . . 0.0 110.835 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -127.96 111.58 13.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.861 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp -101.71 155.24 18.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -131.71 144.99 51.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.937 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.407 ' C ' HD23 ' A' ' 326' ' ' LEU . 2.4 tt -59.25 -54.86 42.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.906 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -91.5 39.37 1.0 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -80.96 106.7 13.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 88.08 43.54 5.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.458 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 83.5 mt -143.1 124.09 14.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.912 0.387 . . . . 0.0 110.909 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.418 ' HE3' ' CE2' ' A' ' 366' ' ' TYR . 28.3 mtpt -95.41 139.09 32.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 375' ' ' HIS . 88.5 m-85 -135.2 147.32 49.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -130.01 115.31 16.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 2.6 mt -90.77 148.08 22.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -107.14 176.93 5.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.944 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -74.79 -22.08 58.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -72.46 -35.97 68.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.897 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.2 m -95.54 150.87 38.09 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.622 0.725 . . . . 0.0 111.127 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 120.94 7.66 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.664 2.243 . . . . 0.0 112.41 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 0.411 ' HD2' ' CE3' ' A' ' 356' ' ' TRP . 27.7 ttp85 -87.19 -49.87 6.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.863 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -42.4 -36.77 1.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -83.05 -63.83 1.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.059 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 53.3 mt -53.95 -59.45 4.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -42.74 -60.51 1.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -51.15 -43.07 61.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.842 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' ILE . . . . . 0.481 ' O ' ' N ' ' A' ' 349' ' ' SER . 11.8 mt -63.64 -72.58 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 29.8 mt -39.16 -43.6 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.15 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 67.6 mtt-85 -68.51 -36.07 78.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.863 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' SER . . . . . 0.481 ' N ' ' O ' ' A' ' 346' ' ' ILE . 29.8 t -69.95 -43.34 71.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . 0.516 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 11.4 m-85 -73.17 -11.23 60.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 91.2 56.58 1.68 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.427 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -132.16 160.55 23.68 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -91.26 125.39 36.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.909 0.385 . . . . 0.0 110.886 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 12.4 p -137.85 139.56 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.132 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' SER . . . . . 0.544 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 42.7 t -136.74 149.34 47.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' TRP . . . . . 0.411 ' CE3' ' HD2' ' A' ' 340' ' ' ARG . 15.1 p90 -129.39 -175.86 3.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.962 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -76.97 105.76 8.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.82 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -38.89 -43.32 0.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.912 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 14.2 t -53.64 -58.73 6.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 18.8 mt -50.53 -48.94 57.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.912 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 4.2 m -158.39 130.0 6.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.902 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 14.9 pt -61.14 176.34 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.14 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 107.37 -39.65 2.81 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.45 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -38.72 158.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.877 0.37 . . . . 0.0 111.084 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 1.2 p -113.46 -45.67 3.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' TYR . . . . . 0.544 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 33.4 p90 -125.43 173.92 8.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.956 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.96 169.34 8.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.863 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 14.0 p -58.85 -31.36 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.111 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 68.1 p -63.6 -16.21 60.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -65.7 99.3 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 372' ' ' ARG . 22.2 t -47.5 -42.11 22.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 371' ' ' SER . 29.9 mmt180 -35.58 -45.25 0.35 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.826 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.436 ' C ' ' O ' ' A' ' 372' ' ' ARG . 77.8 mt -34.45 120.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.131 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 26.7 p -92.32 -44.26 8.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . 0.436 ' HB2' ' CD1' ' A' ' 332' ' ' PHE . 20.1 m80 -129.8 146.25 51.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.799 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -131.1 94.57 3.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.918 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 49.5 mm -58.61 132.44 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . 0.471 HG11 ' NE2' ' A' ' 384' ' ' GLN . 30.6 m -151.94 156.18 6.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.145 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -68.25 -38.74 82.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -122.71 84.17 49.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.57 0.7 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 94.46 0.53 Allowed 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.7 2.267 . . . . 0.0 112.346 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 152.44 -39.92 0.74 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.516 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -118.26 76.75 1.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.738 0.304 . . . . 0.0 110.923 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.597 ' OE1' ' CD1' ' A' ' 392' ' ' TYR . 0.0 OUTLIER -171.49 105.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' THR . . . . . 0.466 ' C ' ' O ' ' A' ' 384' ' ' GLN . 10.5 m 32.9 46.68 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 13.7 p -41.5 149.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 53.8 t -134.14 110.05 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.3 mt -50.0 100.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.127 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 126.09 -42.75 1.45 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -80.25 157.82 26.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.849 0.357 . . . . 0.0 110.862 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 1.8 m -122.73 145.37 48.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.85 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . 0.597 ' CD1' ' OE1' ' A' ' 384' ' ' GLN . 37.7 m-85 -117.98 131.58 56.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 17.3 m -129.6 155.3 41.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.082 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -72.39 161.37 79.4 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.576 0.703 . . . . 0.0 110.922 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -4.24 13.63 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.702 2.268 . . . . 0.0 112.371 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 -86.26 -16.35 37.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 79.7 t90 -65.72 -34.86 79.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 88.9 t -81.09 -49.81 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.106 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -51.13 -30.1 15.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -85.48 -47.3 10.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 63.7 m -56.45 -47.08 79.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.85 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.516 ' HB ' ' CZ ' ' A' ' 350' ' ' PHE . 23.5 m -50.44 -43.8 23.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.152 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -74.35 -40.34 62.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -76.86 0.72 19.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.121 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 41.96 44.74 3.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 25.4 tp -165.42 143.71 6.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.955 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 40.3 mt -69.6 93.94 0.74 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.941 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 65.7 mt -60.4 153.18 61.15 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.6 0.714 . . . . 0.0 110.924 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 114.48 3.72 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.677 2.251 . . . . 0.0 112.347 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 18.7 m -58.89 -27.4 35.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.09 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -50.17 -29.46 9.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.125 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -78.48 -24.98 45.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -106.6 38.03 2.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.944 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 53.1 t80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 -179.969 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 42.7 m -163.18 165.63 24.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 0.0 110.858 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 48.1 m -68.85 164.85 21.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.798 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -99.25 53.27 1.04 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.508 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 30.3 p -162.05 113.31 1.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 0.0 110.861 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 42.5 m -109.59 124.68 51.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -160.73 -70.97 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.444 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 19.0 tptp -152.1 106.53 3.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.343 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -86.15 117.43 24.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.84 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -123.42 41.76 3.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -41.84 132.35 3.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.906 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 22.4 tp -44.01 -54.06 5.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -98.0 36.78 1.5 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -60.94 116.85 4.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.864 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 76.17 -46.72 2.19 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 329' ' ' GLY . 24.3 mt -37.31 125.94 1.02 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.879 0.371 . . . . 0.0 110.95 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -95.24 144.76 25.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -135.06 153.26 52.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.919 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -140.17 117.11 11.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 2.8 mt -97.83 149.95 21.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.924 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -107.54 164.01 12.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.9 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -61.48 -31.1 71.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -41.59 97.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 10.1 m -91.03 150.81 42.43 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.628 0.728 . . . . 0.0 111.116 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 118.61 5.78 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.726 2.284 . . . . 0.0 112.301 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 24.3 ptt85 -89.29 -37.25 15.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.84 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -49.82 -42.75 47.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.851 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -74.8 -62.3 1.59 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.061 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 344' ' ' ALA . 30.9 mt -53.1 -60.36 3.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.908 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 343' ' ' LEU . . . -37.02 -58.9 0.75 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -53.14 -45.84 68.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 23.0 mt -59.23 -69.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.147 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 20.9 mt -40.1 -57.35 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.097 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -58.41 -45.78 87.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 40.2 t -55.04 -34.81 63.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -98.4 29.26 3.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.894 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 54.98 52.17 48.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.515 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -119.62 154.97 16.27 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.437 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -92.8 138.93 31.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.888 0.375 . . . . 0.0 110.864 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.78 140.33 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.118 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 42.0 t -140.04 144.23 36.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.815 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 40.5 p90 -121.13 174.84 6.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 358' ' ' LYS . 19.9 m-20 -65.0 104.15 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 357' ' ' ASP . 12.1 ptpt -36.65 -44.87 0.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 11.3 t -51.93 -48.74 64.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 8.8 mt -53.03 -47.48 68.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.894 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 45.5 t -162.33 156.73 21.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 21.2 tt -73.24 160.21 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.112 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 112.8 -27.64 9.58 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.508 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -41.59 148.26 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.85 0.357 . . . . 0.0 111.118 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 26.0 p -108.76 -64.82 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.151 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -117.2 144.42 44.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.871 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.03 174.15 8.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.887 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 7.1 p -69.62 -22.38 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.094 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 82.6 p -86.14 24.52 1.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.137 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -98.36 102.3 14.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.3 t -46.54 -29.31 1.73 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.824 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -47.43 -40.11 17.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.88 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 58.5 mt -40.06 147.48 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.135 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 55.3 p -125.8 -30.71 2.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -147.59 110.22 4.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.868 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -96.68 100.98 12.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 19.1 mm -68.79 113.48 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 18.7 m -126.65 -178.93 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.136 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.55 -40.5 10.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -128.69 80.9 71.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.657 0.742 . . . . 0.0 110.891 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -10.84 29.55 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.657 2.238 . . . . 0.0 112.33 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -85.4 -20.06 57.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.517 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -102.68 -43.8 5.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.778 0.323 . . . . 0.0 110.898 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -44.82 163.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.937 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 71.4 p -87.4 121.52 29.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.178 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 56.2 p -70.54 151.88 44.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.801 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 87.3 t -129.82 114.38 30.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.142 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 8.8 mt -38.08 116.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.118 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 102.68 -44.79 1.44 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.474 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -77.62 158.03 29.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.819 0.343 . . . . 0.0 110.888 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 82.4 m -133.63 132.73 41.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.861 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -106.68 124.65 49.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 19.2 m -135.44 156.86 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.118 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -71.0 158.86 87.26 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.607 0.718 . . . . 0.0 110.898 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -7.74 21.83 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.684 2.256 . . . . 0.0 112.332 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -79.19 -25.37 42.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.936 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' TRP . . . . . 0.51 ' HB2' ' CD2' ' A' ' 413' ' ' TYR . 92.0 t90 -59.44 -28.11 66.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 39.7 t -72.09 -57.55 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.137 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -50.0 -53.8 24.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.43 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 0.8 OUTLIER -54.85 -45.56 74.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 21.5 m -56.58 -66.7 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 403' ' ' ASN . 26.8 m -47.43 -40.48 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.101 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . 0.429 ' N ' HG23 ' A' ' 402' ' ' VAL . 14.4 m-20 -69.89 -35.07 74.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -92.08 11.65 24.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 404' ' ' ALA . 2.8 mmm180 38.11 44.24 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.839 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 8.1 tp -165.07 150.59 9.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.929 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 97.1 mt -81.16 80.11 7.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.43 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 49.3 mt -46.04 156.45 0.46 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.562 0.696 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 119.01 6.02 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.653 2.235 . . . . 0.0 112.322 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.88 -23.77 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.088 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -53.17 -18.58 2.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -88.73 -33.46 17.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.51 ' CD2' ' HB2' ' A' ' 397' ' ' TRP . 6.4 m-85 -95.3 36.03 1.27 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.902 179.983 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 7.7 t -117.49 164.95 14.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.883 0.373 . . . . 0.0 110.832 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 25.0 p -171.88 156.07 4.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.829 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -136.87 -126.27 2.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.463 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 1.9 t 48.45 46.77 20.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.888 0.375 . . . . 0.0 110.851 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 9.6 t -125.62 141.93 51.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.83 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -149.16 -159.36 8.54 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.48 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.492 ' O ' ' CG ' ' A' ' 323' ' ' HIS . 0.0 OUTLIER -157.73 141.27 15.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.85 0.357 . . . . 0.0 110.894 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.492 ' CG ' ' O ' ' A' ' 322' ' ' LYS . 18.8 m80 -167.31 161.93 14.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.823 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -59.71 91.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . 0.416 ' HD2' ' C ' ' A' ' 350' ' ' PHE . 9.9 mmtp -61.12 161.63 8.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.76 -40.45 72.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.933 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -118.06 40.71 3.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -56.94 114.78 2.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 75.23 -47.41 1.98 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.477 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 329' ' ' GLY . 33.0 mt -35.78 125.16 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.884 0.373 . . . . 0.0 110.929 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -101.96 151.13 22.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.928 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -141.94 154.48 45.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' PHE . . . . . 0.509 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 18.8 t80 -130.87 116.6 18.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.416 ' HG ' ' CG2' ' A' ' 354' ' ' VAL . 6.6 mt -91.09 146.76 23.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -101.72 164.49 11.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.912 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -66.58 -17.3 64.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -78.33 -47.62 17.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.892 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 2.1 m -84.32 148.98 54.16 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.615 0.722 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 138.04 36.99 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.706 2.271 . . . . 0.0 112.35 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 341' ' ' GLU . 16.9 ptt85 -102.23 -48.09 4.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.865 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 340' ' ' ARG . 4.9 pt-20 -35.29 -46.71 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -75.31 -59.05 2.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.072 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 79.4 mt -55.9 -63.64 1.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.93 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -39.42 -54.35 1.91 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.1 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -55.71 -44.78 77.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 21.7 mt -65.8 -67.79 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.135 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . 0.491 ' O ' ' N ' ' A' ' 352' ' ' GLY . 25.5 mt -41.4 -35.21 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 44.4 mtp85 -79.95 -45.65 18.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 32.3 t -56.08 -30.58 62.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . 0.416 ' C ' ' HD2' ' A' ' 325' ' ' LYS . 58.7 m-85 -98.58 26.67 5.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 58.91 58.96 11.8 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.479 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 347' ' ' ILE . . . -129.73 150.37 19.0 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.483 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -96.52 133.28 41.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.894 0.378 . . . . 0.0 110.914 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.416 ' CG2' ' HG ' ' A' ' 334' ' ' LEU . 7.4 p -143.49 143.39 24.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.119 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' SER . . . . . 0.556 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 1.5 t -141.07 156.8 45.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 23.9 p90 -138.09 140.79 40.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -42.77 115.99 0.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -44.7 -57.28 3.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.875 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 78.3 p -41.32 -47.87 3.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.853 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 86.7 mt -61.61 -50.92 70.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 23.3 m -154.95 140.55 17.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.3 pt -69.77 162.39 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.119 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 93.43 39.41 5.05 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.452 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -113.56 149.47 34.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 0.0 111.109 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 41.4 p -98.59 -72.4 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.096 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' TYR . . . . . 0.556 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 18.5 p90 -103.43 161.79 13.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.911 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.01 168.62 11.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.834 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . 0.509 ' HB ' ' CZ ' ' A' ' 333' ' ' PHE . 7.6 p -70.69 -6.65 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.161 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 24.3 p -100.3 18.71 18.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -95.19 118.69 32.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.821 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.2 m -51.17 -43.78 61.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.843 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 21.4 mtt85 -38.93 -40.1 0.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.82 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 57.0 mt -48.55 115.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.103 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 74.8 p -85.25 -43.61 13.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -128.84 158.97 37.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.81 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' GLN . . . . . 0.54 ' CD ' ' CE2' ' A' ' 392' ' ' TYR . 25.9 tt0 -140.62 108.97 5.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 44.6 mm -76.09 139.12 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.192 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 379' ' ' ASP . 18.7 m -154.7 139.59 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . 0.439 ' O ' ' CG ' ' A' ' 380' ' ' ARG . 5.7 t0 -35.95 -45.74 0.43 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . 0.439 ' CG ' ' O ' ' A' ' 379' ' ' ASP . 62.7 mtt180 -161.07 121.6 1.6 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.65 0.738 . . . . 0.0 110.86 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 2.67 3.3 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.673 2.248 . . . . 0.0 112.373 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -96.89 -31.41 7.0 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.48 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -91.84 31.73 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.882 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -174.14 144.07 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.871 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 9.9 t -79.62 158.15 27.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.6 p -110.97 166.64 10.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 56.5 t -98.97 128.39 50.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.4 mt -44.22 110.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.151 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 113.67 -41.25 2.25 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.468 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . 0.514 ' HD2' ' CE1' ' A' ' 392' ' ' TYR . 13.2 ttm-85 -79.52 152.39 30.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.778 0.323 . . . . 0.0 110.9 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 40.5 m -120.27 115.67 24.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . 0.54 ' CE2' ' CD ' ' A' ' 376' ' ' GLN . 7.0 m-85 -92.51 130.4 38.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.919 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 25.1 m -134.97 167.98 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.143 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -83.78 160.56 58.2 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.576 0.703 . . . . 0.0 110.935 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -7.99 22.48 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.708 2.272 . . . . 0.0 112.328 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 12.6 tp-100 -79.18 -12.76 59.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 92.4 t90 -79.79 -13.03 59.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.65 -33.81 6.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.163 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -76.33 -28.75 57.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -81.04 -53.09 6.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.875 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 39.3 m -48.74 -46.44 40.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 18.9 m -64.25 -43.1 97.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.126 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -64.28 -32.31 73.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -97.04 8.84 43.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.094 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 39.77 40.46 0.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 6.9 tp -156.93 149.41 23.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 90.7 mt -78.08 90.59 4.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 84.4 mt -56.35 151.63 27.34 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.581 0.705 . . . . 0.0 110.908 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 107.44 1.86 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.635 2.223 . . . . 0.0 112.37 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.2 m -54.21 -19.03 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.147 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -58.31 -14.52 7.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.107 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -98.43 -16.63 19.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -114.57 28.34 8.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 26.1 t80 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 317' ' ' SER . 87.9 p 41.09 46.47 2.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.863 0.363 . . . . 0.0 110.871 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.448 ' C ' ' O ' ' A' ' 316' ' ' SER . 42.4 p 34.6 44.34 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.819 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -100.48 103.14 2.58 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.527 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 54.8 p -164.87 150.92 10.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.896 0.379 . . . . 0.0 110.848 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 3.2 t -94.11 174.77 6.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 172.1 -175.44 45.37 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.29 177.77 5.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.828 0.347 . . . . 0.0 110.87 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -129.58 78.29 1.84 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -101.94 108.14 19.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -136.84 149.07 47.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.46 ' CD2' HD22 ' A' ' 407' ' ' LEU . 4.8 tp -71.47 -51.59 22.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.916 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . 0.464 ' HB2' ' CA ' ' A' ' 352' ' ' GLY . 22.8 m-85 -86.3 31.7 0.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -66.54 119.83 12.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.862 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 82.7 -53.07 4.79 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.467 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 329' ' ' GLY . 29.7 mt -36.69 124.84 0.86 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.847 0.356 . . . . 0.0 110.87 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -99.82 115.08 28.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -104.32 167.54 9.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' PHE . . . . . 0.41 ' CD1' ' O ' ' A' ' 355' ' ' SER . 34.6 t80 -152.58 115.56 4.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.466 ' HG ' ' CG2' ' A' ' 354' ' ' VAL . 4.1 mt -89.77 128.22 36.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.934 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -83.23 145.99 28.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.03 -20.03 1.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -78.75 -42.49 27.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 13.3 m -82.39 151.21 65.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.623 0.725 . . . . 0.0 111.144 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 124.82 11.47 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.715 2.277 . . . . 0.0 112.366 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 0.438 ' O ' ' C ' ' A' ' 341' ' ' GLU . 15.6 mtm105 -89.42 -55.45 3.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.875 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 340' ' ' ARG . 7.5 pt-20 -35.26 -45.85 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -71.58 -63.76 1.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.099 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 344' ' ' ALA . 35.3 mt -55.46 -63.59 1.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.916 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -37.07 -57.65 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -52.83 -46.21 67.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 14.6 mt -61.18 -62.05 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.129 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 20.3 mt -48.63 -53.03 7.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.155 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -62.07 -40.32 95.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 4.5 m -60.21 -34.88 74.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.821 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . 0.543 ' CD1' HG11 ' A' ' 402' ' ' VAL . 62.2 m-85 -98.79 29.04 3.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 53.8 59.17 10.19 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.477 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . 0.464 ' CA ' ' HB2' ' A' ' 327' ' ' PHE . . . -125.39 156.31 19.16 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.467 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -91.27 142.47 27.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.951 0.405 . . . . 0.0 110.838 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.466 ' CG2' ' HG ' ' A' ' 334' ' ' LEU . 7.5 p -159.11 141.03 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.149 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' SER . . . . . 0.41 ' O ' ' CD1' ' A' ' 333' ' ' PHE . 32.7 t -140.9 157.47 45.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.828 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -136.35 -177.89 4.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.13 119.78 13.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 22.8 mttp -53.52 -55.43 25.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 26.5 t -48.18 -58.94 3.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.87 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 5.9 mt -49.97 -40.54 44.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 3.8 m -160.68 144.72 13.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 7.3 pt -82.27 151.33 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.1 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 109.79 26.94 4.82 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.451 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -99.98 155.87 17.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 111.139 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 23.8 p -108.12 -57.82 2.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.14 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -128.27 136.7 51.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.9 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.92 169.8 14.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.839 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . 0.447 ' HA ' ' CD1' ' A' ' 373' ' ' ILE . 11.3 p -55.54 -29.35 24.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.137 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 75.8 p -65.88 -25.6 67.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.145 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -62.21 98.88 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 60.5 p -49.49 -29.62 6.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -45.99 -40.45 10.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.859 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.447 ' CD1' ' HA ' ' A' ' 368' ' ' VAL . 60.0 mt -38.16 145.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.103 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 75.7 p -117.55 -30.81 5.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.164 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -141.75 124.37 15.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.827 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' GLN . . . . . 0.529 ' NE2' ' CG1' ' A' ' 378' ' ' VAL . 0.2 OUTLIER -106.09 95.04 5.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 48.2 mm -58.62 97.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.108 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . 0.529 ' CG1' ' NE2' ' A' ' 376' ' ' GLN . 27.4 m -118.58 163.3 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.137 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.96 -34.77 64.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -134.64 80.9 49.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.602 0.715 . . . . 0.0 110.906 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 3.05 2.99 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.665 2.244 . . . . 0.0 112.381 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -113.43 -21.56 5.78 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.484 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . 0.421 ' HG3' ' N ' ' A' ' 384' ' ' GLN . 1.0 OUTLIER -92.64 -61.07 1.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.78 0.324 . . . . 0.0 110.888 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.421 ' N ' ' HG3' ' A' ' 383' ' ' GLN . 2.4 pt20 -54.56 138.82 39.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 7.8 t -48.93 146.8 3.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.14 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 25.2 p -118.87 152.71 35.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.848 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.39 119.22 49.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.112 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 5.0 mp -42.57 111.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.17 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 115.18 -38.58 3.07 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.52 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . 0.483 ' HD2' ' CZ ' ' A' ' 392' ' ' TYR . 6.7 ttm180 -83.55 146.81 28.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.765 0.317 . . . . 0.0 110.898 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 43.8 m -114.53 143.61 44.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . 0.483 ' CZ ' ' HD2' ' A' ' 390' ' ' ARG . 3.7 m-85 -123.29 129.33 51.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . 0.447 ' CG1' ' HB ' ' A' ' 410' ' ' VAL . 33.8 m -132.99 152.21 35.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.197 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -71.05 160.91 81.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.576 0.703 . . . . 0.0 110.936 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -4.58 14.3 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.709 2.273 . . . . 0.0 112.315 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . 0.525 ' HA ' ' CD2' ' A' ' 399' ' ' PHE . 14.0 tt0 -85.36 -31.77 22.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -53.78 -30.32 44.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.468 ' O ' ' CG2' ' A' ' 402' ' ' VAL . 21.4 t -72.52 -38.33 59.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.106 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.525 ' CD2' ' HA ' ' A' ' 396' ' ' GLN . 17.3 m-85 -63.19 -52.24 63.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.25 -26.92 67.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 45.8 m -75.81 -59.81 2.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.837 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.543 HG11 ' CD1' ' A' ' 350' ' ' PHE . 5.8 m -55.6 -33.99 34.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.083 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -76.3 -38.74 55.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -85.37 12.34 8.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.085 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 40.04 36.07 0.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 49.7 tp -151.48 151.39 31.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.978 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . 0.46 HD22 ' CD2' ' A' ' 326' ' ' LEU . 46.9 mt -86.83 71.9 10.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.924 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 407' ' ' LEU . 43.6 mt -38.04 156.41 0.1 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.621 0.724 . . . . 0.0 110.906 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 113.6 3.42 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.345 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . 0.447 ' HB ' ' CG1' ' A' ' 393' ' ' VAL . 16.4 m -61.83 -31.22 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -45.21 -44.39 10.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.47 -27.16 67.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -98.35 38.33 1.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.889 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 52.9 p -44.86 166.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.382 . . . . 0.0 110.87 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 47.5 t -130.72 119.86 22.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -39.49 104.1 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.463 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 97.4 p -91.36 90.91 7.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.853 0.359 . . . . 0.0 110.825 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 25.5 m -40.69 -44.27 2.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.86 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 134.92 109.17 1.02 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.454 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 22.3 tttm -84.63 -47.13 10.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.786 0.327 . . . . 0.0 110.899 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.457 ' O ' ' C ' ' A' ' 324' ' ' LYS . 9.0 m170 -71.45 121.86 19.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.858 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 323' ' ' HIS . 0.0 OUTLIER -33.34 141.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt -95.44 138.86 32.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 22.7 tp -53.25 -53.07 56.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . 0.413 ' HB2' ' CA ' ' A' ' 352' ' ' GLY . 24.5 m-85 -95.24 35.52 1.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -60.68 113.08 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 80.51 -41.88 2.56 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.5 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 34.9 mt -44.8 124.75 4.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.903 0.382 . . . . 0.0 110.894 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -95.81 147.39 23.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -137.82 155.77 48.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -139.55 116.3 10.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.434 ' HG ' ' CG2' ' A' ' 354' ' ' VAL . 2.8 mt -94.64 152.65 18.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -114.54 147.88 38.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.453 ' HD2' ' N ' ' A' ' 336' ' ' ARG . 0.5 OUTLIER -46.86 -27.78 1.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -63.87 -48.59 76.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.7 m -86.89 151.14 51.73 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.675 0.75 . . . . 0.0 111.121 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 116.06 4.38 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.67 2.247 . . . . 0.0 112.328 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 0.434 ' HG2' ' N ' ' A' ' 341' ' ' GLU . 0.0 OUTLIER -87.4 -29.98 21.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.884 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.434 ' N ' ' HG2' ' A' ' 340' ' ' ARG . 11.2 pt-20 -50.96 -49.75 59.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -74.3 -57.59 3.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.089 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . 0.443 HD21 ' CZ ' ' A' ' 399' ' ' PHE . 27.6 mt -53.14 -65.33 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 343' ' ' LEU . . . -35.03 -62.66 0.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.059 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . 0.585 ' N ' HH21 ' A' ' 348' ' ' ARG . 19.8 t80 -48.27 -49.73 32.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 349' ' ' SER . 44.4 mt -56.55 -71.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.16 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 352' ' ' GLY . 20.9 mt -37.99 -50.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.138 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . 0.585 HH21 ' N ' ' A' ' 345' ' ' PHE . 75.0 mtm180 -65.21 -37.71 88.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 346' ' ' ILE . 29.6 t -61.2 -42.83 99.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . 0.435 ' CD1' HG13 ' A' ' 402' ' ' VAL . 51.7 m-85 -88.54 23.05 2.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.869 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 60.67 57.2 20.12 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.452 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 347' ' ' ILE . . . -123.01 164.22 16.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.471 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -103.75 130.12 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.924 0.392 . . . . 0.0 110.893 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.434 ' CG2' ' HG ' ' A' ' 334' ' ' LEU . 5.7 p -141.51 142.76 28.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.123 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' SER . . . . . 0.442 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 4.6 t -140.48 162.46 35.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' TRP . . . . . 0.441 ' O ' ' CB ' ' A' ' 364' ' ' ALA . 20.4 p90 -139.32 153.92 47.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.913 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 360' ' ' LEU . 3.9 t70 -45.07 104.87 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 357' ' ' ASP . 7.3 mtpm? -35.92 -36.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.2 t -64.0 -48.35 76.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 357' ' ' ASP . 36.8 mt -55.44 -39.35 70.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 3.7 t -172.23 146.7 1.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.6 pt -66.34 173.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.102 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 104.42 -38.96 3.0 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.499 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 356' ' ' TRP . . . -50.34 140.3 13.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.822 0.344 . . . . 0.0 111.13 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 23.6 p -101.49 -50.94 3.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.186 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' TYR . . . . . 0.442 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 29.9 p90 -112.49 149.64 32.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.52 167.56 19.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.86 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 12.8 p -69.73 -22.56 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.155 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 77.3 p -84.02 13.55 4.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.61 110.49 17.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 22.6 p -55.35 -23.8 25.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -60.94 -36.8 80.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.85 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 66.6 mt -40.55 130.38 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.121 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 69.6 p -97.52 -24.72 15.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.169 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -154.55 149.36 26.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' GLN . . . . . 0.541 ' OE1' ' CE2' ' A' ' 392' ' ' TYR . 52.8 tt0 -134.37 111.56 10.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 19.1 mm -80.0 115.0 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.129 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 29.5 m -131.97 168.98 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.55 -34.59 31.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . 0.438 ' CZ ' ' HG3' ' A' ' 383' ' ' GLN . 81.3 mtp180 -132.23 80.81 62.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.612 0.72 . . . . 0.0 110.872 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -18.6 37.04 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.689 2.259 . . . . 0.0 112.358 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -73.92 -32.45 58.84 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.526 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . 0.438 ' HG3' ' CZ ' ' A' ' 380' ' ' ARG . 21.1 mm-40 -76.12 -49.3 17.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.756 0.312 . . . . 0.0 110.898 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -53.17 178.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 72.4 p -122.2 121.93 38.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 81.3 p -56.88 157.54 5.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 97.3 t -125.43 140.16 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.131 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.1 mt -37.82 111.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.093 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 92.13 -49.07 2.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.489 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . 0.463 ' HD2' ' N ' ' A' ' 391' ' ' CYS . 6.9 tmm_? -84.43 146.28 27.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.806 0.336 . . . . 0.0 110.863 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' CYS . . . . . 0.463 ' N ' ' HD2' ' A' ' 390' ' ' ARG . 88.3 m -134.8 147.55 49.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . 0.541 ' CE2' ' OE1' ' A' ' 376' ' ' GLN . 5.2 m-85 -94.62 132.87 38.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 4.2 m -138.26 158.13 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.116 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -78.7 161.32 69.67 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.608 0.718 . . . . 0.0 110.913 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -6.19 18.02 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.643 2.229 . . . . 0.0 112.341 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -80.96 -23.74 38.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.946 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 92.5 t90 -63.73 -27.97 69.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 48.0 t -75.0 -70.27 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.443 ' CZ ' HD21 ' A' ' 343' ' ' LEU . 5.4 m-30 -42.07 -36.95 1.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.88 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -72.44 -44.31 62.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 75.8 m -63.55 -54.47 35.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.81 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.435 HG13 ' CD1' ' A' ' 350' ' ' PHE . 2.5 m -56.74 -33.88 41.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.089 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -79.48 -29.48 41.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -94.5 9.17 39.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.071 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? 40.19 32.71 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.62 137.4 17.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.93 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 48.1 mt -74.1 85.37 1.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 45.5 mt -51.57 154.15 3.48 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.552 0.691 . . . . 0.0 110.977 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 107.93 1.96 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.711 2.274 . . . . 0.0 112.326 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.1 m -54.84 -16.78 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.141 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -62.16 -19.16 62.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -90.74 -24.24 20.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -104.96 38.27 1.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.905 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 6.0 t80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 15.6 m -86.03 153.87 21.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.913 0.387 . . . . 0.0 110.8 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 26.7 t -102.35 148.79 25.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.847 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -178.56 107.48 0.23 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.464 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 21.4 m -72.29 83.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.944 0.402 . . . . 0.0 110.872 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 30.0 p -70.96 96.54 1.31 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.866 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 159.97 147.49 4.92 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.468 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 18.5 mmtm -107.83 141.0 40.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.813 0.339 . . . . 0.0 110.884 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -134.0 170.69 15.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.828 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.32 98.88 6.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -91.03 133.89 34.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.903 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 15.9 tp -57.69 -52.57 64.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -92.41 38.39 1.01 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -71.69 141.15 49.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.919 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 45.49 43.45 10.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.451 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 42.1 mt -132.23 126.81 34.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.86 0.362 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.53 ' HE3' ' CE2' ' A' ' 366' ' ' TYR . 37.1 mtpt -99.32 141.38 32.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.909 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -133.18 156.16 47.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' PHE . . . . . 0.461 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 8.9 t80 -138.36 115.63 11.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.86 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 2.9 mt -94.47 151.96 18.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.933 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -104.45 177.12 4.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -77.48 -27.51 51.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.855 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -72.13 -26.04 61.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.1 m -102.15 148.39 35.31 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.603 0.716 . . . . 0.0 111.122 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 122.31 8.97 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.633 2.222 . . . . 0.0 112.343 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 0.49 ' O ' ' CB ' ' A' ' 344' ' ' ALA . 6.3 ppt_? -95.08 -30.67 13.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.463 ' N ' ' HD2' ' A' ' 340' ' ' ARG . 8.1 pt-20 -52.07 -37.82 55.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -86.26 -60.67 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.112 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . 0.53 HD22 ' CE2' ' A' ' 399' ' ' PHE . 54.9 mt -52.7 -55.58 21.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' A' ' 340' ' ' ARG . . . -45.35 -58.6 3.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.07 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . 0.407 ' O ' ' N ' ' A' ' 349' ' ' SER . 4.8 t80 -56.38 -46.93 79.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' ILE . . . . . 0.412 ' CD1' ' CE1' ' A' ' 399' ' ' PHE . 29.2 mt -55.83 -67.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.147 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 17.0 mt -45.77 -37.94 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.167 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -78.97 -26.72 43.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 345' ' ' PHE . 16.7 t -82.53 -21.9 35.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.837 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -101.18 15.56 28.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 72.31 73.37 0.85 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.501 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -158.1 169.03 34.69 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.455 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -106.03 143.47 34.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.832 0.349 . . . . 0.0 110.947 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 11.7 p -157.82 128.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.151 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' SER . . . . . 0.54 ' HB2' ' CE1' ' A' ' 366' ' ' TYR . 1.9 m -133.7 154.15 51.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' TRP . . . . . 0.466 ' CD1' ' O ' ' A' ' 361' ' ' CYS . 14.3 p90 -122.16 -178.5 3.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.884 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 358' ' ' LYS . 10.9 t70 -73.83 111.75 9.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.854 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 357' ' ' ASP . 27.4 mttt -35.0 -51.47 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 7.9 t -57.97 -49.11 77.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 28.1 mt -51.31 -51.12 57.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' CYS . . . . . 0.466 ' O ' ' CD1' ' A' ' 356' ' ' TRP . 1.8 m -160.91 143.28 12.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 45.0 pt -66.22 160.08 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.41 ' O ' ' CZ2' ' A' ' 356' ' ' TRP . . . 96.91 36.21 5.08 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.464 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -117.33 147.17 42.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.816 0.341 . . . . 0.0 111.116 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 21.9 p -105.18 -71.06 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.146 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' TYR . . . . . 0.54 ' CE1' ' HB2' ' A' ' 355' ' ' SER . 13.6 p90 -96.34 146.59 24.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.934 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.76 170.66 11.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . 0.461 ' HB ' ' CZ ' ' A' ' 333' ' ' PHE . 7.3 p -64.55 -18.05 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.134 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 70.1 p -85.37 22.85 1.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.181 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -104.73 103.83 13.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 30.0 m -50.35 -37.09 35.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 30.6 mtt180 -40.59 -39.84 1.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.86 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 70.6 mt -45.65 117.64 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.158 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 48.9 p -81.64 -44.93 16.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -126.32 138.87 53.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.861 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' GLN . . . . . 0.46 ' OE1' ' CZ ' ' A' ' 390' ' ' ARG . 37.6 tt0 -122.32 99.05 6.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.914 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . 0.424 ' N ' ' O ' ' A' ' 333' ' ' PHE . 25.8 mm -65.87 129.46 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 35.4 m -152.27 146.67 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.139 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -68.21 -34.54 76.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.827 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.2 mtp85 -132.7 89.86 34.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.612 0.72 . . . . 0.0 110.878 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -27.06 27.17 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.668 2.245 . . . . 0.0 112.337 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -72.58 -59.2 4.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.528 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . 0.457 ' HG3' ' N ' ' A' ' 384' ' ' GLN . 12.1 pt20 -43.03 -36.96 1.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.808 0.337 . . . . 0.0 110.921 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.457 ' N ' ' HG3' ' A' ' 383' ' ' GLN . 10.4 pt20 -104.32 114.67 29.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.95 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 16.2 m -51.37 153.11 2.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.159 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 6.9 t -91.51 173.18 8.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.858 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.9 t -127.77 130.91 70.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.111 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 29.3 mm -42.37 125.95 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.143 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 94.68 -33.52 5.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.487 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . 0.46 ' CZ ' ' OE1' ' A' ' 376' ' ' GLN . 19.8 ttp180 -93.97 146.11 24.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.782 0.325 . . . . 0.0 110.881 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 62.5 m -129.22 127.8 42.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -96.61 133.64 40.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 17.0 m -143.21 142.76 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.123 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -57.85 158.45 12.48 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.607 0.718 . . . . 0.0 110.93 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -7.25 20.6 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.709 2.273 . . . . 0.0 112.294 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.31 -33.75 42.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' TRP . . . . . 0.442 ' CE2' HG12 ' A' ' 410' ' ' VAL . 69.1 t90 -48.49 -31.16 6.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.926 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 65.7 t -80.22 -55.03 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.53 ' CE2' HD22 ' A' ' 343' ' ' LEU . 68.1 m-85 -54.23 -22.02 10.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -85.45 -41.39 15.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 405' ' ' ARG . 20.3 m -66.53 -51.92 51.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 15.3 m -49.77 -38.12 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.141 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -78.12 -44.18 26.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -83.08 8.28 13.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.138 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 404' ' ' ALA . 7.9 mmm180 35.57 46.0 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 12.6 tp -156.18 148.18 23.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.932 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 13.5 mt -80.0 84.14 5.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 33.1 mt -55.53 154.36 12.63 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.598 0.714 . . . . 0.0 110.886 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 114.13 3.61 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.707 2.271 . . . . 0.0 112.293 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . 0.442 HG12 ' CE2' ' A' ' 397' ' ' TRP . 35.2 m -60.57 -21.27 22.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.123 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -55.54 -40.05 71.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.085 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.38 -9.99 59.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -121.34 38.41 4.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.887 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 10.4 t80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 -179.976 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 14.5 m -130.33 -57.26 1.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.814 0.34 . . . . 0.0 110.852 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 54.9 p -169.6 158.58 7.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.807 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -146.47 95.23 0.17 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.476 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 21.3 t -141.1 140.54 34.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.876 0.37 . . . . 0.0 110.86 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 44.3 m -128.49 114.23 16.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.872 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 152.39 142.42 3.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.485 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.26 110.81 18.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.745 0.307 . . . . 0.0 110.919 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 51.3 m170 -100.47 119.72 38.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.845 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -69.71 144.01 52.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -121.69 118.71 29.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 11.6 tp -44.37 -50.58 9.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.866 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -93.01 42.59 1.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -74.56 133.86 42.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 52.32 55.29 22.75 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.486 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 88.0 mt -147.55 118.1 7.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.88 0.371 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -93.43 126.26 38.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.948 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.499 ' CD1' ' HB2' ' A' ' 375' ' ' HIS . 74.5 m-85 -120.29 160.36 23.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' PHE . . . . . 0.523 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 36.8 t80 -141.11 117.01 10.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 7.4 mt -93.67 142.84 26.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' ASN . . . . . 0.454 ' ND2' HG11 ' A' ' 378' ' ' VAL . 2.7 m-80 -101.22 158.25 16.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.422 ' HB3' ' CD1' ' A' ' 360' ' ' LEU . 12.9 ptt180 -58.78 -29.53 66.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.846 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . 0.462 ' CG ' ' OD2' ' A' ' 379' ' ' ASP . 11.6 tp10 -66.19 -48.0 72.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 5.1 m -80.82 150.64 69.66 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.582 0.706 . . . . 0.0 111.184 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 110.34 2.53 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.677 2.251 . . . . 0.0 112.3 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -86.53 -38.67 16.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -44.69 -41.33 6.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -82.42 -58.49 2.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.075 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 71.4 mt -53.99 -61.23 2.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -39.66 -55.55 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.068 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -58.81 -44.54 90.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 47.8 mt -59.65 -62.33 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.151 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 20.1 mt -51.97 -55.88 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -56.43 -40.26 74.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 29.5 t -64.92 -43.96 91.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . 0.464 ' CZ ' HG22 ' A' ' 402' ' ' VAL . 14.0 m-85 -73.44 -9.16 58.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 90.83 54.55 2.03 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.497 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -128.91 161.95 22.46 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.492 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -92.06 129.07 38.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.912 0.387 . . . . 0.0 110.851 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 10.8 p -148.06 143.2 19.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.155 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' SER . . . . . 0.528 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 5.1 t -147.39 152.26 37.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.868 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' TRP . . . . . 0.492 ' CD1' ' HB3' ' A' ' 361' ' ' CYS . 31.7 p90 -128.45 173.15 10.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.59 109.28 1.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.821 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -46.45 -34.34 4.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 28.4 t -69.41 -55.18 11.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.814 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.422 ' CD1' ' HB3' ' A' ' 336' ' ' ARG . 18.5 mt -54.91 -44.14 73.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.894 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' CYS . . . . . 0.492 ' HB3' ' CD1' ' A' ' 356' ' ' TRP . 2.1 t -147.21 159.97 43.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 15.7 tt -86.55 162.26 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.149 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 85.98 43.1 6.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.508 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -107.04 165.8 11.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.878 0.37 . . . . 0.0 111.09 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 20.9 p -129.78 -64.05 0.89 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.143 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' TYR . . . . . 0.528 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 8.3 p90 -112.31 145.91 39.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.953 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.13 167.17 22.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.88 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . 0.523 ' HB ' ' CZ ' ' A' ' 333' ' ' PHE . 7.5 p -63.62 -20.49 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.107 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 79.1 p -93.65 26.62 3.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.142 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -93.87 113.58 25.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 372' ' ' ARG . 11.9 t -53.62 -45.76 70.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.871 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 371' ' ' SER . 18.5 mmt180 -37.15 -42.42 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.917 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 34.0 mt -47.75 129.95 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.096 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 41.6 p -94.73 -43.1 8.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.106 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . 0.499 ' HB2' ' CD1' ' A' ' 332' ' ' PHE . 37.3 m80 -128.82 148.47 50.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -128.74 115.42 17.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.927 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 27.0 mm -82.72 116.17 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.167 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . 0.454 HG11 ' ND2' ' A' ' 335' ' ' ASN . 30.9 m -141.05 158.19 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . 0.462 ' OD2' ' CG ' ' A' ' 337' ' ' GLU . 2.8 m-20 -71.48 -37.7 71.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -127.69 81.98 69.19 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.578 0.704 . . . . 0.0 110.892 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -23.07 31.34 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.715 2.277 . . . . 0.0 112.373 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -68.64 -47.16 58.13 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.476 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -63.11 -48.9 76.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.775 0.321 . . . . 0.0 110.88 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -45.81 164.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.91 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 51.6 m -95.87 126.68 41.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.117 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 72.4 m -67.21 139.78 57.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 90.5 t -129.78 119.36 47.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.112 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 5.0 mp -39.94 134.41 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 88.76 -40.8 3.05 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.455 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . 0.428 ' NH1' ' O ' ' A' ' 368' ' ' VAL . 14.5 ttp180 -95.65 145.79 25.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.756 0.312 . . . . 0.0 110.871 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 84.0 m -132.85 124.33 27.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -90.89 128.07 36.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.954 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 19.7 m -135.99 151.11 28.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.088 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -66.55 158.12 80.1 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.602 0.715 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -5.5 16.34 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.662 2.241 . . . . 0.0 112.362 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -80.68 -14.77 57.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -73.12 -49.77 26.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 51.7 t -55.5 -41.75 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.12 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -65.03 -64.53 0.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.462 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 2.4 m-20 -50.42 -33.42 20.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.836 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 69.6 m -70.49 -26.24 63.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.464 HG22 ' CZ ' ' A' ' 350' ' ' PHE . 2.2 t -89.23 -45.73 15.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.096 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -67.73 -31.68 71.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -88.08 5.99 38.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.087 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? 40.08 44.4 1.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 43.0 tp -165.13 144.24 6.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 16.4 mt -74.95 99.31 3.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.462 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 52.2 mt -71.55 153.62 93.56 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.634 0.731 . . . . 0.0 110.924 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 119.57 6.49 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.702 2.268 . . . . 0.0 112.35 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.09 -28.6 44.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.136 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -52.9 -21.82 4.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -84.52 -32.65 23.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -104.96 42.51 1.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.923 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 3.7 t80 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.88 179.966 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 316' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 315' ' ' GLY . 2.0 m -35.44 -53.88 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 0.0 110.837 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 3.1 m -57.9 136.14 56.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.847 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 61.37 141.93 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.451 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 33.1 m -85.89 170.25 12.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.918 0.389 . . . . 0.0 110.806 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 27.4 p -165.38 159.33 16.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.846 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -125.3 -111.57 1.85 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.496 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -94.59 82.04 3.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.788 0.327 . . . . 0.0 110.926 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -122.02 171.62 8.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.845 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 8.9 mtpt -138.38 161.08 37.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -139.91 146.63 39.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.409 ' CD2' HD23 ' A' ' 407' ' ' LEU . 2.5 tt -57.26 -52.6 64.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.936 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -92.15 38.54 1.0 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -77.21 124.37 27.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 69.01 49.2 42.71 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.544 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 88.9 mt -148.19 124.46 10.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.854 0.359 . . . . 0.0 110.935 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.464 ' HE2' ' CE2' ' A' ' 366' ' ' TYR . 45.3 mttt -95.54 133.11 39.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -119.26 152.8 36.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.909 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -130.98 119.04 21.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.879 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 7.3 mt -97.95 140.89 31.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -98.34 -175.14 3.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.872 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -82.46 -33.74 28.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -69.81 -36.6 75.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.1 m -87.16 145.28 37.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.658 0.742 . . . . 0.0 111.107 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 127.32 14.44 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.664 2.242 . . . . 0.0 112.33 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 0.406 ' C ' ' HD2' ' A' ' 340' ' ' ARG . 0.0 OUTLIER -96.86 -40.19 9.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -45.65 -41.36 10.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -78.9 -66.91 0.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.139 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . 0.535 HD21 ' CE1' ' A' ' 399' ' ' PHE . 60.2 mt -44.57 -58.26 3.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -43.3 -54.79 4.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -55.39 -40.61 71.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 15.6 mt -68.64 -72.91 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.145 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 26.1 mt -37.33 -37.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.122 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -75.18 -47.99 25.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 47.5 t -55.52 -31.18 61.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.804 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . 0.414 ' CE2' ' HB ' ' A' ' 402' ' ' VAL . 20.7 m-85 -98.72 26.22 5.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 53.02 71.44 0.69 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.521 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -136.87 173.07 22.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.49 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -109.17 128.23 54.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 110.902 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.06 131.58 17.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.119 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' SER . . . . . 0.556 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 10.4 t -136.2 163.86 29.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' TRP . . . . . 0.493 ' CD1' ' HB2' ' A' ' 361' ' ' CYS . 34.0 p90 -142.35 159.07 42.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.905 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . 0.444 ' HB2' ' CD1' ' A' ' 360' ' ' LEU . 7.0 m-20 -55.65 120.88 7.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -45.08 -59.38 2.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 14.7 t -45.4 -48.88 13.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.824 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.444 ' CD1' ' HB2' ' A' ' 357' ' ' ASP . 32.3 mt -55.97 -49.62 73.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.973 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' CYS . . . . . 0.493 ' HB2' ' CD1' ' A' ' 356' ' ' TRP . 62.1 m -154.03 157.4 38.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.2 tt -84.9 158.48 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.117 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 91.73 36.38 6.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.486 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -105.52 158.2 16.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 0.0 111.087 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' THR . . . . . 0.434 ' OG1' ' CD2' ' A' ' 366' ' ' TYR . 22.3 p -111.99 -64.14 1.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.124 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' TYR . . . . . 0.556 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 16.0 p90 -110.18 139.43 45.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -76.74 171.46 14.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 13.6 p -64.12 -11.77 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.175 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 25.3 p -96.89 15.66 21.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.147 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . 0.427 ' CB ' ' HB2' ' A' ' 366' ' ' TYR . 0.9 OUTLIER -96.03 107.2 19.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.886 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 59.0 p -52.24 -33.34 41.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . 0.406 ' HB3' ' NZ ' ' A' ' 331' ' ' LYS . 26.1 mmm-85 -40.05 -45.14 1.88 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.877 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.428 HG12 ' CE1' ' A' ' 366' ' ' TYR . 20.7 mt -41.24 136.16 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.192 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 50.6 p -112.12 -23.87 10.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.114 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -134.47 134.16 41.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.847 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' GLN . . . . . 0.425 ' HG2' ' CE2' ' A' ' 392' ' ' TYR . 2.0 tp-100 -124.59 105.5 9.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.896 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 6.0 mm -84.38 126.38 40.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.09 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 13.5 m -139.11 152.36 23.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.12 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -67.19 -42.49 84.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . 0.414 ' NH1' ' HB3' ' A' ' 380' ' ' ARG . 0.0 OUTLIER -132.12 90.42 35.0 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 0.0 110.866 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -19.45 36.3 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.668 2.246 . . . . 0.0 112.352 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -65.48 -47.03 82.41 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.531 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -80.92 -42.22 21.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.756 0.312 . . . . 0.0 110.894 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -51.93 153.49 2.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.0 149.67 23.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.139 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 26.1 p -108.86 153.11 23.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.839 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 26.1 t -119.65 128.43 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.14 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.3 mt -40.4 117.67 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.167 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 103.88 -43.14 1.73 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.466 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -87.67 148.7 24.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 0.0 110.867 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 4.0 t -123.58 145.51 48.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . 0.425 ' CE2' ' HG2' ' A' ' 376' ' ' GLN . 2.9 m-85 -107.28 118.05 35.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.942 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 31.4 m -124.85 160.32 30.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.135 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -76.02 159.59 80.29 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.57 0.7 . . . . 0.0 110.887 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -6.69 19.18 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.669 2.246 . . . . 0.0 112.357 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -83.55 -15.9 47.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.947 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -66.09 -26.55 67.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 85.9 t -76.43 -51.34 19.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.161 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.535 ' CE1' HD21 ' A' ' 343' ' ' LEU . 11.1 m-30 -60.18 -30.67 69.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.445 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 1.0 OUTLIER -80.55 -36.45 33.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.904 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 71.8 m -69.27 -49.47 55.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.414 ' HB ' ' CE2' ' A' ' 350' ' ' PHE . 34.9 m -60.43 -45.29 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.117 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -65.08 -39.04 92.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -87.16 9.49 19.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.128 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' A' ' 404' ' ' ALA . 12.6 mmm-85 34.71 45.31 0.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -165.32 136.1 3.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . 0.409 HD23 ' CD2' ' A' ' 326' ' ' LEU . 15.6 mt -66.1 95.99 0.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.955 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.445 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 45.6 mt -64.75 156.1 80.07 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.607 0.718 . . . . 0.0 110.941 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 116.04 4.37 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.701 2.267 . . . . 0.0 112.361 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.9 m -58.02 -26.15 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.133 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -50.94 -34.3 28.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.072 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -75.72 -26.12 57.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -108.77 42.67 1.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 43.4 t80 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.898 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 82.3 p -152.68 163.58 39.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 0.0 110.889 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 5.5 t -142.3 169.48 17.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.888 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -155.72 76.8 0.21 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.481 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 90.1 p -148.04 153.83 39.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.923 0.392 . . . . 0.0 110.806 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 48.3 t -128.16 87.92 2.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 64.18 53.87 33.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.493 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -111.24 84.31 1.92 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.796 0.332 . . . . 0.0 110.849 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -109.9 100.1 9.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.864 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -112.87 78.19 1.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.938 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -125.32 136.68 53.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.941 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 2.0 tt -60.91 -48.62 80.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.939 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -93.48 38.87 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.848 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . 0.488 ' CD ' ' N ' ' A' ' 329' ' ' GLY . 3.9 tp10 -72.41 133.12 44.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . 0.488 ' N ' ' CD ' ' A' ' 328' ' ' GLU . . . 58.31 53.19 47.78 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.484 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 89.8 mt -148.14 132.6 17.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.884 0.373 . . . . 0.0 110.941 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -109.62 132.99 53.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.959 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -126.05 140.82 52.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.852 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -119.97 115.36 23.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.889 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 8.1 mt -89.08 145.57 25.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -98.87 -179.65 4.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -81.96 -17.96 45.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -79.3 -45.07 20.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.845 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 2.0 m -83.95 150.16 57.99 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.617 0.722 . . . . 0.0 111.18 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 137.69 35.96 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.712 2.275 . . . . 0.0 112.342 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 344' ' ' ALA . 0.0 OUTLIER -105.62 -34.73 7.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.905 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -50.91 -41.61 58.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -81.5 -48.41 11.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.083 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 75.7 mt -67.15 -65.67 0.65 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -38.09 -45.23 0.9 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.08 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -68.33 -44.77 74.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 25.8 mt -61.8 -63.03 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.104 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 28.1 mt -51.4 -43.01 29.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -67.63 -33.99 76.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 17.7 t -72.23 -44.05 63.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . 0.516 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 14.2 m-85 -72.68 1.16 8.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 81.42 54.78 3.4 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.499 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -129.19 153.42 19.83 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.461 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -91.81 126.36 36.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.926 0.393 . . . . 0.0 110.846 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 6.5 p -139.99 137.92 38.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.046 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' SER . . . . . 0.525 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 29.4 t -136.18 160.77 37.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 31.8 p90 -135.41 -175.37 3.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.925 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 358' ' ' LYS . 12.5 m-20 -78.08 113.22 15.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.416 ' NZ ' ' OD1' ' A' ' 367' ' ' ASP . 1.3 mppt? -38.31 -56.2 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 17.7 t -44.88 -50.11 10.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 29.1 mt -57.02 -35.68 69.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.944 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 1.9 t -174.64 156.61 2.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 10.6 tt -81.36 163.23 3.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 111.16 -33.57 5.79 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.467 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -40.47 147.14 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 0.0 111.143 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 42.8 p -110.92 -58.97 2.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.094 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' TYR . . . . . 0.525 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 18.7 p90 -111.51 146.36 37.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.905 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -86.47 165.51 16.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.838 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 13.7 p -56.73 -30.83 33.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.125 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 73.2 p -67.15 -25.84 66.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.211 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -56.69 103.65 0.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 53.9 m -54.7 -26.85 36.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -46.13 -40.11 10.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 68.4 mt -44.92 120.98 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 71.2 p -89.17 -50.58 6.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.142 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -120.7 146.69 46.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.829 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -131.44 102.7 6.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 31.8 mm -71.59 130.18 35.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.147 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 22.1 m -143.01 164.2 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.157 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 380' ' ' ARG . 0.4 OUTLIER -57.95 -48.45 79.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . 0.472 ' N ' ' OD1' ' A' ' 379' ' ' ASP . 53.4 mtm-85 -145.78 104.96 4.22 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.637 0.732 . . . . 0.0 110.861 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -0.05 6.31 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.694 2.262 . . . . 0.0 112.377 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -103.67 -34.78 3.71 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.528 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -71.23 -71.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.726 0.298 . . . . 0.0 110.861 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -61.85 143.6 56.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 96.5 m -69.05 128.95 38.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 9.2 p -80.9 166.02 21.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 388' ' ' ILE . 97.5 t -94.73 108.7 21.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.401 ' C ' ' O ' ' A' ' 387' ' ' VAL . 5.3 mp -36.32 102.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.148 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 125.2 -44.84 1.22 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.463 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 11.6 ttm-85 -78.9 160.51 27.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 110.852 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 73.6 m -119.21 115.81 24.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -96.0 136.04 36.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 17.8 m -139.47 153.11 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.13 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -68.81 159.24 83.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.57 0.7 . . . . 0.0 110.912 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -8.02 22.54 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.677 2.251 . . . . 0.0 112.398 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -81.22 -20.8 40.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 70.3 t90 -60.55 -43.05 97.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.99 -55.9 20.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.161 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -51.8 -35.62 44.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -76.4 -38.99 54.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.829 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 36.8 m -64.3 -48.23 76.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.815 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.516 ' HB ' ' CZ ' ' A' ' 350' ' ' PHE . 22.3 m -61.11 -46.22 97.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.104 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . 0.438 ' N ' HG23 ' A' ' 402' ' ' VAL . 41.5 t30 -62.13 -42.76 99.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -83.38 0.39 46.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 44.07 41.94 4.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -163.3 131.53 3.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 71.4 mt -61.15 103.13 0.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 35.0 mt -70.4 154.2 94.62 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.592 0.71 . . . . 0.0 110.878 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 105.28 1.45 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.711 2.274 . . . . 0.0 112.343 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 32.7 m -51.58 -23.97 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.157 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -49.41 -34.52 16.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.094 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -74.37 -40.53 62.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -91.07 40.1 1.01 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 34.2 t80 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.88 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 24.8 m -141.05 135.95 31.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.394 . . . . 0.0 110.857 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 61.8 p -132.89 133.57 43.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.848 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 62.55 95.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.507 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 18.9 p -91.53 50.17 1.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.361 . . . . 0.0 110.843 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 57.1 p -167.56 121.74 0.98 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 166.94 120.75 0.53 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.479 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -62.63 130.03 43.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.459 ' CD2' ' O ' ' A' ' 323' ' ' HIS . 0.3 OUTLIER -55.26 109.19 0.5 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.843 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 39.6 tttm -171.56 125.74 0.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 59.5 mmtt -135.11 123.2 22.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.923 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 2.4 tt -39.65 -48.08 2.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -96.87 42.0 1.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -80.53 107.12 13.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 90.31 43.82 4.85 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.493 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 96.6 mt -144.43 129.27 18.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.83 0.348 . . . . 0.0 110.959 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.41 ' CE ' ' HB3' ' A' ' 372' ' ' ARG . 19.7 mttm -96.79 143.57 27.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -134.33 144.09 48.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -129.57 116.72 19.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 5.4 mt -97.33 147.68 23.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.969 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -110.35 154.52 23.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -52.48 -36.63 55.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -56.62 -47.8 78.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.0 m -88.94 148.61 41.62 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.575 0.703 . . . . 0.0 111.142 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 125.04 11.68 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.713 2.276 . . . . 0.0 112.343 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 344' ' ' ALA . 0.3 OUTLIER -95.07 -40.99 9.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.857 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 342' ' ' ALA . 8.1 pt-20 -42.37 -42.89 3.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.424 ' N ' ' HG3' ' A' ' 341' ' ' GLU . . . -76.64 -46.7 24.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . 0.506 HD21 ' CZ ' ' A' ' 399' ' ' PHE . 24.2 mt -71.02 -66.34 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.939 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -34.65 -46.08 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.117 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -65.2 -43.33 91.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.926 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 343' ' ' LEU . 15.9 mt -62.7 -67.23 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.121 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 17.6 mt -42.34 -40.26 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 -72.77 -41.83 64.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 33.7 t -60.28 -33.18 71.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . 0.558 ' CZ ' HG11 ' A' ' 402' ' ' VAL . 22.8 m-85 -92.55 14.85 15.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.907 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 63.61 55.81 23.0 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.439 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -120.98 179.72 16.27 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.499 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -113.8 125.01 53.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 0.0 110.913 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 6.9 p -141.79 134.18 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 16.3 t -131.26 158.44 40.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.835 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 41.3 p90 -136.13 178.46 7.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.945 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 358' ' ' LYS . 0.6 OUTLIER -72.24 106.68 4.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.869 179.888 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 357' ' ' ASP . 0.1 OUTLIER -37.84 -45.61 0.86 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.918 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 58.8 m -42.09 -46.39 4.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 31.4 mt -60.01 -50.7 72.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 6.2 t -166.43 161.78 16.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 34.8 pt -64.21 175.34 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 364' ' ' ALA . . . 103.51 -35.07 5.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.508 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 363' ' ' GLY . . . -35.63 139.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.364 . . . . 0.0 111.087 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 37.2 p -113.37 -52.87 2.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.16 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -128.3 145.9 50.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.947 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -74.28 172.58 11.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.879 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 14.0 p -73.36 -14.12 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.135 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 41.3 p -96.94 19.65 12.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.144 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -95.79 105.95 18.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.832 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 8.4 t -47.05 -32.98 4.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . 0.41 ' HB3' ' CE ' ' A' ' 331' ' ' LYS . 9.0 mmt180 -41.95 -43.43 3.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.862 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.41 HG21 ' N ' ' A' ' 374' ' ' THR . 94.0 mt -49.62 135.9 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.112 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.41 ' N ' HG21 ' A' ' 373' ' ' ILE . 77.2 p -106.21 -39.43 5.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.123 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -128.83 122.11 29.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.81 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -105.2 112.69 25.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 49.6 mm -86.13 117.56 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.121 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 29.3 m -136.29 178.2 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.195 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -82.34 -43.91 16.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -125.51 82.2 63.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.573 0.702 . . . . 0.0 110.917 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -14.83 36.71 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.648 2.232 . . . . 0.0 112.354 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -72.78 -54.19 7.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.455 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -99.04 41.48 1.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.74 0.305 . . . . 0.0 110.893 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 385' ' ' THR . 4.3 tp-100 -122.76 100.86 7.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.969 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' THR . . . . . 0.415 ' C ' ' O ' ' A' ' 384' ' ' GLN . 31.3 m -36.59 122.77 0.79 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.114 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 34.4 p -102.73 -179.64 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 59.7 t -130.93 141.05 47.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.093 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.6 mt -42.2 113.89 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.133 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 104.27 -44.72 1.42 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.503 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 25.2 ttp180 -81.11 139.81 35.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.817 0.341 . . . . 0.0 110.861 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 61.8 m -127.38 125.6 40.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -85.86 137.19 32.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.932 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 23.4 m -142.34 164.46 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.119 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -79.04 160.79 70.49 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.567 0.699 . . . . 0.0 110.93 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 -4.83 14.79 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.669 2.246 . . . . 0.0 112.383 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -79.27 -34.22 42.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -50.7 -35.69 32.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.923 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 44.1 t -65.66 -51.57 61.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.107 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.506 ' CZ ' HD21 ' A' ' 343' ' ' LEU . 17.3 m-85 -57.27 -36.92 71.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.882 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.433 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 11.2 m-20 -73.8 -40.39 63.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.853 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 1.9 m -72.55 -23.28 60.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.831 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.558 HG11 ' CZ ' ' A' ' 350' ' ' PHE . 2.2 t -87.25 -31.13 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.14 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -85.37 -24.76 27.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -95.52 8.97 41.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.066 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 404' ' ' ALA . 10.2 mmt85 37.15 42.72 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.877 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 21.2 tp -166.69 142.22 4.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.94 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 13.0 mt -69.19 102.87 1.78 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 17.8 mt -73.68 154.29 89.42 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.593 0.711 . . . . 0.0 110.912 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 108.4 2.06 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.714 2.276 . . . . 0.0 112.319 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.0 m -53.52 -25.36 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.164 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -53.45 -16.16 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.074 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -95.03 -22.4 17.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.868 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -111.81 36.0 3.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.935 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 2.2 t80 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.921 -179.977 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 80.7 p -99.93 -58.28 1.95 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.921 0.391 . . . . 0.0 110.839 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 65.0 m -58.36 177.24 0.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.862 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 161.9 65.95 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.456 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 21.0 t -170.73 139.54 1.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.356 . . . . 0.0 110.883 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 321' ' ' GLY . 32.6 m -140.37 170.97 14.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.828 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 320' ' ' SER . . . 37.28 82.38 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.479 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.94 152.24 1.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 0.0 110.893 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -75.38 170.53 15.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -142.5 135.45 28.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.942 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -130.92 144.77 51.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.876 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 7.5 tp -65.15 -38.65 91.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -105.87 30.16 6.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -54.1 113.84 1.39 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 78.73 -45.35 2.68 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.517 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 15.8 mt -39.6 130.34 1.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.872 0.368 . . . . 0.0 110.912 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -98.97 152.14 20.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -144.65 148.38 34.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -135.59 116.69 14.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.915 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 2.6 mt -94.42 139.97 30.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -88.97 171.15 10.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -77.47 -9.89 59.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.845 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -87.31 -42.84 12.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 5.7 m -84.92 150.97 56.86 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.637 0.732 . . . . 0.0 111.105 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 115.34 4.05 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.681 2.254 . . . . 0.0 112.307 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -94.56 -39.7 10.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -40.2 -36.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -86.66 -49.22 7.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.106 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 30.8 mt -60.29 -61.78 2.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.945 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -38.73 -62.64 0.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.098 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -48.85 -42.01 34.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 23.3 mt -65.81 -72.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.122 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 27.5 mt -38.95 -44.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.153 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -66.78 -42.68 85.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 8.9 t -65.74 -28.48 69.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.849 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -88.6 12.85 13.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.835 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 68.93 50.65 33.6 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.488 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -132.35 156.55 22.08 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.434 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -91.52 132.39 36.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.909 0.385 . . . . 0.0 110.911 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.24 142.8 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.157 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 26.3 t -137.05 159.85 40.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -139.65 174.42 10.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.5 119.13 4.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.887 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.43 -8.72 14.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 4.3 t -88.64 -23.41 23.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.836 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 12.5 mt -75.38 -51.02 14.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 2.7 t -162.48 164.66 26.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.865 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.6 pt -62.47 172.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.137 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 364' ' ' ALA . . . 105.95 -42.87 1.8 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.49 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 363' ' ' GLY . . . -35.3 124.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.893 0.378 . . . . 0.0 111.106 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 41.5 p -97.15 -65.17 0.98 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.152 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -109.61 158.74 17.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 370' ' ' ASP . 3.0 m-20 -83.23 167.97 17.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.914 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.08 -28.77 37.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.108 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 60.8 p -83.0 20.42 1.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.167 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 367' ' ' ASP . 2.8 m-20 -92.36 98.92 11.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 372' ' ' ARG . 16.6 t -43.16 -42.65 4.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.841 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 371' ' ' SER . 48.2 mtp180 -37.45 -41.46 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 78.4 mt -45.92 123.72 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 70.4 p -84.69 -45.1 12.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.14 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . 0.524 ' CD2' ' SG ' ' A' ' 391' ' ' CYS . 51.5 m80 -133.05 141.58 48.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.911 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -123.62 116.71 23.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 49.6 mm -82.42 127.78 39.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.144 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 15.4 m -140.24 172.65 11.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.103 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -90.47 -42.97 10.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.798 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 11.5 ptt-85 -121.22 81.2 36.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.568 0.699 . . . . 0.0 110.846 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 3.07 3.01 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.661 2.241 . . . . 0.0 112.325 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -97.3 -28.14 8.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.477 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -77.28 -71.33 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.787 0.327 . . . . 0.0 110.896 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.574 ' OE1' ' CE2' ' A' ' 392' ' ' TYR . 3.2 pp0? -57.34 120.78 8.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 66.5 p -58.85 140.67 54.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.156 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 27.8 p -68.32 161.12 28.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 388' ' ' ILE . 42.0 t -120.96 121.44 65.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.082 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.422 ' C ' ' O ' ' A' ' 387' ' ' VAL . 10.0 mt -36.17 132.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.124 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 86.48 -48.65 3.94 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.457 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -85.88 138.49 31.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.324 . . . . 0.0 110.901 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' CYS . . . . . 0.524 ' SG ' ' CD2' ' A' ' 375' ' ' HIS . 6.3 p -118.65 129.73 55.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . 0.574 ' CE2' ' OE1' ' A' ' 384' ' ' GLN . 7.8 m-85 -98.23 126.76 43.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . 0.443 ' CG1' ' HB ' ' A' ' 410' ' ' VAL . 34.4 m -136.08 146.92 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.075 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -61.67 161.14 22.11 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.632 0.729 . . . . 0.0 110.859 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -10.47 28.66 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.705 2.27 . . . . 0.0 112.335 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -76.02 -26.42 56.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 85.6 t90 -56.82 -23.58 44.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 3.9 t -87.83 -53.87 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -50.24 -33.54 19.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -79.56 -51.21 9.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 69.9 m -54.4 -51.45 64.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 5.3 m -54.79 -44.24 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.13 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -69.84 -35.26 74.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.848 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -87.98 9.01 23.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 39.13 38.3 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.936 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . 0.414 ' C ' HD23 ' A' ' 406' ' ' LEU . 1.0 OUTLIER -153.68 153.5 32.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.941 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 29.1 mt -85.78 93.59 8.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.11 152.88 76.62 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.73 . . . . 0.0 110.896 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 116.28 4.49 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.642 2.228 . . . . 0.0 112.356 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . 0.443 ' HB ' ' CG1' ' A' ' 393' ' ' VAL . 32.2 m -60.19 -19.74 18.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -63.01 -21.38 66.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.066 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -86.98 -17.27 33.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.937 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -115.49 42.68 2.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 41.7 t80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.812 -179.963 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 316' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 315' ' ' GLY . 87.4 p 34.43 41.9 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 3.5 t -163.69 160.52 22.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.858 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 164.2 55.34 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.465 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.1 m -102.95 104.14 14.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.909 0.385 . . . . 0.0 110.812 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 58.7 m -76.32 168.49 19.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -158.43 175.62 35.52 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.534 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -152.95 138.48 17.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.787 0.327 . . . . 0.0 110.898 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -147.07 162.45 38.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.851 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -103.0 118.42 36.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.929 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm -82.79 133.84 35.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.91 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.448 ' CD1' ' HA ' ' A' ' 405' ' ' ARG . 2.1 tt -53.03 -40.92 64.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.934 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -101.63 40.53 1.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -79.14 123.76 27.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.935 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 70.8 50.41 24.53 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.497 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 72.5 mt -142.91 162.28 35.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.86 0.362 . . . . 0.0 110.934 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -131.07 123.16 28.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.93 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.52 ' CD1' ' HB2' ' A' ' 375' ' ' HIS . 78.6 m-85 -119.42 147.49 44.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -132.31 119.91 21.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 3.6 mt -99.13 148.46 24.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' ASN . . . . . 0.469 ' ND2' HG11 ' A' ' 378' ' ' VAL . 2.6 m-80 -104.28 175.51 5.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -71.27 -31.86 68.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.842 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -63.58 -45.42 90.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 2.9 m -82.17 149.61 62.7 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.642 0.735 . . . . 0.0 111.135 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 111.82 2.91 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.688 2.259 . . . . 0.0 112.363 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 0.448 ' O ' ' C ' ' A' ' 341' ' ' GLU . 26.1 ttp85 -78.45 -49.13 14.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 340' ' ' ARG . 1.2 mt-10 -33.59 -69.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.894 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -57.76 -64.04 1.04 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.128 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . 0.529 HD23 ' CE1' ' A' ' 399' ' ' PHE . 29.2 mt -42.08 -70.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 343' ' ' LEU . . . -36.98 -66.53 0.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.096 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -44.01 -49.18 8.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 28.7 mt -57.76 -67.67 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.123 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 29.2 mt -42.48 -44.64 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.164 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 10.3 mtp-105 -65.1 -49.23 70.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 13.2 t -57.26 -21.08 31.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -102.2 22.75 12.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 55.96 50.29 62.23 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.513 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -122.39 163.12 15.91 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.523 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -101.96 126.5 48.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 110.895 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 6.7 p -138.94 138.64 41.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.119 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' SER . . . . . 0.424 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 7.4 t -131.23 161.63 31.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -139.34 174.64 10.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -64.24 107.55 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.852 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -42.39 -44.21 3.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 5.4 t -53.57 -52.34 60.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 41.7 mt -48.63 -51.09 29.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 2.7 m -158.41 166.08 33.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 20.9 tt -80.54 151.97 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 125.41 -36.61 2.74 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -40.81 145.88 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.868 0.366 . . . . 0.0 111.097 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' THR . . . . . 0.532 ' OG1' ' CD2' ' A' ' 366' ' ' TYR . 80.8 p -110.16 -64.25 1.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' TYR . . . . . 0.532 ' CD2' ' OG1' ' A' ' 365' ' ' THR . 2.2 p90 -106.55 159.07 16.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.17 168.22 19.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.892 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 8.2 p -76.26 -3.17 4.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.163 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 73.7 p -108.08 19.76 19.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.17 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -92.94 105.9 17.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.84 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 372' ' ' ARG . 75.3 m -41.12 -42.3 1.98 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.814 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 371' ' ' SER . 62.4 mtt180 -35.75 -44.0 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 85.6 mt -44.54 130.66 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 33.6 p -103.6 -33.1 9.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.126 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . 0.52 ' HB2' ' CD1' ' A' ' 332' ' ' PHE . 24.7 m80 -138.58 124.13 19.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.806 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -112.73 94.6 4.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 16.1 mm -63.45 120.64 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . 0.469 HG11 ' ND2' ' A' ' 335' ' ' ASN . 27.5 m -136.19 164.58 31.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.158 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -77.08 -44.77 29.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 27.3 mmm-85 -124.07 82.79 56.22 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.63 0.729 . . . . 0.0 110.847 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -14.0 35.55 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.676 2.25 . . . . 0.0 112.341 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -79.58 -32.89 36.22 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.515 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 384' ' ' GLN . 7.1 mm100 -84.98 -55.22 4.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.786 0.327 . . . . 0.0 110.91 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 383' ' ' GLN . 30.5 mm-40 -37.47 140.0 0.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 23.5 m -78.0 91.07 4.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.142 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 94.1 p -44.18 156.4 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.84 127.08 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.134 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 18.7 mm -39.99 129.27 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.12 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 91.97 -40.22 2.93 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.549 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -91.27 146.53 23.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.792 0.33 . . . . 0.0 110.881 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 18.4 m -124.17 124.06 41.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -90.22 125.49 35.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 15.2 m -130.59 167.41 25.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.127 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -88.21 161.05 44.44 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.614 0.721 . . . . 0.0 110.876 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -5.33 15.98 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.646 2.231 . . . . 0.0 112.353 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 -81.03 -23.68 38.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -62.53 -35.65 80.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.917 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.68 -61.6 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.132 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.529 ' CE1' HD23 ' A' ' 343' ' ' LEU . 7.9 m-30 -48.14 -31.64 5.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.432 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 3.0 m-20 -76.85 -41.97 41.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 50.6 m -65.9 -52.37 50.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.824 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 4.5 m -54.59 -33.43 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.174 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -87.43 -18.29 30.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.849 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -102.93 9.26 38.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.108 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . 0.448 ' HA ' ' CD1' ' A' ' 326' ' ' LEU . 9.7 mpt_? 39.59 30.38 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 13.0 tp -149.19 164.2 35.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 408' ' ' LEU . 94.2 mt -97.61 68.12 2.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.432 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 27.9 mt -35.41 153.33 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.564 0.697 . . . . 0.0 110.94 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 114.84 3.83 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.701 2.267 . . . . 0.0 112.399 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.8 m -53.5 -22.17 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.124 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -54.22 -42.96 70.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.086 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -70.09 -8.15 47.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -127.32 43.91 3.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.988 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 91.6 t80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.864 -179.936 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 49.8 m -41.99 156.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 0.0 110.899 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 8.4 t -58.06 105.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -167.5 153.05 22.18 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.518 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 26.3 m -54.53 119.15 4.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 110.873 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 98.7 p -88.51 96.68 10.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.871 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -100.51 143.73 16.43 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.497 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -87.58 131.42 34.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.767 0.318 . . . . 0.0 110.913 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -136.45 151.05 49.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.868 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -103.68 100.4 10.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -82.65 150.79 26.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.02 -44.12 94.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -103.46 40.0 1.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -76.06 130.32 38.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 62.84 50.46 63.62 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.502 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 82.5 mt -146.08 120.27 9.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.842 0.353 . . . . 0.0 110.905 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -95.1 120.62 35.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -112.43 159.42 18.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' PHE . . . . . 0.459 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 35.4 t80 -141.69 116.71 9.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.872 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 3.8 mt -94.05 148.77 21.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.927 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -96.16 179.25 5.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 18.4 ptt85 -73.69 -39.88 64.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.4 -49.3 76.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.1 m -69.24 150.39 97.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.65 0.738 . . . . 0.0 111.14 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 122.16 8.85 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.701 2.268 . . . . 0.0 112.341 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' A' ' 344' ' ' ALA . 5.5 tmm_? -89.6 -37.4 14.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -60.02 -38.55 83.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.934 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.82 -59.65 2.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.087 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 51.5 mt -56.44 -59.2 5.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 340' ' ' ARG . . . -43.96 -56.89 3.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -54.11 -42.9 69.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.832 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 17.1 mt -66.92 -70.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.117 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 37.7 mt -43.69 -37.25 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.153 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -73.2 -37.2 66.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 7.4 m -72.57 -30.2 64.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . 0.514 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 15.3 m-85 -85.87 7.0 25.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.858 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 72.58 59.07 4.63 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.495 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -138.85 156.36 24.24 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.513 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -92.16 133.38 35.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.92 0.39 . . . . 0.0 110.871 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.6 138.7 25.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.126 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' SER . . . . . 0.52 ' CB ' ' CE1' ' A' ' 366' ' ' TYR . 5.1 t -134.05 157.28 46.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.863 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 22.6 p90 -141.03 177.14 8.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.39 111.31 4.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -50.33 -39.7 46.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 28.1 t -48.61 -47.96 39.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 76.0 mt -60.5 -47.03 87.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.904 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 1.8 m -166.64 137.37 3.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 26.1 pt -60.53 168.6 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 113.19 -36.96 3.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.501 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -45.45 166.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.853 0.358 . . . . 0.0 111.109 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' THR . . . . . 0.482 ' OG1' ' CD2' ' A' ' 366' ' ' TYR . 71.6 p -116.8 -68.94 0.88 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.12 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' TYR . . . . . 0.52 ' CE1' ' CB ' ' A' ' 355' ' ' SER . 0.9 OUTLIER -101.54 159.96 14.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.957 -179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -86.94 167.26 14.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.866 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . 0.459 ' HB ' ' CZ ' ' A' ' 333' ' ' PHE . 11.7 p -69.68 -30.3 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.109 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.5 p -83.49 20.61 1.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.139 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -95.06 121.76 37.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 99.0 p -69.78 -18.68 63.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 27.5 mtt-85 -57.33 -33.32 67.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.865 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.454 HG21 ' N ' ' A' ' 374' ' ' THR . 71.4 mt -54.64 144.26 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.454 ' N ' HG21 ' A' ' 373' ' ' ILE . 25.7 p -104.48 -42.04 5.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.145 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -128.54 133.0 48.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.847 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' GLN . . . . . 0.41 ' CD ' ' CZ ' ' A' ' 392' ' ' TYR . 24.9 tt0 -113.56 104.71 12.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 9.2 mm -77.56 123.04 33.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . 0.428 HG13 ' NE2' ' A' ' 384' ' ' GLN . 18.3 m -135.79 148.48 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.113 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -56.33 -39.01 72.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -148.14 104.98 3.59 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.591 0.71 . . . . 0.0 110.855 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.73 -6.38 18.44 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.69 2.26 . . . . 0.0 112.38 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 383' ' ' GLN . . . -83.21 -68.69 1.41 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 382' ' ' GLY . 12.3 mm100 -36.43 -49.64 0.73 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.696 0.284 . . . . 0.0 110.885 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.428 ' NE2' HG13 ' A' ' 378' ' ' VAL . 14.3 pt20 -98.62 143.43 29.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 69.3 p -90.09 127.48 36.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.141 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' SER . . . . . 0.431 ' HB2' ' CD1' ' A' ' 392' ' ' TYR . 90.4 p -62.81 159.25 16.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 88.0 t -90.3 148.52 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.111 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 6.4 mm -54.81 129.42 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.148 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 92.06 -42.44 2.75 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.498 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -85.59 146.04 27.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.765 0.317 . . . . 0.0 110.829 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 81.6 m -113.39 132.06 55.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . 0.431 ' CD1' ' HB2' ' A' ' 386' ' ' SER . 3.3 m-85 -104.13 125.3 50.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . 0.425 ' CG1' ' HB ' ' A' ' 410' ' ' VAL . 6.0 m -131.64 149.7 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -63.49 158.91 55.29 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.656 0.741 . . . . 0.0 110.859 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -6.95 19.85 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.706 2.271 . . . . 0.0 112.342 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -81.39 -26.17 35.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 81.8 t90 -54.13 -43.53 70.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 85.5 t -65.24 -47.67 86.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.114 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -58.93 -33.19 70.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.538 ' CB ' ' CD1' ' A' ' 408' ' ' LEU . 61.6 m-20 -75.95 -31.24 58.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 26.2 m -72.84 -51.65 17.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.847 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.514 ' HB ' ' CZ ' ' A' ' 350' ' ' PHE . 12.5 m -56.13 -40.5 64.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.094 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -67.36 -40.78 85.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -92.15 14.32 16.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 404' ' ' ALA . 1.2 mpp_? 34.3 40.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.859 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.63 149.3 23.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 50.0 mt -75.69 103.45 5.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.538 ' CD1' ' CB ' ' A' ' 400' ' ' ASP . 12.4 mt -70.8 155.35 93.51 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.587 0.708 . . . . 0.0 110.934 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 105.3 1.46 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.658 2.239 . . . . 0.0 112.362 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . 0.425 ' HB ' ' CG1' ' A' ' 393' ' ' VAL . 34.5 m -56.07 -16.63 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.135 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.11 93.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -71.18 -12.31 61.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.869 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -119.62 30.31 7.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.888 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 81.2 t80 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.892 179.995 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.469 -0.253 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 28.6 m -151.26 107.17 3.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.893 0.378 . . . . 0.0 110.879 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 33.2 p -55.72 137.15 50.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 45.65 -147.08 2.3 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.492 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 3.6 m -163.16 139.51 7.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.895 0.378 . . . . 0.0 110.864 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 51.6 p -113.29 131.82 55.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.834 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 322' ' ' LYS . . . -135.86 -79.42 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.502 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 321' ' ' GLY . 30.8 mtmt 34.41 47.76 0.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.778 0.323 . . . . 0.0 110.865 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -160.58 134.92 7.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.855 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 39.8 mmtt -60.67 155.6 18.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 36.8 mmtt -121.29 164.32 17.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.414 HD22 ' C ' ' A' ' 326' ' ' LEU . 2.1 tt -70.01 -49.23 53.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.982 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -106.59 37.82 2.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -57.15 116.07 3.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 77.68 -50.81 3.31 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.494 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 329' ' ' GLY . 19.3 mt -34.65 127.66 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.886 0.374 . . . . 0.0 110.943 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -104.11 146.77 28.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -138.72 155.12 48.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -137.37 116.61 12.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.855 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 3.0 mt -92.52 144.86 24.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.931 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -89.4 -177.67 5.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 14.0 ptt-85 -80.7 -34.79 34.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -67.16 -42.56 84.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 4.3 m -78.89 150.02 74.68 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.61 0.719 . . . . 0.0 111.145 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 110.95 2.67 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.671 2.248 . . . . 0.0 112.39 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 0.459 ' HD2' ' N ' ' A' ' 341' ' ' GLU . 6.2 ppt_? -85.57 -36.11 20.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.459 ' N ' ' HD2' ' A' ' 340' ' ' ARG . 9.3 pt-20 -54.0 -39.41 66.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -79.51 -64.67 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.084 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 32.0 mt -50.07 -60.04 3.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.922 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 340' ' ' ARG . . . -42.4 -56.28 3.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.08 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -54.79 -45.98 74.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.914 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 19.8 mt -60.63 -62.35 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.123 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 23.9 mt -51.9 -43.85 36.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.118 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 70.1 mtp85 -67.01 -32.36 73.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.859 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 26.3 t -74.41 -39.58 62.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . 0.535 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 20.5 m-85 -75.15 -5.59 45.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.905 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 89.0 55.21 2.16 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.462 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -134.34 163.64 24.61 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.512 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -95.69 126.51 41.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.91 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 12.0 p -142.37 141.13 28.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.15 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 18.2 t -143.99 151.95 40.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 31.7 p90 -129.04 172.92 10.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.919 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -59.29 111.26 1.29 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -44.58 -36.77 3.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.4 t -58.1 -50.9 71.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 38.6 mt -48.55 -47.7 39.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.911 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 5.0 t -171.69 145.8 2.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.86 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.3 pt -59.87 166.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.091 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 114.63 -35.21 4.52 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.475 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -51.99 158.77 0.99 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.872 0.367 . . . . 0.0 111.101 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 6.1 p -115.14 -65.7 1.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.166 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -107.56 152.36 24.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.423 ' N ' ' OD2' ' A' ' 370' ' ' ASP . 64.0 m-20 -81.35 173.27 12.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.826 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 12.2 p -69.29 -21.19 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.086 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.6 p -87.34 25.22 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.095 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . 0.423 ' OD2' ' N ' ' A' ' 367' ' ' ASP . 6.6 m-20 -103.27 104.36 14.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 372' ' ' ARG . 11.8 t -39.92 -42.13 1.29 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 371' ' ' SER . 24.8 mmt180 -35.67 -45.54 0.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.873 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.403 ' HB ' ' NH1' ' A' ' 390' ' ' ARG . 41.1 mt -46.6 124.97 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.08 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 44.3 p -97.17 -46.61 6.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.165 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -124.32 141.04 52.39 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.881 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -120.8 111.02 17.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 39.6 mm -76.27 124.9 35.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.083 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 34.5 m -145.08 152.33 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.133 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.37 -37.37 66.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -127.29 86.03 59.62 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.653 0.74 . . . . 0.0 110.891 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 3.22 2.86 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.692 2.261 . . . . 0.0 112.348 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -100.74 -42.8 2.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.52 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -55.13 -68.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.776 0.322 . . . . 0.0 110.956 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.429 ' NE2' ' CD2' ' A' ' 392' ' ' TYR . 4.2 pp0? -63.53 151.67 40.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 98.9 m -89.8 119.87 30.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.185 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 60.6 p -55.15 161.48 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.836 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 71.0 t -108.46 120.36 59.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.141 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 5.0 mt -39.31 104.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.156 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 119.07 -43.18 1.63 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.48 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . 0.403 ' NH1' ' HB ' ' A' ' 373' ' ' ILE . 11.8 ttm-85 -80.53 158.19 25.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.741 0.305 . . . . 0.0 110.907 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 55.8 m -126.06 128.88 48.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.891 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . 0.429 ' CD2' ' NE2' ' A' ' 384' ' ' GLN . 3.0 m-85 -105.65 132.47 51.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.907 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . 0.442 HG11 ' CG1' ' A' ' 410' ' ' VAL . 14.2 m -143.39 147.38 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.127 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -55.12 156.21 7.71 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.59 0.709 . . . . 0.0 110.952 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -3.93 12.98 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.359 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 41.5 tp60 -85.13 -28.98 25.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.937 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -48.74 -28.14 3.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.467 ' O ' ' CG2' ' A' ' 402' ' ' VAL . 56.3 t -85.44 -29.58 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.105 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -72.73 -37.2 67.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.906 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.471 ' OD2' ' CZ ' ' A' ' 413' ' ' TYR . 0.8 OUTLIER -84.34 -23.2 30.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.927 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 3.2 m -81.09 -47.85 12.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.535 ' HB ' ' CZ ' ' A' ' 350' ' ' PHE . 13.2 m -57.5 -36.88 55.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.156 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -69.9 -34.39 73.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -95.66 15.08 20.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.081 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 404' ' ' ALA . 9.9 mmt85 35.89 39.73 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.892 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 27.5 tp -147.89 163.29 37.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 42.1 mt -95.0 81.02 3.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 62.7 mt -47.71 155.67 0.77 Allowed Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.605 0.716 . . . . 0.0 110.916 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 118.07 5.46 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.668 2.245 . . . . 0.0 112.326 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . 0.442 ' CG1' HG11 ' A' ' 393' ' ' VAL . 23.2 m -58.54 -31.28 43.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.144 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -42.88 -52.55 5.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.128 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -59.07 -39.68 82.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.471 ' CZ ' ' OD2' ' A' ' 400' ' ' ASP . 68.6 m-85 -95.21 45.76 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 31.8 t80 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 27.4 p -158.3 145.4 17.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.903 0.382 . . . . 0.0 110.854 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.8 t -128.83 171.87 11.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.816 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 150.79 156.99 7.6 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.488 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 31.8 t -157.34 134.9 10.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.881 0.372 . . . . 0.0 110.848 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 74.0 m -67.06 133.93 50.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.846 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -115.28 161.62 12.74 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.509 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -107.58 39.02 2.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.81 0.338 . . . . 0.0 110.854 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -153.6 122.64 6.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.858 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.95 160.9 0.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -110.91 141.92 43.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.881 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 14.3 tp -42.4 -37.7 1.65 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.888 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -116.96 50.02 1.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -87.87 137.72 32.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 58.11 41.73 94.77 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.491 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 72.5 mt -141.38 120.22 12.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.902 0.382 . . . . 0.0 110.945 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -93.94 117.25 29.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -105.86 158.44 16.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -141.1 119.86 12.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.883 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.466 ' HG ' ' CG2' ' A' ' 354' ' ' VAL . 14.6 mt -95.53 142.67 27.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.916 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -100.9 179.32 4.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.867 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.448 ' HG2' ' N ' ' A' ' 337' ' ' GLU . 0.0 OUTLIER -78.24 -29.21 48.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.847 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . 0.448 ' N ' ' HG2' ' A' ' 336' ' ' ARG . 20.8 tt0 -72.48 -15.69 61.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 10.6 m -110.02 150.98 42.18 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.636 0.731 . . . . 0.0 111.109 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 115.49 4.11 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.695 2.263 . . . . 0.0 112.354 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 341' ' ' GLU . 19.5 ttp-105 -77.04 -69.69 0.51 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 340' ' ' ARG . 8.3 pt-20 -35.07 -44.58 0.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.17 -64.14 0.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.099 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 346' ' ' ILE . 36.6 mt -59.35 -63.16 1.4 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.903 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 343' ' ' LEU . . . -36.84 -51.86 0.91 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.073 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -59.14 -40.05 84.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' ILE . . . . . 0.64 ' CD1' ' CE1' ' A' ' 399' ' ' PHE . 27.5 mt -67.24 -64.21 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 24.9 mt -48.08 -41.73 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -68.4 -39.25 81.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 12.1 t -68.17 -22.99 64.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -105.48 22.52 15.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 57.46 63.75 5.01 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.471 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -133.81 155.79 21.97 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.503 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -92.25 130.98 37.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.861 0.362 . . . . 0.0 110.908 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.466 ' CG2' ' HG ' ' A' ' 334' ' ' LEU . 7.4 p -146.39 132.2 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 9.6 t -130.06 163.46 26.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -135.04 178.69 6.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.865 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 358' ' ' LYS . 7.7 t70 -70.94 105.89 3.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 357' ' ' ASP . 70.3 mttt -35.47 -44.15 0.28 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.896 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 28.7 t -58.69 -52.95 63.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.834 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 18.5 mt -50.87 -49.44 59.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 3.0 m -160.35 145.35 14.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.3 pt -72.22 176.72 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 92.82 -15.85 61.7 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.48 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -56.75 -177.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.908 0.385 . . . . 0.0 111.099 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 72.7 p -131.47 -66.72 0.72 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -117.53 157.0 27.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.64 168.97 11.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' VAL . . . . . 0.427 ' HA ' ' CD1' ' A' ' 373' ' ' ILE . 9.9 p -66.24 -22.46 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 61.1 p -84.68 26.27 0.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -110.75 109.44 19.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 67.7 m -47.2 -38.23 11.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -40.15 -41.86 1.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' ILE . . . . . 0.427 ' CD1' ' HA ' ' A' ' 368' ' ' VAL . 86.8 mt -41.94 138.65 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.137 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 42.2 p -108.48 -26.82 10.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.15 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -153.44 133.07 13.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.853 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' GLN . . . . . 0.565 ' NE2' ' CG1' ' A' ' 378' ' ' VAL . 1.0 OUTLIER -112.33 94.06 4.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 30.2 mm -55.78 98.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.121 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . 0.565 ' CG1' ' NE2' ' A' ' 376' ' ' GLN . 26.8 m -122.02 140.32 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.138 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . 0.433 ' OD1' ' C ' ' A' ' 379' ' ' ASP . 4.3 t0 -48.04 -43.39 30.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.901 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -129.45 86.93 54.7 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.635 0.731 . . . . 0.0 110.823 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . 0.415 ' N ' HG23 ' A' ' 378' ' ' VAL . 54.2 Cg_endo -69.78 -9.74 26.83 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.687 2.258 . . . . 0.0 112.365 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -85.4 -39.41 8.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.504 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -73.31 -52.52 13.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.712 0.292 . . . . 0.0 110.91 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -45.51 142.01 2.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 57.9 m -71.15 101.17 2.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.106 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 24.9 p -53.56 167.71 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.817 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 389' ' ' GLY . 81.9 t -130.64 134.58 61.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.131 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.401 ' N ' HG12 ' A' ' 387' ' ' VAL . 15.3 mm -56.98 86.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.09 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 387' ' ' VAL . . . 135.06 -27.36 3.16 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.506 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -99.96 156.66 17.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.851 0.357 . . . . 0.0 110.855 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 72.3 m -129.73 123.87 32.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -97.37 121.58 39.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 21.8 m -126.83 164.01 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.144 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -87.49 161.36 45.66 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.606 0.717 . . . . 0.0 110.902 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -4.64 14.42 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.706 2.271 . . . . 0.0 112.348 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -82.99 -14.17 54.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -77.73 -13.77 59.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.439 ' O ' ' CG2' ' A' ' 402' ' ' VAL . 42.1 t -89.18 -41.15 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.154 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.64 ' CE1' ' CD1' ' A' ' 346' ' ' ILE . 47.8 m-85 -71.8 -34.37 69.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.859 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.32 -45.7 53.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.884 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 2.6 m -62.6 -56.25 19.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 398' ' ' VAL . 15.4 m -50.64 -42.54 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -70.62 -37.96 73.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.928 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -89.87 10.73 22.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 404' ' ' ALA . 46.8 mmm-85 37.21 44.05 0.4 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 28.7 tp -153.69 142.68 21.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 20.4 mt -80.73 73.95 7.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 75.4 mt -40.69 152.35 0.24 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.605 0.717 . . . . 0.0 110.91 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 105.6 1.51 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.688 2.259 . . . . 0.0 112.353 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.8 m -50.78 -22.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.111 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -50.94 -35.83 35.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.122 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -69.39 -38.28 77.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.942 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -90.81 41.57 1.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.908 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 16.5 t80 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.944 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.818 0.342 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 1.9 tt -67.54 -35.14 78.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -112.94 37.28 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -59.81 112.66 1.92 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 83.61 -49.19 4.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.453 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 330' ' ' LEU . 12.5 mt -35.41 129.72 0.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 110.946 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -103.07 130.15 50.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.864 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -121.53 164.46 17.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -143.02 139.22 30.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.43 HD11 HG21 ' A' ' 354' ' ' VAL . 3.5 mt -116.22 146.21 42.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -104.94 169.67 8.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -71.46 -13.28 61.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.837 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -82.97 -45.77 13.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.3 m -84.36 150.6 57.75 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.618 0.723 . . . . 0.0 111.102 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 120.7 7.44 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.658 2.239 . . . . 0.0 112.382 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 5.9 ptt180 -93.78 -38.4 11.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -45.44 -37.59 5.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -86.25 -57.43 3.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.08 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 89.3 mt -54.2 -60.42 3.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -42.11 -64.8 0.53 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.092 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -47.79 -40.69 21.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 346' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 347' ' ' ILE . 16.6 mt -66.41 -72.42 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.13 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' ILE . . . . . 0.451 ' N ' HG22 ' A' ' 346' ' ' ILE . 22.4 mt -40.48 -38.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -67.2 -53.67 28.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 11.0 p -55.03 -36.27 65.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -80.72 11.35 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.857 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 65.96 48.83 62.64 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.536 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -122.13 160.77 16.49 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.476 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -93.57 131.11 39.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.906 0.384 . . . . 0.0 110.886 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.43 HG21 HD11 ' A' ' 334' ' ' LEU . 14.1 p -147.82 134.21 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.144 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 355' ' ' SER . . . . . 0.53 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 23.1 t -137.82 158.23 44.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 29.0 p90 -130.44 168.24 17.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.938 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.534 ' CB ' HD12 ' A' ' 360' ' ' LEU . 3.1 t70 -56.57 122.03 11.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.819 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -51.7 -48.44 63.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 40.2 t -57.73 -48.48 79.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.534 HD12 ' CB ' ' A' ' 357' ' ' ASP . 32.6 mt -50.45 -51.18 49.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.93 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 4.7 m -160.23 139.23 10.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 12.6 pt -66.66 156.55 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.131 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 108.49 14.72 15.31 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.486 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -97.82 162.42 13.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.916 0.389 . . . . 0.0 111.067 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 19.5 p -116.22 -68.41 0.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.159 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' TYR . . . . . 0.53 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 9.6 p90 -99.99 147.28 25.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.906 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.97 175.86 9.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.842 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 368' ' ' VAL . . . . . 0.634 ' O ' HG22 ' A' ' 368' ' ' VAL . 7.9 p -75.26 3.24 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.09 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 74.6 p -112.15 27.54 9.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.121 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -104.69 101.55 11.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 9.7 m -42.66 -35.13 1.03 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.819 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -40.9 -43.68 2.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.817 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 66.1 mt -44.17 125.33 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.148 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 43.0 p -92.84 -45.05 8.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.133 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -127.41 135.84 51.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' GLN . . . . . 0.576 ' NE2' ' CE2' ' A' ' 392' ' ' TYR . 40.6 tt0 -120.33 123.84 44.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 33.0 mm -92.32 133.75 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.153 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 19.4 m -149.99 153.03 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -76.16 -28.94 57.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -134.73 80.85 48.79 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.592 0.711 . . . . 0.0 110.87 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -18.25 37.27 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.678 2.252 . . . . 0.0 112.299 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -77.52 -64.32 2.09 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.488 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -42.3 -57.72 2.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.797 0.332 . . . . 0.0 110.909 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -79.86 129.04 34.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.943 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 70.6 p -63.1 -179.85 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.121 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 25.3 p -110.98 178.87 4.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 49.0 t -125.29 137.97 55.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.107 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.0 mt -44.12 123.34 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.106 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 89.26 -44.29 3.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.561 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -82.16 137.41 34.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.827 0.346 . . . . 0.0 110.889 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 23.5 m -120.61 117.38 27.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' TYR . . . . . 0.576 ' CE2' ' NE2' ' A' ' 376' ' ' GLN . 9.7 m-85 -80.79 145.64 31.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.942 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 31.3 m -150.56 165.33 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.115 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -78.39 158.18 76.84 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.6 0.715 . . . . 0.0 110.894 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -4.36 13.91 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.675 2.25 . . . . 0.0 112.351 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -86.74 -23.85 25.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -59.82 -33.37 71.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 75.4 t -76.16 -47.2 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.138 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -58.35 -36.5 73.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.866 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.85 -27.38 60.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 40.4 m -76.13 -51.27 12.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 14.8 m -53.5 -41.98 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.157 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -69.27 -34.78 75.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -93.07 3.28 56.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 42.58 44.72 3.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.449 ' HG ' ' N ' ' A' ' 407' ' ' LEU . 18.6 tp -160.86 154.84 22.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.906 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.449 ' N ' ' HG ' ' A' ' 406' ' ' LEU . 97.3 mt -84.9 99.68 11.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.01 154.97 91.43 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.597 0.713 . . . . 0.0 110.902 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 105.73 1.54 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.711 2.274 . . . . 0.0 112.33 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.2 m -53.9 -16.62 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -58.27 -23.85 57.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.103 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -86.0 -31.65 21.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.908 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -102.6 39.85 1.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 43.2 t80 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.825 0.345 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.445 ' O ' HD13 ' A' ' 326' ' ' LEU . 1.3 tm? -54.26 -41.76 69.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -112.89 47.86 1.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -72.87 138.09 46.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.885 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 49.03 60.0 6.44 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.5 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 90.6 mt -150.17 121.39 7.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.823 0.344 . . . . 0.0 110.935 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -99.5 123.36 43.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -115.12 164.09 14.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -138.2 117.03 12.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.864 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.669 HD11 HG21 ' A' ' 354' ' ' VAL . 4.7 mt -93.02 141.38 28.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.92 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -95.81 -177.18 3.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -85.66 -20.84 28.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.831 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -78.6 -18.32 54.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 6.0 m -108.12 150.61 40.66 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.595 0.712 . . . . 0.0 111.126 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 119.22 6.2 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.685 2.257 . . . . 0.0 112.346 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 0.488 ' HG3' HD12 ' A' ' 334' ' ' LEU . 34.3 ttp180 -85.41 -56.78 3.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 340' ' ' ARG . 6.8 pt-20 -36.84 -39.58 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.909 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -79.0 -64.55 1.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.092 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' LEU . . . . . 0.411 HD21 ' CE2' ' A' ' 399' ' ' PHE . 52.6 mt -57.2 -61.67 2.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.894 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -41.54 -48.65 3.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.125 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -63.59 -48.97 75.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 16.8 mt -55.25 -64.82 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.159 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 32.7 mt -50.42 -47.66 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -64.6 -24.22 67.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 23.2 t -84.52 -29.7 25.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -83.53 -8.99 59.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 93.1 42.63 4.29 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.486 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -122.97 164.34 15.97 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.501 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -93.29 135.04 34.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 110.949 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.669 HG21 HD11 ' A' ' 334' ' ' LEU . 12.6 p -149.88 125.84 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.158 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 2.0 t -128.24 161.18 29.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 41.0 p90 -138.7 171.92 13.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.951 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -67.73 111.17 4.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -42.58 -54.26 4.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.4 t -41.47 -59.61 1.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 9.0 mt -51.65 -50.71 59.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 4.8 m -154.39 141.88 19.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 20.7 pt -73.92 -175.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.15 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 86.43 -15.39 50.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.451 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -63.73 166.3 7.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 0.0 111.105 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 41.0 p -117.32 -70.51 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.169 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -109.52 139.06 44.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.939 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.56 169.76 15.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.83 -19.48 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.153 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 62.7 p -84.44 26.3 0.8 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.14 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -115.05 121.09 42.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.7 t -58.41 -36.12 73.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -38.92 -40.42 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.928 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 49.8 mt -46.34 138.32 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 26.5 p -113.57 -22.85 10.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.15 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -150.26 155.33 39.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' GLN . . . . . 0.467 ' HG2' HG13 ' A' ' 378' ' ' VAL . 17.3 tt0 -135.79 111.88 9.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.95 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 377' ' ' ILE . . . . . 0.869 HD13 HG23 ' A' ' 393' ' ' VAL . 46.8 mm -82.75 113.74 22.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.155 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 378' ' ' VAL . . . . . 0.467 HG13 ' HG2' ' A' ' 376' ' ' GLN . 29.2 m -131.34 148.08 32.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.11 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -62.25 -42.93 99.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -131.93 82.19 60.42 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.593 0.711 . . . . 0.0 110.931 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' PRO . . . . . 0.444 ' HB3' ' CG2' ' A' ' 378' ' ' VAL . 53.5 Cg_endo -69.76 -13.86 35.26 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.686 2.257 . . . . 0.0 112.352 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -73.92 -44.83 29.25 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.522 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' GLN . . . . . 0.415 ' HG3' ' N ' ' A' ' 384' ' ' GLN . 3.1 pt20 -62.27 -37.34 85.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.737 0.303 . . . . 0.0 110.885 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.415 ' N ' ' HG3' ' A' ' 383' ' ' GLN . 7.8 pt20 -98.34 118.07 34.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 44.7 p -50.49 175.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' SER . . . . . 0.518 ' HA ' ' CE1' ' A' ' 392' ' ' TYR . 1.9 t -104.81 178.66 4.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 74.4 t -119.56 136.23 57.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.149 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 5.9 mm -51.21 103.97 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 109.44 -28.34 11.02 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.497 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -105.96 148.77 27.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.787 0.327 . . . . 0.0 110.858 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 63.7 m -125.17 131.29 53.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 392' ' ' TYR . . . . . 0.518 ' CE1' ' HA ' ' A' ' 386' ' ' SER . 24.9 m-85 -91.43 131.74 36.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.869 HG23 HD13 ' A' ' 377' ' ' ILE . 11.3 m -130.0 166.99 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.107 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -86.73 161.36 47.92 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.603 0.716 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -7.42 21.01 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.684 2.256 . . . . 0.0 112.328 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -80.86 -24.4 38.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.885 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' TRP . . . . . 0.415 ' CH2' HD22 ' A' ' 407' ' ' LEU . 41.5 t90 -59.1 -42.14 89.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.617 ' O ' HG22 ' A' ' 402' ' ' VAL . 96.1 t -67.68 -58.37 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.156 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 399' ' ' PHE . . . . . 0.411 ' CE2' HD21 ' A' ' 343' ' ' LEU . 59.7 m-85 -52.31 -26.53 12.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.419 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 24.2 t0 -85.07 -49.97 7.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.861 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 15.4 m -56.75 -51.25 69.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.859 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 398' ' ' VAL . 27.7 m -55.53 -40.31 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.147 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 403' ' ' ASN . . . . . 0.409 ' N ' HG23 ' A' ' 402' ' ' VAL . 18.7 m-20 -80.21 -9.14 59.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 404' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -113.14 8.6 18.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 405' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 404' ' ' ALA . 1.3 mpt_? 34.42 42.64 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 7.5 tp -162.8 144.28 10.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.868 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 407' ' ' LEU . 12.4 mt -72.6 89.49 1.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.933 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.419 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 35.9 mt -56.62 154.34 17.86 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.569 0.699 . . . . 0.0 110.971 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 108.76 2.15 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.705 2.27 . . . . 0.0 112.348 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.3 m -57.19 -21.71 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.115 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -58.11 -12.0 3.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.105 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.39 -27.89 14.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -108.65 37.01 2.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 5.5 t80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.877 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.84 0.352 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 13.8 tp -49.23 -53.46 21.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.894 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' PHE . . . . . 0.418 ' HA ' HD12 ' A' ' 330' ' ' LEU . 16.6 m-85 -96.75 41.86 1.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -71.93 138.01 47.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 47.24 51.43 14.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.482 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 327' ' ' PHE . 58.0 mt -139.43 122.18 16.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 0.0 110.924 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -93.98 129.25 40.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.891 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -125.81 152.19 45.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.878 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -131.91 136.01 47.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.5 HD12 ' HG3' ' A' ' 340' ' ' ARG . 8.0 mt -112.46 137.53 50.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -85.7 -178.23 6.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -81.68 -23.4 36.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -77.48 -44.49 28.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.6 m -75.33 149.53 84.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.644 0.735 . . . . 0.0 111.103 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 124.74 11.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.65 2.234 . . . . 0.0 112.334 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 0.5 ' HG3' HD12 ' A' ' 334' ' ' LEU . 19.2 ttp180 -89.82 -60.12 2.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -38.07 -39.57 0.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.46 -60.11 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.084 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 49.4 mt -60.28 -63.42 1.3 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -39.84 -55.07 2.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.129 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -55.63 -44.53 77.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.868 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 18.5 mt -63.13 -67.92 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.129 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 33.5 mt -46.88 -42.42 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.108 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -68.95 -30.2 68.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 29.2 t -78.2 -34.05 49.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.892 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 350' ' ' PHE . . . . . 0.433 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 14.9 m-85 -83.42 7.62 16.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.857 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 76.36 63.96 2.27 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.55 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -145.42 154.75 26.13 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.516 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -92.57 125.66 37.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.879 0.371 . . . . 0.0 110.883 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.42 HG21 HD11 ' A' ' 334' ' ' LEU . 7.0 p -131.66 140.95 46.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.111 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 32.5 t -132.39 159.29 39.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.847 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 356' ' ' TRP . . . . . 0.434 ' CD1' ' SG ' ' A' ' 361' ' ' CYS . 48.8 p90 -149.48 165.89 30.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.921 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.554 ' HB3' HD12 ' A' ' 360' ' ' LEU . 2.4 t70 -55.06 110.01 0.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.855 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.449 ' CD ' ' HB3' ' A' ' 364' ' ' ALA . 14.2 mmmt -54.86 -35.53 64.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 5.4 t -55.73 -54.96 37.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.554 HD12 ' HB3' ' A' ' 357' ' ' ASP . 14.7 mt -56.11 -45.3 79.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 361' ' ' CYS . . . . . 0.434 ' SG ' ' CD1' ' A' ' 356' ' ' TRP . 0.8 OUTLIER -151.98 135.37 16.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.874 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 362' ' ' ILE . . . . . 0.529 HD13 ' C ' ' A' ' 362' ' ' ILE . 0.0 OUTLIER -78.89 143.26 12.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 133.06 -29.68 3.17 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.476 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.449 ' HB3' ' CD ' ' A' ' 358' ' ' LYS . . . -46.66 171.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 111.025 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 68.3 p -101.04 -69.81 0.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.138 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' TYR . . . . . 0.41 ' HB2' ' CG ' ' A' ' 370' ' ' ASP . 1.1 p90 -112.27 173.18 6.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -86.36 164.91 16.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.56 -23.44 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.147 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 42.0 p -84.03 25.07 0.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.132 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 370' ' ' ASP . . . . . 0.41 ' CG ' ' HB2' ' A' ' 366' ' ' TYR . 0.8 OUTLIER -96.12 100.49 12.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.835 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 372' ' ' ARG . 56.0 m -51.72 -41.03 61.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 372' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 371' ' ' SER . 23.6 mmt180 -37.7 -40.61 0.43 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.893 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 95.4 mt -41.77 121.35 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.13 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 39.2 p -81.25 -40.31 23.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.191 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -132.77 148.79 52.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' GLN . . . . . 0.485 ' OE1' ' NE ' ' A' ' 390' ' ' ARG . 56.8 tt0 -130.37 115.66 17.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.863 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 377' ' ' ILE . . . . . 0.55 HD13 HG23 ' A' ' 393' ' ' VAL . 47.0 mm -83.04 127.95 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.114 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 31.0 m -148.69 159.69 6.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.134 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.01 -38.73 35.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 -130.26 80.8 69.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.632 0.729 . . . . 0.0 110.917 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -15.55 37.2 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.701 2.267 . . . . 0.0 112.349 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -64.47 -53.85 32.98 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.45 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -89.19 30.56 0.96 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.714 0.292 . . . . 0.0 110.89 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -109.05 121.98 46.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.926 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 39.8 m -58.33 87.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 53.3 p -52.22 159.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 96.1 t -129.01 141.27 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.6 mt -51.35 115.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 101.51 -46.34 1.29 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.539 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' ARG . . . . . 0.485 ' NE ' ' OE1' ' A' ' 376' ' ' GLN . 15.4 ttp180 -80.68 144.87 31.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 110.852 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 10.3 m -124.4 134.26 53.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' TYR . . . . . 0.433 ' CZ ' ' OE1' ' A' ' 376' ' ' GLN . 3.0 m-85 -96.74 116.53 29.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.918 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.55 HG23 HD13 ' A' ' 377' ' ' ILE . 21.0 m -123.93 158.69 29.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.126 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -75.99 158.28 82.5 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.602 0.715 . . . . 0.0 110.919 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -4.16 13.45 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.665 2.244 . . . . 0.0 112.345 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -84.6 -16.33 42.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.962 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 69.1 t90 -65.34 -39.21 92.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.938 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 73.6 t -72.54 -52.76 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -51.2 -37.13 44.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.481 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 1.1 m-20 -73.49 -45.61 52.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 69.2 m -56.67 -58.03 9.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.852 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.456 HG23 ' N ' ' A' ' 403' ' ' ASN . 30.9 m -47.94 -43.58 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.104 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 403' ' ' ASN . . . . . 0.456 ' N ' HG23 ' A' ' 402' ' ' VAL . 6.6 t30 -66.13 -43.67 86.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 404' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -86.53 10.53 15.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.086 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 405' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' A' ' 404' ' ' ALA . 3.2 mpt_? 36.56 37.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 15.1 tp -151.49 145.01 24.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.432 ' HA ' HD23 ' A' ' 407' ' ' LEU . 17.6 mt -74.91 89.37 2.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.94 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.481 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 34.8 mt -60.52 154.91 52.57 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.626 0.727 . . . . 0.0 110.913 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 113.47 3.38 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.731 2.287 . . . . 0.0 112.344 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 410' ' ' VAL . . . . . 0.46 ' HB ' HG11 ' A' ' 393' ' ' VAL . 19.5 m -55.17 -28.25 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.137 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -48.09 -30.33 4.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.136 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -77.76 -35.65 51.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.855 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -106.05 49.66 0.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 42.1 t80 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.838 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.824 0.345 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 12.2 tp -68.79 -50.55 49.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' PHE . . . . . 0.441 ' HA ' HD12 ' A' ' 330' ' ' LEU . 22.7 m-85 -87.49 31.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -66.09 118.22 9.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.832 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 66.28 49.32 57.94 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 327' ' ' PHE . 67.9 mt -141.21 122.14 14.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.904 0.383 . . . . 0.0 110.914 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -95.54 139.8 31.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.503 ' CD1' ' HB2' ' A' ' 375' ' ' HIS . 80.7 m-85 -133.79 153.57 51.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' PHE . . . . . 0.475 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 9.4 t80 -129.56 117.6 20.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.848 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.635 HD12 ' HG3' ' A' ' 340' ' ' ARG . 12.7 mt -94.68 132.2 39.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.926 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -90.63 165.68 13.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.55 ' HB3' HD11 ' A' ' 360' ' ' LEU . 0.1 OUTLIER -65.15 -30.07 70.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.828 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 337' ' ' GLU . . . . . 0.457 ' N ' ' HG2' ' A' ' 336' ' ' ARG . 9.1 pt-20 -65.56 -37.41 86.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.0 m -91.01 150.7 42.26 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.633 0.73 . . . . 0.0 111.106 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' PRO . . . . . 0.437 ' O ' HD12 ' A' ' 343' ' ' LEU . 53.4 Cg_endo -69.79 128.46 16.04 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.683 2.255 . . . . 0.0 112.324 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 0.635 ' HG3' HD12 ' A' ' 334' ' ' LEU . 31.1 ttm180 -92.0 -49.3 6.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.866 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -42.68 -39.61 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -79.97 -65.74 0.97 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.052 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' LEU . . . . . 0.505 HD13 HD22 ' A' ' 334' ' ' LEU . 68.6 mt -51.79 -62.53 1.57 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -40.74 -59.81 1.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -51.62 -49.14 62.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.843 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 346' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 349' ' ' SER . 31.1 mt -57.74 -70.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.136 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 347' ' ' ILE . . . . . 0.412 ' N ' HG22 ' A' ' 346' ' ' ILE . 28.0 mt -42.26 -52.19 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.105 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 26.5 mtt-85 -64.5 -25.66 68.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.882 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 346' ' ' ILE . 43.4 t -80.12 -30.21 39.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -92.04 14.0 17.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.893 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 70.93 57.47 6.31 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.508 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -135.22 161.04 24.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.512 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -94.81 135.06 36.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.874 0.368 . . . . 0.0 110.869 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.543 HG21 HD11 ' A' ' 334' ' ' LEU . 8.1 p -148.37 133.98 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.169 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 17.3 t -132.42 162.84 30.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 356' ' ' TRP . . . . . 0.534 ' CZ2' ' O ' ' A' ' 363' ' ' GLY . 20.2 p90 -137.4 -176.39 4.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.944 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.436 ' HB2' HD12 ' A' ' 360' ' ' LEU . 0.6 OUTLIER -75.38 118.92 18.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.822 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -58.89 -15.7 13.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 4.5 p -83.04 -27.66 30.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 336' ' ' ARG . 22.7 mt -76.94 -49.65 15.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.96 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 8.2 m -157.86 139.55 13.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 24.3 pt -56.53 155.75 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.534 ' O ' ' CZ2' ' A' ' 356' ' ' TRP . . . 100.52 38.17 3.55 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.486 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -105.47 117.23 33.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 0.0 111.079 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 45.3 p -69.65 -61.0 1.96 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.153 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -126.53 158.37 36.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.22 169.9 11.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 368' ' ' VAL . . . . . 0.475 ' HB ' ' CZ ' ' A' ' 333' ' ' PHE . 11.5 p -68.01 -10.6 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.106 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 73.4 p -95.6 14.16 23.85 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.12 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' ASP . . . . . 0.48 ' OD1' ' CG ' ' A' ' 372' ' ' ARG . 4.6 t70 -87.54 107.54 18.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 64.1 p -50.74 -28.47 9.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.842 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' ARG . . . . . 0.48 ' CG ' ' OD1' ' A' ' 370' ' ' ASP . 17.0 mmm180 -54.03 -30.46 47.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.872 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 87.2 mt -51.53 126.64 6.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.105 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 47.4 p -95.53 -43.0 8.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 375' ' ' HIS . . . . . 0.503 ' HB2' ' CD1' ' A' ' 332' ' ' PHE . 20.0 m80 -130.11 155.04 46.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 376' ' ' GLN . . . . . 0.577 ' CD ' ' CE2' ' A' ' 392' ' ' TYR . 59.6 tt0 -136.18 115.0 12.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.9 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 377' ' ' ILE . . . . . 0.411 ' O ' ' CG1' ' A' ' 378' ' ' VAL . 45.3 mm -80.65 136.43 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 378' ' ' VAL . . . . . 0.411 ' CG1' ' O ' ' A' ' 377' ' ' ILE . 35.4 m -158.01 142.2 7.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.125 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -60.1 -32.67 71.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -128.55 80.92 71.67 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.617 0.722 . . . . 0.0 110.882 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -3.51 12.16 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.674 2.249 . . . . 0.0 112.358 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -106.52 -49.19 0.92 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.487 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -52.93 -73.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.783 0.325 . . . . 0.0 110.915 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -55.38 130.21 41.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.894 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 20.3 p -63.55 131.28 47.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 54.7 p -85.28 149.53 25.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.828 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 388' ' ' ILE . 63.2 t -75.82 114.8 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.104 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.637 ' H ' HD12 ' A' ' 388' ' ' ILE . 2.1 mp -36.17 104.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.134 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 122.26 -45.11 1.24 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 11.1 ttm-85 -76.55 159.45 30.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.8 0.333 . . . . 0.0 110.83 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 19.0 m -122.31 134.85 54.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.937 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 392' ' ' TYR . . . . . 0.577 ' CE2' ' CD ' ' A' ' 376' ' ' GLN . 2.4 m-85 -112.85 147.55 36.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.944 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 20.8 m -151.25 145.69 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.135 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -61.35 158.36 38.39 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.557 0.694 . . . . 0.0 110.938 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -4.63 14.39 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.378 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -85.95 -19.0 31.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -64.63 -34.03 77.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 80.7 t -71.23 -32.82 48.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.182 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' PHE . . . . . 0.458 ' O ' HG22 ' A' ' 402' ' ' VAL . 38.4 m-85 -74.85 -60.03 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.873 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -52.93 -17.9 1.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 16.9 m -82.33 -53.21 6.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 399' ' ' PHE . 6.2 m -58.01 -37.54 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.158 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -72.56 -34.66 67.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.957 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 404' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 406' ' ' LEU . . . -94.31 9.23 38.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.095 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 405' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 404' ' ' ALA . 0.9 OUTLIER 36.95 31.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 404' ' ' ALA . 0.0 OUTLIER -147.27 130.98 16.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 98.1 mt -66.67 85.66 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.946 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 32.0 mt -51.24 155.38 2.37 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.633 0.73 . . . . 0.0 110.882 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 118.82 5.91 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.691 2.261 . . . . 0.0 112.359 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.1 m -64.74 -25.51 38.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.088 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -54.55 -15.32 1.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.103 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -94.42 -30.97 14.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -96.06 33.34 1.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.95 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 16.5 t80 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.85 0.357 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 18.8 tp -59.75 -54.92 40.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -95.18 37.5 1.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -73.03 139.35 46.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 53.72 47.98 62.91 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.493 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 71.9 mt -142.45 122.26 13.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.913 0.387 . . . . 0.0 110.878 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -96.13 126.76 41.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -119.34 152.81 36.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 333' ' ' PHE . . . . . 0.419 ' CD1' ' O ' ' A' ' 355' ' ' SER . 59.0 t80 -131.88 124.85 30.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.914 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.587 HD11 HG21 ' A' ' 354' ' ' VAL . 7.2 mt -101.78 133.15 46.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.969 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -88.74 163.99 15.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.765 ' HB3' HD11 ' A' ' 360' ' ' LEU . 2.0 ptp85 -65.2 -13.36 58.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -85.84 -46.76 10.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 4.1 m -77.94 151.1 78.93 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.652 0.739 . . . . 0.0 111.142 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 127.64 14.93 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.676 2.251 . . . . 0.0 112.36 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 0.565 ' HA ' HD13 ' A' ' 334' ' ' LEU . 0.5 OUTLIER -95.51 -55.05 3.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -39.15 -42.07 0.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -77.5 -51.12 11.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.121 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' LEU . . . . . 0.434 HD23 ' CE1' ' A' ' 399' ' ' PHE . 87.8 mt -65.16 -64.11 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -38.72 -53.14 1.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -57.54 -47.95 80.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 346' ' ' ILE . . . . . 0.437 HD12 ' HE1' ' A' ' 399' ' ' PHE . 38.0 mt -62.59 -67.95 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.117 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 32.2 mt -44.26 -37.33 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.085 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -77.99 -35.0 50.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 46.7 t -67.62 -29.65 69.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.858 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -94.99 20.45 8.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 64.46 63.56 4.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.519 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -136.72 164.48 25.18 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.512 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -104.15 129.29 51.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.884 0.374 . . . . 0.0 110.868 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.587 HG21 HD11 ' A' ' 334' ' ' LEU . 7.3 p -137.86 138.91 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.12 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 355' ' ' SER . . . . . 0.419 ' O ' ' CD1' ' A' ' 333' ' ' PHE . 8.4 t -140.56 149.82 42.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' TRP . . . . . 0.457 ' O ' ' HB1' ' A' ' 364' ' ' ALA . 40.6 p90 -131.7 175.89 8.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.868 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.679 ' HB2' HD12 ' A' ' 360' ' ' LEU . 18.5 m-20 -62.17 114.95 3.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -44.88 -46.3 10.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.3 m -53.26 -51.83 60.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.855 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.765 HD11 ' HB3' ' A' ' 336' ' ' ARG . 21.4 mt -46.56 -49.84 18.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.921 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 1.8 t -168.19 153.33 6.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 36.2 pt -63.32 177.08 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.119 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 94.42 -37.22 3.47 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 356' ' ' TRP . . . -44.63 152.11 0.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.821 0.343 . . . . 0.0 111.121 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 5.1 p -116.2 -65.28 1.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.156 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -111.22 144.93 39.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.943 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -88.7 171.66 9.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.12 -17.35 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 22.6 p -79.24 12.09 2.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.166 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -101.43 140.56 35.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.854 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 372' ' ' ARG . 4.9 t -80.5 -40.52 25.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 372' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 371' ' ' SER . 9.0 ptp180 -36.69 -42.68 0.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.922 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.587 HG22 ' HG3' ' A' ' 390' ' ' ARG . 73.4 mt -40.11 136.89 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.146 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 58.1 p -115.22 -24.72 8.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -139.91 143.03 36.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.868 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' GLN . . . . . 0.5 ' OE1' ' N ' ' A' ' 377' ' ' ILE . 0.7 OUTLIER -137.13 108.98 7.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 377' ' ' ILE . . . . . 0.5 ' N ' ' OE1' ' A' ' 376' ' ' GLN . 5.5 mm -79.39 127.0 39.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.127 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 30.6 m -139.98 155.94 24.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.158 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -81.51 -23.34 37.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.407 ' O ' ' CG ' ' A' ' 383' ' ' GLN . 75.7 mtt180 -130.75 83.0 62.96 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.583 0.706 . . . . 0.0 110.852 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -18.41 36.99 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.651 2.234 . . . . 0.0 112.335 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -67.53 -55.25 15.67 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.468 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 383' ' ' GLN . . . . . 0.407 ' CG ' ' O ' ' A' ' 380' ' ' ARG . 2.0 pt20 -46.26 -33.85 4.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.763 0.316 . . . . 0.0 110.92 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -84.3 149.97 25.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.36 -70.7 0.71 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.119 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 96.7 p -175.13 164.23 3.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' VAL . . . . . 0.531 HG23 ' CE1' ' A' ' 392' ' ' TYR . 74.6 t -133.05 153.73 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.145 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.52 ' N ' HD13 ' A' ' 388' ' ' ILE . 3.5 mm -68.66 99.41 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.176 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 92.95 -35.01 4.25 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.482 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' ARG . . . . . 0.587 ' HG3' HG22 ' A' ' 373' ' ' ILE . 8.3 ttm180 -93.0 151.36 19.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.762 0.315 . . . . 0.0 110.888 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 391' ' ' CYS . . . . . 0.424 ' N ' ' HG2' ' A' ' 390' ' ' ARG . 83.3 m -134.18 139.6 45.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 392' ' ' TYR . . . . . 0.531 ' CE1' HG23 ' A' ' 387' ' ' VAL . 68.0 m-85 -81.38 140.67 34.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.416 ' CG1' ' HB ' ' A' ' 410' ' ' VAL . 12.0 m -150.62 166.66 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.115 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -89.42 159.32 44.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.596 0.712 . . . . 0.0 110.878 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.439 ' HA ' HG21 ' A' ' 377' ' ' ILE . 54.2 Cg_endo -69.7 -3.73 12.56 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.717 2.278 . . . . 0.0 112.379 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -84.91 -31.25 23.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.923 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 69.1 t90 -50.5 -38.44 44.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.08 -61.21 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.074 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' PHE . . . . . 0.437 ' HE1' HD12 ' A' ' 346' ' ' ILE . 12.3 m-30 -51.7 -29.63 19.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.405 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 19.4 m-20 -73.32 -52.03 15.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 401' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 405' ' ' ARG . 14.6 m -58.47 -47.36 84.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.844 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.533 HG23 ' N ' ' A' ' 403' ' ' ASN . 27.3 m -61.24 -46.27 96.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.119 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 403' ' ' ASN . . . . . 0.533 ' N ' HG23 ' A' ' 402' ' ' VAL . 41.2 t30 -70.07 -8.08 46.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -122.93 0.48 9.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.097 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' A' ' 401' ' ' SER . 0.2 OUTLIER 44.53 32.12 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.642 HD13 ' N ' ' A' ' 407' ' ' LEU . 1.0 OUTLIER -141.94 140.69 32.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.642 ' N ' HD13 ' A' ' 406' ' ' LEU . 12.4 mt -71.77 81.63 0.88 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.405 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 43.0 mt -55.22 155.64 8.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.599 0.714 . . . . 0.0 110.929 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 115.67 4.21 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.685 2.256 . . . . 0.0 112.325 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 410' ' ' VAL . . . . . 0.416 ' HB ' ' CG1' ' A' ' 393' ' ' VAL . 32.6 m -65.56 -21.39 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.144 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 411' ' ' ALA . . . . . 0.547 ' HA ' ' CE2' ' A' ' 414' ' ' PHE . . . -64.1 -33.8 76.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.171 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -75.93 1.07 16.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -126.06 41.56 3.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.967 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 414' ' ' PHE . . . . . 0.547 ' CE2' ' HA ' ' A' ' 411' ' ' ALA . 2.5 m-85 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.918 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.759 0.314 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 2.4 tt -59.25 -54.86 42.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.906 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' PHE . . . . . 0.432 ' HZ ' HG13 ' A' ' 398' ' ' VAL . 18.4 m-85 -91.5 39.37 1.0 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -80.96 106.7 13.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 88.08 43.54 5.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.458 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.568 HD11 HD11 ' A' ' 407' ' ' LEU . 83.5 mt -143.1 124.09 14.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.912 0.387 . . . . 0.0 110.909 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.439 ' HE3' ' CE2' ' A' ' 366' ' ' TYR . 28.3 mtpt -95.41 139.09 32.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.445 ' CD1' ' HB2' ' A' ' 375' ' ' HIS . 88.5 m-85 -135.2 147.32 49.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -130.01 115.31 16.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.655 HD11 HG21 ' A' ' 354' ' ' VAL . 2.6 mt -90.77 148.08 22.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -107.14 176.93 5.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.944 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.457 ' HB3' HD11 ' A' ' 360' ' ' LEU . 8.4 ptp85 -74.79 -22.08 58.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.879 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -72.46 -35.97 68.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.897 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.43 HG11 HG22 ' A' ' 377' ' ' ILE . 3.2 m -95.54 150.87 38.09 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.622 0.725 . . . . 0.0 111.127 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 120.94 7.66 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.664 2.243 . . . . 0.0 112.41 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 0.528 ' HG3' HD12 ' A' ' 334' ' ' LEU . 27.7 ttp85 -87.19 -49.87 6.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.863 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -42.4 -36.77 1.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -83.05 -63.83 1.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.059 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 53.3 mt -53.95 -59.45 4.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -42.74 -60.51 1.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -51.15 -43.07 61.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.842 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 346' ' ' ILE . . . . . 0.505 HG22 ' N ' ' A' ' 347' ' ' ILE . 11.8 mt -63.64 -72.58 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 347' ' ' ILE . . . . . 0.505 ' N ' HG22 ' A' ' 346' ' ' ILE . 29.8 mt -39.16 -43.6 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.15 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 67.6 mtt-85 -68.51 -36.07 78.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.863 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' SER . . . . . 0.481 ' N ' ' O ' ' A' ' 346' ' ' ILE . 29.8 t -69.95 -43.34 71.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 350' ' ' PHE . . . . . 0.523 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 11.4 m-85 -73.17 -11.23 60.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 91.2 56.58 1.68 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.427 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -132.16 160.55 23.68 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -91.26 125.39 36.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.909 0.385 . . . . 0.0 110.886 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.655 HG21 HD11 ' A' ' 334' ' ' LEU . 12.4 p -137.85 139.56 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.132 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 355' ' ' SER . . . . . 0.563 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 42.7 t -136.74 149.34 47.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 356' ' ' TRP . . . . . 0.421 ' CE3' ' HD2' ' A' ' 340' ' ' ARG . 15.1 p90 -129.39 -175.86 3.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.962 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.7 ' HB2' HD12 ' A' ' 360' ' ' LEU . 24.3 m-20 -76.97 105.76 8.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.82 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.514 ' HG2' ' HB3' ' A' ' 364' ' ' ALA . 7.1 mtpm? -38.89 -43.32 0.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.912 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 14.2 t -53.64 -58.73 6.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 357' ' ' ASP . 18.8 mt -50.53 -48.94 57.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.912 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 4.2 m -158.39 130.0 6.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.902 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 14.9 pt -61.14 176.34 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.14 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 107.37 -39.65 2.81 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.45 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.514 ' HB3' ' HG2' ' A' ' 358' ' ' LYS . . . -38.72 158.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.877 0.37 . . . . 0.0 111.084 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 1.2 p -113.46 -45.67 3.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' TYR . . . . . 0.563 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 33.4 p90 -125.43 173.92 8.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.956 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.96 169.34 8.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.863 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 14.0 p -58.85 -31.36 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.111 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 68.1 p -63.6 -16.21 60.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -65.7 99.3 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 372' ' ' ARG . 22.2 t -47.5 -42.11 22.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 372' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 371' ' ' SER . 29.9 mmt180 -35.58 -45.25 0.35 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.826 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.436 ' C ' ' O ' ' A' ' 372' ' ' ARG . 77.8 mt -34.45 120.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.131 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 26.7 p -92.32 -44.26 8.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 375' ' ' HIS . . . . . 0.445 ' HB2' ' CD1' ' A' ' 332' ' ' PHE . 20.1 m80 -129.8 146.25 51.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.799 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -131.1 94.57 3.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.918 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 377' ' ' ILE . . . . . 0.452 HD13 HG23 ' A' ' 393' ' ' VAL . 49.5 mm -58.61 132.44 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 30.6 m -151.94 156.18 6.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.145 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -68.25 -38.74 82.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -122.71 84.17 49.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.57 0.7 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 94.46 0.53 Allowed 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.7 2.267 . . . . 0.0 112.346 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 152.44 -39.92 0.74 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.516 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -118.26 76.75 1.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.738 0.304 . . . . 0.0 110.923 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.738 ' NE2' ' CD1' ' A' ' 392' ' ' TYR . 3.0 pp0? -171.49 105.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 385' ' ' THR . . . . . 0.466 ' C ' ' O ' ' A' ' 384' ' ' GLN . 10.5 m 32.9 46.68 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 13.7 p -41.5 149.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 53.8 t -134.14 110.05 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.3 mt -50.0 100.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.127 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 126.09 -42.75 1.45 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -80.25 157.82 26.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.849 0.357 . . . . 0.0 110.862 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 1.8 m -122.73 145.37 48.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.85 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 392' ' ' TYR . . . . . 0.738 ' CD1' ' NE2' ' A' ' 384' ' ' GLN . 37.7 m-85 -117.98 131.58 56.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.507 HG11 HG12 ' A' ' 410' ' ' VAL . 17.3 m -129.6 155.3 41.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.082 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -72.39 161.37 79.4 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.576 0.703 . . . . 0.0 110.922 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -4.24 13.63 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.702 2.268 . . . . 0.0 112.371 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 -86.26 -16.35 37.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 79.7 t90 -65.72 -34.86 79.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.432 HG13 ' HZ ' ' A' ' 327' ' ' PHE . 88.9 t -81.09 -49.81 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.106 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -51.13 -30.1 15.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.486 ' OD2' HD11 ' A' ' 408' ' ' LEU . 6.5 t70 -85.48 -47.3 10.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 63.7 m -56.45 -47.08 79.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.85 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.523 ' HB ' ' CZ ' ' A' ' 350' ' ' PHE . 23.5 m -50.44 -43.8 23.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.152 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 403' ' ' ASN . . . . . 0.444 ' N ' HG23 ' A' ' 402' ' ' VAL . 21.9 t-20 -74.35 -40.34 62.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -76.86 0.72 19.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.121 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 41.96 44.74 3.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 25.4 tp -165.42 143.71 6.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.955 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.568 HD11 HD11 ' A' ' 330' ' ' LEU . 40.3 mt -69.6 93.94 0.74 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.941 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.486 HD11 ' OD2' ' A' ' 400' ' ' ASP . 65.7 mt -60.4 153.18 61.15 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.6 0.714 . . . . 0.0 110.924 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 114.48 3.72 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.677 2.251 . . . . 0.0 112.347 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' VAL . . . . . 0.507 HG12 HG11 ' A' ' 393' ' ' VAL . 18.7 m -58.89 -27.4 35.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.09 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -50.17 -29.46 9.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.125 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -78.48 -24.98 45.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -106.6 38.03 2.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.944 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 53.1 t80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 -179.969 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.824 0.345 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 22.4 tp -44.01 -54.06 5.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -98.0 36.78 1.5 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -60.94 116.85 4.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.864 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 76.17 -46.72 2.19 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 329' ' ' GLY . 24.3 mt -37.31 125.94 1.02 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.879 0.371 . . . . 0.0 110.95 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -95.24 144.76 25.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -135.06 153.26 52.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.919 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -140.17 117.11 11.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.64 HD22 HD13 ' A' ' 343' ' ' LEU . 2.8 mt -97.83 149.95 21.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.924 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -107.54 164.01 12.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.9 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.594 ' HB3' HD11 ' A' ' 360' ' ' LEU . 15.1 ptp180 -61.48 -31.1 71.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -41.59 97.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 10.1 m -91.03 150.81 42.43 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.628 0.728 . . . . 0.0 111.116 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 118.61 5.78 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.726 2.284 . . . . 0.0 112.301 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 0.517 ' HA ' HD13 ' A' ' 334' ' ' LEU . 24.3 ptt85 -89.29 -37.25 15.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.84 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -49.82 -42.75 47.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.851 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -74.8 -62.3 1.59 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.061 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 343' ' ' LEU . . . . . 0.64 HD13 HD22 ' A' ' 334' ' ' LEU . 30.9 mt -53.1 -60.36 3.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.908 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 343' ' ' LEU . . . -37.02 -58.9 0.75 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -53.14 -45.84 68.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 23.0 mt -59.23 -69.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.147 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 20.9 mt -40.1 -57.35 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.097 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -58.41 -45.78 87.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 40.2 t -55.04 -34.81 63.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -98.4 29.26 3.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.894 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 54.98 52.17 48.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.515 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -119.62 154.97 16.27 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.437 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -92.8 138.93 31.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.888 0.375 . . . . 0.0 110.864 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.435 HG21 HD11 ' A' ' 334' ' ' LEU . 7.3 p -154.78 140.33 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.118 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 42.0 t -140.04 144.23 36.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.815 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 40.5 p90 -121.13 174.84 6.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.727 ' HB2' HD12 ' A' ' 360' ' ' LEU . 19.9 m-20 -65.0 104.15 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 357' ' ' ASP . 12.1 ptpt -36.65 -44.87 0.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 11.3 t -51.93 -48.74 64.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.727 HD12 ' HB2' ' A' ' 357' ' ' ASP . 8.8 mt -53.03 -47.48 68.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.894 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 45.5 t -162.33 156.73 21.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 21.2 tt -73.24 160.21 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.112 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 112.8 -27.64 9.58 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.508 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -41.59 148.26 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.85 0.357 . . . . 0.0 111.118 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 26.0 p -108.76 -64.82 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.151 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -117.2 144.42 44.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.871 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.03 174.15 8.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.887 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 7.1 p -69.62 -22.38 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.094 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 82.6 p -86.14 24.52 1.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.137 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -98.36 102.3 14.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.3 t -46.54 -29.31 1.73 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.824 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -47.43 -40.11 17.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.88 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 58.5 mt -40.06 147.48 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.135 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 55.3 p -125.8 -30.71 2.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -147.59 110.22 4.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.868 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' GLN . . . . . 0.416 ' HG2' HG13 ' A' ' 378' ' ' VAL . 20.2 tt0 -96.68 100.98 12.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 377' ' ' ILE . . . . . 0.421 HD13 HG23 ' A' ' 393' ' ' VAL . 19.1 mm -68.79 113.48 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 378' ' ' VAL . . . . . 0.416 HG13 ' HG2' ' A' ' 376' ' ' GLN . 18.7 m -126.65 -178.93 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.136 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.55 -40.5 10.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -128.69 80.9 71.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.657 0.742 . . . . 0.0 110.891 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -10.84 29.55 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.657 2.238 . . . . 0.0 112.33 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -85.4 -20.06 57.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.517 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -102.68 -43.8 5.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.778 0.323 . . . . 0.0 110.898 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -44.82 163.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.937 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 71.4 p -87.4 121.52 29.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.178 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 56.2 p -70.54 151.88 44.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.801 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 87.3 t -129.82 114.38 30.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.142 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 8.8 mt -38.08 116.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.118 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 102.68 -44.79 1.44 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.474 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -77.62 158.03 29.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.819 0.343 . . . . 0.0 110.888 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 82.4 m -133.63 132.73 41.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.861 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -106.68 124.65 49.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.427 HG11 ' HB ' ' A' ' 410' ' ' VAL . 19.2 m -135.44 156.86 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.118 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -71.0 158.86 87.26 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.607 0.718 . . . . 0.0 110.898 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -7.74 21.83 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.684 2.256 . . . . 0.0 112.332 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -79.19 -25.37 42.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.936 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' TRP . . . . . 0.516 ' HB2' ' CD2' ' A' ' 413' ' ' TYR . 92.0 t90 -59.44 -28.11 66.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 39.7 t -72.09 -57.55 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.137 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -50.0 -53.8 24.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.448 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 0.8 OUTLIER -54.85 -45.56 74.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 21.5 m -56.58 -66.7 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 26.8 m -47.43 -40.48 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.101 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -69.89 -35.07 74.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -92.08 11.65 24.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 405' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 404' ' ' ALA . 2.8 mmm180 38.11 44.24 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.839 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 8.1 tp -165.07 150.59 9.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.929 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 97.1 mt -81.16 80.11 7.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.448 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 49.3 mt -46.04 156.45 0.46 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.562 0.696 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 119.01 6.02 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.653 2.235 . . . . 0.0 112.322 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' VAL . . . . . 0.427 ' HB ' HG11 ' A' ' 393' ' ' VAL . 35.3 m -64.88 -23.77 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.088 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -53.17 -18.58 2.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -88.73 -33.46 17.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.516 ' CD2' ' HB2' ' A' ' 397' ' ' TRP . 6.4 m-85 -95.3 36.03 1.27 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.902 179.983 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 325' ' ' LYS . . . . . 0.435 ' HD2' ' C ' ' A' ' 350' ' ' PHE . 9.9 mmtp . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.841 0.353 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 326' ' ' LEU . 0.2 OUTLIER -70.76 -40.45 72.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.933 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -118.06 40.71 3.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -56.94 114.78 2.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 329' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 75.23 -47.41 1.98 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.477 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 329' ' ' GLY . 33.0 mt -35.78 125.16 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.884 0.373 . . . . 0.0 110.929 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -101.96 151.13 22.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.928 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -141.94 154.48 45.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' PHE . . . . . 0.518 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 18.8 t80 -130.87 116.6 18.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.413 ' HG ' ' CG2' ' A' ' 354' ' ' VAL . 6.6 mt -91.09 146.76 23.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -101.72 164.49 11.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.912 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.552 ' HB3' HD22 ' A' ' 360' ' ' LEU . 8.9 ptt180 -66.58 -17.3 64.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -78.33 -47.62 17.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.892 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 2.1 m -84.32 148.98 54.16 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.615 0.722 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' PRO . . . . . 0.588 ' O ' HD12 ' A' ' 343' ' ' LEU . 54.2 Cg_endo -69.73 138.04 36.99 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.706 2.271 . . . . 0.0 112.35 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 341' ' ' GLU . 16.9 ptt85 -102.23 -48.09 4.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.865 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 340' ' ' ARG . 4.9 pt-20 -35.29 -46.71 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -75.31 -59.05 2.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.072 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' LEU . . . . . 0.588 HD12 ' O ' ' A' ' 339' ' ' PRO . 79.4 mt -55.9 -63.64 1.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.93 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -39.42 -54.35 1.91 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.1 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -55.71 -44.78 77.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 346' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 347' ' ' ILE . 21.7 mt -65.8 -67.79 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.135 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 347' ' ' ILE . . . . . 0.491 ' O ' ' N ' ' A' ' 352' ' ' GLY . 25.5 mt -41.4 -35.21 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 44.4 mtp85 -79.95 -45.65 18.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 32.3 t -56.08 -30.58 62.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 350' ' ' PHE . . . . . 0.435 ' C ' ' HD2' ' A' ' 325' ' ' LYS . 58.7 m-85 -98.58 26.67 5.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 58.91 58.96 11.8 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.479 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 347' ' ' ILE . . . -129.73 150.37 19.0 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.483 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -96.52 133.28 41.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.894 0.378 . . . . 0.0 110.914 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.413 ' CG2' ' HG ' ' A' ' 334' ' ' LEU . 7.4 p -143.49 143.39 24.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.119 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 355' ' ' SER . . . . . 0.568 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 1.5 t -141.07 156.8 45.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 356' ' ' TRP . . . . . 0.442 ' O ' ' HB2' ' A' ' 364' ' ' ALA . 23.9 p90 -138.09 140.79 40.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.892 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.727 ' HB2' HD12 ' A' ' 360' ' ' LEU . 6.2 m-20 -42.77 115.99 0.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -44.7 -57.28 3.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.875 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 78.3 p -41.32 -47.87 3.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.853 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.727 HD12 ' HB2' ' A' ' 357' ' ' ASP . 86.7 mt -61.61 -50.92 70.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.895 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 23.3 m -154.95 140.55 17.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.3 pt -69.77 162.39 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.119 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 93.43 39.41 5.05 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.452 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 356' ' ' TRP . . . -113.56 149.47 34.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 0.0 111.109 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 41.4 p -98.59 -72.4 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.096 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' TYR . . . . . 0.568 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 18.5 p90 -103.43 161.79 13.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.911 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.01 168.62 11.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.834 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 368' ' ' VAL . . . . . 0.528 ' O ' HG22 ' A' ' 368' ' ' VAL . 7.6 p -70.69 -6.65 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.161 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 24.3 p -100.3 18.71 18.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -95.19 118.69 32.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.821 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.2 m -51.17 -43.78 61.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.843 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 21.4 mtt85 -38.93 -40.1 0.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.82 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 57.0 mt -48.55 115.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.103 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 74.8 p -85.25 -43.61 13.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -128.84 158.97 37.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.81 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 376' ' ' GLN . . . . . 0.54 ' CD ' ' CE2' ' A' ' 392' ' ' TYR . 25.9 tt0 -140.62 108.97 5.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 377' ' ' ILE . . . . . 0.436 HD13 HG23 ' A' ' 393' ' ' VAL . 44.6 mm -76.09 139.12 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.192 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 378' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 379' ' ' ASP . 18.7 m -154.7 139.59 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 379' ' ' ASP . . . . . 0.439 ' O ' ' CG ' ' A' ' 380' ' ' ARG . 5.7 t0 -35.95 -45.74 0.43 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.439 ' CG ' ' O ' ' A' ' 379' ' ' ASP . 62.7 mtt180 -161.07 121.6 1.6 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.65 0.738 . . . . 0.0 110.86 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 2.67 3.3 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.673 2.248 . . . . 0.0 112.373 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -96.89 -31.41 7.0 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.48 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -91.84 31.73 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.882 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -174.14 144.07 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.871 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 9.9 t -79.62 158.15 27.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.6 p -110.97 166.64 10.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 56.5 t -98.97 128.39 50.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.4 mt -44.22 110.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.151 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 113.67 -41.25 2.25 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.468 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' ARG . . . . . 0.509 ' HD2' ' CE1' ' A' ' 392' ' ' TYR . 13.2 ttm-85 -79.52 152.39 30.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.778 0.323 . . . . 0.0 110.9 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 40.5 m -120.27 115.67 24.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' TYR . . . . . 0.54 ' CE2' ' CD ' ' A' ' 376' ' ' GLN . 7.0 m-85 -92.51 130.4 38.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.919 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.436 HG23 HD13 ' A' ' 377' ' ' ILE . 25.1 m -134.97 167.98 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.143 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -83.78 160.56 58.2 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.576 0.703 . . . . 0.0 110.935 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -7.99 22.48 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.708 2.272 . . . . 0.0 112.328 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 12.6 tp-100 -79.18 -12.76 59.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 92.4 t90 -79.79 -13.03 59.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.475 ' O ' HG22 ' A' ' 402' ' ' VAL . 60.1 t -89.65 -33.81 6.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.163 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -76.33 -28.75 57.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.454 ' HB3' HD12 ' A' ' 408' ' ' LEU . 8.5 t0 -81.04 -53.09 6.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.875 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 39.3 m -48.74 -46.44 40.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 398' ' ' VAL . 18.9 m -64.25 -43.1 97.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.126 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 403' ' ' ASN . . . . . 0.433 ' N ' HG23 ' A' ' 402' ' ' VAL . 17.6 t-20 -64.28 -32.31 73.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -97.04 8.84 43.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.094 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 39.77 40.46 0.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 6.9 tp -156.93 149.41 23.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 90.7 mt -78.08 90.59 4.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 400' ' ' ASP . 84.4 mt -56.35 151.63 27.34 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.581 0.705 . . . . 0.0 110.908 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 107.44 1.86 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.635 2.223 . . . . 0.0 112.37 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.2 m -54.21 -19.03 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.147 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -58.31 -14.52 7.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.107 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -98.43 -16.63 19.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -114.57 28.34 8.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 26.1 t80 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.807 0.337 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.449 HD21 HD23 ' A' ' 407' ' ' LEU . 4.8 tp -71.47 -51.59 22.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.916 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 327' ' ' PHE . . . . . 0.489 ' HB2' ' CA ' ' A' ' 352' ' ' GLY . 22.8 m-85 -86.3 31.7 0.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -66.54 119.83 12.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.862 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 82.7 -53.07 4.79 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.467 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 329' ' ' GLY . 29.7 mt -36.69 124.84 0.86 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.847 0.356 . . . . 0.0 110.87 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -99.82 115.08 28.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -104.32 167.54 9.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 333' ' ' PHE . . . . . 0.41 ' CD1' ' O ' ' A' ' 355' ' ' SER . 34.6 t80 -152.58 115.56 4.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.59 HD13 ' HA ' ' A' ' 340' ' ' ARG . 4.1 mt -89.77 128.22 36.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.934 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 335' ' ' ASN . . . . . 0.44 ' O ' HG22 ' A' ' 338' ' ' VAL . 2.6 t-20 -83.23 145.99 28.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.546 ' HB3' HD13 ' A' ' 360' ' ' LEU . 0.0 OUTLIER -51.03 -20.03 1.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -78.75 -42.49 27.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 335' ' ' ASN . 13.3 m -82.39 151.21 65.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.623 0.725 . . . . 0.0 111.144 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 339' ' ' PRO . . . . . 0.524 ' O ' HD12 ' A' ' 343' ' ' LEU . 54.0 Cg_endo -69.71 124.82 11.47 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.715 2.277 . . . . 0.0 112.366 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 0.59 ' HA ' HD13 ' A' ' 334' ' ' LEU . 15.6 mtm105 -89.42 -55.45 3.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.875 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 340' ' ' ARG . 7.5 pt-20 -35.26 -45.85 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -71.58 -63.76 1.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.099 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 343' ' ' LEU . . . . . 0.685 HD11 ' HB3' ' A' ' 395' ' ' PRO . 35.3 mt -55.46 -63.59 1.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.916 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -37.07 -57.65 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -52.83 -46.21 67.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 346' ' ' ILE . . . . . 0.689 ' CG2' HG11 ' A' ' 402' ' ' VAL . 14.6 mt -61.18 -62.05 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.129 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 20.3 mt -48.63 -53.03 7.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.155 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -62.07 -40.32 95.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 4.5 m -60.21 -34.88 74.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.821 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -98.79 29.04 3.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 53.8 59.17 10.19 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.477 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' GLY . . . . . 0.489 ' CA ' ' HB2' ' A' ' 327' ' ' PHE . . . -125.39 156.31 19.16 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.467 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -91.27 142.47 27.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.951 0.405 . . . . 0.0 110.838 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.462 ' CG2' ' HG ' ' A' ' 334' ' ' LEU . 7.5 p -159.11 141.03 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.149 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 355' ' ' SER . . . . . 0.41 ' O ' ' CD1' ' A' ' 333' ' ' PHE . 32.7 t -140.9 157.47 45.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.828 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -136.35 -177.89 4.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.673 ' HB2' HD12 ' A' ' 360' ' ' LEU . 2.9 m-20 -69.13 119.78 13.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 22.8 mttp -53.52 -55.43 25.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 26.5 t -48.18 -58.94 3.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.87 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.673 HD12 ' HB2' ' A' ' 357' ' ' ASP . 5.9 mt -49.97 -40.54 44.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 3.8 m -160.68 144.72 13.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 7.3 pt -82.27 151.33 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.1 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 109.79 26.94 4.82 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.451 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -99.98 155.87 17.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 111.139 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 23.8 p -108.12 -57.82 2.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.14 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -128.27 136.7 51.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.9 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.92 169.8 14.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.839 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' VAL . . . . . 0.46 ' HA ' ' CD1' ' A' ' 373' ' ' ILE . 11.3 p -55.54 -29.35 24.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.137 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 75.8 p -65.88 -25.6 67.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.145 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -62.21 98.88 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 60.5 p -49.49 -29.62 6.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -45.99 -40.45 10.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.859 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.46 ' CD1' ' HA ' ' A' ' 368' ' ' VAL . 60.0 mt -38.16 145.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.103 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 75.7 p -117.55 -30.81 5.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.164 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -141.75 124.37 15.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.827 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 376' ' ' GLN . . . . . 0.529 ' NE2' ' CG1' ' A' ' 378' ' ' VAL . 0.2 OUTLIER -106.09 95.04 5.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 48.2 mm -58.62 97.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.108 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' VAL . . . . . 0.529 ' CG1' ' NE2' ' A' ' 376' ' ' GLN . 27.4 m -118.58 163.3 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.137 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.96 -34.77 64.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -134.64 80.9 49.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.602 0.715 . . . . 0.0 110.906 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 3.05 2.99 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.665 2.244 . . . . 0.0 112.381 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -113.43 -21.56 5.78 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.484 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' GLN . . . . . 0.412 ' HG3' ' N ' ' A' ' 384' ' ' GLN . 1.0 OUTLIER -92.64 -61.07 1.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.78 0.324 . . . . 0.0 110.888 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.412 ' N ' ' HG3' ' A' ' 383' ' ' GLN . 2.4 pt20 -54.56 138.82 39.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 7.8 t -48.93 146.8 3.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.14 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 25.2 p -118.87 152.71 35.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.848 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.39 119.22 49.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.112 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.762 ' H ' HD12 ' A' ' 388' ' ' ILE . 5.0 mp -42.57 111.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.17 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 115.18 -38.58 3.07 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.52 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' ARG . . . . . 0.492 ' HD2' ' CZ ' ' A' ' 392' ' ' TYR . 6.7 ttm180 -83.55 146.81 28.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.765 0.317 . . . . 0.0 110.898 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 43.8 m -114.53 143.61 44.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 392' ' ' TYR . . . . . 0.492 ' CZ ' ' HD2' ' A' ' 390' ' ' ARG . 3.7 m-85 -123.29 129.33 51.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.488 HG11 ' CG1' ' A' ' 410' ' ' VAL . 33.8 m -132.99 152.21 35.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.197 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -71.05 160.91 81.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.576 0.703 . . . . 0.0 110.936 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.685 ' HB3' HD11 ' A' ' 343' ' ' LEU . 53.6 Cg_endo -69.74 -4.58 14.3 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.709 2.273 . . . . 0.0 112.315 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 396' ' ' GLN . . . . . 0.537 ' HA ' ' CD2' ' A' ' 399' ' ' PHE . 14.0 tt0 -85.36 -31.77 22.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -53.78 -30.32 44.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.985 ' O ' HG22 ' A' ' 402' ' ' VAL . 21.4 t -72.52 -38.33 59.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.106 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 399' ' ' PHE . . . . . 0.537 ' CD2' ' HA ' ' A' ' 396' ' ' GLN . 17.3 m-85 -63.19 -52.24 63.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.25 -26.92 67.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 45.8 m -75.81 -59.81 2.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.837 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.985 HG22 ' O ' ' A' ' 398' ' ' VAL . 5.8 m -55.6 -33.99 34.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.083 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -76.3 -38.74 55.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -85.37 12.34 8.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.085 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 40.04 36.07 0.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.403 HD12 ' H ' ' A' ' 407' ' ' LEU . 49.7 tp -151.48 151.39 31.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.978 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.449 HD23 HD21 ' A' ' 326' ' ' LEU . 46.9 mt -86.83 71.9 10.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.924 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 407' ' ' LEU . 43.6 mt -38.04 156.41 0.1 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.621 0.724 . . . . 0.0 110.906 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 113.6 3.42 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.345 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' VAL . . . . . 0.488 ' CG1' HG11 ' A' ' 393' ' ' VAL . 16.4 m -61.83 -31.22 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -45.21 -44.39 10.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.47 -27.16 67.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -98.35 38.33 1.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.889 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.801 0.334 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 22.7 tp -53.25 -53.07 56.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' PHE . . . . . 0.438 ' HB2' ' CA ' ' A' ' 352' ' ' GLY . 24.5 m-85 -95.24 35.52 1.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -60.68 113.08 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 80.51 -41.88 2.56 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.5 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 34.9 mt -44.8 124.75 4.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.903 0.382 . . . . 0.0 110.894 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -95.81 147.39 23.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -137.82 155.77 48.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -139.55 116.3 10.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.696 HD11 HG21 ' A' ' 354' ' ' VAL . 2.8 mt -94.64 152.65 18.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -114.54 147.88 38.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.447 ' HD2' ' N ' ' A' ' 336' ' ' ARG . 0.5 OUTLIER -46.86 -27.78 1.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -63.87 -48.59 76.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.7 m -86.89 151.14 51.73 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.675 0.75 . . . . 0.0 111.121 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' PRO . . . . . 0.618 ' O ' HD12 ' A' ' 343' ' ' LEU . 54.0 Cg_endo -69.77 116.06 4.38 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.67 2.247 . . . . 0.0 112.328 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 0.426 ' HG2' ' N ' ' A' ' 341' ' ' GLU . 0.0 OUTLIER -87.4 -29.98 21.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.884 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.426 ' N ' ' HG2' ' A' ' 340' ' ' ARG . 11.2 pt-20 -50.96 -49.75 59.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.401 ' N ' ' HG3' ' A' ' 341' ' ' GLU . . . -74.3 -57.59 3.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.089 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 343' ' ' LEU . . . . . 0.666 HD23 ' CE1' ' A' ' 399' ' ' PHE . 27.6 mt -53.14 -65.33 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 343' ' ' LEU . . . -35.03 -62.66 0.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.059 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 345' ' ' PHE . . . . . 0.603 ' N ' HH21 ' A' ' 348' ' ' ARG . 19.8 t80 -48.27 -49.73 32.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 346' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 349' ' ' SER . 44.4 mt -56.55 -71.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.16 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 347' ' ' ILE . . . . . 0.429 ' O ' ' N ' ' A' ' 352' ' ' GLY . 20.9 mt -37.99 -50.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.138 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 348' ' ' ARG . . . . . 0.603 HH21 ' N ' ' A' ' 345' ' ' PHE . 75.0 mtm180 -65.21 -37.71 88.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 349' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 346' ' ' ILE . 29.6 t -61.2 -42.83 99.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -88.54 23.05 2.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.869 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 60.67 57.2 20.12 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.452 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 352' ' ' GLY . . . . . 0.438 ' CA ' ' HB2' ' A' ' 327' ' ' PHE . . . -123.01 164.22 16.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.471 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -103.75 130.12 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.924 0.392 . . . . 0.0 110.893 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.696 HG21 HD11 ' A' ' 334' ' ' LEU . 5.7 p -141.51 142.76 28.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.123 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 355' ' ' SER . . . . . 0.458 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 4.6 t -140.48 162.46 35.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' TRP . . . . . 0.568 ' O ' ' HB2' ' A' ' 364' ' ' ALA . 20.4 p90 -139.32 153.92 47.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.913 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 360' ' ' LEU . 3.9 t70 -45.07 104.87 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 357' ' ' ASP . 7.3 mtpm? -35.92 -36.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.2 t -64.0 -48.35 76.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 357' ' ' ASP . 36.8 mt -55.44 -39.35 70.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 3.7 t -172.23 146.7 1.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.6 pt -66.34 173.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.102 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 104.42 -38.96 3.0 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.499 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 356' ' ' TRP . . . -50.34 140.3 13.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.822 0.344 . . . . 0.0 111.13 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 23.6 p -101.49 -50.94 3.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.186 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' TYR . . . . . 0.458 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 29.9 p90 -112.49 149.64 32.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.52 167.56 19.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.86 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 12.8 p -69.73 -22.56 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.155 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 77.3 p -84.02 13.55 4.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.61 110.49 17.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 22.6 p -55.35 -23.8 25.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -60.94 -36.8 80.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.85 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.417 HG21 HH11 ' A' ' 390' ' ' ARG . 66.6 mt -40.55 130.38 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.121 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 69.6 p -97.52 -24.72 15.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.169 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -154.55 149.36 26.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 376' ' ' GLN . . . . . 0.541 ' OE1' ' CE2' ' A' ' 392' ' ' TYR . 52.8 tt0 -134.37 111.56 10.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 19.1 mm -80.0 115.0 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.129 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' VAL . . . . . 0.533 HG13 ' HG2' ' A' ' 376' ' ' GLN . 29.5 m -131.97 168.98 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.55 -34.59 31.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.458 ' CZ ' ' HG3' ' A' ' 383' ' ' GLN . 81.3 mtp180 -132.23 80.81 62.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.612 0.72 . . . . 0.0 110.872 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -18.6 37.04 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.689 2.259 . . . . 0.0 112.358 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -73.92 -32.45 58.84 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.526 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 383' ' ' GLN . . . . . 0.458 ' HG3' ' CZ ' ' A' ' 380' ' ' ARG . 13.8 mm100 -76.12 -49.3 17.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.756 0.312 . . . . 0.0 110.898 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -53.17 178.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 72.4 p -122.2 121.93 38.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 81.3 p -56.88 157.54 5.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 97.3 t -125.43 140.16 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.131 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.1 mt -37.82 111.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.093 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 92.13 -49.07 2.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.489 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' ARG . . . . . 0.468 ' HD2' ' N ' ' A' ' 391' ' ' CYS . 6.9 tmm_? -84.43 146.28 27.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.806 0.336 . . . . 0.0 110.863 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 391' ' ' CYS . . . . . 0.468 ' N ' ' HD2' ' A' ' 390' ' ' ARG . 88.3 m -134.8 147.55 49.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 392' ' ' TYR . . . . . 0.541 ' CE2' ' OE1' ' A' ' 376' ' ' GLN . 5.2 m-85 -94.62 132.87 38.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 4.2 m -138.26 158.13 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.116 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -78.7 161.32 69.67 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.608 0.718 . . . . 0.0 110.913 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -6.19 18.02 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.643 2.229 . . . . 0.0 112.341 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -80.96 -23.74 38.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.946 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 92.5 t90 -63.73 -27.97 69.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.696 ' O ' HG22 ' A' ' 402' ' ' VAL . 48.0 t -75.0 -70.27 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 399' ' ' PHE . . . . . 0.666 ' CE1' HD23 ' A' ' 343' ' ' LEU . 5.4 m-30 -42.07 -36.95 1.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.88 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -72.44 -44.31 62.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 75.8 m -63.55 -54.47 35.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.81 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 398' ' ' VAL . 2.5 m -56.74 -33.88 41.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.089 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -79.48 -29.48 41.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -94.5 9.17 39.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.071 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? 40.19 32.71 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.597 HD13 ' N ' ' A' ' 407' ' ' LEU . 0.9 OUTLIER -152.62 137.4 17.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.93 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.597 ' N ' HD13 ' A' ' 406' ' ' LEU . 48.1 mt -74.1 85.37 1.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 45.5 mt -51.57 154.15 3.48 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.552 0.691 . . . . 0.0 110.977 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 107.93 1.96 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.711 2.274 . . . . 0.0 112.326 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.1 m -54.84 -16.78 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.141 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -62.16 -19.16 62.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -90.74 -24.24 20.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -104.96 38.27 1.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.905 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 6.0 t80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.813 0.34 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 15.9 tp -57.69 -52.57 64.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 327' ' ' PHE . . . . . 0.472 ' HA ' HD12 ' A' ' 330' ' ' LEU . 25.4 m-85 -92.41 38.39 1.01 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -71.69 141.15 49.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.919 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 45.49 43.45 10.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.451 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 327' ' ' PHE . 42.1 mt -132.23 126.81 34.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.86 0.362 . . . . 0.0 110.899 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.549 ' HE3' ' CE2' ' A' ' 366' ' ' TYR . 37.1 mtpt -99.32 141.38 32.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.909 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -133.18 156.16 47.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 333' ' ' PHE . . . . . 0.467 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 8.9 t80 -138.36 115.63 11.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.86 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.531 HD11 HG21 ' A' ' 354' ' ' VAL . 2.9 mt -94.47 151.96 18.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.933 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -104.45 177.12 4.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -77.48 -27.51 51.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.855 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -72.13 -26.04 61.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.1 m -102.15 148.39 35.31 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.603 0.716 . . . . 0.0 111.122 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 339' ' ' PRO . . . . . 0.465 ' O ' HD12 ' A' ' 343' ' ' LEU . 53.4 Cg_endo -69.83 122.31 8.97 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.633 2.222 . . . . 0.0 112.343 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 0.5 ' O ' ' HB3' ' A' ' 344' ' ' ALA . 6.3 ppt_? -95.08 -30.67 13.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.461 ' N ' ' HD2' ' A' ' 340' ' ' ARG . 8.1 pt-20 -52.07 -37.82 55.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -86.26 -60.67 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.112 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 343' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 339' ' ' PRO . 54.9 mt -52.7 -55.58 21.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 340' ' ' ARG . . . -45.35 -58.6 3.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.07 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 345' ' ' PHE . . . . . 0.407 ' O ' ' N ' ' A' ' 349' ' ' SER . 4.8 t80 -56.38 -46.93 79.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 346' ' ' ILE . . . . . 0.412 ' CD1' ' CE1' ' A' ' 399' ' ' PHE . 29.2 mt -55.83 -67.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.147 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 17.0 mt -45.77 -37.94 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.167 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -78.97 -26.72 43.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 349' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 345' ' ' PHE . 16.7 t -82.53 -21.9 35.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.837 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -101.18 15.56 28.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 72.31 73.37 0.85 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.501 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -158.1 169.03 34.69 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.455 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -106.03 143.47 34.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.832 0.349 . . . . 0.0 110.947 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.531 HG21 HD11 ' A' ' 334' ' ' LEU . 11.7 p -157.82 128.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.151 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 355' ' ' SER . . . . . 0.548 ' HB2' ' CE1' ' A' ' 366' ' ' TYR . 1.9 m -133.7 154.15 51.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 356' ' ' TRP . . . . . 0.466 ' CD1' ' O ' ' A' ' 361' ' ' CYS . 14.3 p90 -122.16 -178.5 3.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.884 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 358' ' ' LYS . 10.9 t70 -73.83 111.75 9.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.854 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 357' ' ' ASP . 27.4 mttt -35.0 -51.47 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 7.9 t -57.97 -49.11 77.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 28.1 mt -51.31 -51.12 57.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 361' ' ' CYS . . . . . 0.466 ' O ' ' CD1' ' A' ' 356' ' ' TRP . 1.8 m -160.91 143.28 12.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 45.0 pt -66.22 160.08 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.41 ' O ' ' CZ2' ' A' ' 356' ' ' TRP . . . 96.91 36.21 5.08 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.464 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -117.33 147.17 42.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.816 0.341 . . . . 0.0 111.116 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 21.9 p -105.18 -71.06 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.146 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 366' ' ' TYR . . . . . 0.549 ' CE2' ' HE3' ' A' ' 331' ' ' LYS . 13.6 p90 -96.34 146.59 24.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.934 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.76 170.66 11.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 368' ' ' VAL . . . . . 0.467 ' HB ' ' CZ ' ' A' ' 333' ' ' PHE . 7.3 p -64.55 -18.05 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.134 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 70.1 p -85.37 22.85 1.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.181 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -104.73 103.83 13.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 30.0 m -50.35 -37.09 35.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 30.6 mtt180 -40.59 -39.84 1.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.86 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 70.6 mt -45.65 117.64 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.158 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 48.9 p -81.64 -44.93 16.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -126.32 138.87 53.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.861 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 376' ' ' GLN . . . . . 0.46 ' OE1' ' CZ ' ' A' ' 390' ' ' ARG . 37.6 tt0 -122.32 99.05 6.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.914 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 377' ' ' ILE . . . . . 0.424 ' N ' ' O ' ' A' ' 333' ' ' PHE . 25.8 mm -65.87 129.46 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 35.4 m -152.27 146.67 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.139 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -68.21 -34.54 76.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.827 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.404 ' HA ' ' HD2' ' A' ' 381' ' ' PRO . 20.2 mtp85 -132.7 89.86 34.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.612 0.72 . . . . 0.0 110.878 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 381' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 380' ' ' ARG . 53.6 Cg_endo -69.71 -27.06 27.17 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.668 2.245 . . . . 0.0 112.337 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -72.58 -59.2 4.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.528 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 383' ' ' GLN . . . . . 0.47 ' HG3' ' N ' ' A' ' 384' ' ' GLN . 12.1 pt20 -43.03 -36.96 1.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.808 0.337 . . . . 0.0 110.921 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.47 ' N ' ' HG3' ' A' ' 383' ' ' GLN . 10.4 pt20 -104.32 114.67 29.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.95 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 16.2 m -51.37 153.11 2.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.159 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 6.9 t -91.51 173.18 8.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.858 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.9 t -127.77 130.91 70.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.111 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 29.3 mm -42.37 125.95 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.143 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 94.68 -33.52 5.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.487 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 390' ' ' ARG . . . . . 0.46 ' CZ ' ' OE1' ' A' ' 376' ' ' GLN . 19.8 ttp180 -93.97 146.11 24.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.782 0.325 . . . . 0.0 110.881 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 62.5 m -129.22 127.8 42.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -96.61 133.64 40.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.507 HG11 ' HB ' ' A' ' 410' ' ' VAL . 17.0 m -143.21 142.76 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.123 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -57.85 158.45 12.48 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.607 0.718 . . . . 0.0 110.93 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -7.25 20.6 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.709 2.273 . . . . 0.0 112.294 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.31 -33.75 42.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 397' ' ' TRP . . . . . 0.457 ' CE2' HG12 ' A' ' 410' ' ' VAL . 69.1 t90 -48.49 -31.16 6.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.926 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.515 ' O ' HG22 ' A' ' 402' ' ' VAL . 65.7 t -80.22 -55.03 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 399' ' ' PHE . . . . . 0.433 ' CE2' HD21 ' A' ' 343' ' ' LEU . 68.1 m-85 -54.23 -22.02 10.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -85.45 -41.39 15.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 401' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 405' ' ' ARG . 20.3 m -66.53 -51.92 51.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 398' ' ' VAL . 15.3 m -49.77 -38.12 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.141 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -78.12 -44.18 26.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 404' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -83.08 8.28 13.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.138 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 405' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 404' ' ' ALA . 7.9 mmm180 35.57 46.0 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 12.6 tp -156.18 148.18 23.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.932 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 13.5 mt -80.0 84.14 5.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 33.1 mt -55.53 154.36 12.63 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.598 0.714 . . . . 0.0 110.886 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 114.13 3.61 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.707 2.271 . . . . 0.0 112.293 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 410' ' ' VAL . . . . . 0.507 ' HB ' HG11 ' A' ' 393' ' ' VAL . 35.2 m -60.57 -21.27 22.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.123 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -55.54 -40.05 71.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.085 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.38 -9.99 59.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -121.34 38.41 4.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.887 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 10.4 t80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 -179.976 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.795 0.331 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 11.6 tp -44.37 -50.58 9.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.866 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -93.01 42.59 1.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -74.56 133.86 42.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 52.32 55.29 22.75 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.486 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 88.0 mt -147.55 118.1 7.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.88 0.371 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -93.43 126.26 38.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.948 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.518 ' CD1' ' HB2' ' A' ' 375' ' ' HIS . 74.5 m-85 -120.29 160.36 23.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 333' ' ' PHE . . . . . 0.528 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 36.8 t80 -141.11 117.01 10.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.475 HD11 HG21 ' A' ' 354' ' ' VAL . 7.4 mt -93.67 142.84 26.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.904 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 335' ' ' ASN . . . . . 0.403 ' OD1' HG12 ' A' ' 378' ' ' VAL . 3.7 m120 -101.22 158.25 16.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.776 ' HB3' HD13 ' A' ' 360' ' ' LEU . 12.9 ptt180 -58.78 -29.53 66.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.846 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 337' ' ' GLU . . . . . 0.462 ' CG ' ' OD2' ' A' ' 379' ' ' ASP . 11.6 tp10 -66.19 -48.0 72.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 5.1 m -80.82 150.64 69.66 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.582 0.706 . . . . 0.0 111.184 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 110.34 2.53 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.677 2.251 . . . . 0.0 112.3 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -86.53 -38.67 16.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -44.69 -41.33 6.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -82.42 -58.49 2.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.075 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 71.4 mt -53.99 -61.23 2.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -39.66 -55.55 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.068 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -58.81 -44.54 90.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 47.8 mt -59.65 -62.33 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.151 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 20.1 mt -51.97 -55.88 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -56.43 -40.26 74.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 29.5 t -64.92 -43.96 91.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 350' ' ' PHE . . . . . 0.468 ' CZ ' HG22 ' A' ' 402' ' ' VAL . 14.0 m-85 -73.44 -9.16 58.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 90.83 54.55 2.03 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.497 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -128.91 161.95 22.46 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.492 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -92.06 129.07 38.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.912 0.387 . . . . 0.0 110.851 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.475 HG21 HD11 ' A' ' 334' ' ' LEU . 10.8 p -148.06 143.2 19.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.155 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 355' ' ' SER . . . . . 0.553 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 5.1 t -147.39 152.26 37.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.868 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 356' ' ' TRP . . . . . 0.509 ' CD1' ' HB3' ' A' ' 361' ' ' CYS . 31.7 p90 -128.45 173.15 10.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.668 ' HB2' HD12 ' A' ' 360' ' ' LEU . 1.2 m-20 -61.59 109.28 1.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.821 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -46.45 -34.34 4.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 28.4 t -69.41 -55.18 11.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.814 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.776 HD13 ' HB3' ' A' ' 336' ' ' ARG . 18.5 mt -54.91 -44.14 73.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.894 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 361' ' ' CYS . . . . . 0.509 ' HB3' ' CD1' ' A' ' 356' ' ' TRP . 2.1 t -147.21 159.97 43.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 15.7 tt -86.55 162.26 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.149 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 85.98 43.1 6.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.508 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -107.04 165.8 11.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.878 0.37 . . . . 0.0 111.09 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 20.9 p -129.78 -64.05 0.89 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.143 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 366' ' ' TYR . . . . . 0.553 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 8.3 p90 -112.31 145.91 39.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.953 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.13 167.17 22.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.88 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 368' ' ' VAL . . . . . 0.528 ' HB ' ' CZ ' ' A' ' 333' ' ' PHE . 7.5 p -63.62 -20.49 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.107 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 79.1 p -93.65 26.62 3.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.142 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -93.87 113.58 25.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 372' ' ' ARG . 11.9 t -53.62 -45.76 70.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.871 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 372' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 371' ' ' SER . 18.5 mmt180 -37.15 -42.42 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.917 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 34.0 mt -47.75 129.95 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.096 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 41.6 p -94.73 -43.1 8.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.106 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 375' ' ' HIS . . . . . 0.518 ' HB2' ' CD1' ' A' ' 332' ' ' PHE . 37.3 m80 -128.82 148.47 50.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -128.74 115.42 17.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.927 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 27.0 mm -82.72 116.17 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.167 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 378' ' ' VAL . . . . . 0.403 HG12 ' OD1' ' A' ' 335' ' ' ASN . 30.9 m -141.05 158.19 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 379' ' ' ASP . . . . . 0.462 ' OD2' ' CG ' ' A' ' 337' ' ' GLU . 2.8 m-20 -71.48 -37.7 71.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -127.69 81.98 69.19 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.578 0.704 . . . . 0.0 110.892 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -23.07 31.34 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.715 2.277 . . . . 0.0 112.373 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -68.64 -47.16 58.13 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.476 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -63.11 -48.9 76.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.775 0.321 . . . . 0.0 110.88 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -45.81 164.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.91 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 51.6 m -95.87 126.68 41.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.117 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 72.4 m -67.21 139.78 57.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 90.5 t -129.78 119.36 47.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.112 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.783 ' H ' HD12 ' A' ' 388' ' ' ILE . 5.0 mp -39.94 134.41 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 88.76 -40.8 3.05 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.455 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 390' ' ' ARG . . . . . 0.425 ' NH1' ' O ' ' A' ' 368' ' ' VAL . 14.5 ttp180 -95.65 145.79 25.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.756 0.312 . . . . 0.0 110.871 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 84.0 m -132.85 124.33 27.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -90.89 128.07 36.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.954 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 19.7 m -135.99 151.11 28.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.088 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -66.55 158.12 80.1 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.602 0.715 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -5.5 16.34 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.662 2.241 . . . . 0.0 112.362 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -80.68 -14.77 57.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -73.12 -49.77 26.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 51.7 t -55.5 -41.75 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.12 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -65.03 -64.53 0.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.484 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 2.4 m-20 -50.42 -33.42 20.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.836 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 69.6 m -70.49 -26.24 63.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.468 HG22 ' CZ ' ' A' ' 350' ' ' PHE . 2.2 t -89.23 -45.73 15.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.096 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -67.73 -31.68 71.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -88.08 5.99 38.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.087 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? 40.08 44.4 1.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 43.0 tp -165.13 144.24 6.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 16.4 mt -74.95 99.31 3.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.484 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 52.2 mt -71.55 153.62 93.56 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.634 0.731 . . . . 0.0 110.924 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 119.57 6.49 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.702 2.268 . . . . 0.0 112.35 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.09 -28.6 44.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.136 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -52.9 -21.82 4.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -84.52 -32.65 23.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -104.96 42.51 1.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.923 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 3.7 t80 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.88 179.966 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.809 0.338 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.443 HD11 ' HA ' ' A' ' 405' ' ' ARG . 2.5 tt -57.26 -52.6 64.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.936 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -92.15 38.54 1.0 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -77.21 124.37 27.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 69.01 49.2 42.71 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.544 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.498 HD11 HD11 ' A' ' 407' ' ' LEU . 88.9 mt -148.19 124.46 10.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.854 0.359 . . . . 0.0 110.935 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.46 ' HZ2' ' HB3' ' A' ' 372' ' ' ARG . 45.3 mttt -95.54 133.11 39.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -119.26 152.8 36.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.909 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -130.98 119.04 21.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.879 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.729 HD11 HG21 ' A' ' 354' ' ' VAL . 7.3 mt -97.95 140.89 31.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -98.34 -175.14 3.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.872 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -82.46 -33.74 28.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -69.81 -36.6 75.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.562 HG11 HG22 ' A' ' 377' ' ' ILE . 3.1 m -87.16 145.28 37.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.658 0.742 . . . . 0.0 111.107 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 339' ' ' PRO . . . . . 0.519 ' O ' HD12 ' A' ' 343' ' ' LEU . 53.6 Cg_endo -69.74 127.32 14.44 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.664 2.242 . . . . 0.0 112.33 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.86 -40.19 9.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -45.65 -41.36 10.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -78.9 -66.91 0.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.139 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 343' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 339' ' ' PRO . 60.2 mt -44.57 -58.26 3.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -43.3 -54.79 4.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -55.39 -40.61 71.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 346' ' ' ILE . . . . . 0.553 ' CG2' HG11 ' A' ' 402' ' ' VAL . 15.6 mt -68.64 -72.91 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.145 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 347' ' ' ILE . . . . . 0.472 ' N ' HG22 ' A' ' 346' ' ' ILE . 26.1 mt -37.33 -37.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.122 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -75.18 -47.99 25.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 47.5 t -55.52 -31.18 61.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.804 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 350' ' ' PHE . . . . . 0.422 ' CE2' ' HB ' ' A' ' 402' ' ' VAL . 20.7 m-85 -98.72 26.22 5.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 53.02 71.44 0.69 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.521 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -136.87 173.07 22.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.49 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -109.17 128.23 54.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 110.902 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.729 HG21 HD11 ' A' ' 334' ' ' LEU . 7.6 p -144.06 131.58 17.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.119 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 355' ' ' SER . . . . . 0.579 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 10.4 t -136.2 163.86 29.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 356' ' ' TRP . . . . . 0.508 ' CD1' ' HB2' ' A' ' 361' ' ' CYS . 34.0 p90 -142.35 159.07 42.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.905 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.844 ' HB2' HD12 ' A' ' 360' ' ' LEU . 7.0 m-20 -55.65 120.88 7.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -45.08 -59.38 2.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 14.7 t -45.4 -48.88 13.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.824 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.844 HD12 ' HB2' ' A' ' 357' ' ' ASP . 32.3 mt -55.97 -49.62 73.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.973 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 361' ' ' CYS . . . . . 0.508 ' HB2' ' CD1' ' A' ' 356' ' ' TRP . 62.1 m -154.03 157.4 38.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.2 tt -84.9 158.48 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.117 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 91.73 36.38 6.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.486 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -105.52 158.2 16.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 0.0 111.087 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.434 ' OG1' ' CD2' ' A' ' 366' ' ' TYR . 22.3 p -111.99 -64.14 1.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.124 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 366' ' ' TYR . . . . . 0.579 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 16.0 p90 -110.18 139.43 45.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -76.74 171.46 14.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 368' ' ' VAL . . . . . 0.419 ' O ' HG22 ' A' ' 368' ' ' VAL . 13.6 p -64.12 -11.77 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.175 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 25.3 p -96.89 15.66 21.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.147 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 370' ' ' ASP . . . . . 0.442 ' CB ' ' HB2' ' A' ' 366' ' ' TYR . 0.9 OUTLIER -96.03 107.2 19.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.886 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 59.0 p -52.24 -33.34 41.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 372' ' ' ARG . . . . . 0.46 ' HB3' ' HZ2' ' A' ' 331' ' ' LYS . 26.1 mmm-85 -40.05 -45.14 1.88 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.877 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.446 HG12 ' CE1' ' A' ' 366' ' ' TYR . 20.7 mt -41.24 136.16 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.192 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 50.6 p -112.12 -23.87 10.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.114 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -134.47 134.16 41.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.847 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 376' ' ' GLN . . . . . 0.446 ' HG2' ' CE2' ' A' ' 392' ' ' TYR . 2.0 tp-100 -124.59 105.5 9.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.896 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 377' ' ' ILE . . . . . 0.562 HG22 HG11 ' A' ' 338' ' ' VAL . 6.0 mm -84.38 126.38 40.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.09 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 13.5 m -139.11 152.36 23.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.12 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -67.19 -42.49 84.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.426 ' HB3' ' NH1' ' A' ' 380' ' ' ARG . 0.0 OUTLIER -132.12 90.42 35.0 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 0.0 110.866 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -19.45 36.3 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.668 2.246 . . . . 0.0 112.352 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -65.48 -47.03 82.41 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.531 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -80.92 -42.22 21.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.756 0.312 . . . . 0.0 110.894 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -51.93 153.49 2.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.0 149.67 23.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.139 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 26.1 p -108.86 153.11 23.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.839 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 26.1 t -119.65 128.43 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.14 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.3 mt -40.4 117.67 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.167 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 103.88 -43.14 1.73 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.466 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -87.67 148.7 24.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 0.0 110.867 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 4.0 t -123.58 145.51 48.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 392' ' ' TYR . . . . . 0.446 ' CE2' ' HG2' ' A' ' 376' ' ' GLN . 2.9 m-85 -107.28 118.05 35.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.942 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.427 HG23 ' CD1' ' A' ' 377' ' ' ILE . 31.4 m -124.85 160.32 30.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.135 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -76.02 159.59 80.29 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.57 0.7 . . . . 0.0 110.887 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -6.69 19.18 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.669 2.246 . . . . 0.0 112.357 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -83.55 -15.9 47.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.947 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -66.09 -26.55 67.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.425 ' O ' HG22 ' A' ' 402' ' ' VAL . 85.9 t -76.43 -51.34 19.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.161 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -60.18 -30.67 69.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.464 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 1.0 OUTLIER -80.55 -36.45 33.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.904 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 71.8 m -69.27 -49.47 55.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.553 HG11 ' CG2' ' A' ' 346' ' ' ILE . 34.9 m -60.43 -45.29 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.117 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 403' ' ' ASN . . . . . 0.499 ' N ' HG23 ' A' ' 402' ' ' VAL . 20.9 t-20 -65.08 -39.04 92.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 404' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -87.16 9.49 19.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.128 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 405' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' A' ' 404' ' ' ALA . 12.6 mmm-85 34.71 45.31 0.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.646 HD13 ' N ' ' A' ' 407' ' ' LEU . 0.4 OUTLIER -165.32 136.1 3.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.646 ' N ' HD13 ' A' ' 406' ' ' LEU . 15.6 mt -66.1 95.99 0.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.955 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.464 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 45.6 mt -64.75 156.1 80.07 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.607 0.718 . . . . 0.0 110.941 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 116.04 4.37 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.701 2.267 . . . . 0.0 112.361 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.9 m -58.02 -26.15 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.133 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -50.94 -34.3 28.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.072 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -75.72 -26.12 57.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -108.77 42.67 1.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 43.4 t80 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.898 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.802 0.334 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 2.0 tt -60.91 -48.62 80.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.939 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 327' ' ' PHE . . . . . 0.411 ' HA ' HD12 ' A' ' 330' ' ' LEU . 14.0 m-85 -93.48 38.87 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.848 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 328' ' ' GLU . . . . . 0.488 ' CD ' ' N ' ' A' ' 329' ' ' GLY . 3.9 tp10 -72.41 133.12 44.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 329' ' ' GLY . . . . . 0.488 ' N ' ' CD ' ' A' ' 328' ' ' GLU . . . 58.31 53.19 47.78 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.484 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 327' ' ' PHE . 89.8 mt -148.14 132.6 17.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.884 0.373 . . . . 0.0 110.941 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -109.62 132.99 53.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.959 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -126.05 140.82 52.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.852 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -119.97 115.36 23.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.889 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 8.1 mt -89.08 145.57 25.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -98.87 -179.65 4.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -81.96 -17.96 45.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -79.3 -45.07 20.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.845 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 2.0 m -83.95 150.16 57.99 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.617 0.722 . . . . 0.0 111.18 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 339' ' ' PRO . . . . . 0.727 ' O ' HD12 ' A' ' 343' ' ' LEU . 53.4 Cg_endo -69.79 137.69 35.96 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.712 2.275 . . . . 0.0 112.342 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 344' ' ' ALA . 0.0 OUTLIER -105.62 -34.73 7.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.905 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -50.91 -41.61 58.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -81.5 -48.41 11.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.083 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 343' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 339' ' ' PRO . 75.7 mt -67.15 -65.67 0.65 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -38.09 -45.23 0.9 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.08 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -68.33 -44.77 74.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 25.8 mt -61.8 -63.03 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.104 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 28.1 mt -51.4 -43.01 29.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -67.63 -33.99 76.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 17.7 t -72.23 -44.05 63.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 350' ' ' PHE . . . . . 0.523 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 14.2 m-85 -72.68 1.16 8.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 81.42 54.78 3.4 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.499 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -129.19 153.42 19.83 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.461 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -91.81 126.36 36.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.926 0.393 . . . . 0.0 110.846 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 6.5 p -139.99 137.92 38.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.046 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 355' ' ' SER . . . . . 0.548 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 29.4 t -136.18 160.77 37.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 31.8 p90 -135.41 -175.37 3.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.925 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.719 ' HB2' HD12 ' A' ' 360' ' ' LEU . 12.5 m-20 -78.08 113.22 15.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 357' ' ' ASP . 1.3 mppt? -38.31 -56.2 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 17.7 t -44.88 -50.11 10.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.719 HD12 ' HB2' ' A' ' 357' ' ' ASP . 29.1 mt -57.02 -35.68 69.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.944 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 1.9 t -174.64 156.61 2.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 10.6 tt -81.36 163.23 3.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 111.16 -33.57 5.79 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.467 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -40.47 147.14 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 0.0 111.143 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.479 ' HG1' ' HD2' ' A' ' 366' ' ' TYR . 42.8 p -110.92 -58.97 2.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.094 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 366' ' ' TYR . . . . . 0.548 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 18.7 p90 -111.51 146.36 37.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.905 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -86.47 165.51 16.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.838 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 13.7 p -56.73 -30.83 33.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.125 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 73.2 p -67.15 -25.84 66.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.211 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -56.69 103.65 0.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 53.9 m -54.7 -26.85 36.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -46.13 -40.11 10.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 68.4 mt -44.92 120.98 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 71.2 p -89.17 -50.58 6.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.142 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -120.7 146.69 46.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.829 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -131.44 102.7 6.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 377' ' ' ILE . . . . . 0.632 HD13 HG23 ' A' ' 393' ' ' VAL . 31.8 mm -71.59 130.18 35.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.147 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 22.1 m -143.01 164.2 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.157 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 379' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 380' ' ' ARG . 0.4 OUTLIER -57.95 -48.45 79.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.472 ' N ' ' OD1' ' A' ' 379' ' ' ASP . 53.4 mtm-85 -145.78 104.96 4.22 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.637 0.732 . . . . 0.0 110.861 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -0.05 6.31 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.694 2.262 . . . . 0.0 112.377 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -103.67 -34.78 3.71 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.528 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -71.23 -71.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.726 0.298 . . . . 0.0 110.861 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -61.85 143.6 56.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 96.5 m -69.05 128.95 38.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 9.2 p -80.9 166.02 21.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' VAL . . . . . 0.46 HG23 ' OH ' ' A' ' 392' ' ' TYR . 97.5 t -94.73 108.7 21.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.752 ' H ' HD12 ' A' ' 388' ' ' ILE . 5.3 mp -36.32 102.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.148 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 125.2 -44.84 1.22 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.463 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 11.6 ttm-85 -78.9 160.51 27.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 110.852 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 73.6 m -119.21 115.81 24.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 392' ' ' TYR . . . . . 0.46 ' OH ' HG23 ' A' ' 387' ' ' VAL . 7.4 m-85 -96.0 136.04 36.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.632 HG23 HD13 ' A' ' 377' ' ' ILE . 17.8 m -139.47 153.11 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.13 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -68.81 159.24 83.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.57 0.7 . . . . 0.0 110.912 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -8.02 22.54 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.677 2.251 . . . . 0.0 112.398 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -81.22 -20.8 40.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 70.3 t90 -60.55 -43.05 97.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.99 -55.9 20.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.161 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -51.8 -35.62 44.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -76.4 -38.99 54.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.829 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 36.8 m -64.3 -48.23 76.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.815 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.523 ' HB ' ' CZ ' ' A' ' 350' ' ' PHE . 22.3 m -61.11 -46.22 97.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.104 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 403' ' ' ASN . . . . . 0.493 ' N ' HG23 ' A' ' 402' ' ' VAL . 41.5 t30 -62.13 -42.76 99.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -83.38 0.39 46.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 44.07 41.94 4.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.565 HD13 ' N ' ' A' ' 407' ' ' LEU . 0.4 OUTLIER -163.3 131.53 3.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.565 ' N ' HD13 ' A' ' 406' ' ' LEU . 71.4 mt -61.15 103.13 0.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 35.0 mt -70.4 154.2 94.62 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.592 0.71 . . . . 0.0 110.878 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 105.28 1.45 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.711 2.274 . . . . 0.0 112.343 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 32.7 m -51.58 -23.97 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.157 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -49.41 -34.52 16.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.094 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -74.37 -40.53 62.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -91.07 40.1 1.01 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 34.2 t80 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.88 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 59.5 mmtt . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.793 0.33 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 2.4 tt -39.65 -48.08 2.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -96.87 42.0 1.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -80.53 107.12 13.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 90.31 43.82 4.85 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.493 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.45 HD11 HD11 ' A' ' 407' ' ' LEU . 96.6 mt -144.43 129.27 18.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.83 0.348 . . . . 0.0 110.959 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.417 ' CE ' ' HB3' ' A' ' 372' ' ' ARG . 19.7 mttm -96.79 143.57 27.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -134.33 144.09 48.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -129.57 116.72 19.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.542 HD11 HG21 ' A' ' 354' ' ' VAL . 5.4 mt -97.33 147.68 23.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.969 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -110.35 154.52 23.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -52.48 -36.63 55.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -56.62 -47.8 78.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.0 m -88.94 148.61 41.62 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.575 0.703 . . . . 0.0 111.142 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 339' ' ' PRO . . . . . 0.563 ' O ' HD12 ' A' ' 343' ' ' LEU . 54.2 Cg_endo -69.76 125.04 11.68 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.713 2.276 . . . . 0.0 112.343 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 344' ' ' ALA . 0.3 OUTLIER -95.07 -40.99 9.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.857 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' A' ' 342' ' ' ALA . 8.1 pt-20 -42.37 -42.89 3.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.431 ' N ' ' HG3' ' A' ' 341' ' ' GLU . . . -76.64 -46.7 24.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 343' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 339' ' ' PRO . 24.2 mt -71.02 -66.34 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.939 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -34.65 -46.08 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.117 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -65.2 -43.33 91.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.926 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 346' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 343' ' ' LEU . 15.9 mt -62.7 -67.23 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.121 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 17.6 mt -42.34 -40.26 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 -72.77 -41.83 64.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 33.7 t -60.28 -33.18 71.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 350' ' ' PHE . . . . . 0.67 ' CZ ' HG13 ' A' ' 402' ' ' VAL . 22.8 m-85 -92.55 14.85 15.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.907 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 63.61 55.81 23.0 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.439 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -120.98 179.72 16.27 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.499 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -113.8 125.01 53.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 0.0 110.913 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.542 HG21 HD11 ' A' ' 334' ' ' LEU . 6.9 p -141.79 134.18 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 16.3 t -131.26 158.44 40.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.835 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 41.3 p90 -136.13 178.46 7.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.945 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 358' ' ' LYS . 0.6 OUTLIER -72.24 106.68 4.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.869 179.888 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 357' ' ' ASP . 0.1 OUTLIER -37.84 -45.61 0.86 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.918 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 58.8 m -42.09 -46.39 4.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 31.4 mt -60.01 -50.7 72.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 6.2 t -166.43 161.78 16.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 34.8 pt -64.21 175.34 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 364' ' ' ALA . . . 103.51 -35.07 5.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.508 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 363' ' ' GLY . . . -35.63 139.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.364 . . . . 0.0 111.087 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 37.2 p -113.37 -52.87 2.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.16 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -128.3 145.9 50.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.947 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -74.28 172.58 11.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.879 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 14.0 p -73.36 -14.12 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.135 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 41.3 p -96.94 19.65 12.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.144 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -95.79 105.95 18.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.832 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 8.4 t -47.05 -32.98 4.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 372' ' ' ARG . . . . . 0.417 ' HB3' ' CE ' ' A' ' 331' ' ' LYS . 9.0 mmt180 -41.95 -43.43 3.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.862 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 94.0 mt -49.62 135.9 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.112 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 77.2 p -106.21 -39.43 5.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.123 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -128.83 122.11 29.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.81 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -105.2 112.69 25.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 377' ' ' ILE . . . . . 0.467 HD13 HG23 ' A' ' 393' ' ' VAL . 49.6 mm -86.13 117.56 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.121 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 29.3 m -136.29 178.2 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.195 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -82.34 -43.91 16.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -125.51 82.2 63.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.573 0.702 . . . . 0.0 110.917 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -14.83 36.71 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.648 2.232 . . . . 0.0 112.354 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -72.78 -54.19 7.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.455 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -99.04 41.48 1.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.74 0.305 . . . . 0.0 110.893 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 385' ' ' THR . 4.3 tp-100 -122.76 100.86 7.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.969 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 385' ' ' THR . . . . . 0.415 ' C ' ' O ' ' A' ' 384' ' ' GLN . 31.3 m -36.59 122.77 0.79 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.114 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 34.4 p -102.73 -179.64 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 59.7 t -130.93 141.05 47.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.093 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.6 mt -42.2 113.89 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.133 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 104.27 -44.72 1.42 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.503 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 25.2 ttp180 -81.11 139.81 35.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.817 0.341 . . . . 0.0 110.861 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 61.8 m -127.38 125.6 40.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 392' ' ' TYR . . . . . 0.407 ' CE2' ' HG3' ' A' ' 384' ' ' GLN . 2.8 m-85 -85.86 137.19 32.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.932 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.467 HG23 HD13 ' A' ' 377' ' ' ILE . 23.4 m -142.34 164.46 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.119 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -79.04 160.79 70.49 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.567 0.699 . . . . 0.0 110.93 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 -4.83 14.79 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.669 2.246 . . . . 0.0 112.383 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -79.27 -34.22 42.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -50.7 -35.69 32.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.923 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 44.1 t -65.66 -51.57 61.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.107 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -57.27 -36.92 71.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.882 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.456 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 11.2 m-20 -73.8 -40.39 63.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.853 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 1.9 m -72.55 -23.28 60.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.831 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.67 HG13 ' CZ ' ' A' ' 350' ' ' PHE . 2.2 t -87.25 -31.13 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.14 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -85.37 -24.76 27.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 404' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -95.52 8.97 41.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.066 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 405' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 404' ' ' ALA . 10.2 mmt85 37.15 42.72 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.877 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 21.2 tp -166.69 142.22 4.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.94 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.45 HD11 HD11 ' A' ' 330' ' ' LEU . 13.0 mt -69.19 102.87 1.78 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.456 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 17.8 mt -73.68 154.29 89.42 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.593 0.711 . . . . 0.0 110.912 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 108.4 2.06 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.714 2.276 . . . . 0.0 112.319 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 410' ' ' VAL . . . . . 0.407 ' HB ' HG11 ' A' ' 393' ' ' VAL . 28.0 m -53.52 -25.36 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.164 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -53.45 -16.16 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.074 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -95.03 -22.4 17.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.868 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -111.81 36.0 3.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.935 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 2.2 t80 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.921 -179.977 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.786 0.327 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 7.5 tp -65.15 -38.65 91.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -105.87 30.16 6.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -54.1 113.84 1.39 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 78.73 -45.35 2.68 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.517 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.432 HD22 ' CE1' ' A' ' 375' ' ' HIS . 15.8 mt -39.6 130.34 1.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.872 0.368 . . . . 0.0 110.912 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -98.97 152.14 20.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -144.65 148.38 34.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -135.59 116.69 14.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.915 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.662 HD22 HD13 ' A' ' 343' ' ' LEU . 2.6 mt -94.42 139.97 30.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -88.97 171.15 10.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.447 ' CB ' HD11 ' A' ' 360' ' ' LEU . 28.9 ptt180 -77.47 -9.89 59.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.845 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -87.31 -42.84 12.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 5.7 m -84.92 150.97 56.86 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.637 0.732 . . . . 0.0 111.105 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 339' ' ' PRO . . . . . 0.572 ' O ' HD12 ' A' ' 343' ' ' LEU . 53.9 Cg_endo -69.8 115.34 4.05 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.681 2.254 . . . . 0.0 112.307 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -94.56 -39.7 10.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -40.2 -36.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -86.66 -49.22 7.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.106 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 343' ' ' LEU . . . . . 0.662 HD13 HD22 ' A' ' 334' ' ' LEU . 30.8 mt -60.29 -61.78 2.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.945 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -38.73 -62.64 0.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.098 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -48.85 -42.01 34.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 346' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 347' ' ' ILE . 23.3 mt -65.81 -72.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.122 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 347' ' ' ILE . . . . . 0.46 ' N ' HG22 ' A' ' 346' ' ' ILE . 27.5 mt -38.95 -44.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.153 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -66.78 -42.68 85.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 8.9 t -65.74 -28.48 69.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.849 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 350' ' ' PHE . . . . . 0.474 ' CZ ' HG12 ' A' ' 402' ' ' VAL . 18.5 m-85 -88.6 12.85 13.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.835 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 68.93 50.65 33.6 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.488 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -132.35 156.55 22.08 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.434 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -91.52 132.39 36.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.909 0.385 . . . . 0.0 110.911 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.457 HG21 HD11 ' A' ' 334' ' ' LEU . 7.1 p -140.24 142.8 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.157 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 26.3 t -137.05 159.85 40.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -139.65 174.42 10.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.5 119.13 4.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.887 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.43 -8.72 14.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 4.3 t -88.64 -23.41 23.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.836 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.447 HD11 ' CB ' ' A' ' 336' ' ' ARG . 12.5 mt -75.38 -51.02 14.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 2.7 t -162.48 164.66 26.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.865 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.6 pt -62.47 172.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.137 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 364' ' ' ALA . . . 105.95 -42.87 1.8 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.49 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 363' ' ' GLY . . . -35.3 124.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.893 0.378 . . . . 0.0 111.106 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 41.5 p -97.15 -65.17 0.98 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.152 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -109.61 158.74 17.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 370' ' ' ASP . 3.0 m-20 -83.23 167.97 17.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.914 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.08 -28.77 37.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.108 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 60.8 p -83.0 20.42 1.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.167 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 370' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 367' ' ' ASP . 2.8 m-20 -92.36 98.92 11.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 372' ' ' ARG . 16.6 t -43.16 -42.65 4.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.841 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 372' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 371' ' ' SER . 48.2 mtp180 -37.45 -41.46 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 78.4 mt -45.92 123.72 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 70.4 p -84.69 -45.1 12.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.14 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 375' ' ' HIS . . . . . 0.524 ' CD2' ' SG ' ' A' ' 391' ' ' CYS . 51.5 m80 -133.05 141.58 48.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.911 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -123.62 116.71 23.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 49.6 mm -82.42 127.78 39.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.144 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 15.4 m -140.24 172.65 11.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.103 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -90.47 -42.97 10.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.798 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 11.5 ptt-85 -121.22 81.2 36.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.568 0.699 . . . . 0.0 110.846 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 3.07 3.01 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.661 2.241 . . . . 0.0 112.325 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -97.3 -28.14 8.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.477 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -77.28 -71.33 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.787 0.327 . . . . 0.0 110.896 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.718 ' NE2' ' CE2' ' A' ' 392' ' ' TYR . 0.0 OUTLIER -57.34 120.78 8.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 66.5 p -58.85 140.67 54.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.156 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 27.8 p -68.32 161.12 28.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 387' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 388' ' ' ILE . 42.0 t -120.96 121.44 65.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.082 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.422 ' C ' ' O ' ' A' ' 387' ' ' VAL . 10.0 mt -36.17 132.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.124 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 86.48 -48.65 3.94 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.457 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -85.88 138.49 31.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.324 . . . . 0.0 110.901 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 391' ' ' CYS . . . . . 0.524 ' SG ' ' CD2' ' A' ' 375' ' ' HIS . 6.3 p -118.65 129.73 55.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 392' ' ' TYR . . . . . 0.718 ' CE2' ' NE2' ' A' ' 384' ' ' GLN . 7.8 m-85 -98.23 126.76 43.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.633 HG11 ' HB ' ' A' ' 410' ' ' VAL . 34.4 m -136.08 146.92 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.075 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -61.67 161.14 22.11 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.632 0.729 . . . . 0.0 110.859 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.459 ' HB3' HD11 ' A' ' 343' ' ' LEU . 54.2 Cg_endo -69.75 -10.47 28.66 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.705 2.27 . . . . 0.0 112.335 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -76.02 -26.42 56.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 85.6 t90 -56.82 -23.58 44.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.898 ' O ' HG22 ' A' ' 402' ' ' VAL . 3.9 t -87.83 -53.87 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -50.24 -33.54 19.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -79.56 -51.21 9.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 69.9 m -54.4 -51.45 64.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.898 HG22 ' O ' ' A' ' 398' ' ' VAL . 5.3 m -54.79 -44.24 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.13 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -69.84 -35.26 74.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.848 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -87.98 9.01 23.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 39.13 38.3 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.936 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.468 ' C ' HD23 ' A' ' 406' ' ' LEU . 1.0 OUTLIER -153.68 153.5 32.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.941 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 29.1 mt -85.78 93.59 8.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.11 152.88 76.62 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.73 . . . . 0.0 110.896 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 116.28 4.49 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.642 2.228 . . . . 0.0 112.356 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 410' ' ' VAL . . . . . 0.633 ' HB ' HG11 ' A' ' 393' ' ' VAL . 32.2 m -60.19 -19.74 18.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -63.01 -21.38 66.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.066 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -86.98 -17.27 33.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.937 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -115.49 42.68 2.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 41.7 t80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.812 -179.963 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.821 0.343 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.459 ' CD1' ' HA ' ' A' ' 405' ' ' ARG . 2.1 tt -53.03 -40.92 64.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.934 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -101.63 40.53 1.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -79.14 123.76 27.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.935 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 70.8 50.41 24.53 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.497 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 72.5 mt -142.91 162.28 35.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.86 0.362 . . . . 0.0 110.934 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -131.07 123.16 28.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.93 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.534 ' CD1' ' HB2' ' A' ' 375' ' ' HIS . 78.6 m-85 -119.42 147.49 44.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -132.31 119.91 21.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.817 HD22 HD13 ' A' ' 343' ' ' LEU . 3.6 mt -99.13 148.46 24.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -104.28 175.51 5.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.673 ' HB3' HD11 ' A' ' 360' ' ' LEU . 30.8 ptt180 -71.27 -31.86 68.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.842 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -63.58 -45.42 90.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 2.9 m -82.17 149.61 62.7 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.642 0.735 . . . . 0.0 111.135 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 339' ' ' PRO . . . . . 0.412 ' O ' HD12 ' A' ' 343' ' ' LEU . 54.1 Cg_endo -69.76 111.82 2.91 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.688 2.259 . . . . 0.0 112.363 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 0.448 ' O ' ' C ' ' A' ' 341' ' ' GLU . 26.1 ttp85 -78.45 -49.13 14.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 340' ' ' ARG . 1.2 mt-10 -33.59 -69.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.894 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -57.76 -64.04 1.04 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.128 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 343' ' ' LEU . . . . . 0.817 HD13 HD22 ' A' ' 334' ' ' LEU . 29.2 mt -42.08 -70.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 343' ' ' LEU . . . -36.98 -66.53 0.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.096 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -44.01 -49.18 8.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 28.7 mt -57.76 -67.67 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.123 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 29.2 mt -42.48 -44.64 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.164 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 348' ' ' ARG . . . . . 0.411 ' NH1' ' HB3' ' A' ' 348' ' ' ARG . 10.3 mtp-105 -65.1 -49.23 70.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 13.2 t -57.26 -21.08 31.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -102.2 22.75 12.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 55.96 50.29 62.23 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.513 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -122.39 163.12 15.91 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.523 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -101.96 126.5 48.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 110.895 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.758 HG21 HD11 ' A' ' 334' ' ' LEU . 6.7 p -138.94 138.64 41.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.119 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 355' ' ' SER . . . . . 0.445 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 7.4 t -131.23 161.63 31.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -139.34 174.64 10.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.511 ' HB3' HD12 ' A' ' 360' ' ' LEU . 28.4 t0 -64.24 107.55 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.852 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -42.39 -44.21 3.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 5.4 t -53.57 -52.34 60.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.673 HD11 ' HB3' ' A' ' 336' ' ' ARG . 41.7 mt -48.63 -51.09 29.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 2.7 m -158.41 166.08 33.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 20.9 tt -80.54 151.97 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 125.41 -36.61 2.74 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -40.81 145.88 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.868 0.366 . . . . 0.0 111.097 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.501 ' OG1' ' CD2' ' A' ' 366' ' ' TYR . 80.8 p -110.16 -64.25 1.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 366' ' ' TYR . . . . . 0.501 ' CD2' ' OG1' ' A' ' 365' ' ' THR . 2.2 p90 -106.55 159.07 16.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.17 168.22 19.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.892 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 368' ' ' VAL . . . . . 0.438 ' O ' HG22 ' A' ' 368' ' ' VAL . 8.2 p -76.26 -3.17 4.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.163 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 73.7 p -108.08 19.76 19.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.17 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -92.94 105.9 17.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.84 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 372' ' ' ARG . 75.3 m -41.12 -42.3 1.98 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.814 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 372' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 371' ' ' SER . 62.4 mtt180 -35.75 -44.0 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 85.6 mt -44.54 130.66 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 33.6 p -103.6 -33.1 9.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.126 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 375' ' ' HIS . . . . . 0.534 ' HB2' ' CD1' ' A' ' 332' ' ' PHE . 24.7 m80 -138.58 124.13 19.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.806 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -112.73 94.6 4.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 377' ' ' ILE . . . . . 0.588 HD13 HG23 ' A' ' 393' ' ' VAL . 16.1 mm -63.45 120.64 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.19 164.58 31.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.158 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -77.08 -44.77 29.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 27.3 mmm-85 -124.07 82.79 56.22 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.63 0.729 . . . . 0.0 110.847 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -14.0 35.55 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.676 2.25 . . . . 0.0 112.341 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -79.58 -32.89 36.22 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.515 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 383' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 384' ' ' GLN . 7.1 mm100 -84.98 -55.22 4.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.786 0.327 . . . . 0.0 110.91 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 383' ' ' GLN . 30.5 mm-40 -37.47 140.0 0.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 23.5 m -78.0 91.07 4.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.142 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 94.1 p -44.18 156.4 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.84 127.08 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.134 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 18.7 mm -39.99 129.27 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.12 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 91.97 -40.22 2.93 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.549 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -91.27 146.53 23.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.792 0.33 . . . . 0.0 110.881 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 18.4 m -124.17 124.06 41.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -90.22 125.49 35.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.588 HG23 HD13 ' A' ' 377' ' ' ILE . 15.2 m -130.59 167.41 25.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.127 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -88.21 161.05 44.44 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.614 0.721 . . . . 0.0 110.876 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.477 ' HB3' HD11 ' A' ' 343' ' ' LEU . 53.7 Cg_endo -69.79 -5.33 15.98 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.646 2.231 . . . . 0.0 112.353 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 -81.03 -23.68 38.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -62.53 -35.65 80.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.917 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.676 ' O ' HG22 ' A' ' 402' ' ' VAL . 65.7 t -66.68 -61.6 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.132 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 7.9 m-30 -48.14 -31.64 5.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.449 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 3.0 m-20 -76.85 -41.97 41.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 50.6 m -65.9 -52.37 50.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.824 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 398' ' ' VAL . 4.5 m -54.59 -33.43 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.174 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -87.43 -18.29 30.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.849 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -102.93 9.26 38.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.108 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 405' ' ' ARG . . . . . 0.459 ' HA ' ' CD1' ' A' ' 326' ' ' LEU . 9.7 mpt_? 39.59 30.38 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 13.0 tp -149.19 164.2 35.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 408' ' ' LEU . 94.2 mt -97.61 68.12 2.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.449 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 27.9 mt -35.41 153.33 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.564 0.697 . . . . 0.0 110.94 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 114.84 3.83 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.701 2.267 . . . . 0.0 112.399 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.8 m -53.5 -22.17 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.124 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -54.22 -42.96 70.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.086 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -70.09 -8.15 47.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -127.32 43.91 3.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.988 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 91.6 t80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.864 -179.936 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.834 0.349 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.02 -44.12 94.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -103.46 40.0 1.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -76.06 130.32 38.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 62.84 50.46 63.62 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.502 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 82.5 mt -146.08 120.27 9.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.842 0.353 . . . . 0.0 110.905 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -95.1 120.62 35.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -112.43 159.42 18.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 333' ' ' PHE . . . . . 0.464 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 35.4 t80 -141.69 116.71 9.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.872 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.775 HD22 HD13 ' A' ' 343' ' ' LEU . 3.8 mt -94.05 148.77 21.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.927 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -96.16 179.25 5.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.588 ' HB3' HD11 ' A' ' 360' ' ' LEU . 18.4 ptt85 -73.69 -39.88 64.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.4 -49.3 76.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.1 m -69.24 150.39 97.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.65 0.738 . . . . 0.0 111.14 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 122.16 8.85 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.701 2.268 . . . . 0.0 112.341 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' A' ' 344' ' ' ALA . 5.5 tmm_? -89.6 -37.4 14.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -60.02 -38.55 83.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.934 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.82 -59.65 2.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.087 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 343' ' ' LEU . . . . . 0.775 HD13 HD22 ' A' ' 334' ' ' LEU . 51.5 mt -56.44 -59.2 5.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 340' ' ' ARG . . . -43.96 -56.89 3.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -54.11 -42.9 69.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.832 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 346' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 347' ' ' ILE . 17.1 mt -66.92 -70.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.117 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 347' ' ' ILE . . . . . 0.413 ' N ' HG22 ' A' ' 346' ' ' ILE . 37.7 mt -43.69 -37.25 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.153 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -73.2 -37.2 66.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 7.4 m -72.57 -30.2 64.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 350' ' ' PHE . . . . . 0.52 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 15.3 m-85 -85.87 7.0 25.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.858 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 72.58 59.07 4.63 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.495 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -138.85 156.36 24.24 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.513 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -92.16 133.38 35.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.92 0.39 . . . . 0.0 110.871 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.454 HG21 HD11 ' A' ' 334' ' ' LEU . 7.3 p -143.6 138.7 25.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.126 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 355' ' ' SER . . . . . 0.533 ' HB2' ' CE1' ' A' ' 366' ' ' TYR . 5.1 t -134.05 157.28 46.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.863 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 22.6 p90 -141.03 177.14 8.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.39 111.31 4.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -50.33 -39.7 46.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 28.1 t -48.61 -47.96 39.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.588 HD11 ' HB3' ' A' ' 336' ' ' ARG . 76.0 mt -60.5 -47.03 87.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.904 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 1.8 m -166.64 137.37 3.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 26.1 pt -60.53 168.6 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 113.19 -36.96 3.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.501 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -45.45 166.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.853 0.358 . . . . 0.0 111.109 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.482 ' OG1' ' CD2' ' A' ' 366' ' ' TYR . 71.6 p -116.8 -68.94 0.88 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.12 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 366' ' ' TYR . . . . . 0.533 ' CE1' ' HB2' ' A' ' 355' ' ' SER . 0.9 OUTLIER -101.54 159.96 14.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.957 -179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -86.94 167.26 14.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.866 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 368' ' ' VAL . . . . . 0.464 ' HB ' ' CZ ' ' A' ' 333' ' ' PHE . 11.7 p -69.68 -30.3 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.109 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.5 p -83.49 20.61 1.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.139 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -95.06 121.76 37.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 99.0 p -69.78 -18.68 63.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 27.5 mtt-85 -57.33 -33.32 67.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.865 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 71.4 mt -54.64 144.26 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 25.7 p -104.48 -42.04 5.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.145 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -128.54 133.0 48.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.847 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 376' ' ' GLN . . . . . 0.41 ' CD ' ' CZ ' ' A' ' 392' ' ' TYR . 24.9 tt0 -113.56 104.71 12.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 9.2 mm -77.56 123.04 33.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 18.3 m -135.79 148.48 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.113 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -56.33 -39.01 72.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -148.14 104.98 3.59 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.591 0.71 . . . . 0.0 110.855 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.73 -6.38 18.44 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.69 2.26 . . . . 0.0 112.38 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 382' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 383' ' ' GLN . . . -83.21 -68.69 1.41 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 383' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 382' ' ' GLY . 12.3 mm100 -36.43 -49.64 0.73 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.696 0.284 . . . . 0.0 110.885 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -98.62 143.43 29.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 69.3 p -90.09 127.48 36.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.141 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 386' ' ' SER . . . . . 0.453 ' HB2' ' CD1' ' A' ' 392' ' ' TYR . 90.4 p -62.81 159.25 16.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 88.0 t -90.3 148.52 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.111 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 6.4 mm -54.81 129.42 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.148 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 92.06 -42.44 2.75 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.498 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -85.59 146.04 27.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.765 0.317 . . . . 0.0 110.829 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 81.6 m -113.39 132.06 55.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 392' ' ' TYR . . . . . 0.453 ' CD1' ' HB2' ' A' ' 386' ' ' SER . 3.3 m-85 -104.13 125.3 50.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.59 HG11 ' HB ' ' A' ' 410' ' ' VAL . 6.0 m -131.64 149.7 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -63.49 158.91 55.29 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.656 0.741 . . . . 0.0 110.859 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -6.95 19.85 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.706 2.271 . . . . 0.0 112.342 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -81.39 -26.17 35.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 397' ' ' TRP . . . . . 0.508 ' CE2' HG12 ' A' ' 410' ' ' VAL . 81.8 t90 -54.13 -43.53 70.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.433 ' O ' HG22 ' A' ' 402' ' ' VAL . 85.5 t -65.24 -47.67 86.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.114 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -58.93 -33.19 70.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.538 ' CB ' ' CD1' ' A' ' 408' ' ' LEU . 61.6 m-20 -75.95 -31.24 58.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 26.2 m -72.84 -51.65 17.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.847 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.52 ' HB ' ' CZ ' ' A' ' 350' ' ' PHE . 12.5 m -56.13 -40.5 64.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.094 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -67.36 -40.78 85.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 404' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -92.15 14.32 16.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 405' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 404' ' ' ALA . 1.2 mpp_? 34.3 40.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.859 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.763 HD13 ' N ' ' A' ' 407' ' ' LEU . 0.6 OUTLIER -156.63 149.3 23.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.763 ' N ' HD13 ' A' ' 406' ' ' LEU . 50.0 mt -75.69 103.45 5.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.538 ' CD1' ' CB ' ' A' ' 400' ' ' ASP . 12.4 mt -70.8 155.35 93.51 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.587 0.708 . . . . 0.0 110.934 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 105.3 1.46 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.658 2.239 . . . . 0.0 112.362 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 410' ' ' VAL . . . . . 0.59 ' HB ' HG11 ' A' ' 393' ' ' VAL . 34.5 m -56.07 -16.63 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.135 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.11 93.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -71.18 -12.31 61.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.869 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -119.62 30.31 7.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.888 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 81.2 t80 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.892 179.995 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 36.8 mmtt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.824 0.345 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 2.1 tt -70.01 -49.23 53.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.982 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -106.59 37.82 2.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -57.15 116.07 3.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 329' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 77.68 -50.81 3.31 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.494 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 329' ' ' GLY . 19.3 mt -34.65 127.66 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.886 0.374 . . . . 0.0 110.943 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -104.11 146.77 28.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -138.72 155.12 48.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -137.37 116.61 12.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.855 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.65 HD13 ' HA ' ' A' ' 340' ' ' ARG . 3.0 mt -92.52 144.86 24.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.931 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -89.4 -177.67 5.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.635 ' HB3' HD11 ' A' ' 360' ' ' LEU . 14.0 ptt-85 -80.7 -34.79 34.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -67.16 -42.56 84.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.496 HG12 ' OD2' ' A' ' 379' ' ' ASP . 4.3 m -78.89 150.02 74.68 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.61 0.719 . . . . 0.0 111.145 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 110.95 2.67 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.671 2.248 . . . . 0.0 112.39 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 0.65 ' HA ' HD13 ' A' ' 334' ' ' LEU . 6.2 ppt_? -85.57 -36.11 20.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.449 ' N ' ' HD2' ' A' ' 340' ' ' ARG . 9.3 pt-20 -54.0 -39.41 66.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -79.51 -64.67 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.084 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 32.0 mt -50.07 -60.04 3.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.922 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 340' ' ' ARG . . . -42.4 -56.28 3.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.08 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -54.79 -45.98 74.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.914 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 346' ' ' ILE . . . . . 0.427 ' CG2' HG11 ' A' ' 402' ' ' VAL . 19.8 mt -60.63 -62.35 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.123 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 23.9 mt -51.9 -43.85 36.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.118 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 70.1 mtp85 -67.01 -32.36 73.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.859 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 26.3 t -74.41 -39.58 62.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 350' ' ' PHE . . . . . 0.543 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 20.5 m-85 -75.15 -5.59 45.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.905 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 89.0 55.21 2.16 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.462 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -134.34 163.64 24.61 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.512 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -95.69 126.51 41.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.91 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.428 HG11 ' HA ' ' A' ' 344' ' ' ALA . 12.0 p -142.37 141.13 28.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.15 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 18.2 t -143.99 151.95 40.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 31.7 p90 -129.04 172.92 10.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.919 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -59.29 111.26 1.29 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.447 ' HG2' ' HB3' ' A' ' 364' ' ' ALA . 40.1 mtpt -44.58 -36.77 3.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.4 t -58.1 -50.9 71.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.635 HD11 ' HB3' ' A' ' 336' ' ' ARG . 38.6 mt -48.55 -47.7 39.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.911 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 5.0 t -171.69 145.8 2.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.86 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.3 pt -59.87 166.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.091 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 114.63 -35.21 4.52 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.475 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.447 ' HB3' ' HG2' ' A' ' 358' ' ' LYS . . . -51.99 158.77 0.99 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.872 0.367 . . . . 0.0 111.101 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 6.1 p -115.14 -65.7 1.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.166 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -107.56 152.36 24.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.426 ' O ' HD11 ' A' ' 373' ' ' ILE . 64.0 m-20 -81.35 173.27 12.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.826 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 12.2 p -69.29 -21.19 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.086 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.6 p -87.34 25.22 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.095 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 370' ' ' ASP . . . . . 0.423 ' OD2' ' N ' ' A' ' 367' ' ' ASP . 6.6 m-20 -103.27 104.36 14.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 372' ' ' ARG . 11.8 t -39.92 -42.13 1.29 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 372' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 371' ' ' SER . 24.8 mmt180 -35.67 -45.54 0.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.873 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.426 HD11 ' O ' ' A' ' 367' ' ' ASP . 41.1 mt -46.6 124.97 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.08 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 44.3 p -97.17 -46.61 6.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.165 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -124.32 141.04 52.39 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.881 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -120.8 111.02 17.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 39.6 mm -76.27 124.9 35.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.083 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 34.5 m -145.08 152.33 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.133 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 379' ' ' ASP . . . . . 0.496 ' OD2' HG12 ' A' ' 338' ' ' VAL . 2.9 m-20 -73.37 -37.37 66.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -127.29 86.03 59.62 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.653 0.74 . . . . 0.0 110.891 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 3.22 2.86 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.692 2.261 . . . . 0.0 112.348 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -100.74 -42.8 2.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.52 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -55.13 -68.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.776 0.322 . . . . 0.0 110.956 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.429 ' NE2' ' CD2' ' A' ' 392' ' ' TYR . 4.2 pp0? -63.53 151.67 40.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 98.9 m -89.8 119.87 30.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.185 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 60.6 p -55.15 161.48 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.836 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 71.0 t -108.46 120.36 59.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.141 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 5.0 mt -39.31 104.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.156 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 119.07 -43.18 1.63 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.48 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 390' ' ' ARG . . . . . 0.412 ' NH1' ' HB ' ' A' ' 373' ' ' ILE . 11.8 ttm-85 -80.53 158.19 25.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.741 0.305 . . . . 0.0 110.907 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 55.8 m -126.06 128.88 48.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.891 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 392' ' ' TYR . . . . . 0.429 ' CD2' ' NE2' ' A' ' 384' ' ' GLN . 3.0 m-85 -105.65 132.47 51.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.907 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.469 HG11 ' CG1' ' A' ' 410' ' ' VAL . 14.2 m -143.39 147.38 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.127 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -55.12 156.21 7.71 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.59 0.709 . . . . 0.0 110.952 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -3.93 12.98 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.359 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 41.5 tp60 -85.13 -28.98 25.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.937 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -48.74 -28.14 3.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.865 ' O ' HG22 ' A' ' 402' ' ' VAL . 56.3 t -85.44 -29.58 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.105 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -72.73 -37.2 67.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.906 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 400' ' ' ASP . . . . . 0.669 ' OD1' HD12 ' A' ' 408' ' ' LEU . 0.8 OUTLIER -84.34 -23.2 30.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.927 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 3.2 m -81.09 -47.85 12.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.865 HG22 ' O ' ' A' ' 398' ' ' VAL . 13.2 m -57.5 -36.88 55.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.156 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -69.9 -34.39 73.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 404' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -95.66 15.08 20.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.081 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 405' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 404' ' ' ALA . 9.9 mmt85 35.89 39.73 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.892 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 27.5 tp -147.89 163.29 37.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 42.1 mt -95.0 81.02 3.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.669 HD12 ' OD1' ' A' ' 400' ' ' ASP . 62.7 mt -47.71 155.67 0.77 Allowed Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.605 0.716 . . . . 0.0 110.916 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 118.07 5.46 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.668 2.245 . . . . 0.0 112.326 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 410' ' ' VAL . . . . . 0.469 ' CG1' HG11 ' A' ' 393' ' ' VAL . 23.2 m -58.54 -31.28 43.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.144 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -42.88 -52.55 5.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.128 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -59.07 -39.68 82.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.471 ' CZ ' ' OD2' ' A' ' 400' ' ' ASP . 68.6 m-85 -95.21 45.76 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 31.8 t80 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.823 0.344 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 14.3 tp -42.4 -37.7 1.65 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.888 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -116.96 50.02 1.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -87.87 137.72 32.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 58.11 41.73 94.77 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.491 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 72.5 mt -141.38 120.22 12.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.902 0.382 . . . . 0.0 110.945 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -93.94 117.25 29.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -105.86 158.44 16.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -141.1 119.86 12.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.883 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.684 HD22 HD13 ' A' ' 343' ' ' LEU . 14.6 mt -95.53 142.67 27.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.916 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -100.9 179.32 4.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.867 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.437 ' HG2' ' N ' ' A' ' 337' ' ' GLU . 0.0 OUTLIER -78.24 -29.21 48.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.847 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 337' ' ' GLU . . . . . 0.437 ' N ' ' HG2' ' A' ' 336' ' ' ARG . 20.8 tt0 -72.48 -15.69 61.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 10.6 m -110.02 150.98 42.18 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.636 0.731 . . . . 0.0 111.109 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 115.49 4.11 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.695 2.263 . . . . 0.0 112.354 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 0.429 ' HB3' ' NH1' ' A' ' 340' ' ' ARG . 19.5 ttp-105 -77.04 -69.69 0.51 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 340' ' ' ARG . 8.3 pt-20 -35.07 -44.58 0.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.17 -64.14 0.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.099 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 343' ' ' LEU . . . . . 0.684 HD13 HD22 ' A' ' 334' ' ' LEU . 36.6 mt -59.35 -63.16 1.4 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.903 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 343' ' ' LEU . . . -36.84 -51.86 0.91 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.073 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -59.14 -40.05 84.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 346' ' ' ILE . . . . . 0.767 HD11 ' CE1' ' A' ' 399' ' ' PHE . 27.5 mt -67.24 -64.21 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 24.9 mt -48.08 -41.73 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -68.4 -39.25 81.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 12.1 t -68.17 -22.99 64.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -105.48 22.52 15.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 57.46 63.75 5.01 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.471 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -133.81 155.79 21.97 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.503 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -92.25 130.98 37.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.861 0.362 . . . . 0.0 110.908 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.544 HG21 HD11 ' A' ' 334' ' ' LEU . 7.4 p -146.39 132.2 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 9.6 t -130.06 163.46 26.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 356' ' ' TRP . . . . . 0.406 ' CD1' ' HB2' ' A' ' 364' ' ' ALA . 18.4 p90 -135.04 178.69 6.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.865 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.605 ' HB3' HD12 ' A' ' 360' ' ' LEU . 7.7 t70 -70.94 105.89 3.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 357' ' ' ASP . 70.3 mttt -35.47 -44.15 0.28 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.896 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 28.7 t -58.69 -52.95 63.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.834 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.605 HD12 ' HB3' ' A' ' 357' ' ' ASP . 18.5 mt -50.87 -49.44 59.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 3.0 m -160.35 145.35 14.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.3 pt -72.22 176.72 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 92.82 -15.85 61.7 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.48 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.406 ' HB2' ' CD1' ' A' ' 356' ' ' TRP . . . -56.75 -177.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.908 0.385 . . . . 0.0 111.099 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 72.7 p -131.47 -66.72 0.72 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -117.53 157.0 27.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.433 ' O ' HD11 ' A' ' 373' ' ' ILE . 1.1 m-20 -90.64 168.97 11.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 368' ' ' VAL . . . . . 0.433 ' HA ' ' CD1' ' A' ' 373' ' ' ILE . 9.9 p -66.24 -22.46 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 61.1 p -84.68 26.27 0.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -110.75 109.44 19.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 67.7 m -47.2 -38.23 11.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -40.15 -41.86 1.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 373' ' ' ILE . . . . . 0.433 ' CD1' ' HA ' ' A' ' 368' ' ' VAL . 86.8 mt -41.94 138.65 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.137 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 42.2 p -108.48 -26.82 10.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.15 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -153.44 133.07 13.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.853 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 376' ' ' GLN . . . . . 0.569 ' OE1' HG13 ' A' ' 378' ' ' VAL . 1.0 OUTLIER -112.33 94.06 4.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 30.2 mm -55.78 98.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.121 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 378' ' ' VAL . . . . . 0.569 HG13 ' OE1' ' A' ' 376' ' ' GLN . 26.8 m -122.02 140.32 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.138 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 379' ' ' ASP . . . . . 0.433 ' OD1' ' C ' ' A' ' 379' ' ' ASP . 4.3 t0 -48.04 -43.39 30.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.901 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -129.45 86.93 54.7 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.635 0.731 . . . . 0.0 110.823 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -9.74 26.83 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.687 2.258 . . . . 0.0 112.365 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -85.4 -39.41 8.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.504 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -73.31 -52.52 13.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.712 0.292 . . . . 0.0 110.91 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -45.51 142.01 2.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 57.9 m -71.15 101.17 2.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.106 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 24.9 p -53.56 167.71 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.817 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 387' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 389' ' ' GLY . 81.9 t -130.64 134.58 61.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.131 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.54 HG22 ' O ' ' A' ' 388' ' ' ILE . 15.3 mm -56.98 86.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.09 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 389' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 387' ' ' VAL . . . 135.06 -27.36 3.16 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.506 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -99.96 156.66 17.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.851 0.357 . . . . 0.0 110.855 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 72.3 m -129.73 123.87 32.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -97.37 121.58 39.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 21.8 m -126.83 164.01 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.144 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -87.49 161.36 45.66 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.606 0.717 . . . . 0.0 110.902 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -4.64 14.42 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.706 2.271 . . . . 0.0 112.348 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -82.99 -14.17 54.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -77.73 -13.77 59.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.827 ' O ' HG22 ' A' ' 402' ' ' VAL . 42.1 t -89.18 -41.15 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.154 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 399' ' ' PHE . . . . . 0.767 ' CE1' HD11 ' A' ' 346' ' ' ILE . 47.8 m-85 -71.8 -34.37 69.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.859 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.32 -45.7 53.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.884 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 2.6 m -62.6 -56.25 19.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.827 HG22 ' O ' ' A' ' 398' ' ' VAL . 15.4 m -50.64 -42.54 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -70.62 -37.96 73.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.928 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 404' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -89.87 10.73 22.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 405' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 404' ' ' ALA . 46.8 mmm-85 37.21 44.05 0.4 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 28.7 tp -153.69 142.68 21.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 20.4 mt -80.73 73.95 7.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 75.4 mt -40.69 152.35 0.24 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.605 0.717 . . . . 0.0 110.91 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 105.6 1.51 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.688 2.259 . . . . 0.0 112.353 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.8 m -50.78 -22.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.111 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -50.94 -35.83 35.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.122 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -69.39 -38.28 77.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.942 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -90.81 41.57 1.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.908 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 16.5 t80 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.944 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 48.0 m -128.21 138.03 52.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.812 0.339 . . . . 0.0 110.885 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 16.6 m -110.89 166.91 10.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.857 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 154.88 152.1 6.04 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.459 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 4.9 t -93.38 159.33 15.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.861 0.362 . . . . 0.0 110.873 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 96.7 p -104.94 -45.96 4.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.822 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 166.61 -70.05 0.18 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.468 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 29.6 mmtm -130.0 175.9 8.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.769 0.319 . . . . 0.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -102.73 52.07 0.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.834 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -128.33 92.1 3.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -132.38 145.94 51.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 1.9 tt -67.54 -35.14 78.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -112.94 37.28 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -59.81 112.66 1.92 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 83.61 -49.19 4.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.453 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 330' ' ' LEU . 12.5 mt -35.41 129.72 0.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 110.946 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -103.07 130.15 50.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.864 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -121.53 164.46 17.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -143.02 139.22 30.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.43 HD11 HG21 ' A' ' 354' ' ' VAL . 3.5 mt -116.22 146.21 42.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -104.94 169.67 8.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -71.46 -13.28 61.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.837 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -82.97 -45.77 13.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.3 m -84.36 150.6 57.75 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.618 0.723 . . . . 0.0 111.102 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 120.7 7.44 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.658 2.239 . . . . 0.0 112.382 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 5.9 ptt180 -93.78 -38.4 11.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -45.44 -37.59 5.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -86.25 -57.43 3.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.08 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 89.3 mt -54.2 -60.42 3.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -42.11 -64.8 0.53 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.092 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -47.79 -40.69 21.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 347' ' ' ILE . 16.6 mt -66.41 -72.42 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.13 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' ILE . . . . . 0.451 ' N ' HG22 ' A' ' 346' ' ' ILE . 22.4 mt -40.48 -38.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -67.2 -53.67 28.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 11.0 p -55.03 -36.27 65.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -80.72 11.35 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.857 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 65.96 48.83 62.64 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.536 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -122.13 160.77 16.49 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.476 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -93.57 131.11 39.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.906 0.384 . . . . 0.0 110.886 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.43 HG21 HD11 ' A' ' 334' ' ' LEU . 14.1 p -147.82 134.21 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.144 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' SER . . . . . 0.53 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 23.1 t -137.82 158.23 44.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 29.0 p90 -130.44 168.24 17.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.938 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.534 ' CB ' HD12 ' A' ' 360' ' ' LEU . 3.1 t70 -56.57 122.03 11.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.819 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -51.7 -48.44 63.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 40.2 t -57.73 -48.48 79.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.534 HD12 ' CB ' ' A' ' 357' ' ' ASP . 32.6 mt -50.45 -51.18 49.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.93 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 4.7 m -160.23 139.23 10.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 12.6 pt -66.66 156.55 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.131 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 108.49 14.72 15.31 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.486 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -97.82 162.42 13.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.916 0.389 . . . . 0.0 111.067 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 19.5 p -116.22 -68.41 0.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.159 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' TYR . . . . . 0.53 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 9.6 p90 -99.99 147.28 25.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.906 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.97 175.86 9.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.842 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' VAL . . . . . 0.634 ' O ' HG22 ' A' ' 368' ' ' VAL . 7.9 p -75.26 3.24 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.09 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 74.6 p -112.15 27.54 9.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.121 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -104.69 101.55 11.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 9.7 m -42.66 -35.13 1.03 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.819 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -40.9 -43.68 2.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.817 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 66.1 mt -44.17 125.33 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.148 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 43.0 p -92.84 -45.05 8.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.133 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -127.41 135.84 51.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' GLN . . . . . 0.576 ' NE2' ' CE2' ' A' ' 392' ' ' TYR . 40.6 tt0 -120.33 123.84 44.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 33.0 mm -92.32 133.75 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.153 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 19.4 m -149.99 153.03 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -76.16 -28.94 57.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -134.73 80.85 48.79 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.592 0.711 . . . . 0.0 110.87 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -18.25 37.27 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.678 2.252 . . . . 0.0 112.299 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -77.52 -64.32 2.09 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.488 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -42.3 -57.72 2.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.797 0.332 . . . . 0.0 110.909 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -79.86 129.04 34.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.943 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 70.6 p -63.1 -179.85 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.121 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 25.3 p -110.98 178.87 4.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 49.0 t -125.29 137.97 55.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.107 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.0 mt -44.12 123.34 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.106 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 89.26 -44.29 3.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.561 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -82.16 137.41 34.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.827 0.346 . . . . 0.0 110.889 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 23.5 m -120.61 117.38 27.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' TYR . . . . . 0.576 ' CE2' ' NE2' ' A' ' 376' ' ' GLN . 9.7 m-85 -80.79 145.64 31.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.942 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 31.3 m -150.56 165.33 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.115 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -78.39 158.18 76.84 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.6 0.715 . . . . 0.0 110.894 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -4.36 13.91 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.675 2.25 . . . . 0.0 112.351 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -86.74 -23.85 25.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -59.82 -33.37 71.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 75.4 t -76.16 -47.2 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.138 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -58.35 -36.5 73.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.866 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.85 -27.38 60.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 40.4 m -76.13 -51.27 12.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 14.8 m -53.5 -41.98 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.157 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -69.27 -34.78 75.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -93.07 3.28 56.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 42.58 44.72 3.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.449 ' HG ' ' N ' ' A' ' 407' ' ' LEU . 18.6 tp -160.86 154.84 22.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.906 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.449 ' N ' ' HG ' ' A' ' 406' ' ' LEU . 97.3 mt -84.9 99.68 11.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.01 154.97 91.43 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.597 0.713 . . . . 0.0 110.902 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 105.73 1.54 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.711 2.274 . . . . 0.0 112.33 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.2 m -53.9 -16.62 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -58.27 -23.85 57.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.103 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -86.0 -31.65 21.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.908 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -102.6 39.85 1.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 43.2 t80 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 82.9 p -170.31 133.6 1.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.862 0.363 . . . . 0.0 110.911 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 47.5 t -88.88 160.55 17.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.888 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 125.3 134.57 4.17 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.524 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 77.2 p -42.47 143.44 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.882 0.373 . . . . 0.0 110.911 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 62.9 m -117.82 135.53 54.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.824 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -121.34 -77.43 0.46 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.535 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt -73.19 161.0 31.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.855 0.36 . . . . 0.0 110.883 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -118.43 40.85 3.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -146.17 146.05 30.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -134.53 142.9 47.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.88 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.445 ' O ' HD13 ' A' ' 326' ' ' LEU . 1.3 tm? -54.26 -41.76 69.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -112.89 47.86 1.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -72.87 138.09 46.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.885 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 49.03 60.0 6.44 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.5 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 90.6 mt -150.17 121.39 7.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.823 0.344 . . . . 0.0 110.935 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -99.5 123.36 43.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -115.12 164.09 14.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -138.2 117.03 12.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.864 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.669 HD11 HG21 ' A' ' 354' ' ' VAL . 4.7 mt -93.02 141.38 28.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.92 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -95.81 -177.18 3.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -85.66 -20.84 28.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.831 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -78.6 -18.32 54.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 6.0 m -108.12 150.61 40.66 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.595 0.712 . . . . 0.0 111.126 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 119.22 6.2 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.685 2.257 . . . . 0.0 112.346 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 0.488 ' HG3' HD12 ' A' ' 334' ' ' LEU . 34.3 ttp180 -85.41 -56.78 3.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 340' ' ' ARG . 6.8 pt-20 -36.84 -39.58 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.909 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -79.0 -64.55 1.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.092 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' LEU . . . . . 0.411 HD21 ' CE2' ' A' ' 399' ' ' PHE . 52.6 mt -57.2 -61.67 2.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.894 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -41.54 -48.65 3.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.125 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -63.59 -48.97 75.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 16.8 mt -55.25 -64.82 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.159 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 32.7 mt -50.42 -47.66 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -64.6 -24.22 67.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 23.2 t -84.52 -29.7 25.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -83.53 -8.99 59.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 93.1 42.63 4.29 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.486 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -122.97 164.34 15.97 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.501 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -93.29 135.04 34.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 110.949 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.669 HG21 HD11 ' A' ' 334' ' ' LEU . 12.6 p -149.88 125.84 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.158 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 2.0 t -128.24 161.18 29.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 41.0 p90 -138.7 171.92 13.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.951 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -67.73 111.17 4.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -42.58 -54.26 4.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.4 t -41.47 -59.61 1.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 9.0 mt -51.65 -50.71 59.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 4.8 m -154.39 141.88 19.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 20.7 pt -73.92 -175.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.15 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 86.43 -15.39 50.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.451 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -63.73 166.3 7.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 0.0 111.105 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 41.0 p -117.32 -70.51 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.169 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -109.52 139.06 44.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.939 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.56 169.76 15.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.83 -19.48 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.153 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 62.7 p -84.44 26.3 0.8 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.14 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -115.05 121.09 42.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.7 t -58.41 -36.12 73.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -38.92 -40.42 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.928 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 49.8 mt -46.34 138.32 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 26.5 p -113.57 -22.85 10.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.15 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -150.26 155.33 39.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' GLN . . . . . 0.467 ' HG2' HG13 ' A' ' 378' ' ' VAL . 17.3 tt0 -135.79 111.88 9.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.95 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 377' ' ' ILE . . . . . 0.869 HD13 HG23 ' A' ' 393' ' ' VAL . 46.8 mm -82.75 113.74 22.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.155 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.467 HG13 ' HG2' ' A' ' 376' ' ' GLN . 29.2 m -131.34 148.08 32.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.11 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -62.25 -42.93 99.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -131.93 82.19 60.42 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.593 0.711 . . . . 0.0 110.931 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.444 ' HB3' ' CG2' ' A' ' 378' ' ' VAL . 53.5 Cg_endo -69.76 -13.86 35.26 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.686 2.257 . . . . 0.0 112.352 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -73.92 -44.83 29.25 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.522 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' GLN . . . . . 0.415 ' HG3' ' N ' ' A' ' 384' ' ' GLN . 3.1 pt20 -62.27 -37.34 85.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.737 0.303 . . . . 0.0 110.885 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.415 ' N ' ' HG3' ' A' ' 383' ' ' GLN . 7.8 pt20 -98.34 118.07 34.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 44.7 p -50.49 175.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' SER . . . . . 0.518 ' HA ' ' CE1' ' A' ' 392' ' ' TYR . 1.9 t -104.81 178.66 4.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 74.4 t -119.56 136.23 57.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.149 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 5.9 mm -51.21 103.97 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 109.44 -28.34 11.02 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.497 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -105.96 148.77 27.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.787 0.327 . . . . 0.0 110.858 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 63.7 m -125.17 131.29 53.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' TYR . . . . . 0.518 ' CE1' ' HA ' ' A' ' 386' ' ' SER . 24.9 m-85 -91.43 131.74 36.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.869 HG23 HD13 ' A' ' 377' ' ' ILE . 11.3 m -130.0 166.99 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.107 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -86.73 161.36 47.92 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.603 0.716 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -7.42 21.01 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.684 2.256 . . . . 0.0 112.328 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -80.86 -24.4 38.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.885 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' TRP . . . . . 0.415 ' CH2' HD22 ' A' ' 407' ' ' LEU . 41.5 t90 -59.1 -42.14 89.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.617 ' O ' HG22 ' A' ' 402' ' ' VAL . 96.1 t -67.68 -58.37 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.156 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' PHE . . . . . 0.411 ' CE2' HD21 ' A' ' 343' ' ' LEU . 59.7 m-85 -52.31 -26.53 12.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.419 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 24.2 t0 -85.07 -49.97 7.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.861 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 15.4 m -56.75 -51.25 69.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.859 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 398' ' ' VAL . 27.7 m -55.53 -40.31 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.147 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 403' ' ' ASN . . . . . 0.409 ' N ' HG23 ' A' ' 402' ' ' VAL . 18.7 m-20 -80.21 -9.14 59.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 404' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -113.14 8.6 18.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 405' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 404' ' ' ALA . 1.3 mpt_? 34.42 42.64 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 7.5 tp -162.8 144.28 10.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.868 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 407' ' ' LEU . 12.4 mt -72.6 89.49 1.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.933 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.419 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 35.9 mt -56.62 154.34 17.86 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.569 0.699 . . . . 0.0 110.971 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 108.76 2.15 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.705 2.27 . . . . 0.0 112.348 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.3 m -57.19 -21.71 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.115 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -58.11 -12.0 3.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.105 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.39 -27.89 14.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -108.65 37.01 2.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 5.5 t80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.877 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 68.8 m 41.69 48.29 3.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.895 0.379 . . . . 0.0 110.868 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 20.7 m -104.3 -49.97 3.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.846 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 59.36 170.59 0.37 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.468 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 1.2 t -108.97 170.67 7.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.837 0.351 . . . . 0.0 110.879 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.1 t -110.47 41.77 1.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 69.18 -100.79 0.74 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.469 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -138.87 119.6 14.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 0.0 110.908 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -125.57 171.59 10.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.869 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -125.72 115.67 20.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -110.9 129.88 55.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 13.8 tp -49.23 -53.46 21.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.894 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' PHE . . . . . 0.418 ' HA ' HD12 ' A' ' 330' ' ' LEU . 16.6 m-85 -96.75 41.86 1.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -71.93 138.01 47.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 47.24 51.43 14.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.482 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 327' ' ' PHE . 58.0 mt -139.43 122.18 16.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 0.0 110.924 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -93.98 129.25 40.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.891 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -125.81 152.19 45.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.878 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -131.91 136.01 47.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.5 HD12 ' HG3' ' A' ' 340' ' ' ARG . 8.0 mt -112.46 137.53 50.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -85.7 -178.23 6.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -81.68 -23.4 36.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -77.48 -44.49 28.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.6 m -75.33 149.53 84.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.644 0.735 . . . . 0.0 111.103 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 124.74 11.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.65 2.234 . . . . 0.0 112.334 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 0.5 ' HG3' HD12 ' A' ' 334' ' ' LEU . 19.2 ttp180 -89.82 -60.12 2.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -38.07 -39.57 0.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.46 -60.11 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.084 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 49.4 mt -60.28 -63.42 1.3 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -39.84 -55.07 2.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.129 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -55.63 -44.53 77.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.868 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 18.5 mt -63.13 -67.92 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.129 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 33.5 mt -46.88 -42.42 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.108 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -68.95 -30.2 68.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 29.2 t -78.2 -34.05 49.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.892 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' PHE . . . . . 0.433 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 14.9 m-85 -83.42 7.62 16.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.857 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 76.36 63.96 2.27 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.55 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -145.42 154.75 26.13 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.516 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -92.57 125.66 37.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.879 0.371 . . . . 0.0 110.883 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.42 HG21 HD11 ' A' ' 334' ' ' LEU . 7.0 p -131.66 140.95 46.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.111 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 32.5 t -132.39 159.29 39.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.847 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' TRP . . . . . 0.434 ' CD1' ' SG ' ' A' ' 361' ' ' CYS . 48.8 p90 -149.48 165.89 30.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.921 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.554 ' HB3' HD12 ' A' ' 360' ' ' LEU . 2.4 t70 -55.06 110.01 0.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.855 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.449 ' CD ' ' HB3' ' A' ' 364' ' ' ALA . 14.2 mmmt -54.86 -35.53 64.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 5.4 t -55.73 -54.96 37.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.554 HD12 ' HB3' ' A' ' 357' ' ' ASP . 14.7 mt -56.11 -45.3 79.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 361' ' ' CYS . . . . . 0.434 ' SG ' ' CD1' ' A' ' 356' ' ' TRP . 0.8 OUTLIER -151.98 135.37 16.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.874 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.529 HD13 ' C ' ' A' ' 362' ' ' ILE . 0.0 OUTLIER -78.89 143.26 12.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 133.06 -29.68 3.17 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.476 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.449 ' HB3' ' CD ' ' A' ' 358' ' ' LYS . . . -46.66 171.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 111.025 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 68.3 p -101.04 -69.81 0.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.138 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' TYR . . . . . 0.41 ' HB2' ' CG ' ' A' ' 370' ' ' ASP . 1.1 p90 -112.27 173.18 6.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -86.36 164.91 16.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.56 -23.44 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.147 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 42.0 p -84.03 25.07 0.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.132 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' ASP . . . . . 0.41 ' CG ' ' HB2' ' A' ' 366' ' ' TYR . 0.8 OUTLIER -96.12 100.49 12.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.835 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 372' ' ' ARG . 56.0 m -51.72 -41.03 61.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 372' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 371' ' ' SER . 23.6 mmt180 -37.7 -40.61 0.43 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.893 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 95.4 mt -41.77 121.35 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.13 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 39.2 p -81.25 -40.31 23.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.191 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -132.77 148.79 52.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' GLN . . . . . 0.485 ' OE1' ' NE ' ' A' ' 390' ' ' ARG . 56.8 tt0 -130.37 115.66 17.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.863 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 377' ' ' ILE . . . . . 0.55 HD13 HG23 ' A' ' 393' ' ' VAL . 47.0 mm -83.04 127.95 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.114 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 31.0 m -148.69 159.69 6.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.134 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.01 -38.73 35.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 -130.26 80.8 69.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.632 0.729 . . . . 0.0 110.917 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -15.55 37.2 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.701 2.267 . . . . 0.0 112.349 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -64.47 -53.85 32.98 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.45 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -89.19 30.56 0.96 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.714 0.292 . . . . 0.0 110.89 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -109.05 121.98 46.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.926 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 39.8 m -58.33 87.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 53.3 p -52.22 159.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 96.1 t -129.01 141.27 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.6 mt -51.35 115.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 101.51 -46.34 1.29 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.539 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' ARG . . . . . 0.485 ' NE ' ' OE1' ' A' ' 376' ' ' GLN . 15.4 ttp180 -80.68 144.87 31.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 110.852 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 10.3 m -124.4 134.26 53.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' TYR . . . . . 0.433 ' CZ ' ' OE1' ' A' ' 376' ' ' GLN . 3.0 m-85 -96.74 116.53 29.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.918 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.55 HG23 HD13 ' A' ' 377' ' ' ILE . 21.0 m -123.93 158.69 29.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.126 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -75.99 158.28 82.5 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.602 0.715 . . . . 0.0 110.919 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -4.16 13.45 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.665 2.244 . . . . 0.0 112.345 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -84.6 -16.33 42.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.962 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 69.1 t90 -65.34 -39.21 92.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.938 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 73.6 t -72.54 -52.76 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -51.2 -37.13 44.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.481 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 1.1 m-20 -73.49 -45.61 52.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 69.2 m -56.67 -58.03 9.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.852 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.456 HG23 ' N ' ' A' ' 403' ' ' ASN . 30.9 m -47.94 -43.58 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.104 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 403' ' ' ASN . . . . . 0.456 ' N ' HG23 ' A' ' 402' ' ' VAL . 6.6 t30 -66.13 -43.67 86.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 404' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -86.53 10.53 15.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.086 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 405' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' A' ' 404' ' ' ALA . 3.2 mpt_? 36.56 37.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 15.1 tp -151.49 145.01 24.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.432 ' HA ' HD23 ' A' ' 407' ' ' LEU . 17.6 mt -74.91 89.37 2.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.94 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.481 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 34.8 mt -60.52 154.91 52.57 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.626 0.727 . . . . 0.0 110.913 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 113.47 3.38 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.731 2.287 . . . . 0.0 112.344 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.46 ' HB ' HG11 ' A' ' 393' ' ' VAL . 19.5 m -55.17 -28.25 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.137 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -48.09 -30.33 4.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.136 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -77.76 -35.65 51.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.855 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -106.05 49.66 0.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 42.1 t80 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.838 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.519 -0.233 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 1.4 t -143.16 151.85 41.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.849 0.356 . . . . 0.0 110.846 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 31.3 t -58.51 147.46 31.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.15 -73.99 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.529 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 63.2 p -147.52 134.26 20.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 110.879 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 7.4 m -88.5 102.54 15.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.831 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -81.96 89.7 1.44 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.467 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -74.1 103.3 4.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.786 0.327 . . . . 0.0 110.861 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -119.77 172.11 7.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.808 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.46 107.85 2.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -108.15 152.05 25.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.868 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 12.2 tp -68.79 -50.55 49.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' PHE . . . . . 0.441 ' HA ' HD12 ' A' ' 330' ' ' LEU . 22.7 m-85 -87.49 31.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -66.09 118.22 9.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.832 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 66.28 49.32 57.94 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 327' ' ' PHE . 67.9 mt -141.21 122.14 14.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.904 0.383 . . . . 0.0 110.914 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -95.54 139.8 31.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.503 ' CD1' ' HB2' ' A' ' 375' ' ' HIS . 80.7 m-85 -133.79 153.57 51.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' PHE . . . . . 0.475 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 9.4 t80 -129.56 117.6 20.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.848 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.635 HD12 ' HG3' ' A' ' 340' ' ' ARG . 12.7 mt -94.68 132.2 39.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.926 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -90.63 165.68 13.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.55 ' HB3' HD11 ' A' ' 360' ' ' LEU . 0.1 OUTLIER -65.15 -30.07 70.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.828 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 337' ' ' GLU . . . . . 0.457 ' N ' ' HG2' ' A' ' 336' ' ' ARG . 9.1 pt-20 -65.56 -37.41 86.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.0 m -91.01 150.7 42.26 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.633 0.73 . . . . 0.0 111.106 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' PRO . . . . . 0.437 ' O ' HD12 ' A' ' 343' ' ' LEU . 53.4 Cg_endo -69.79 128.46 16.04 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.683 2.255 . . . . 0.0 112.324 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 0.635 ' HG3' HD12 ' A' ' 334' ' ' LEU . 31.1 ttm180 -92.0 -49.3 6.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.866 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -42.68 -39.61 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -79.97 -65.74 0.97 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.052 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' LEU . . . . . 0.505 HD13 HD22 ' A' ' 334' ' ' LEU . 68.6 mt -51.79 -62.53 1.57 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -40.74 -59.81 1.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -51.62 -49.14 62.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.843 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 349' ' ' SER . 31.1 mt -57.74 -70.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.136 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' ILE . . . . . 0.412 ' N ' HG22 ' A' ' 346' ' ' ILE . 28.0 mt -42.26 -52.19 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.105 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 26.5 mtt-85 -64.5 -25.66 68.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.882 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 346' ' ' ILE . 43.4 t -80.12 -30.21 39.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -92.04 14.0 17.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.893 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 70.93 57.47 6.31 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.508 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -135.22 161.04 24.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.512 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -94.81 135.06 36.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.874 0.368 . . . . 0.0 110.869 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.543 HG21 HD11 ' A' ' 334' ' ' LEU . 8.1 p -148.37 133.98 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.169 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 17.3 t -132.42 162.84 30.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' TRP . . . . . 0.534 ' CZ2' ' O ' ' A' ' 363' ' ' GLY . 20.2 p90 -137.4 -176.39 4.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.944 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.436 ' HB2' HD12 ' A' ' 360' ' ' LEU . 0.6 OUTLIER -75.38 118.92 18.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.822 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -58.89 -15.7 13.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 4.5 p -83.04 -27.66 30.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 336' ' ' ARG . 22.7 mt -76.94 -49.65 15.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.96 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 8.2 m -157.86 139.55 13.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 24.3 pt -56.53 155.75 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.534 ' O ' ' CZ2' ' A' ' 356' ' ' TRP . . . 100.52 38.17 3.55 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.486 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -105.47 117.23 33.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 0.0 111.079 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 45.3 p -69.65 -61.0 1.96 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.153 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -126.53 158.37 36.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.22 169.9 11.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 368' ' ' VAL . . . . . 0.475 ' HB ' ' CZ ' ' A' ' 333' ' ' PHE . 11.5 p -68.01 -10.6 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.106 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 73.4 p -95.6 14.16 23.85 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.12 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' ASP . . . . . 0.48 ' OD1' ' CG ' ' A' ' 372' ' ' ARG . 4.6 t70 -87.54 107.54 18.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 64.1 p -50.74 -28.47 9.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.842 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' ARG . . . . . 0.48 ' CG ' ' OD1' ' A' ' 370' ' ' ASP . 17.0 mmm180 -54.03 -30.46 47.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.872 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 87.2 mt -51.53 126.64 6.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.105 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 47.4 p -95.53 -43.0 8.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' HIS . . . . . 0.503 ' HB2' ' CD1' ' A' ' 332' ' ' PHE . 20.0 m80 -130.11 155.04 46.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 376' ' ' GLN . . . . . 0.577 ' CD ' ' CE2' ' A' ' 392' ' ' TYR . 59.6 tt0 -136.18 115.0 12.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.9 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 377' ' ' ILE . . . . . 0.411 ' O ' ' CG1' ' A' ' 378' ' ' VAL . 45.3 mm -80.65 136.43 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.411 ' CG1' ' O ' ' A' ' 377' ' ' ILE . 35.4 m -158.01 142.2 7.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.125 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -60.1 -32.67 71.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -128.55 80.92 71.67 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.617 0.722 . . . . 0.0 110.882 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -3.51 12.16 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.674 2.249 . . . . 0.0 112.358 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -106.52 -49.19 0.92 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.487 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -52.93 -73.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.783 0.325 . . . . 0.0 110.915 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -55.38 130.21 41.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.894 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 20.3 p -63.55 131.28 47.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 54.7 p -85.28 149.53 25.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.828 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 388' ' ' ILE . 63.2 t -75.82 114.8 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.104 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.637 ' H ' HD12 ' A' ' 388' ' ' ILE . 2.1 mp -36.17 104.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.134 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 122.26 -45.11 1.24 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 11.1 ttm-85 -76.55 159.45 30.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.8 0.333 . . . . 0.0 110.83 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 19.0 m -122.31 134.85 54.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.937 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' TYR . . . . . 0.577 ' CE2' ' CD ' ' A' ' 376' ' ' GLN . 2.4 m-85 -112.85 147.55 36.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.944 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 20.8 m -151.25 145.69 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.135 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -61.35 158.36 38.39 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.557 0.694 . . . . 0.0 110.938 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -4.63 14.39 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.378 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -85.95 -19.0 31.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -64.63 -34.03 77.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 80.7 t -71.23 -32.82 48.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.182 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' PHE . . . . . 0.458 ' O ' HG22 ' A' ' 402' ' ' VAL . 38.4 m-85 -74.85 -60.03 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.873 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -52.93 -17.9 1.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 16.9 m -82.33 -53.21 6.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 399' ' ' PHE . 6.2 m -58.01 -37.54 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.158 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -72.56 -34.66 67.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.957 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 406' ' ' LEU . . . -94.31 9.23 38.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.095 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 405' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 404' ' ' ALA . 0.9 OUTLIER 36.95 31.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 404' ' ' ALA . 0.0 OUTLIER -147.27 130.98 16.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 98.1 mt -66.67 85.66 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.946 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 32.0 mt -51.24 155.38 2.37 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.633 0.73 . . . . 0.0 110.882 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 118.82 5.91 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.691 2.261 . . . . 0.0 112.359 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.1 m -64.74 -25.51 38.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.088 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -54.55 -15.32 1.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.103 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -94.42 -30.97 14.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -96.06 33.34 1.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.95 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 16.5 t80 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 33.6 p -99.29 42.07 1.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.874 0.368 . . . . 0.0 110.882 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 41.4 t -44.0 -48.66 8.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 154.95 -141.5 8.2 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.503 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 50.6 p -96.38 85.61 3.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.903 0.382 . . . . 0.0 110.88 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 45.3 t -157.02 138.33 13.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.882 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -103.9 79.86 0.31 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.488 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -80.05 -52.69 7.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.831 0.348 . . . . 0.0 110.885 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 21.3 m170 47.85 45.72 18.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.36 109.9 3.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -117.91 153.44 33.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 18.8 tp -59.75 -54.92 40.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -95.18 37.5 1.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -73.03 139.35 46.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 53.72 47.98 62.91 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.493 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 71.9 mt -142.45 122.26 13.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.913 0.387 . . . . 0.0 110.878 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -96.13 126.76 41.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -119.34 152.81 36.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' PHE . . . . . 0.419 ' CD1' ' O ' ' A' ' 355' ' ' SER . 59.0 t80 -131.88 124.85 30.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.914 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.587 HD11 HG21 ' A' ' 354' ' ' VAL . 7.2 mt -101.78 133.15 46.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.969 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -88.74 163.99 15.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.765 ' HB3' HD11 ' A' ' 360' ' ' LEU . 2.0 ptp85 -65.2 -13.36 58.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -85.84 -46.76 10.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 4.1 m -77.94 151.1 78.93 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.652 0.739 . . . . 0.0 111.142 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 127.64 14.93 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.676 2.251 . . . . 0.0 112.36 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 0.565 ' HA ' HD13 ' A' ' 334' ' ' LEU . 0.5 OUTLIER -95.51 -55.05 3.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -39.15 -42.07 0.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -77.5 -51.12 11.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.121 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' LEU . . . . . 0.434 HD23 ' CE1' ' A' ' 399' ' ' PHE . 87.8 mt -65.16 -64.11 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -38.72 -53.14 1.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -57.54 -47.95 80.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' ILE . . . . . 0.437 HD12 ' HE1' ' A' ' 399' ' ' PHE . 38.0 mt -62.59 -67.95 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.117 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 32.2 mt -44.26 -37.33 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.085 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -77.99 -35.0 50.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 46.7 t -67.62 -29.65 69.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.858 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -94.99 20.45 8.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 64.46 63.56 4.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.519 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -136.72 164.48 25.18 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.512 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -104.15 129.29 51.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.884 0.374 . . . . 0.0 110.868 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.587 HG21 HD11 ' A' ' 334' ' ' LEU . 7.3 p -137.86 138.91 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.12 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 355' ' ' SER . . . . . 0.419 ' O ' ' CD1' ' A' ' 333' ' ' PHE . 8.4 t -140.56 149.82 42.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' TRP . . . . . 0.457 ' O ' ' HB1' ' A' ' 364' ' ' ALA . 40.6 p90 -131.7 175.89 8.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.868 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.679 ' HB2' HD12 ' A' ' 360' ' ' LEU . 18.5 m-20 -62.17 114.95 3.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -44.88 -46.3 10.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.3 m -53.26 -51.83 60.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.855 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.765 HD11 ' HB3' ' A' ' 336' ' ' ARG . 21.4 mt -46.56 -49.84 18.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.921 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 1.8 t -168.19 153.33 6.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 36.2 pt -63.32 177.08 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.119 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 94.42 -37.22 3.47 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 356' ' ' TRP . . . -44.63 152.11 0.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.821 0.343 . . . . 0.0 111.121 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 5.1 p -116.2 -65.28 1.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.156 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -111.22 144.93 39.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.943 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -88.7 171.66 9.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.12 -17.35 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 22.6 p -79.24 12.09 2.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.166 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -101.43 140.56 35.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.854 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 372' ' ' ARG . 4.9 t -80.5 -40.52 25.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 372' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 371' ' ' SER . 9.0 ptp180 -36.69 -42.68 0.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.922 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.587 HG22 ' HG3' ' A' ' 390' ' ' ARG . 73.4 mt -40.11 136.89 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.146 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 58.1 p -115.22 -24.72 8.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -139.91 143.03 36.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.868 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' GLN . . . . . 0.5 ' OE1' ' N ' ' A' ' 377' ' ' ILE . 0.7 OUTLIER -137.13 108.98 7.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 377' ' ' ILE . . . . . 0.5 ' N ' ' OE1' ' A' ' 376' ' ' GLN . 5.5 mm -79.39 127.0 39.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.127 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 30.6 m -139.98 155.94 24.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.158 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -81.51 -23.34 37.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.407 ' O ' ' CG ' ' A' ' 383' ' ' GLN . 75.7 mtt180 -130.75 83.0 62.96 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.583 0.706 . . . . 0.0 110.852 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -18.41 36.99 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.651 2.234 . . . . 0.0 112.335 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -67.53 -55.25 15.67 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.468 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' GLN . . . . . 0.407 ' CG ' ' O ' ' A' ' 380' ' ' ARG . 2.0 pt20 -46.26 -33.85 4.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.763 0.316 . . . . 0.0 110.92 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -84.3 149.97 25.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.36 -70.7 0.71 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.119 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 96.7 p -175.13 164.23 3.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' VAL . . . . . 0.531 HG23 ' CE1' ' A' ' 392' ' ' TYR . 74.6 t -133.05 153.73 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.145 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.52 ' N ' HD13 ' A' ' 388' ' ' ILE . 3.5 mm -68.66 99.41 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.176 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 92.95 -35.01 4.25 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.482 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' ARG . . . . . 0.587 ' HG3' HG22 ' A' ' 373' ' ' ILE . 8.3 ttm180 -93.0 151.36 19.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.762 0.315 . . . . 0.0 110.888 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' CYS . . . . . 0.424 ' N ' ' HG2' ' A' ' 390' ' ' ARG . 83.3 m -134.18 139.6 45.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' TYR . . . . . 0.531 ' CE1' HG23 ' A' ' 387' ' ' VAL . 68.0 m-85 -81.38 140.67 34.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.416 ' CG1' ' HB ' ' A' ' 410' ' ' VAL . 12.0 m -150.62 166.66 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.115 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -89.42 159.32 44.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.596 0.712 . . . . 0.0 110.878 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.439 ' HA ' HG21 ' A' ' 377' ' ' ILE . 54.2 Cg_endo -69.7 -3.73 12.56 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.717 2.278 . . . . 0.0 112.379 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -84.91 -31.25 23.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.923 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 69.1 t90 -50.5 -38.44 44.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.08 -61.21 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.074 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' PHE . . . . . 0.437 ' HE1' HD12 ' A' ' 346' ' ' ILE . 12.3 m-30 -51.7 -29.63 19.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.405 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 19.4 m-20 -73.32 -52.03 15.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 401' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 405' ' ' ARG . 14.6 m -58.47 -47.36 84.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.844 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.533 HG23 ' N ' ' A' ' 403' ' ' ASN . 27.3 m -61.24 -46.27 96.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.119 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 403' ' ' ASN . . . . . 0.533 ' N ' HG23 ' A' ' 402' ' ' VAL . 41.2 t30 -70.07 -8.08 46.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -122.93 0.48 9.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.097 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' A' ' 401' ' ' SER . 0.2 OUTLIER 44.53 32.12 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.642 HD13 ' N ' ' A' ' 407' ' ' LEU . 1.0 OUTLIER -141.94 140.69 32.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.642 ' N ' HD13 ' A' ' 406' ' ' LEU . 12.4 mt -71.77 81.63 0.88 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.405 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 43.0 mt -55.22 155.64 8.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.599 0.714 . . . . 0.0 110.929 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 115.67 4.21 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.685 2.256 . . . . 0.0 112.325 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.416 ' HB ' ' CG1' ' A' ' 393' ' ' VAL . 32.6 m -65.56 -21.39 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.144 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 411' ' ' ALA . . . . . 0.547 ' HA ' ' CE2' ' A' ' 414' ' ' PHE . . . -64.1 -33.8 76.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.171 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -75.93 1.07 16.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -126.06 41.56 3.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.967 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' PHE . . . . . 0.547 ' CE2' ' HA ' ' A' ' 411' ' ' ALA . 2.5 m-85 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.918 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.254 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 68.0 m 42.78 48.06 4.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.877 0.37 . . . . 0.0 110.888 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 33.3 t -124.6 100.65 6.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.844 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 68.75 -161.44 51.41 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.482 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 30.2 t -148.7 153.76 38.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.821 0.343 . . . . 0.0 110.865 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 14.4 t -104.91 162.51 13.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.871 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 103.74 148.57 19.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.479 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 32.1 tttp 66.06 44.42 2.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.826 0.346 . . . . 0.0 110.835 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -127.96 111.58 13.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.861 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp -101.71 155.24 18.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -131.71 144.99 51.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.937 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 2.4 tt -59.25 -54.86 42.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.906 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' PHE . . . . . 0.432 ' HZ ' HG13 ' A' ' 398' ' ' VAL . 18.4 m-85 -91.5 39.37 1.0 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -80.96 106.7 13.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 88.08 43.54 5.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.458 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.568 HD11 HD11 ' A' ' 407' ' ' LEU . 83.5 mt -143.1 124.09 14.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.912 0.387 . . . . 0.0 110.909 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.439 ' HE3' ' CE2' ' A' ' 366' ' ' TYR . 28.3 mtpt -95.41 139.09 32.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.445 ' CD1' ' HB2' ' A' ' 375' ' ' HIS . 88.5 m-85 -135.2 147.32 49.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -130.01 115.31 16.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.655 HD11 HG21 ' A' ' 354' ' ' VAL . 2.6 mt -90.77 148.08 22.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -107.14 176.93 5.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.944 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.457 ' HB3' HD11 ' A' ' 360' ' ' LEU . 8.4 ptp85 -74.79 -22.08 58.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.879 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -72.46 -35.97 68.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.897 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.43 HG11 HG22 ' A' ' 377' ' ' ILE . 3.2 m -95.54 150.87 38.09 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.622 0.725 . . . . 0.0 111.127 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 120.94 7.66 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.664 2.243 . . . . 0.0 112.41 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 0.528 ' HG3' HD12 ' A' ' 334' ' ' LEU . 27.7 ttp85 -87.19 -49.87 6.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.863 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -42.4 -36.77 1.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -83.05 -63.83 1.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.059 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 53.3 mt -53.95 -59.45 4.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -42.74 -60.51 1.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -51.15 -43.07 61.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.842 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' ILE . . . . . 0.505 HG22 ' N ' ' A' ' 347' ' ' ILE . 11.8 mt -63.64 -72.58 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' ILE . . . . . 0.505 ' N ' HG22 ' A' ' 346' ' ' ILE . 29.8 mt -39.16 -43.6 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.15 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 67.6 mtt-85 -68.51 -36.07 78.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.863 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' SER . . . . . 0.481 ' N ' ' O ' ' A' ' 346' ' ' ILE . 29.8 t -69.95 -43.34 71.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 350' ' ' PHE . . . . . 0.523 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 11.4 m-85 -73.17 -11.23 60.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 91.2 56.58 1.68 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.427 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -132.16 160.55 23.68 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -91.26 125.39 36.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.909 0.385 . . . . 0.0 110.886 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.655 HG21 HD11 ' A' ' 334' ' ' LEU . 12.4 p -137.85 139.56 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.132 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 355' ' ' SER . . . . . 0.563 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 42.7 t -136.74 149.34 47.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 356' ' ' TRP . . . . . 0.421 ' CE3' ' HD2' ' A' ' 340' ' ' ARG . 15.1 p90 -129.39 -175.86 3.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.962 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.7 ' HB2' HD12 ' A' ' 360' ' ' LEU . 24.3 m-20 -76.97 105.76 8.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.82 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.514 ' HG2' ' HB3' ' A' ' 364' ' ' ALA . 7.1 mtpm? -38.89 -43.32 0.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.912 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 14.2 t -53.64 -58.73 6.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 357' ' ' ASP . 18.8 mt -50.53 -48.94 57.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.912 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 4.2 m -158.39 130.0 6.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.902 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 14.9 pt -61.14 176.34 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.14 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 107.37 -39.65 2.81 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.45 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.514 ' HB3' ' HG2' ' A' ' 358' ' ' LYS . . . -38.72 158.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.877 0.37 . . . . 0.0 111.084 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 1.2 p -113.46 -45.67 3.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' TYR . . . . . 0.563 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 33.4 p90 -125.43 173.92 8.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.956 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.96 169.34 8.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.863 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 14.0 p -58.85 -31.36 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.111 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 68.1 p -63.6 -16.21 60.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -65.7 99.3 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 372' ' ' ARG . 22.2 t -47.5 -42.11 22.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 372' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 371' ' ' SER . 29.9 mmt180 -35.58 -45.25 0.35 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.826 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.436 ' C ' ' O ' ' A' ' 372' ' ' ARG . 77.8 mt -34.45 120.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.131 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 26.7 p -92.32 -44.26 8.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' HIS . . . . . 0.445 ' HB2' ' CD1' ' A' ' 332' ' ' PHE . 20.1 m80 -129.8 146.25 51.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.799 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -131.1 94.57 3.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.918 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' ILE . . . . . 0.452 HD13 HG23 ' A' ' 393' ' ' VAL . 49.5 mm -58.61 132.44 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 30.6 m -151.94 156.18 6.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.145 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -68.25 -38.74 82.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -122.71 84.17 49.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.57 0.7 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 94.46 0.53 Allowed 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.7 2.267 . . . . 0.0 112.346 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 152.44 -39.92 0.74 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.516 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -118.26 76.75 1.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.738 0.304 . . . . 0.0 110.923 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.738 ' NE2' ' CD1' ' A' ' 392' ' ' TYR . 3.0 pp0? -171.49 105.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 385' ' ' THR . . . . . 0.466 ' C ' ' O ' ' A' ' 384' ' ' GLN . 10.5 m 32.9 46.68 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 13.7 p -41.5 149.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 53.8 t -134.14 110.05 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.3 mt -50.0 100.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.127 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 126.09 -42.75 1.45 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -80.25 157.82 26.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.849 0.357 . . . . 0.0 110.862 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 1.8 m -122.73 145.37 48.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.85 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' TYR . . . . . 0.738 ' CD1' ' NE2' ' A' ' 384' ' ' GLN . 37.7 m-85 -117.98 131.58 56.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.507 HG11 HG12 ' A' ' 410' ' ' VAL . 17.3 m -129.6 155.3 41.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.082 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -72.39 161.37 79.4 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.576 0.703 . . . . 0.0 110.922 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -4.24 13.63 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.702 2.268 . . . . 0.0 112.371 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 -86.26 -16.35 37.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 79.7 t90 -65.72 -34.86 79.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.432 HG13 ' HZ ' ' A' ' 327' ' ' PHE . 88.9 t -81.09 -49.81 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.106 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -51.13 -30.1 15.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.486 ' OD2' HD11 ' A' ' 408' ' ' LEU . 6.5 t70 -85.48 -47.3 10.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 63.7 m -56.45 -47.08 79.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.85 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.523 ' HB ' ' CZ ' ' A' ' 350' ' ' PHE . 23.5 m -50.44 -43.8 23.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.152 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' ASN . . . . . 0.444 ' N ' HG23 ' A' ' 402' ' ' VAL . 21.9 t-20 -74.35 -40.34 62.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -76.86 0.72 19.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.121 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 41.96 44.74 3.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 25.4 tp -165.42 143.71 6.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.955 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.568 HD11 HD11 ' A' ' 330' ' ' LEU . 40.3 mt -69.6 93.94 0.74 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.941 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.486 HD11 ' OD2' ' A' ' 400' ' ' ASP . 65.7 mt -60.4 153.18 61.15 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.6 0.714 . . . . 0.0 110.924 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 114.48 3.72 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.677 2.251 . . . . 0.0 112.347 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.507 HG12 HG11 ' A' ' 393' ' ' VAL . 18.7 m -58.89 -27.4 35.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.09 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -50.17 -29.46 9.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.125 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -78.48 -24.98 45.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -106.6 38.03 2.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.944 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 53.1 t80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 -179.969 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 42.7 m -163.18 165.63 24.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 0.0 110.858 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 48.1 m -68.85 164.85 21.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.798 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -99.25 53.27 1.04 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.508 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 30.3 p -162.05 113.31 1.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 0.0 110.861 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 42.5 m -109.59 124.68 51.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -160.73 -70.97 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.444 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 19.0 tptp -152.1 106.53 3.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.343 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -86.15 117.43 24.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.84 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -123.42 41.76 3.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -41.84 132.35 3.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.906 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 22.4 tp -44.01 -54.06 5.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -98.0 36.78 1.5 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -60.94 116.85 4.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.864 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 76.17 -46.72 2.19 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 329' ' ' GLY . 24.3 mt -37.31 125.94 1.02 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.879 0.371 . . . . 0.0 110.95 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -95.24 144.76 25.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -135.06 153.26 52.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.919 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -140.17 117.11 11.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.64 HD22 HD13 ' A' ' 343' ' ' LEU . 2.8 mt -97.83 149.95 21.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.924 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -107.54 164.01 12.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.9 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.594 ' HB3' HD11 ' A' ' 360' ' ' LEU . 15.1 ptp180 -61.48 -31.1 71.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -41.59 97.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 10.1 m -91.03 150.81 42.43 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.628 0.728 . . . . 0.0 111.116 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 118.61 5.78 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.726 2.284 . . . . 0.0 112.301 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 0.517 ' HA ' HD13 ' A' ' 334' ' ' LEU . 24.3 ptt85 -89.29 -37.25 15.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.84 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -49.82 -42.75 47.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.851 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -74.8 -62.3 1.59 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.061 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' LEU . . . . . 0.64 HD13 HD22 ' A' ' 334' ' ' LEU . 30.9 mt -53.1 -60.36 3.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.908 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 343' ' ' LEU . . . -37.02 -58.9 0.75 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -53.14 -45.84 68.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 23.0 mt -59.23 -69.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.147 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 20.9 mt -40.1 -57.35 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.097 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -58.41 -45.78 87.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 40.2 t -55.04 -34.81 63.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -98.4 29.26 3.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.894 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 54.98 52.17 48.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.515 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -119.62 154.97 16.27 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.437 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -92.8 138.93 31.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.888 0.375 . . . . 0.0 110.864 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.435 HG21 HD11 ' A' ' 334' ' ' LEU . 7.3 p -154.78 140.33 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.118 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 42.0 t -140.04 144.23 36.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.815 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 40.5 p90 -121.13 174.84 6.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.727 ' HB2' HD12 ' A' ' 360' ' ' LEU . 19.9 m-20 -65.0 104.15 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 357' ' ' ASP . 12.1 ptpt -36.65 -44.87 0.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 11.3 t -51.93 -48.74 64.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.727 HD12 ' HB2' ' A' ' 357' ' ' ASP . 8.8 mt -53.03 -47.48 68.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.894 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 45.5 t -162.33 156.73 21.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 21.2 tt -73.24 160.21 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.112 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 112.8 -27.64 9.58 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.508 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -41.59 148.26 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.85 0.357 . . . . 0.0 111.118 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 26.0 p -108.76 -64.82 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.151 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -117.2 144.42 44.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.871 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.03 174.15 8.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.887 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 7.1 p -69.62 -22.38 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.094 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 82.6 p -86.14 24.52 1.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.137 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -98.36 102.3 14.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.3 t -46.54 -29.31 1.73 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.824 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -47.43 -40.11 17.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.88 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 58.5 mt -40.06 147.48 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.135 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 55.3 p -125.8 -30.71 2.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -147.59 110.22 4.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.868 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' GLN . . . . . 0.416 ' HG2' HG13 ' A' ' 378' ' ' VAL . 20.2 tt0 -96.68 100.98 12.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 377' ' ' ILE . . . . . 0.421 HD13 HG23 ' A' ' 393' ' ' VAL . 19.1 mm -68.79 113.48 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.416 HG13 ' HG2' ' A' ' 376' ' ' GLN . 18.7 m -126.65 -178.93 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.136 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.55 -40.5 10.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -128.69 80.9 71.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.657 0.742 . . . . 0.0 110.891 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -10.84 29.55 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.657 2.238 . . . . 0.0 112.33 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -85.4 -20.06 57.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.517 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -102.68 -43.8 5.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.778 0.323 . . . . 0.0 110.898 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -44.82 163.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.937 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 71.4 p -87.4 121.52 29.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.178 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 56.2 p -70.54 151.88 44.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.801 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 87.3 t -129.82 114.38 30.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.142 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 8.8 mt -38.08 116.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.118 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 102.68 -44.79 1.44 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.474 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -77.62 158.03 29.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.819 0.343 . . . . 0.0 110.888 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 82.4 m -133.63 132.73 41.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.861 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -106.68 124.65 49.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.427 HG11 ' HB ' ' A' ' 410' ' ' VAL . 19.2 m -135.44 156.86 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.118 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -71.0 158.86 87.26 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.607 0.718 . . . . 0.0 110.898 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -7.74 21.83 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.684 2.256 . . . . 0.0 112.332 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -79.19 -25.37 42.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.936 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' TRP . . . . . 0.516 ' HB2' ' CD2' ' A' ' 413' ' ' TYR . 92.0 t90 -59.44 -28.11 66.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 39.7 t -72.09 -57.55 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.137 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -50.0 -53.8 24.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.448 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 0.8 OUTLIER -54.85 -45.56 74.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 21.5 m -56.58 -66.7 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 26.8 m -47.43 -40.48 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.101 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -69.89 -35.07 74.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -92.08 11.65 24.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 405' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 404' ' ' ALA . 2.8 mmm180 38.11 44.24 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.839 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 8.1 tp -165.07 150.59 9.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.929 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 97.1 mt -81.16 80.11 7.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.448 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 49.3 mt -46.04 156.45 0.46 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.562 0.696 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 119.01 6.02 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.653 2.235 . . . . 0.0 112.322 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.427 ' HB ' HG11 ' A' ' 393' ' ' VAL . 35.3 m -64.88 -23.77 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.088 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -53.17 -18.58 2.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -88.73 -33.46 17.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.516 ' CD2' ' HB2' ' A' ' 397' ' ' TRP . 6.4 m-85 -95.3 36.03 1.27 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.902 179.983 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 7.7 t -117.49 164.95 14.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.883 0.373 . . . . 0.0 110.832 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 25.0 p -171.88 156.07 4.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.829 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -136.87 -126.27 2.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.463 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 1.9 t 48.45 46.77 20.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.888 0.375 . . . . 0.0 110.851 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 9.6 t -125.62 141.93 51.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.83 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -149.16 -159.36 8.54 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.48 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.492 ' O ' ' CG ' ' A' ' 323' ' ' HIS . 0.0 OUTLIER -157.73 141.27 15.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.85 0.357 . . . . 0.0 110.894 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.492 ' CG ' ' O ' ' A' ' 322' ' ' LYS . 18.8 m80 -167.31 161.93 14.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.823 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -59.71 91.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' LYS . . . . . 0.435 ' HD2' ' C ' ' A' ' 350' ' ' PHE . 9.9 mmtp -61.12 161.63 8.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 326' ' ' LEU . 0.2 OUTLIER -70.76 -40.45 72.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.933 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -118.06 40.71 3.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -56.94 114.78 2.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 75.23 -47.41 1.98 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.477 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 329' ' ' GLY . 33.0 mt -35.78 125.16 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.884 0.373 . . . . 0.0 110.929 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -101.96 151.13 22.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.928 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -141.94 154.48 45.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' PHE . . . . . 0.518 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 18.8 t80 -130.87 116.6 18.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.413 ' HG ' ' CG2' ' A' ' 354' ' ' VAL . 6.6 mt -91.09 146.76 23.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -101.72 164.49 11.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.912 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.552 ' HB3' HD22 ' A' ' 360' ' ' LEU . 8.9 ptt180 -66.58 -17.3 64.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -78.33 -47.62 17.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.892 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 2.1 m -84.32 148.98 54.16 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.615 0.722 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' PRO . . . . . 0.588 ' O ' HD12 ' A' ' 343' ' ' LEU . 54.2 Cg_endo -69.73 138.04 36.99 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.706 2.271 . . . . 0.0 112.35 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 341' ' ' GLU . 16.9 ptt85 -102.23 -48.09 4.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.865 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 340' ' ' ARG . 4.9 pt-20 -35.29 -46.71 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -75.31 -59.05 2.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.072 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' LEU . . . . . 0.588 HD12 ' O ' ' A' ' 339' ' ' PRO . 79.4 mt -55.9 -63.64 1.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.93 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -39.42 -54.35 1.91 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.1 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -55.71 -44.78 77.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 346' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 347' ' ' ILE . 21.7 mt -65.8 -67.79 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.135 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 347' ' ' ILE . . . . . 0.491 ' O ' ' N ' ' A' ' 352' ' ' GLY . 25.5 mt -41.4 -35.21 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 44.4 mtp85 -79.95 -45.65 18.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 32.3 t -56.08 -30.58 62.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' PHE . . . . . 0.435 ' C ' ' HD2' ' A' ' 325' ' ' LYS . 58.7 m-85 -98.58 26.67 5.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 58.91 58.96 11.8 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.479 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 347' ' ' ILE . . . -129.73 150.37 19.0 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.483 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -96.52 133.28 41.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.894 0.378 . . . . 0.0 110.914 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.413 ' CG2' ' HG ' ' A' ' 334' ' ' LEU . 7.4 p -143.49 143.39 24.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.119 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 355' ' ' SER . . . . . 0.568 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 1.5 t -141.07 156.8 45.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 356' ' ' TRP . . . . . 0.442 ' O ' ' HB2' ' A' ' 364' ' ' ALA . 23.9 p90 -138.09 140.79 40.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.892 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.727 ' HB2' HD12 ' A' ' 360' ' ' LEU . 6.2 m-20 -42.77 115.99 0.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -44.7 -57.28 3.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.875 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 78.3 p -41.32 -47.87 3.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.853 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.727 HD12 ' HB2' ' A' ' 357' ' ' ASP . 86.7 mt -61.61 -50.92 70.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.895 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 23.3 m -154.95 140.55 17.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.3 pt -69.77 162.39 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.119 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 93.43 39.41 5.05 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.452 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 356' ' ' TRP . . . -113.56 149.47 34.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 0.0 111.109 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 41.4 p -98.59 -72.4 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.096 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' TYR . . . . . 0.568 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 18.5 p90 -103.43 161.79 13.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.911 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.01 168.62 11.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.834 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 368' ' ' VAL . . . . . 0.528 ' O ' HG22 ' A' ' 368' ' ' VAL . 7.6 p -70.69 -6.65 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.161 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 24.3 p -100.3 18.71 18.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -95.19 118.69 32.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.821 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.2 m -51.17 -43.78 61.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.843 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 21.4 mtt85 -38.93 -40.1 0.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.82 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 57.0 mt -48.55 115.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.103 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 74.8 p -85.25 -43.61 13.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -128.84 158.97 37.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.81 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' GLN . . . . . 0.54 ' CD ' ' CE2' ' A' ' 392' ' ' TYR . 25.9 tt0 -140.62 108.97 5.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 377' ' ' ILE . . . . . 0.436 HD13 HG23 ' A' ' 393' ' ' VAL . 44.6 mm -76.09 139.12 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.192 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 379' ' ' ASP . 18.7 m -154.7 139.59 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 379' ' ' ASP . . . . . 0.439 ' O ' ' CG ' ' A' ' 380' ' ' ARG . 5.7 t0 -35.95 -45.74 0.43 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.439 ' CG ' ' O ' ' A' ' 379' ' ' ASP . 62.7 mtt180 -161.07 121.6 1.6 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.65 0.738 . . . . 0.0 110.86 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 2.67 3.3 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.673 2.248 . . . . 0.0 112.373 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -96.89 -31.41 7.0 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.48 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -91.84 31.73 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.882 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -174.14 144.07 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.871 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 9.9 t -79.62 158.15 27.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.6 p -110.97 166.64 10.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 56.5 t -98.97 128.39 50.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.4 mt -44.22 110.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.151 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 113.67 -41.25 2.25 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.468 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' ARG . . . . . 0.509 ' HD2' ' CE1' ' A' ' 392' ' ' TYR . 13.2 ttm-85 -79.52 152.39 30.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.778 0.323 . . . . 0.0 110.9 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 40.5 m -120.27 115.67 24.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' TYR . . . . . 0.54 ' CE2' ' CD ' ' A' ' 376' ' ' GLN . 7.0 m-85 -92.51 130.4 38.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.919 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.436 HG23 HD13 ' A' ' 377' ' ' ILE . 25.1 m -134.97 167.98 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.143 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -83.78 160.56 58.2 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.576 0.703 . . . . 0.0 110.935 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -7.99 22.48 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.708 2.272 . . . . 0.0 112.328 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 12.6 tp-100 -79.18 -12.76 59.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 92.4 t90 -79.79 -13.03 59.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.475 ' O ' HG22 ' A' ' 402' ' ' VAL . 60.1 t -89.65 -33.81 6.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.163 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -76.33 -28.75 57.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.454 ' HB3' HD12 ' A' ' 408' ' ' LEU . 8.5 t0 -81.04 -53.09 6.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.875 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 39.3 m -48.74 -46.44 40.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 398' ' ' VAL . 18.9 m -64.25 -43.1 97.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.126 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' ASN . . . . . 0.433 ' N ' HG23 ' A' ' 402' ' ' VAL . 17.6 t-20 -64.28 -32.31 73.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -97.04 8.84 43.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.094 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 39.77 40.46 0.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 6.9 tp -156.93 149.41 23.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 90.7 mt -78.08 90.59 4.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 400' ' ' ASP . 84.4 mt -56.35 151.63 27.34 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.581 0.705 . . . . 0.0 110.908 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 107.44 1.86 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.635 2.223 . . . . 0.0 112.37 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.2 m -54.21 -19.03 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.147 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -58.31 -14.52 7.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.107 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -98.43 -16.63 19.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -114.57 28.34 8.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 26.1 t80 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 316' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 317' ' ' SER . 87.9 p 41.09 46.47 2.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.863 0.363 . . . . 0.0 110.871 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.448 ' C ' ' O ' ' A' ' 316' ' ' SER . 42.4 p 34.6 44.34 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.819 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -100.48 103.14 2.58 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.527 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 54.8 p -164.87 150.92 10.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.896 0.379 . . . . 0.0 110.848 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 3.2 t -94.11 174.77 6.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 172.1 -175.44 45.37 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.29 177.77 5.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.828 0.347 . . . . 0.0 110.87 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -129.58 78.29 1.84 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -101.94 108.14 19.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -136.84 149.07 47.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.449 HD21 HD23 ' A' ' 407' ' ' LEU . 4.8 tp -71.47 -51.59 22.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.916 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 327' ' ' PHE . . . . . 0.489 ' HB2' ' CA ' ' A' ' 352' ' ' GLY . 22.8 m-85 -86.3 31.7 0.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -66.54 119.83 12.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.862 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 82.7 -53.07 4.79 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.467 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 329' ' ' GLY . 29.7 mt -36.69 124.84 0.86 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.847 0.356 . . . . 0.0 110.87 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -99.82 115.08 28.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -104.32 167.54 9.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' PHE . . . . . 0.41 ' CD1' ' O ' ' A' ' 355' ' ' SER . 34.6 t80 -152.58 115.56 4.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.59 HD13 ' HA ' ' A' ' 340' ' ' ARG . 4.1 mt -89.77 128.22 36.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.934 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 335' ' ' ASN . . . . . 0.44 ' O ' HG22 ' A' ' 338' ' ' VAL . 2.6 t-20 -83.23 145.99 28.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.546 ' HB3' HD13 ' A' ' 360' ' ' LEU . 0.0 OUTLIER -51.03 -20.03 1.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -78.75 -42.49 27.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 335' ' ' ASN . 13.3 m -82.39 151.21 65.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.623 0.725 . . . . 0.0 111.144 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 339' ' ' PRO . . . . . 0.524 ' O ' HD12 ' A' ' 343' ' ' LEU . 54.0 Cg_endo -69.71 124.82 11.47 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.715 2.277 . . . . 0.0 112.366 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 0.59 ' HA ' HD13 ' A' ' 334' ' ' LEU . 15.6 mtm105 -89.42 -55.45 3.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.875 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 340' ' ' ARG . 7.5 pt-20 -35.26 -45.85 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -71.58 -63.76 1.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.099 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' LEU . . . . . 0.685 HD11 ' HB3' ' A' ' 395' ' ' PRO . 35.3 mt -55.46 -63.59 1.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.916 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -37.07 -57.65 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -52.83 -46.21 67.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' ILE . . . . . 0.689 ' CG2' HG11 ' A' ' 402' ' ' VAL . 14.6 mt -61.18 -62.05 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.129 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 20.3 mt -48.63 -53.03 7.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.155 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -62.07 -40.32 95.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 4.5 m -60.21 -34.88 74.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.821 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -98.79 29.04 3.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 53.8 59.17 10.19 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.477 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' GLY . . . . . 0.489 ' CA ' ' HB2' ' A' ' 327' ' ' PHE . . . -125.39 156.31 19.16 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.467 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -91.27 142.47 27.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.951 0.405 . . . . 0.0 110.838 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.462 ' CG2' ' HG ' ' A' ' 334' ' ' LEU . 7.5 p -159.11 141.03 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.149 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 355' ' ' SER . . . . . 0.41 ' O ' ' CD1' ' A' ' 333' ' ' PHE . 32.7 t -140.9 157.47 45.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.828 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -136.35 -177.89 4.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.673 ' HB2' HD12 ' A' ' 360' ' ' LEU . 2.9 m-20 -69.13 119.78 13.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 22.8 mttp -53.52 -55.43 25.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 26.5 t -48.18 -58.94 3.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.87 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.673 HD12 ' HB2' ' A' ' 357' ' ' ASP . 5.9 mt -49.97 -40.54 44.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 3.8 m -160.68 144.72 13.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 7.3 pt -82.27 151.33 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.1 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 109.79 26.94 4.82 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.451 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -99.98 155.87 17.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 111.139 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 23.8 p -108.12 -57.82 2.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.14 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -128.27 136.7 51.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.9 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.92 169.8 14.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.839 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' VAL . . . . . 0.46 ' HA ' ' CD1' ' A' ' 373' ' ' ILE . 11.3 p -55.54 -29.35 24.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.137 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 75.8 p -65.88 -25.6 67.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.145 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -62.21 98.88 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 60.5 p -49.49 -29.62 6.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -45.99 -40.45 10.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.859 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.46 ' CD1' ' HA ' ' A' ' 368' ' ' VAL . 60.0 mt -38.16 145.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.103 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 75.7 p -117.55 -30.81 5.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.164 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -141.75 124.37 15.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.827 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' GLN . . . . . 0.529 ' NE2' ' CG1' ' A' ' 378' ' ' VAL . 0.2 OUTLIER -106.09 95.04 5.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 48.2 mm -58.62 97.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.108 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.529 ' CG1' ' NE2' ' A' ' 376' ' ' GLN . 27.4 m -118.58 163.3 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.137 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.96 -34.77 64.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -134.64 80.9 49.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.602 0.715 . . . . 0.0 110.906 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 3.05 2.99 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.665 2.244 . . . . 0.0 112.381 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -113.43 -21.56 5.78 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.484 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' GLN . . . . . 0.412 ' HG3' ' N ' ' A' ' 384' ' ' GLN . 1.0 OUTLIER -92.64 -61.07 1.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.78 0.324 . . . . 0.0 110.888 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.412 ' N ' ' HG3' ' A' ' 383' ' ' GLN . 2.4 pt20 -54.56 138.82 39.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 7.8 t -48.93 146.8 3.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.14 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 25.2 p -118.87 152.71 35.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.848 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.39 119.22 49.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.112 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.762 ' H ' HD12 ' A' ' 388' ' ' ILE . 5.0 mp -42.57 111.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.17 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 115.18 -38.58 3.07 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.52 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' ARG . . . . . 0.492 ' HD2' ' CZ ' ' A' ' 392' ' ' TYR . 6.7 ttm180 -83.55 146.81 28.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.765 0.317 . . . . 0.0 110.898 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 43.8 m -114.53 143.61 44.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' TYR . . . . . 0.492 ' CZ ' ' HD2' ' A' ' 390' ' ' ARG . 3.7 m-85 -123.29 129.33 51.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.488 HG11 ' CG1' ' A' ' 410' ' ' VAL . 33.8 m -132.99 152.21 35.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.197 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -71.05 160.91 81.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.576 0.703 . . . . 0.0 110.936 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.685 ' HB3' HD11 ' A' ' 343' ' ' LEU . 53.6 Cg_endo -69.74 -4.58 14.3 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.709 2.273 . . . . 0.0 112.315 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 396' ' ' GLN . . . . . 0.537 ' HA ' ' CD2' ' A' ' 399' ' ' PHE . 14.0 tt0 -85.36 -31.77 22.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -53.78 -30.32 44.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.985 ' O ' HG22 ' A' ' 402' ' ' VAL . 21.4 t -72.52 -38.33 59.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.106 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 399' ' ' PHE . . . . . 0.537 ' CD2' ' HA ' ' A' ' 396' ' ' GLN . 17.3 m-85 -63.19 -52.24 63.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.25 -26.92 67.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 45.8 m -75.81 -59.81 2.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.837 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.985 HG22 ' O ' ' A' ' 398' ' ' VAL . 5.8 m -55.6 -33.99 34.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.083 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -76.3 -38.74 55.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -85.37 12.34 8.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.085 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 40.04 36.07 0.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.403 HD12 ' H ' ' A' ' 407' ' ' LEU . 49.7 tp -151.48 151.39 31.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.978 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.449 HD23 HD21 ' A' ' 326' ' ' LEU . 46.9 mt -86.83 71.9 10.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.924 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 407' ' ' LEU . 43.6 mt -38.04 156.41 0.1 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.621 0.724 . . . . 0.0 110.906 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 113.6 3.42 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.345 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.488 ' CG1' HG11 ' A' ' 393' ' ' VAL . 16.4 m -61.83 -31.22 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -45.21 -44.39 10.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.47 -27.16 67.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -98.35 38.33 1.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.889 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 52.9 p -44.86 166.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.382 . . . . 0.0 110.87 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 47.5 t -130.72 119.86 22.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -39.49 104.1 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.463 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 97.4 p -91.36 90.91 7.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.853 0.359 . . . . 0.0 110.825 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 25.5 m -40.69 -44.27 2.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.86 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 134.92 109.17 1.02 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.454 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 22.3 tttm -84.63 -47.13 10.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.786 0.327 . . . . 0.0 110.899 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.457 ' O ' ' C ' ' A' ' 324' ' ' LYS . 9.0 m170 -71.45 121.86 19.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.858 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 323' ' ' HIS . 0.0 OUTLIER -33.34 141.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt -95.44 138.86 32.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 22.7 tp -53.25 -53.07 56.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' PHE . . . . . 0.438 ' HB2' ' CA ' ' A' ' 352' ' ' GLY . 24.5 m-85 -95.24 35.52 1.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -60.68 113.08 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 80.51 -41.88 2.56 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.5 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 34.9 mt -44.8 124.75 4.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.903 0.382 . . . . 0.0 110.894 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -95.81 147.39 23.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -137.82 155.77 48.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -139.55 116.3 10.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.696 HD11 HG21 ' A' ' 354' ' ' VAL . 2.8 mt -94.64 152.65 18.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -114.54 147.88 38.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.447 ' HD2' ' N ' ' A' ' 336' ' ' ARG . 0.5 OUTLIER -46.86 -27.78 1.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -63.87 -48.59 76.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.7 m -86.89 151.14 51.73 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.675 0.75 . . . . 0.0 111.121 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' PRO . . . . . 0.618 ' O ' HD12 ' A' ' 343' ' ' LEU . 54.0 Cg_endo -69.77 116.06 4.38 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.67 2.247 . . . . 0.0 112.328 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 0.426 ' HG2' ' N ' ' A' ' 341' ' ' GLU . 0.0 OUTLIER -87.4 -29.98 21.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.884 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.426 ' N ' ' HG2' ' A' ' 340' ' ' ARG . 11.2 pt-20 -50.96 -49.75 59.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.401 ' N ' ' HG3' ' A' ' 341' ' ' GLU . . . -74.3 -57.59 3.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.089 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 343' ' ' LEU . . . . . 0.666 HD23 ' CE1' ' A' ' 399' ' ' PHE . 27.6 mt -53.14 -65.33 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 343' ' ' LEU . . . -35.03 -62.66 0.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.059 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' PHE . . . . . 0.603 ' N ' HH21 ' A' ' 348' ' ' ARG . 19.8 t80 -48.27 -49.73 32.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 349' ' ' SER . 44.4 mt -56.55 -71.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.16 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 347' ' ' ILE . . . . . 0.429 ' O ' ' N ' ' A' ' 352' ' ' GLY . 20.9 mt -37.99 -50.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.138 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 348' ' ' ARG . . . . . 0.603 HH21 ' N ' ' A' ' 345' ' ' PHE . 75.0 mtm180 -65.21 -37.71 88.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 349' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 346' ' ' ILE . 29.6 t -61.2 -42.83 99.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -88.54 23.05 2.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.869 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 60.67 57.2 20.12 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.452 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' GLY . . . . . 0.438 ' CA ' ' HB2' ' A' ' 327' ' ' PHE . . . -123.01 164.22 16.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.471 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -103.75 130.12 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.924 0.392 . . . . 0.0 110.893 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.696 HG21 HD11 ' A' ' 334' ' ' LEU . 5.7 p -141.51 142.76 28.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.123 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 355' ' ' SER . . . . . 0.458 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 4.6 t -140.48 162.46 35.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' TRP . . . . . 0.568 ' O ' ' HB2' ' A' ' 364' ' ' ALA . 20.4 p90 -139.32 153.92 47.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.913 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 360' ' ' LEU . 3.9 t70 -45.07 104.87 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 357' ' ' ASP . 7.3 mtpm? -35.92 -36.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.2 t -64.0 -48.35 76.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 357' ' ' ASP . 36.8 mt -55.44 -39.35 70.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 3.7 t -172.23 146.7 1.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.6 pt -66.34 173.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.102 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 104.42 -38.96 3.0 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.499 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 356' ' ' TRP . . . -50.34 140.3 13.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.822 0.344 . . . . 0.0 111.13 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 23.6 p -101.49 -50.94 3.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.186 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' TYR . . . . . 0.458 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 29.9 p90 -112.49 149.64 32.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.52 167.56 19.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.86 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 12.8 p -69.73 -22.56 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.155 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 77.3 p -84.02 13.55 4.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.61 110.49 17.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 22.6 p -55.35 -23.8 25.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -60.94 -36.8 80.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.85 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.417 HG21 HH11 ' A' ' 390' ' ' ARG . 66.6 mt -40.55 130.38 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.121 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 69.6 p -97.52 -24.72 15.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.169 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -154.55 149.36 26.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' GLN . . . . . 0.541 ' OE1' ' CE2' ' A' ' 392' ' ' TYR . 52.8 tt0 -134.37 111.56 10.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 19.1 mm -80.0 115.0 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.129 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.533 HG13 ' HG2' ' A' ' 376' ' ' GLN . 29.5 m -131.97 168.98 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.55 -34.59 31.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.458 ' CZ ' ' HG3' ' A' ' 383' ' ' GLN . 81.3 mtp180 -132.23 80.81 62.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.612 0.72 . . . . 0.0 110.872 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -18.6 37.04 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.689 2.259 . . . . 0.0 112.358 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -73.92 -32.45 58.84 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.526 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' GLN . . . . . 0.458 ' HG3' ' CZ ' ' A' ' 380' ' ' ARG . 13.8 mm100 -76.12 -49.3 17.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.756 0.312 . . . . 0.0 110.898 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -53.17 178.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 72.4 p -122.2 121.93 38.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 81.3 p -56.88 157.54 5.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 97.3 t -125.43 140.16 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.131 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.1 mt -37.82 111.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.093 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 92.13 -49.07 2.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.489 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' ARG . . . . . 0.468 ' HD2' ' N ' ' A' ' 391' ' ' CYS . 6.9 tmm_? -84.43 146.28 27.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.806 0.336 . . . . 0.0 110.863 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 391' ' ' CYS . . . . . 0.468 ' N ' ' HD2' ' A' ' 390' ' ' ARG . 88.3 m -134.8 147.55 49.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' TYR . . . . . 0.541 ' CE2' ' OE1' ' A' ' 376' ' ' GLN . 5.2 m-85 -94.62 132.87 38.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 4.2 m -138.26 158.13 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.116 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -78.7 161.32 69.67 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.608 0.718 . . . . 0.0 110.913 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -6.19 18.02 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.643 2.229 . . . . 0.0 112.341 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -80.96 -23.74 38.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.946 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 92.5 t90 -63.73 -27.97 69.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.696 ' O ' HG22 ' A' ' 402' ' ' VAL . 48.0 t -75.0 -70.27 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 399' ' ' PHE . . . . . 0.666 ' CE1' HD23 ' A' ' 343' ' ' LEU . 5.4 m-30 -42.07 -36.95 1.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.88 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -72.44 -44.31 62.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 75.8 m -63.55 -54.47 35.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.81 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 398' ' ' VAL . 2.5 m -56.74 -33.88 41.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.089 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -79.48 -29.48 41.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -94.5 9.17 39.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.071 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? 40.19 32.71 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.597 HD13 ' N ' ' A' ' 407' ' ' LEU . 0.9 OUTLIER -152.62 137.4 17.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.93 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.597 ' N ' HD13 ' A' ' 406' ' ' LEU . 48.1 mt -74.1 85.37 1.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 45.5 mt -51.57 154.15 3.48 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.552 0.691 . . . . 0.0 110.977 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 107.93 1.96 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.711 2.274 . . . . 0.0 112.326 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.1 m -54.84 -16.78 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.141 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -62.16 -19.16 62.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -90.74 -24.24 20.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -104.96 38.27 1.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.905 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 6.0 t80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 15.6 m -86.03 153.87 21.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.913 0.387 . . . . 0.0 110.8 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 26.7 t -102.35 148.79 25.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.847 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -178.56 107.48 0.23 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.464 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 21.4 m -72.29 83.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.944 0.402 . . . . 0.0 110.872 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 30.0 p -70.96 96.54 1.31 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.866 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 159.97 147.49 4.92 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.468 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 18.5 mmtm -107.83 141.0 40.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.813 0.339 . . . . 0.0 110.884 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -134.0 170.69 15.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.828 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.32 98.88 6.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -91.03 133.89 34.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.903 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 15.9 tp -57.69 -52.57 64.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' PHE . . . . . 0.472 ' HA ' HD12 ' A' ' 330' ' ' LEU . 25.4 m-85 -92.41 38.39 1.01 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -71.69 141.15 49.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.919 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 45.49 43.45 10.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.451 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 327' ' ' PHE . 42.1 mt -132.23 126.81 34.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.86 0.362 . . . . 0.0 110.899 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.549 ' HE3' ' CE2' ' A' ' 366' ' ' TYR . 37.1 mtpt -99.32 141.38 32.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.909 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -133.18 156.16 47.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 333' ' ' PHE . . . . . 0.467 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 8.9 t80 -138.36 115.63 11.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.86 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.531 HD11 HG21 ' A' ' 354' ' ' VAL . 2.9 mt -94.47 151.96 18.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.933 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -104.45 177.12 4.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -77.48 -27.51 51.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.855 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -72.13 -26.04 61.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.1 m -102.15 148.39 35.31 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.603 0.716 . . . . 0.0 111.122 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 339' ' ' PRO . . . . . 0.465 ' O ' HD12 ' A' ' 343' ' ' LEU . 53.4 Cg_endo -69.83 122.31 8.97 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.633 2.222 . . . . 0.0 112.343 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 0.5 ' O ' ' HB3' ' A' ' 344' ' ' ALA . 6.3 ppt_? -95.08 -30.67 13.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.461 ' N ' ' HD2' ' A' ' 340' ' ' ARG . 8.1 pt-20 -52.07 -37.82 55.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -86.26 -60.67 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.112 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 343' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 339' ' ' PRO . 54.9 mt -52.7 -55.58 21.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 340' ' ' ARG . . . -45.35 -58.6 3.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.07 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 345' ' ' PHE . . . . . 0.407 ' O ' ' N ' ' A' ' 349' ' ' SER . 4.8 t80 -56.38 -46.93 79.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 346' ' ' ILE . . . . . 0.412 ' CD1' ' CE1' ' A' ' 399' ' ' PHE . 29.2 mt -55.83 -67.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.147 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 17.0 mt -45.77 -37.94 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.167 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -78.97 -26.72 43.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 345' ' ' PHE . 16.7 t -82.53 -21.9 35.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.837 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -101.18 15.56 28.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 72.31 73.37 0.85 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.501 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -158.1 169.03 34.69 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.455 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -106.03 143.47 34.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.832 0.349 . . . . 0.0 110.947 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.531 HG21 HD11 ' A' ' 334' ' ' LEU . 11.7 p -157.82 128.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.151 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 355' ' ' SER . . . . . 0.548 ' HB2' ' CE1' ' A' ' 366' ' ' TYR . 1.9 m -133.7 154.15 51.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 356' ' ' TRP . . . . . 0.466 ' CD1' ' O ' ' A' ' 361' ' ' CYS . 14.3 p90 -122.16 -178.5 3.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.884 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 358' ' ' LYS . 10.9 t70 -73.83 111.75 9.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.854 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 357' ' ' ASP . 27.4 mttt -35.0 -51.47 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 7.9 t -57.97 -49.11 77.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 28.1 mt -51.31 -51.12 57.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' CYS . . . . . 0.466 ' O ' ' CD1' ' A' ' 356' ' ' TRP . 1.8 m -160.91 143.28 12.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 45.0 pt -66.22 160.08 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.41 ' O ' ' CZ2' ' A' ' 356' ' ' TRP . . . 96.91 36.21 5.08 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.464 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -117.33 147.17 42.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.816 0.341 . . . . 0.0 111.116 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 21.9 p -105.18 -71.06 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.146 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' TYR . . . . . 0.549 ' CE2' ' HE3' ' A' ' 331' ' ' LYS . 13.6 p90 -96.34 146.59 24.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.934 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.76 170.66 11.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 368' ' ' VAL . . . . . 0.467 ' HB ' ' CZ ' ' A' ' 333' ' ' PHE . 7.3 p -64.55 -18.05 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.134 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 70.1 p -85.37 22.85 1.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.181 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -104.73 103.83 13.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 30.0 m -50.35 -37.09 35.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 30.6 mtt180 -40.59 -39.84 1.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.86 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 70.6 mt -45.65 117.64 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.158 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 48.9 p -81.64 -44.93 16.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -126.32 138.87 53.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.861 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' GLN . . . . . 0.46 ' OE1' ' CZ ' ' A' ' 390' ' ' ARG . 37.6 tt0 -122.32 99.05 6.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.914 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 377' ' ' ILE . . . . . 0.424 ' N ' ' O ' ' A' ' 333' ' ' PHE . 25.8 mm -65.87 129.46 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 35.4 m -152.27 146.67 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.139 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -68.21 -34.54 76.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.827 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.404 ' HA ' ' HD2' ' A' ' 381' ' ' PRO . 20.2 mtp85 -132.7 89.86 34.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.612 0.72 . . . . 0.0 110.878 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 380' ' ' ARG . 53.6 Cg_endo -69.71 -27.06 27.17 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.668 2.245 . . . . 0.0 112.337 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -72.58 -59.2 4.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.528 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' GLN . . . . . 0.47 ' HG3' ' N ' ' A' ' 384' ' ' GLN . 12.1 pt20 -43.03 -36.96 1.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.808 0.337 . . . . 0.0 110.921 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.47 ' N ' ' HG3' ' A' ' 383' ' ' GLN . 10.4 pt20 -104.32 114.67 29.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.95 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 16.2 m -51.37 153.11 2.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.159 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 6.9 t -91.51 173.18 8.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.858 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.9 t -127.77 130.91 70.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.111 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 29.3 mm -42.37 125.95 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.143 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 94.68 -33.52 5.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.487 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' ARG . . . . . 0.46 ' CZ ' ' OE1' ' A' ' 376' ' ' GLN . 19.8 ttp180 -93.97 146.11 24.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.782 0.325 . . . . 0.0 110.881 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 62.5 m -129.22 127.8 42.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -96.61 133.64 40.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.507 HG11 ' HB ' ' A' ' 410' ' ' VAL . 17.0 m -143.21 142.76 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.123 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -57.85 158.45 12.48 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.607 0.718 . . . . 0.0 110.93 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -7.25 20.6 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.709 2.273 . . . . 0.0 112.294 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.31 -33.75 42.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' TRP . . . . . 0.457 ' CE2' HG12 ' A' ' 410' ' ' VAL . 69.1 t90 -48.49 -31.16 6.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.926 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.515 ' O ' HG22 ' A' ' 402' ' ' VAL . 65.7 t -80.22 -55.03 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 399' ' ' PHE . . . . . 0.433 ' CE2' HD21 ' A' ' 343' ' ' LEU . 68.1 m-85 -54.23 -22.02 10.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -85.45 -41.39 15.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 405' ' ' ARG . 20.3 m -66.53 -51.92 51.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 398' ' ' VAL . 15.3 m -49.77 -38.12 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.141 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -78.12 -44.18 26.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -83.08 8.28 13.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.138 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 405' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 404' ' ' ALA . 7.9 mmm180 35.57 46.0 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 12.6 tp -156.18 148.18 23.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.932 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 13.5 mt -80.0 84.14 5.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 33.1 mt -55.53 154.36 12.63 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.598 0.714 . . . . 0.0 110.886 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 114.13 3.61 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.707 2.271 . . . . 0.0 112.293 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.507 ' HB ' HG11 ' A' ' 393' ' ' VAL . 35.2 m -60.57 -21.27 22.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.123 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -55.54 -40.05 71.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.085 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.38 -9.99 59.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -121.34 38.41 4.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.887 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 10.4 t80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 -179.976 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 14.5 m -130.33 -57.26 1.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.814 0.34 . . . . 0.0 110.852 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 54.9 p -169.6 158.58 7.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.807 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -146.47 95.23 0.17 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.476 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 21.3 t -141.1 140.54 34.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.876 0.37 . . . . 0.0 110.86 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 44.3 m -128.49 114.23 16.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.872 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 152.39 142.42 3.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.485 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.26 110.81 18.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.745 0.307 . . . . 0.0 110.919 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 51.3 m170 -100.47 119.72 38.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.845 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -69.71 144.01 52.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -121.69 118.71 29.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 11.6 tp -44.37 -50.58 9.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.866 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -93.01 42.59 1.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -74.56 133.86 42.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 52.32 55.29 22.75 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.486 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 88.0 mt -147.55 118.1 7.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.88 0.371 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -93.43 126.26 38.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.948 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.518 ' CD1' ' HB2' ' A' ' 375' ' ' HIS . 74.5 m-85 -120.29 160.36 23.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 333' ' ' PHE . . . . . 0.528 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 36.8 t80 -141.11 117.01 10.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.475 HD11 HG21 ' A' ' 354' ' ' VAL . 7.4 mt -93.67 142.84 26.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.904 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 335' ' ' ASN . . . . . 0.403 ' OD1' HG12 ' A' ' 378' ' ' VAL . 3.7 m120 -101.22 158.25 16.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.776 ' HB3' HD13 ' A' ' 360' ' ' LEU . 12.9 ptt180 -58.78 -29.53 66.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.846 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 337' ' ' GLU . . . . . 0.462 ' CG ' ' OD2' ' A' ' 379' ' ' ASP . 11.6 tp10 -66.19 -48.0 72.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 5.1 m -80.82 150.64 69.66 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.582 0.706 . . . . 0.0 111.184 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 110.34 2.53 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.677 2.251 . . . . 0.0 112.3 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -86.53 -38.67 16.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -44.69 -41.33 6.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -82.42 -58.49 2.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.075 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 71.4 mt -53.99 -61.23 2.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -39.66 -55.55 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.068 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -58.81 -44.54 90.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 47.8 mt -59.65 -62.33 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.151 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 20.1 mt -51.97 -55.88 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -56.43 -40.26 74.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 29.5 t -64.92 -43.96 91.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 350' ' ' PHE . . . . . 0.468 ' CZ ' HG22 ' A' ' 402' ' ' VAL . 14.0 m-85 -73.44 -9.16 58.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 90.83 54.55 2.03 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.497 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -128.91 161.95 22.46 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.492 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -92.06 129.07 38.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.912 0.387 . . . . 0.0 110.851 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.475 HG21 HD11 ' A' ' 334' ' ' LEU . 10.8 p -148.06 143.2 19.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.155 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 355' ' ' SER . . . . . 0.553 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 5.1 t -147.39 152.26 37.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.868 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 356' ' ' TRP . . . . . 0.509 ' CD1' ' HB3' ' A' ' 361' ' ' CYS . 31.7 p90 -128.45 173.15 10.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.668 ' HB2' HD12 ' A' ' 360' ' ' LEU . 1.2 m-20 -61.59 109.28 1.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.821 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -46.45 -34.34 4.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 28.4 t -69.41 -55.18 11.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.814 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.776 HD13 ' HB3' ' A' ' 336' ' ' ARG . 18.5 mt -54.91 -44.14 73.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.894 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 361' ' ' CYS . . . . . 0.509 ' HB3' ' CD1' ' A' ' 356' ' ' TRP . 2.1 t -147.21 159.97 43.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 15.7 tt -86.55 162.26 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.149 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 85.98 43.1 6.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.508 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -107.04 165.8 11.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.878 0.37 . . . . 0.0 111.09 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 20.9 p -129.78 -64.05 0.89 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.143 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' TYR . . . . . 0.553 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 8.3 p90 -112.31 145.91 39.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.953 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.13 167.17 22.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.88 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 368' ' ' VAL . . . . . 0.528 ' HB ' ' CZ ' ' A' ' 333' ' ' PHE . 7.5 p -63.62 -20.49 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.107 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 79.1 p -93.65 26.62 3.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.142 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -93.87 113.58 25.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 372' ' ' ARG . 11.9 t -53.62 -45.76 70.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.871 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 372' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 371' ' ' SER . 18.5 mmt180 -37.15 -42.42 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.917 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 34.0 mt -47.75 129.95 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.096 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 41.6 p -94.73 -43.1 8.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.106 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 375' ' ' HIS . . . . . 0.518 ' HB2' ' CD1' ' A' ' 332' ' ' PHE . 37.3 m80 -128.82 148.47 50.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -128.74 115.42 17.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.927 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 27.0 mm -82.72 116.17 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.167 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.403 HG12 ' OD1' ' A' ' 335' ' ' ASN . 30.9 m -141.05 158.19 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 379' ' ' ASP . . . . . 0.462 ' OD2' ' CG ' ' A' ' 337' ' ' GLU . 2.8 m-20 -71.48 -37.7 71.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -127.69 81.98 69.19 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.578 0.704 . . . . 0.0 110.892 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -23.07 31.34 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.715 2.277 . . . . 0.0 112.373 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -68.64 -47.16 58.13 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.476 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -63.11 -48.9 76.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.775 0.321 . . . . 0.0 110.88 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -45.81 164.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.91 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 51.6 m -95.87 126.68 41.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.117 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 72.4 m -67.21 139.78 57.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 90.5 t -129.78 119.36 47.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.112 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.783 ' H ' HD12 ' A' ' 388' ' ' ILE . 5.0 mp -39.94 134.41 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 88.76 -40.8 3.05 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.455 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' ARG . . . . . 0.425 ' NH1' ' O ' ' A' ' 368' ' ' VAL . 14.5 ttp180 -95.65 145.79 25.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.756 0.312 . . . . 0.0 110.871 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 84.0 m -132.85 124.33 27.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -90.89 128.07 36.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.954 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 19.7 m -135.99 151.11 28.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.088 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -66.55 158.12 80.1 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.602 0.715 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -5.5 16.34 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.662 2.241 . . . . 0.0 112.362 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -80.68 -14.77 57.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -73.12 -49.77 26.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 51.7 t -55.5 -41.75 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.12 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -65.03 -64.53 0.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.484 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 2.4 m-20 -50.42 -33.42 20.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.836 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 69.6 m -70.49 -26.24 63.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.468 HG22 ' CZ ' ' A' ' 350' ' ' PHE . 2.2 t -89.23 -45.73 15.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.096 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -67.73 -31.68 71.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -88.08 5.99 38.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.087 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? 40.08 44.4 1.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 43.0 tp -165.13 144.24 6.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 16.4 mt -74.95 99.31 3.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.484 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 52.2 mt -71.55 153.62 93.56 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.634 0.731 . . . . 0.0 110.924 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 119.57 6.49 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.702 2.268 . . . . 0.0 112.35 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.09 -28.6 44.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.136 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -52.9 -21.82 4.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -84.52 -32.65 23.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -104.96 42.51 1.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.923 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 3.7 t80 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.88 179.966 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 316' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 315' ' ' GLY . 2.0 m -35.44 -53.88 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 0.0 110.837 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 3.1 m -57.9 136.14 56.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.847 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 61.37 141.93 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.451 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 33.1 m -85.89 170.25 12.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.918 0.389 . . . . 0.0 110.806 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 27.4 p -165.38 159.33 16.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.846 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -125.3 -111.57 1.85 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.496 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -94.59 82.04 3.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.788 0.327 . . . . 0.0 110.926 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -122.02 171.62 8.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.845 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 8.9 mtpt -138.38 161.08 37.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -139.91 146.63 39.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.443 HD11 ' HA ' ' A' ' 405' ' ' ARG . 2.5 tt -57.26 -52.6 64.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.936 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -92.15 38.54 1.0 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -77.21 124.37 27.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 69.01 49.2 42.71 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.544 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.498 HD11 HD11 ' A' ' 407' ' ' LEU . 88.9 mt -148.19 124.46 10.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.854 0.359 . . . . 0.0 110.935 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.46 ' HZ2' ' HB3' ' A' ' 372' ' ' ARG . 45.3 mttt -95.54 133.11 39.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -119.26 152.8 36.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.909 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -130.98 119.04 21.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.879 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.729 HD11 HG21 ' A' ' 354' ' ' VAL . 7.3 mt -97.95 140.89 31.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -98.34 -175.14 3.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.872 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -82.46 -33.74 28.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -69.81 -36.6 75.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.562 HG11 HG22 ' A' ' 377' ' ' ILE . 3.1 m -87.16 145.28 37.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.658 0.742 . . . . 0.0 111.107 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 339' ' ' PRO . . . . . 0.519 ' O ' HD12 ' A' ' 343' ' ' LEU . 53.6 Cg_endo -69.74 127.32 14.44 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.664 2.242 . . . . 0.0 112.33 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.86 -40.19 9.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -45.65 -41.36 10.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -78.9 -66.91 0.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.139 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 343' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 339' ' ' PRO . 60.2 mt -44.57 -58.26 3.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -43.3 -54.79 4.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -55.39 -40.61 71.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 346' ' ' ILE . . . . . 0.553 ' CG2' HG11 ' A' ' 402' ' ' VAL . 15.6 mt -68.64 -72.91 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.145 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 347' ' ' ILE . . . . . 0.472 ' N ' HG22 ' A' ' 346' ' ' ILE . 26.1 mt -37.33 -37.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.122 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -75.18 -47.99 25.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 47.5 t -55.52 -31.18 61.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.804 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 350' ' ' PHE . . . . . 0.422 ' CE2' ' HB ' ' A' ' 402' ' ' VAL . 20.7 m-85 -98.72 26.22 5.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 53.02 71.44 0.69 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.521 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -136.87 173.07 22.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.49 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -109.17 128.23 54.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 110.902 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.729 HG21 HD11 ' A' ' 334' ' ' LEU . 7.6 p -144.06 131.58 17.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.119 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 355' ' ' SER . . . . . 0.579 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 10.4 t -136.2 163.86 29.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 356' ' ' TRP . . . . . 0.508 ' CD1' ' HB2' ' A' ' 361' ' ' CYS . 34.0 p90 -142.35 159.07 42.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.905 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.844 ' HB2' HD12 ' A' ' 360' ' ' LEU . 7.0 m-20 -55.65 120.88 7.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -45.08 -59.38 2.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 14.7 t -45.4 -48.88 13.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.824 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.844 HD12 ' HB2' ' A' ' 357' ' ' ASP . 32.3 mt -55.97 -49.62 73.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.973 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 361' ' ' CYS . . . . . 0.508 ' HB2' ' CD1' ' A' ' 356' ' ' TRP . 62.1 m -154.03 157.4 38.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.2 tt -84.9 158.48 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.117 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 91.73 36.38 6.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.486 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -105.52 158.2 16.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 0.0 111.087 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.434 ' OG1' ' CD2' ' A' ' 366' ' ' TYR . 22.3 p -111.99 -64.14 1.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.124 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 366' ' ' TYR . . . . . 0.579 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 16.0 p90 -110.18 139.43 45.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -76.74 171.46 14.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' VAL . . . . . 0.419 ' O ' HG22 ' A' ' 368' ' ' VAL . 13.6 p -64.12 -11.77 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.175 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 25.3 p -96.89 15.66 21.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.147 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 370' ' ' ASP . . . . . 0.442 ' CB ' ' HB2' ' A' ' 366' ' ' TYR . 0.9 OUTLIER -96.03 107.2 19.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.886 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 59.0 p -52.24 -33.34 41.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' ARG . . . . . 0.46 ' HB3' ' HZ2' ' A' ' 331' ' ' LYS . 26.1 mmm-85 -40.05 -45.14 1.88 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.877 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.446 HG12 ' CE1' ' A' ' 366' ' ' TYR . 20.7 mt -41.24 136.16 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.192 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 50.6 p -112.12 -23.87 10.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.114 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -134.47 134.16 41.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.847 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' GLN . . . . . 0.446 ' HG2' ' CE2' ' A' ' 392' ' ' TYR . 2.0 tp-100 -124.59 105.5 9.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.896 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 377' ' ' ILE . . . . . 0.562 HG22 HG11 ' A' ' 338' ' ' VAL . 6.0 mm -84.38 126.38 40.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.09 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 13.5 m -139.11 152.36 23.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.12 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -67.19 -42.49 84.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.426 ' HB3' ' NH1' ' A' ' 380' ' ' ARG . 0.0 OUTLIER -132.12 90.42 35.0 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 0.0 110.866 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -19.45 36.3 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.668 2.246 . . . . 0.0 112.352 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -65.48 -47.03 82.41 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.531 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -80.92 -42.22 21.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.756 0.312 . . . . 0.0 110.894 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -51.93 153.49 2.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.0 149.67 23.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.139 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 26.1 p -108.86 153.11 23.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.839 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 26.1 t -119.65 128.43 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.14 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.3 mt -40.4 117.67 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.167 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 103.88 -43.14 1.73 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.466 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -87.67 148.7 24.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 0.0 110.867 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 4.0 t -123.58 145.51 48.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' TYR . . . . . 0.446 ' CE2' ' HG2' ' A' ' 376' ' ' GLN . 2.9 m-85 -107.28 118.05 35.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.942 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.427 HG23 ' CD1' ' A' ' 377' ' ' ILE . 31.4 m -124.85 160.32 30.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.135 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -76.02 159.59 80.29 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.57 0.7 . . . . 0.0 110.887 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -6.69 19.18 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.669 2.246 . . . . 0.0 112.357 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -83.55 -15.9 47.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.947 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -66.09 -26.55 67.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.425 ' O ' HG22 ' A' ' 402' ' ' VAL . 85.9 t -76.43 -51.34 19.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.161 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -60.18 -30.67 69.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.464 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 1.0 OUTLIER -80.55 -36.45 33.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.904 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 71.8 m -69.27 -49.47 55.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.553 HG11 ' CG2' ' A' ' 346' ' ' ILE . 34.9 m -60.43 -45.29 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.117 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 403' ' ' ASN . . . . . 0.499 ' N ' HG23 ' A' ' 402' ' ' VAL . 20.9 t-20 -65.08 -39.04 92.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 404' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -87.16 9.49 19.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.128 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 405' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' A' ' 404' ' ' ALA . 12.6 mmm-85 34.71 45.31 0.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.646 HD13 ' N ' ' A' ' 407' ' ' LEU . 0.4 OUTLIER -165.32 136.1 3.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.646 ' N ' HD13 ' A' ' 406' ' ' LEU . 15.6 mt -66.1 95.99 0.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.955 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.464 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 45.6 mt -64.75 156.1 80.07 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.607 0.718 . . . . 0.0 110.941 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 116.04 4.37 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.701 2.267 . . . . 0.0 112.361 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.9 m -58.02 -26.15 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.133 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -50.94 -34.3 28.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.072 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -75.72 -26.12 57.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -108.77 42.67 1.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 43.4 t80 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.898 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 82.3 p -152.68 163.58 39.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 0.0 110.889 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 5.5 t -142.3 169.48 17.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.888 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -155.72 76.8 0.21 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.481 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 90.1 p -148.04 153.83 39.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.923 0.392 . . . . 0.0 110.806 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 48.3 t -128.16 87.92 2.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 64.18 53.87 33.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.493 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -111.24 84.31 1.92 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.796 0.332 . . . . 0.0 110.849 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -109.9 100.1 9.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.864 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -112.87 78.19 1.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.938 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -125.32 136.68 53.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.941 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 2.0 tt -60.91 -48.62 80.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.939 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 327' ' ' PHE . . . . . 0.411 ' HA ' HD12 ' A' ' 330' ' ' LEU . 14.0 m-85 -93.48 38.87 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.848 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 328' ' ' GLU . . . . . 0.488 ' CD ' ' N ' ' A' ' 329' ' ' GLY . 3.9 tp10 -72.41 133.12 44.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 329' ' ' GLY . . . . . 0.488 ' N ' ' CD ' ' A' ' 328' ' ' GLU . . . 58.31 53.19 47.78 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.484 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 327' ' ' PHE . 89.8 mt -148.14 132.6 17.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.884 0.373 . . . . 0.0 110.941 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -109.62 132.99 53.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.959 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -126.05 140.82 52.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.852 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -119.97 115.36 23.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.889 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 8.1 mt -89.08 145.57 25.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -98.87 -179.65 4.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -81.96 -17.96 45.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -79.3 -45.07 20.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.845 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 2.0 m -83.95 150.16 57.99 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.617 0.722 . . . . 0.0 111.18 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 339' ' ' PRO . . . . . 0.727 ' O ' HD12 ' A' ' 343' ' ' LEU . 53.4 Cg_endo -69.79 137.69 35.96 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.712 2.275 . . . . 0.0 112.342 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 344' ' ' ALA . 0.0 OUTLIER -105.62 -34.73 7.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.905 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -50.91 -41.61 58.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -81.5 -48.41 11.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.083 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 343' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 339' ' ' PRO . 75.7 mt -67.15 -65.67 0.65 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -38.09 -45.23 0.9 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.08 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -68.33 -44.77 74.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 25.8 mt -61.8 -63.03 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.104 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 28.1 mt -51.4 -43.01 29.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -67.63 -33.99 76.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 17.7 t -72.23 -44.05 63.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 350' ' ' PHE . . . . . 0.523 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 14.2 m-85 -72.68 1.16 8.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 81.42 54.78 3.4 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.499 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -129.19 153.42 19.83 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.461 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -91.81 126.36 36.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.926 0.393 . . . . 0.0 110.846 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 6.5 p -139.99 137.92 38.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.046 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 355' ' ' SER . . . . . 0.548 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 29.4 t -136.18 160.77 37.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 31.8 p90 -135.41 -175.37 3.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.925 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.719 ' HB2' HD12 ' A' ' 360' ' ' LEU . 12.5 m-20 -78.08 113.22 15.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 357' ' ' ASP . 1.3 mppt? -38.31 -56.2 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 17.7 t -44.88 -50.11 10.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.719 HD12 ' HB2' ' A' ' 357' ' ' ASP . 29.1 mt -57.02 -35.68 69.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.944 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 1.9 t -174.64 156.61 2.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 10.6 tt -81.36 163.23 3.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 111.16 -33.57 5.79 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.467 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -40.47 147.14 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 0.0 111.143 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.479 ' HG1' ' HD2' ' A' ' 366' ' ' TYR . 42.8 p -110.92 -58.97 2.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.094 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 366' ' ' TYR . . . . . 0.548 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 18.7 p90 -111.51 146.36 37.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.905 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -86.47 165.51 16.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.838 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 13.7 p -56.73 -30.83 33.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.125 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 73.2 p -67.15 -25.84 66.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.211 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -56.69 103.65 0.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 53.9 m -54.7 -26.85 36.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -46.13 -40.11 10.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 68.4 mt -44.92 120.98 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 71.2 p -89.17 -50.58 6.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.142 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -120.7 146.69 46.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.829 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -131.44 102.7 6.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 377' ' ' ILE . . . . . 0.632 HD13 HG23 ' A' ' 393' ' ' VAL . 31.8 mm -71.59 130.18 35.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.147 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 22.1 m -143.01 164.2 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.157 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 380' ' ' ARG . 0.4 OUTLIER -57.95 -48.45 79.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.472 ' N ' ' OD1' ' A' ' 379' ' ' ASP . 53.4 mtm-85 -145.78 104.96 4.22 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.637 0.732 . . . . 0.0 110.861 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -0.05 6.31 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.694 2.262 . . . . 0.0 112.377 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -103.67 -34.78 3.71 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.528 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -71.23 -71.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.726 0.298 . . . . 0.0 110.861 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -61.85 143.6 56.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 96.5 m -69.05 128.95 38.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 9.2 p -80.9 166.02 21.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' VAL . . . . . 0.46 HG23 ' OH ' ' A' ' 392' ' ' TYR . 97.5 t -94.73 108.7 21.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.752 ' H ' HD12 ' A' ' 388' ' ' ILE . 5.3 mp -36.32 102.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.148 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 125.2 -44.84 1.22 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.463 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 11.6 ttm-85 -78.9 160.51 27.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 110.852 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 73.6 m -119.21 115.81 24.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' TYR . . . . . 0.46 ' OH ' HG23 ' A' ' 387' ' ' VAL . 7.4 m-85 -96.0 136.04 36.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.632 HG23 HD13 ' A' ' 377' ' ' ILE . 17.8 m -139.47 153.11 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.13 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -68.81 159.24 83.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.57 0.7 . . . . 0.0 110.912 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -8.02 22.54 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.677 2.251 . . . . 0.0 112.398 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -81.22 -20.8 40.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 70.3 t90 -60.55 -43.05 97.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.99 -55.9 20.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.161 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -51.8 -35.62 44.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -76.4 -38.99 54.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.829 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 36.8 m -64.3 -48.23 76.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.815 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.523 ' HB ' ' CZ ' ' A' ' 350' ' ' PHE . 22.3 m -61.11 -46.22 97.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.104 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 403' ' ' ASN . . . . . 0.493 ' N ' HG23 ' A' ' 402' ' ' VAL . 41.5 t30 -62.13 -42.76 99.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -83.38 0.39 46.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 44.07 41.94 4.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.565 HD13 ' N ' ' A' ' 407' ' ' LEU . 0.4 OUTLIER -163.3 131.53 3.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.565 ' N ' HD13 ' A' ' 406' ' ' LEU . 71.4 mt -61.15 103.13 0.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 35.0 mt -70.4 154.2 94.62 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.592 0.71 . . . . 0.0 110.878 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 105.28 1.45 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.711 2.274 . . . . 0.0 112.343 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 32.7 m -51.58 -23.97 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.157 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -49.41 -34.52 16.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.094 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -74.37 -40.53 62.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -91.07 40.1 1.01 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 34.2 t80 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.88 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 24.8 m -141.05 135.95 31.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.394 . . . . 0.0 110.857 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 61.8 p -132.89 133.57 43.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.848 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 62.55 95.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.507 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 18.9 p -91.53 50.17 1.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.361 . . . . 0.0 110.843 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 57.1 p -167.56 121.74 0.98 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 166.94 120.75 0.53 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.479 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -62.63 130.03 43.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.421 ' O ' ' CG ' ' A' ' 323' ' ' HIS . 0.2 OUTLIER -55.26 109.19 0.5 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.843 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 39.6 tttm -171.56 125.74 0.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 59.5 mmtt -135.11 123.2 22.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.923 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 2.4 tt -39.65 -48.08 2.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -96.87 42.0 1.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -80.53 107.12 13.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 90.31 43.82 4.85 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.493 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.45 HD11 HD11 ' A' ' 407' ' ' LEU . 96.6 mt -144.43 129.27 18.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.83 0.348 . . . . 0.0 110.959 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.417 ' CE ' ' HB3' ' A' ' 372' ' ' ARG . 19.7 mttm -96.79 143.57 27.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -134.33 144.09 48.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -129.57 116.72 19.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.542 HD11 HG21 ' A' ' 354' ' ' VAL . 5.4 mt -97.33 147.68 23.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.969 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -110.35 154.52 23.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -52.48 -36.63 55.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -56.62 -47.8 78.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.0 m -88.94 148.61 41.62 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.575 0.703 . . . . 0.0 111.142 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 339' ' ' PRO . . . . . 0.563 ' O ' HD12 ' A' ' 343' ' ' LEU . 54.2 Cg_endo -69.76 125.04 11.68 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.713 2.276 . . . . 0.0 112.343 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 344' ' ' ALA . 0.3 OUTLIER -95.07 -40.99 9.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.857 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' A' ' 342' ' ' ALA . 8.1 pt-20 -42.37 -42.89 3.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.431 ' N ' ' HG3' ' A' ' 341' ' ' GLU . . . -76.64 -46.7 24.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 343' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 339' ' ' PRO . 24.2 mt -71.02 -66.34 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.939 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -34.65 -46.08 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.117 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -65.2 -43.33 91.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.926 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 346' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 343' ' ' LEU . 15.9 mt -62.7 -67.23 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.121 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 17.6 mt -42.34 -40.26 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 -72.77 -41.83 64.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 33.7 t -60.28 -33.18 71.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' PHE . . . . . 0.67 ' CZ ' HG13 ' A' ' 402' ' ' VAL . 22.8 m-85 -92.55 14.85 15.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.907 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 63.61 55.81 23.0 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.439 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -120.98 179.72 16.27 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.499 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -113.8 125.01 53.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 0.0 110.913 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.542 HG21 HD11 ' A' ' 334' ' ' LEU . 6.9 p -141.79 134.18 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 16.3 t -131.26 158.44 40.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.835 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 41.3 p90 -136.13 178.46 7.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.945 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 358' ' ' LYS . 0.6 OUTLIER -72.24 106.68 4.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.869 179.888 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 357' ' ' ASP . 0.1 OUTLIER -37.84 -45.61 0.86 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.918 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 58.8 m -42.09 -46.39 4.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 31.4 mt -60.01 -50.7 72.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 6.2 t -166.43 161.78 16.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 34.8 pt -64.21 175.34 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 364' ' ' ALA . . . 103.51 -35.07 5.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.508 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 363' ' ' GLY . . . -35.63 139.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.364 . . . . 0.0 111.087 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 37.2 p -113.37 -52.87 2.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.16 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -128.3 145.9 50.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.947 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -74.28 172.58 11.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.879 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 14.0 p -73.36 -14.12 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.135 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 41.3 p -96.94 19.65 12.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.144 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -95.79 105.95 18.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.832 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 8.4 t -47.05 -32.98 4.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' ARG . . . . . 0.417 ' HB3' ' CE ' ' A' ' 331' ' ' LYS . 9.0 mmt180 -41.95 -43.43 3.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.862 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 94.0 mt -49.62 135.9 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.112 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 77.2 p -106.21 -39.43 5.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.123 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -128.83 122.11 29.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.81 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -105.2 112.69 25.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 377' ' ' ILE . . . . . 0.467 HD13 HG23 ' A' ' 393' ' ' VAL . 49.6 mm -86.13 117.56 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.121 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 29.3 m -136.29 178.2 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.195 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -82.34 -43.91 16.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -125.51 82.2 63.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.573 0.702 . . . . 0.0 110.917 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -14.83 36.71 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.648 2.232 . . . . 0.0 112.354 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -72.78 -54.19 7.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.455 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -99.04 41.48 1.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.74 0.305 . . . . 0.0 110.893 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 385' ' ' THR . 4.3 tp-100 -122.76 100.86 7.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.969 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 385' ' ' THR . . . . . 0.415 ' C ' ' O ' ' A' ' 384' ' ' GLN . 31.3 m -36.59 122.77 0.79 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.114 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 34.4 p -102.73 -179.64 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 59.7 t -130.93 141.05 47.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.093 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.6 mt -42.2 113.89 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.133 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 104.27 -44.72 1.42 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.503 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 25.2 ttp180 -81.11 139.81 35.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.817 0.341 . . . . 0.0 110.861 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 61.8 m -127.38 125.6 40.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' TYR . . . . . 0.407 ' CE2' ' HG3' ' A' ' 384' ' ' GLN . 2.8 m-85 -85.86 137.19 32.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.932 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.467 HG23 HD13 ' A' ' 377' ' ' ILE . 23.4 m -142.34 164.46 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.119 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -79.04 160.79 70.49 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.567 0.699 . . . . 0.0 110.93 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 -4.83 14.79 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.669 2.246 . . . . 0.0 112.383 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -79.27 -34.22 42.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -50.7 -35.69 32.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.923 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 44.1 t -65.66 -51.57 61.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.107 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -57.27 -36.92 71.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.882 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.456 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 11.2 m-20 -73.8 -40.39 63.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.853 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 1.9 m -72.55 -23.28 60.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.831 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.67 HG13 ' CZ ' ' A' ' 350' ' ' PHE . 2.2 t -87.25 -31.13 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.14 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -85.37 -24.76 27.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -95.52 8.97 41.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.066 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 405' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 404' ' ' ALA . 10.2 mmt85 37.15 42.72 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.877 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 21.2 tp -166.69 142.22 4.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.94 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.45 HD11 HD11 ' A' ' 330' ' ' LEU . 13.0 mt -69.19 102.87 1.78 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.456 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 17.8 mt -73.68 154.29 89.42 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.593 0.711 . . . . 0.0 110.912 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 108.4 2.06 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.714 2.276 . . . . 0.0 112.319 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.407 ' HB ' HG11 ' A' ' 393' ' ' VAL . 28.0 m -53.52 -25.36 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.164 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -53.45 -16.16 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.074 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -95.03 -22.4 17.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.868 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -111.81 36.0 3.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.935 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 2.2 t80 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.921 -179.977 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 80.7 p -99.93 -58.28 1.95 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.921 0.391 . . . . 0.0 110.839 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 65.0 m -58.36 177.24 0.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.862 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 161.9 65.95 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.456 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 21.0 t -170.73 139.54 1.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.356 . . . . 0.0 110.883 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 321' ' ' GLY . 32.6 m -140.37 170.97 14.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.828 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 321' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 320' ' ' SER . . . 37.28 82.38 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.479 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.94 152.24 1.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 0.0 110.893 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -75.38 170.53 15.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -142.5 135.45 28.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.942 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -130.92 144.77 51.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.876 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 7.5 tp -65.15 -38.65 91.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -105.87 30.16 6.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -54.1 113.84 1.39 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 78.73 -45.35 2.68 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.517 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.432 HD22 ' CE1' ' A' ' 375' ' ' HIS . 15.8 mt -39.6 130.34 1.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.872 0.368 . . . . 0.0 110.912 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -98.97 152.14 20.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -144.65 148.38 34.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -135.59 116.69 14.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.915 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.662 HD22 HD13 ' A' ' 343' ' ' LEU . 2.6 mt -94.42 139.97 30.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -88.97 171.15 10.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.447 ' CB ' HD11 ' A' ' 360' ' ' LEU . 28.9 ptt180 -77.47 -9.89 59.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.845 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -87.31 -42.84 12.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 5.7 m -84.92 150.97 56.86 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.637 0.732 . . . . 0.0 111.105 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 339' ' ' PRO . . . . . 0.572 ' O ' HD12 ' A' ' 343' ' ' LEU . 53.9 Cg_endo -69.8 115.34 4.05 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.681 2.254 . . . . 0.0 112.307 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -94.56 -39.7 10.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -40.2 -36.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -86.66 -49.22 7.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.106 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 343' ' ' LEU . . . . . 0.662 HD13 HD22 ' A' ' 334' ' ' LEU . 30.8 mt -60.29 -61.78 2.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.945 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -38.73 -62.64 0.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.098 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -48.85 -42.01 34.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 346' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 347' ' ' ILE . 23.3 mt -65.81 -72.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.122 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 347' ' ' ILE . . . . . 0.46 ' N ' HG22 ' A' ' 346' ' ' ILE . 27.5 mt -38.95 -44.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.153 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -66.78 -42.68 85.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 8.9 t -65.74 -28.48 69.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.849 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 350' ' ' PHE . . . . . 0.474 ' CZ ' HG12 ' A' ' 402' ' ' VAL . 18.5 m-85 -88.6 12.85 13.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.835 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 68.93 50.65 33.6 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.488 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -132.35 156.55 22.08 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.434 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -91.52 132.39 36.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.909 0.385 . . . . 0.0 110.911 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.457 HG21 HD11 ' A' ' 334' ' ' LEU . 7.1 p -140.24 142.8 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.157 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 26.3 t -137.05 159.85 40.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -139.65 174.42 10.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.5 119.13 4.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.887 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.43 -8.72 14.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 4.3 t -88.64 -23.41 23.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.836 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.447 HD11 ' CB ' ' A' ' 336' ' ' ARG . 12.5 mt -75.38 -51.02 14.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 2.7 t -162.48 164.66 26.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.865 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.6 pt -62.47 172.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.137 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 364' ' ' ALA . . . 105.95 -42.87 1.8 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.49 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 363' ' ' GLY . . . -35.3 124.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.893 0.378 . . . . 0.0 111.106 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 41.5 p -97.15 -65.17 0.98 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.152 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -109.61 158.74 17.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 370' ' ' ASP . 3.0 m-20 -83.23 167.97 17.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.914 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.08 -28.77 37.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.108 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 60.8 p -83.0 20.42 1.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.167 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 367' ' ' ASP . 2.8 m-20 -92.36 98.92 11.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 372' ' ' ARG . 16.6 t -43.16 -42.65 4.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.841 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 372' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 371' ' ' SER . 48.2 mtp180 -37.45 -41.46 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 78.4 mt -45.92 123.72 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 70.4 p -84.69 -45.1 12.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.14 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 375' ' ' HIS . . . . . 0.524 ' CD2' ' SG ' ' A' ' 391' ' ' CYS . 51.5 m80 -133.05 141.58 48.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.911 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -123.62 116.71 23.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 49.6 mm -82.42 127.78 39.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.144 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 15.4 m -140.24 172.65 11.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.103 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -90.47 -42.97 10.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.798 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 11.5 ptt-85 -121.22 81.2 36.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.568 0.699 . . . . 0.0 110.846 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 3.07 3.01 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.661 2.241 . . . . 0.0 112.325 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -97.3 -28.14 8.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.477 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -77.28 -71.33 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.787 0.327 . . . . 0.0 110.896 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.718 ' NE2' ' CE2' ' A' ' 392' ' ' TYR . 0.0 OUTLIER -57.34 120.78 8.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 66.5 p -58.85 140.67 54.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.156 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 27.8 p -68.32 161.12 28.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 388' ' ' ILE . 42.0 t -120.96 121.44 65.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.082 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.422 ' C ' ' O ' ' A' ' 387' ' ' VAL . 10.0 mt -36.17 132.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.124 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 86.48 -48.65 3.94 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.457 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -85.88 138.49 31.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.324 . . . . 0.0 110.901 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' CYS . . . . . 0.524 ' SG ' ' CD2' ' A' ' 375' ' ' HIS . 6.3 p -118.65 129.73 55.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 392' ' ' TYR . . . . . 0.718 ' CE2' ' NE2' ' A' ' 384' ' ' GLN . 7.8 m-85 -98.23 126.76 43.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.633 HG11 ' HB ' ' A' ' 410' ' ' VAL . 34.4 m -136.08 146.92 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.075 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -61.67 161.14 22.11 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.632 0.729 . . . . 0.0 110.859 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.459 ' HB3' HD11 ' A' ' 343' ' ' LEU . 54.2 Cg_endo -69.75 -10.47 28.66 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.705 2.27 . . . . 0.0 112.335 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -76.02 -26.42 56.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 85.6 t90 -56.82 -23.58 44.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.898 ' O ' HG22 ' A' ' 402' ' ' VAL . 3.9 t -87.83 -53.87 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -50.24 -33.54 19.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -79.56 -51.21 9.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 69.9 m -54.4 -51.45 64.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.898 HG22 ' O ' ' A' ' 398' ' ' VAL . 5.3 m -54.79 -44.24 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.13 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -69.84 -35.26 74.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.848 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -87.98 9.01 23.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 39.13 38.3 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.936 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.468 HD23 ' C ' ' A' ' 406' ' ' LEU . 1.0 OUTLIER -153.68 153.5 32.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.941 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 29.1 mt -85.78 93.59 8.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.11 152.88 76.62 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.73 . . . . 0.0 110.896 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 116.28 4.49 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.642 2.228 . . . . 0.0 112.356 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.633 ' HB ' HG11 ' A' ' 393' ' ' VAL . 32.2 m -60.19 -19.74 18.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -63.01 -21.38 66.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.066 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -86.98 -17.27 33.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.937 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -115.49 42.68 2.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 41.7 t80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.812 -179.963 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 316' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 315' ' ' GLY . 87.4 p 34.43 41.9 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 3.5 t -163.69 160.52 22.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.858 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 164.2 55.34 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.465 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.1 m -102.95 104.14 14.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.909 0.385 . . . . 0.0 110.812 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 58.7 m -76.32 168.49 19.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -158.43 175.62 35.52 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.534 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -152.95 138.48 17.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.787 0.327 . . . . 0.0 110.898 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -147.07 162.45 38.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.851 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -103.0 118.42 36.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.929 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm -82.79 133.84 35.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.91 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.459 ' CD1' ' HA ' ' A' ' 405' ' ' ARG . 2.1 tt -53.03 -40.92 64.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.934 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -101.63 40.53 1.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -79.14 123.76 27.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.935 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 70.8 50.41 24.53 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.497 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 72.5 mt -142.91 162.28 35.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.86 0.362 . . . . 0.0 110.934 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -131.07 123.16 28.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.93 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.534 ' CD1' ' HB2' ' A' ' 375' ' ' HIS . 78.6 m-85 -119.42 147.49 44.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -132.31 119.91 21.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.817 HD22 HD13 ' A' ' 343' ' ' LEU . 3.6 mt -99.13 148.46 24.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -104.28 175.51 5.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.673 ' HB3' HD11 ' A' ' 360' ' ' LEU . 30.8 ptt180 -71.27 -31.86 68.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.842 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -63.58 -45.42 90.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 2.9 m -82.17 149.61 62.7 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.642 0.735 . . . . 0.0 111.135 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 339' ' ' PRO . . . . . 0.412 ' O ' HD12 ' A' ' 343' ' ' LEU . 54.1 Cg_endo -69.76 111.82 2.91 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.688 2.259 . . . . 0.0 112.363 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 0.448 ' O ' ' C ' ' A' ' 341' ' ' GLU . 26.1 ttp85 -78.45 -49.13 14.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 340' ' ' ARG . 1.2 mt-10 -33.59 -69.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.894 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -57.76 -64.04 1.04 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.128 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 343' ' ' LEU . . . . . 0.817 HD13 HD22 ' A' ' 334' ' ' LEU . 29.2 mt -42.08 -70.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 343' ' ' LEU . . . -36.98 -66.53 0.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.096 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -44.01 -49.18 8.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 28.7 mt -57.76 -67.67 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.123 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 29.2 mt -42.48 -44.64 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.164 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 348' ' ' ARG . . . . . 0.411 ' NH1' ' HB3' ' A' ' 348' ' ' ARG . 10.3 mtp-105 -65.1 -49.23 70.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 13.2 t -57.26 -21.08 31.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -102.2 22.75 12.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 55.96 50.29 62.23 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.513 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -122.39 163.12 15.91 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.523 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -101.96 126.5 48.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 110.895 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.758 HG21 HD11 ' A' ' 334' ' ' LEU . 6.7 p -138.94 138.64 41.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.119 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 355' ' ' SER . . . . . 0.445 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 7.4 t -131.23 161.63 31.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -139.34 174.64 10.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.511 ' HB3' HD12 ' A' ' 360' ' ' LEU . 28.4 t0 -64.24 107.55 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.852 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -42.39 -44.21 3.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 5.4 t -53.57 -52.34 60.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.673 HD11 ' HB3' ' A' ' 336' ' ' ARG . 41.7 mt -48.63 -51.09 29.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 2.7 m -158.41 166.08 33.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 20.9 tt -80.54 151.97 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 125.41 -36.61 2.74 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -40.81 145.88 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.868 0.366 . . . . 0.0 111.097 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.501 ' OG1' ' CD2' ' A' ' 366' ' ' TYR . 80.8 p -110.16 -64.25 1.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 366' ' ' TYR . . . . . 0.501 ' CD2' ' OG1' ' A' ' 365' ' ' THR . 2.2 p90 -106.55 159.07 16.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.17 168.22 19.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.892 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' VAL . . . . . 0.438 ' O ' HG22 ' A' ' 368' ' ' VAL . 8.2 p -76.26 -3.17 4.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.163 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 73.7 p -108.08 19.76 19.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.17 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -92.94 105.9 17.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.84 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 372' ' ' ARG . 75.3 m -41.12 -42.3 1.98 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.814 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 372' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 371' ' ' SER . 62.4 mtt180 -35.75 -44.0 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 85.6 mt -44.54 130.66 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 33.6 p -103.6 -33.1 9.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.126 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 375' ' ' HIS . . . . . 0.534 ' HB2' ' CD1' ' A' ' 332' ' ' PHE . 24.7 m80 -138.58 124.13 19.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.806 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -112.73 94.6 4.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 377' ' ' ILE . . . . . 0.588 HD13 HG23 ' A' ' 393' ' ' VAL . 16.1 mm -63.45 120.64 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.19 164.58 31.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.158 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -77.08 -44.77 29.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 27.3 mmm-85 -124.07 82.79 56.22 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.63 0.729 . . . . 0.0 110.847 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -14.0 35.55 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.676 2.25 . . . . 0.0 112.341 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -79.58 -32.89 36.22 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.515 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 384' ' ' GLN . 7.1 mm100 -84.98 -55.22 4.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.786 0.327 . . . . 0.0 110.91 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 383' ' ' GLN . 30.5 mm-40 -37.47 140.0 0.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 23.5 m -78.0 91.07 4.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.142 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 94.1 p -44.18 156.4 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.84 127.08 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.134 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 18.7 mm -39.99 129.27 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.12 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 91.97 -40.22 2.93 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.549 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -91.27 146.53 23.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.792 0.33 . . . . 0.0 110.881 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 18.4 m -124.17 124.06 41.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -90.22 125.49 35.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.588 HG23 HD13 ' A' ' 377' ' ' ILE . 15.2 m -130.59 167.41 25.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.127 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -88.21 161.05 44.44 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.614 0.721 . . . . 0.0 110.876 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.477 ' HB3' HD11 ' A' ' 343' ' ' LEU . 53.7 Cg_endo -69.79 -5.33 15.98 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.646 2.231 . . . . 0.0 112.353 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 -81.03 -23.68 38.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -62.53 -35.65 80.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.917 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.676 ' O ' HG22 ' A' ' 402' ' ' VAL . 65.7 t -66.68 -61.6 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.132 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 7.9 m-30 -48.14 -31.64 5.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.449 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 3.0 m-20 -76.85 -41.97 41.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 50.6 m -65.9 -52.37 50.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.824 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 398' ' ' VAL . 4.5 m -54.59 -33.43 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.174 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -87.43 -18.29 30.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.849 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -102.93 9.26 38.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.108 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' ARG . . . . . 0.459 ' HA ' ' CD1' ' A' ' 326' ' ' LEU . 9.7 mpt_? 39.59 30.38 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 13.0 tp -149.19 164.2 35.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 408' ' ' LEU . 94.2 mt -97.61 68.12 2.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.449 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 27.9 mt -35.41 153.33 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.564 0.697 . . . . 0.0 110.94 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 114.84 3.83 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.701 2.267 . . . . 0.0 112.399 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.8 m -53.5 -22.17 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.124 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -54.22 -42.96 70.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.086 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -70.09 -8.15 47.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -127.32 43.91 3.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.988 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 91.6 t80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.864 -179.936 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 49.8 m -41.99 156.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 0.0 110.899 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 8.4 t -58.06 105.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -167.5 153.05 22.18 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.518 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 26.3 m -54.53 119.15 4.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 110.873 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 98.7 p -88.51 96.68 10.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.871 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -100.51 143.73 16.43 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.497 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -87.58 131.42 34.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.767 0.318 . . . . 0.0 110.913 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -136.45 151.05 49.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.868 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -103.68 100.4 10.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -82.65 150.79 26.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.02 -44.12 94.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -103.46 40.0 1.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -76.06 130.32 38.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 62.84 50.46 63.62 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.502 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 82.5 mt -146.08 120.27 9.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.842 0.353 . . . . 0.0 110.905 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -95.1 120.62 35.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -112.43 159.42 18.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 333' ' ' PHE . . . . . 0.464 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 35.4 t80 -141.69 116.71 9.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.872 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.775 HD22 HD13 ' A' ' 343' ' ' LEU . 3.8 mt -94.05 148.77 21.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.927 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -96.16 179.25 5.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.588 ' HB3' HD11 ' A' ' 360' ' ' LEU . 18.4 ptt85 -73.69 -39.88 64.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.4 -49.3 76.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.1 m -69.24 150.39 97.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.65 0.738 . . . . 0.0 111.14 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 122.16 8.85 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.701 2.268 . . . . 0.0 112.341 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' A' ' 344' ' ' ALA . 5.5 tmm_? -89.6 -37.4 14.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -60.02 -38.55 83.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.934 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.82 -59.65 2.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.087 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 343' ' ' LEU . . . . . 0.775 HD13 HD22 ' A' ' 334' ' ' LEU . 51.5 mt -56.44 -59.2 5.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 340' ' ' ARG . . . -43.96 -56.89 3.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -54.11 -42.9 69.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.832 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 346' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 347' ' ' ILE . 17.1 mt -66.92 -70.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.117 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 347' ' ' ILE . . . . . 0.413 ' N ' HG22 ' A' ' 346' ' ' ILE . 37.7 mt -43.69 -37.25 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.153 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -73.2 -37.2 66.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 7.4 m -72.57 -30.2 64.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' PHE . . . . . 0.52 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 15.3 m-85 -85.87 7.0 25.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.858 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 72.58 59.07 4.63 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.495 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -138.85 156.36 24.24 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.513 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -92.16 133.38 35.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.92 0.39 . . . . 0.0 110.871 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.454 HG21 HD11 ' A' ' 334' ' ' LEU . 7.3 p -143.6 138.7 25.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.126 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 355' ' ' SER . . . . . 0.533 ' HB2' ' CE1' ' A' ' 366' ' ' TYR . 5.1 t -134.05 157.28 46.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.863 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 22.6 p90 -141.03 177.14 8.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.39 111.31 4.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -50.33 -39.7 46.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 28.1 t -48.61 -47.96 39.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.588 HD11 ' HB3' ' A' ' 336' ' ' ARG . 76.0 mt -60.5 -47.03 87.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.904 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 1.8 m -166.64 137.37 3.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 26.1 pt -60.53 168.6 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 113.19 -36.96 3.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.501 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -45.45 166.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.853 0.358 . . . . 0.0 111.109 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.482 ' OG1' ' CD2' ' A' ' 366' ' ' TYR . 71.6 p -116.8 -68.94 0.88 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.12 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 366' ' ' TYR . . . . . 0.533 ' CE1' ' HB2' ' A' ' 355' ' ' SER . 0.9 OUTLIER -101.54 159.96 14.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.957 -179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -86.94 167.26 14.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.866 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' VAL . . . . . 0.464 ' HB ' ' CZ ' ' A' ' 333' ' ' PHE . 11.7 p -69.68 -30.3 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.109 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.5 p -83.49 20.61 1.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.139 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -95.06 121.76 37.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 99.0 p -69.78 -18.68 63.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 27.5 mtt-85 -57.33 -33.32 67.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.865 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 71.4 mt -54.64 144.26 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 25.7 p -104.48 -42.04 5.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.145 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -128.54 133.0 48.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.847 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 376' ' ' GLN . . . . . 0.41 ' CD ' ' CZ ' ' A' ' 392' ' ' TYR . 24.9 tt0 -113.56 104.71 12.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 9.2 mm -77.56 123.04 33.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 18.3 m -135.79 148.48 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.113 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -56.33 -39.01 72.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -148.14 104.98 3.59 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.591 0.71 . . . . 0.0 110.855 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.73 -6.38 18.44 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.69 2.26 . . . . 0.0 112.38 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 382' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 383' ' ' GLN . . . -83.21 -68.69 1.41 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 383' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 382' ' ' GLY . 12.3 mm100 -36.43 -49.64 0.73 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.696 0.284 . . . . 0.0 110.885 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -98.62 143.43 29.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 69.3 p -90.09 127.48 36.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.141 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' SER . . . . . 0.453 ' HB2' ' CD1' ' A' ' 392' ' ' TYR . 90.4 p -62.81 159.25 16.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 88.0 t -90.3 148.52 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.111 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 6.4 mm -54.81 129.42 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.148 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 92.06 -42.44 2.75 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.498 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -85.59 146.04 27.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.765 0.317 . . . . 0.0 110.829 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 81.6 m -113.39 132.06 55.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' TYR . . . . . 0.453 ' CD1' ' HB2' ' A' ' 386' ' ' SER . 3.3 m-85 -104.13 125.3 50.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.59 HG11 ' HB ' ' A' ' 410' ' ' VAL . 6.0 m -131.64 149.7 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -63.49 158.91 55.29 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.656 0.741 . . . . 0.0 110.859 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -6.95 19.85 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.706 2.271 . . . . 0.0 112.342 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -81.39 -26.17 35.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' TRP . . . . . 0.508 ' CE2' HG12 ' A' ' 410' ' ' VAL . 81.8 t90 -54.13 -43.53 70.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.433 ' O ' HG22 ' A' ' 402' ' ' VAL . 85.5 t -65.24 -47.67 86.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.114 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -58.93 -33.19 70.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.538 ' CB ' ' CD1' ' A' ' 408' ' ' LEU . 61.6 m-20 -75.95 -31.24 58.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 26.2 m -72.84 -51.65 17.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.847 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.52 ' HB ' ' CZ ' ' A' ' 350' ' ' PHE . 12.5 m -56.13 -40.5 64.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.094 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -67.36 -40.78 85.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -92.15 14.32 16.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 405' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 404' ' ' ALA . 1.2 mpp_? 34.3 40.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.859 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.763 HD13 ' N ' ' A' ' 407' ' ' LEU . 0.6 OUTLIER -156.63 149.3 23.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.763 ' N ' HD13 ' A' ' 406' ' ' LEU . 50.0 mt -75.69 103.45 5.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.538 ' CD1' ' CB ' ' A' ' 400' ' ' ASP . 12.4 mt -70.8 155.35 93.51 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.587 0.708 . . . . 0.0 110.934 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 105.3 1.46 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.658 2.239 . . . . 0.0 112.362 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.59 ' HB ' HG11 ' A' ' 393' ' ' VAL . 34.5 m -56.07 -16.63 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.135 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.11 93.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -71.18 -12.31 61.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.869 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -119.62 30.31 7.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.888 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 81.2 t80 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.892 179.995 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.469 -0.253 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 28.6 m -151.26 107.17 3.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.893 0.378 . . . . 0.0 110.879 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 33.2 p -55.72 137.15 50.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 45.65 -147.08 2.3 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.492 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 3.6 m -163.16 139.51 7.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.895 0.378 . . . . 0.0 110.864 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 51.6 p -113.29 131.82 55.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.834 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 322' ' ' LYS . . . -135.86 -79.42 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.502 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 321' ' ' GLY . 30.8 mtmt 34.41 47.76 0.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.778 0.323 . . . . 0.0 110.865 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -160.58 134.92 7.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.855 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 39.8 mmtt -60.67 155.6 18.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 36.8 mmtt -121.29 164.32 17.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 2.1 tt -70.01 -49.23 53.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.982 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -106.59 37.82 2.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -57.15 116.07 3.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 329' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 77.68 -50.81 3.31 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.494 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 329' ' ' GLY . 19.3 mt -34.65 127.66 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.886 0.374 . . . . 0.0 110.943 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -104.11 146.77 28.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -138.72 155.12 48.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -137.37 116.61 12.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.855 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.65 HD13 ' HA ' ' A' ' 340' ' ' ARG . 3.0 mt -92.52 144.86 24.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.931 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -89.4 -177.67 5.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.635 ' HB3' HD11 ' A' ' 360' ' ' LEU . 14.0 ptt-85 -80.7 -34.79 34.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -67.16 -42.56 84.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.496 HG12 ' OD2' ' A' ' 379' ' ' ASP . 4.3 m -78.89 150.02 74.68 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.61 0.719 . . . . 0.0 111.145 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 110.95 2.67 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.671 2.248 . . . . 0.0 112.39 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 0.65 ' HA ' HD13 ' A' ' 334' ' ' LEU . 6.2 ppt_? -85.57 -36.11 20.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.449 ' N ' ' HD2' ' A' ' 340' ' ' ARG . 9.3 pt-20 -54.0 -39.41 66.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -79.51 -64.67 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.084 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 32.0 mt -50.07 -60.04 3.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.922 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 340' ' ' ARG . . . -42.4 -56.28 3.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.08 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -54.79 -45.98 74.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.914 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 346' ' ' ILE . . . . . 0.427 ' CG2' HG11 ' A' ' 402' ' ' VAL . 19.8 mt -60.63 -62.35 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.123 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 23.9 mt -51.9 -43.85 36.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.118 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 70.1 mtp85 -67.01 -32.36 73.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.859 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 26.3 t -74.41 -39.58 62.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 350' ' ' PHE . . . . . 0.543 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 20.5 m-85 -75.15 -5.59 45.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.905 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 89.0 55.21 2.16 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.462 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -134.34 163.64 24.61 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.512 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -95.69 126.51 41.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.91 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.428 HG11 ' HA ' ' A' ' 344' ' ' ALA . 12.0 p -142.37 141.13 28.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.15 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 18.2 t -143.99 151.95 40.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 31.7 p90 -129.04 172.92 10.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.919 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -59.29 111.26 1.29 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.447 ' HG2' ' HB3' ' A' ' 364' ' ' ALA . 40.1 mtpt -44.58 -36.77 3.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.4 t -58.1 -50.9 71.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.635 HD11 ' HB3' ' A' ' 336' ' ' ARG . 38.6 mt -48.55 -47.7 39.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.911 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 5.0 t -171.69 145.8 2.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.86 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.3 pt -59.87 166.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.091 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 114.63 -35.21 4.52 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.475 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.447 ' HB3' ' HG2' ' A' ' 358' ' ' LYS . . . -51.99 158.77 0.99 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.872 0.367 . . . . 0.0 111.101 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 6.1 p -115.14 -65.7 1.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.166 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -107.56 152.36 24.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.426 ' O ' HD11 ' A' ' 373' ' ' ILE . 64.0 m-20 -81.35 173.27 12.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.826 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 12.2 p -69.29 -21.19 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.086 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.6 p -87.34 25.22 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.095 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 370' ' ' ASP . . . . . 0.423 ' OD2' ' N ' ' A' ' 367' ' ' ASP . 6.6 m-20 -103.27 104.36 14.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 372' ' ' ARG . 11.8 t -39.92 -42.13 1.29 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 372' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 371' ' ' SER . 24.8 mmt180 -35.67 -45.54 0.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.873 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.426 HD11 ' O ' ' A' ' 367' ' ' ASP . 41.1 mt -46.6 124.97 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.08 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 44.3 p -97.17 -46.61 6.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.165 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -124.32 141.04 52.39 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.881 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -120.8 111.02 17.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 39.6 mm -76.27 124.9 35.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.083 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 34.5 m -145.08 152.33 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.133 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' ASP . . . . . 0.496 ' OD2' HG12 ' A' ' 338' ' ' VAL . 2.9 m-20 -73.37 -37.37 66.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -127.29 86.03 59.62 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.653 0.74 . . . . 0.0 110.891 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 3.22 2.86 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.692 2.261 . . . . 0.0 112.348 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -100.74 -42.8 2.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.52 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -55.13 -68.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.776 0.322 . . . . 0.0 110.956 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.429 ' NE2' ' CD2' ' A' ' 392' ' ' TYR . 4.2 pp0? -63.53 151.67 40.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 98.9 m -89.8 119.87 30.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.185 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 60.6 p -55.15 161.48 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.836 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 71.0 t -108.46 120.36 59.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.141 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 5.0 mt -39.31 104.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.156 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 119.07 -43.18 1.63 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.48 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' ARG . . . . . 0.412 ' NH1' ' HB ' ' A' ' 373' ' ' ILE . 11.8 ttm-85 -80.53 158.19 25.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.741 0.305 . . . . 0.0 110.907 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 55.8 m -126.06 128.88 48.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.891 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' TYR . . . . . 0.429 ' CD2' ' NE2' ' A' ' 384' ' ' GLN . 3.0 m-85 -105.65 132.47 51.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.907 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.469 HG11 ' CG1' ' A' ' 410' ' ' VAL . 14.2 m -143.39 147.38 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.127 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -55.12 156.21 7.71 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.59 0.709 . . . . 0.0 110.952 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -3.93 12.98 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.359 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 41.5 tp60 -85.13 -28.98 25.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.937 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -48.74 -28.14 3.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.865 ' O ' HG22 ' A' ' 402' ' ' VAL . 56.3 t -85.44 -29.58 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.105 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -72.73 -37.2 67.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.906 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.669 ' OD1' HD12 ' A' ' 408' ' ' LEU . 0.8 OUTLIER -84.34 -23.2 30.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.927 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 3.2 m -81.09 -47.85 12.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.865 HG22 ' O ' ' A' ' 398' ' ' VAL . 13.2 m -57.5 -36.88 55.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.156 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -69.9 -34.39 73.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 404' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -95.66 15.08 20.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.081 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 405' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 404' ' ' ALA . 9.9 mmt85 35.89 39.73 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.892 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 27.5 tp -147.89 163.29 37.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 42.1 mt -95.0 81.02 3.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.669 HD12 ' OD1' ' A' ' 400' ' ' ASP . 62.7 mt -47.71 155.67 0.77 Allowed Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.605 0.716 . . . . 0.0 110.916 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 118.07 5.46 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.668 2.245 . . . . 0.0 112.326 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.469 ' CG1' HG11 ' A' ' 393' ' ' VAL . 23.2 m -58.54 -31.28 43.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.144 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -42.88 -52.55 5.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.128 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -59.07 -39.68 82.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.471 ' CZ ' ' OD2' ' A' ' 400' ' ' ASP . 68.6 m-85 -95.21 45.76 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 31.8 t80 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 27.4 p -158.3 145.4 17.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.903 0.382 . . . . 0.0 110.854 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.8 t -128.83 171.87 11.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.816 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 150.79 156.99 7.6 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.488 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 31.8 t -157.34 134.9 10.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.881 0.372 . . . . 0.0 110.848 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 74.0 m -67.06 133.93 50.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.846 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -115.28 161.62 12.74 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.509 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -107.58 39.02 2.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.81 0.338 . . . . 0.0 110.854 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -153.6 122.64 6.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.858 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.95 160.9 0.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -110.91 141.92 43.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.881 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 14.3 tp -42.4 -37.7 1.65 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.888 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -116.96 50.02 1.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -87.87 137.72 32.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 58.11 41.73 94.77 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.491 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 72.5 mt -141.38 120.22 12.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.902 0.382 . . . . 0.0 110.945 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -93.94 117.25 29.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -105.86 158.44 16.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -141.1 119.86 12.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.883 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.684 HD22 HD13 ' A' ' 343' ' ' LEU . 14.6 mt -95.53 142.67 27.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.916 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -100.9 179.32 4.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.867 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.437 ' HG2' ' N ' ' A' ' 337' ' ' GLU . 0.0 OUTLIER -78.24 -29.21 48.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.847 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 337' ' ' GLU . . . . . 0.437 ' N ' ' HG2' ' A' ' 336' ' ' ARG . 20.8 tt0 -72.48 -15.69 61.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 10.6 m -110.02 150.98 42.18 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.636 0.731 . . . . 0.0 111.109 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 115.49 4.11 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.695 2.263 . . . . 0.0 112.354 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 0.429 ' HB3' ' NH1' ' A' ' 340' ' ' ARG . 19.5 ttp-105 -77.04 -69.69 0.51 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 340' ' ' ARG . 8.3 pt-20 -35.07 -44.58 0.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.17 -64.14 0.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.099 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 343' ' ' LEU . . . . . 0.684 HD13 HD22 ' A' ' 334' ' ' LEU . 36.6 mt -59.35 -63.16 1.4 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.903 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 343' ' ' LEU . . . -36.84 -51.86 0.91 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.073 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -59.14 -40.05 84.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 346' ' ' ILE . . . . . 0.767 HD11 ' CE1' ' A' ' 399' ' ' PHE . 27.5 mt -67.24 -64.21 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 24.9 mt -48.08 -41.73 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -68.4 -39.25 81.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 12.1 t -68.17 -22.99 64.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -105.48 22.52 15.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 57.46 63.75 5.01 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.471 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -133.81 155.79 21.97 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.503 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -92.25 130.98 37.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.861 0.362 . . . . 0.0 110.908 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.544 HG21 HD11 ' A' ' 334' ' ' LEU . 7.4 p -146.39 132.2 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 9.6 t -130.06 163.46 26.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 356' ' ' TRP . . . . . 0.406 ' CD1' ' HB2' ' A' ' 364' ' ' ALA . 18.4 p90 -135.04 178.69 6.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.865 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.605 ' HB3' HD12 ' A' ' 360' ' ' LEU . 7.7 t70 -70.94 105.89 3.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 357' ' ' ASP . 70.3 mttt -35.47 -44.15 0.28 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.896 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 28.7 t -58.69 -52.95 63.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.834 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.605 HD12 ' HB3' ' A' ' 357' ' ' ASP . 18.5 mt -50.87 -49.44 59.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 3.0 m -160.35 145.35 14.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.3 pt -72.22 176.72 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 92.82 -15.85 61.7 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.48 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.406 ' HB2' ' CD1' ' A' ' 356' ' ' TRP . . . -56.75 -177.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.908 0.385 . . . . 0.0 111.099 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 72.7 p -131.47 -66.72 0.72 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -117.53 157.0 27.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.433 ' O ' HD11 ' A' ' 373' ' ' ILE . 1.1 m-20 -90.64 168.97 11.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 368' ' ' VAL . . . . . 0.433 ' HA ' ' CD1' ' A' ' 373' ' ' ILE . 9.9 p -66.24 -22.46 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 61.1 p -84.68 26.27 0.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -110.75 109.44 19.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 67.7 m -47.2 -38.23 11.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -40.15 -41.86 1.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 373' ' ' ILE . . . . . 0.433 ' CD1' ' HA ' ' A' ' 368' ' ' VAL . 86.8 mt -41.94 138.65 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.137 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 42.2 p -108.48 -26.82 10.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.15 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -153.44 133.07 13.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.853 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 376' ' ' GLN . . . . . 0.569 ' OE1' HG13 ' A' ' 378' ' ' VAL . 1.0 OUTLIER -112.33 94.06 4.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 30.2 mm -55.78 98.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.121 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.569 HG13 ' OE1' ' A' ' 376' ' ' GLN . 26.8 m -122.02 140.32 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.138 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 379' ' ' ASP . . . . . 0.433 ' OD1' ' C ' ' A' ' 379' ' ' ASP . 4.3 t0 -48.04 -43.39 30.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.901 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -129.45 86.93 54.7 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.635 0.731 . . . . 0.0 110.823 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -9.74 26.83 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.687 2.258 . . . . 0.0 112.365 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -85.4 -39.41 8.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.504 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -73.31 -52.52 13.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.712 0.292 . . . . 0.0 110.91 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -45.51 142.01 2.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 57.9 m -71.15 101.17 2.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.106 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 24.9 p -53.56 167.71 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.817 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 389' ' ' GLY . 81.9 t -130.64 134.58 61.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.131 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.54 HG22 ' O ' ' A' ' 388' ' ' ILE . 15.3 mm -56.98 86.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.09 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 389' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 387' ' ' VAL . . . 135.06 -27.36 3.16 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.506 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -99.96 156.66 17.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.851 0.357 . . . . 0.0 110.855 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 72.3 m -129.73 123.87 32.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -97.37 121.58 39.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 21.8 m -126.83 164.01 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.144 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -87.49 161.36 45.66 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.606 0.717 . . . . 0.0 110.902 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -4.64 14.42 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.706 2.271 . . . . 0.0 112.348 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -82.99 -14.17 54.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -77.73 -13.77 59.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.827 ' O ' HG22 ' A' ' 402' ' ' VAL . 42.1 t -89.18 -41.15 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.154 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 399' ' ' PHE . . . . . 0.767 ' CE1' HD11 ' A' ' 346' ' ' ILE . 47.8 m-85 -71.8 -34.37 69.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.859 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.32 -45.7 53.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.884 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 2.6 m -62.6 -56.25 19.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.827 HG22 ' O ' ' A' ' 398' ' ' VAL . 15.4 m -50.64 -42.54 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -70.62 -37.96 73.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.928 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -89.87 10.73 22.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 405' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 404' ' ' ALA . 46.8 mmm-85 37.21 44.05 0.4 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 28.7 tp -153.69 142.68 21.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 20.4 mt -80.73 73.95 7.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 75.4 mt -40.69 152.35 0.24 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.605 0.717 . . . . 0.0 110.91 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 105.6 1.51 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.688 2.259 . . . . 0.0 112.353 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.8 m -50.78 -22.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.111 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -50.94 -35.83 35.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.122 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -69.39 -38.28 77.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.942 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -90.81 41.57 1.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.908 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 16.5 t80 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.944 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.818 0.342 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 1.9 tt -67.54 -35.14 78.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -112.94 37.28 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -59.81 112.66 1.92 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 83.61 -49.19 4.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.453 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 330' ' ' LEU . 12.5 mt -35.41 129.72 0.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 110.946 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -103.07 130.15 50.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.864 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -121.53 164.46 17.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -143.02 139.22 30.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.43 HD11 HG21 ' A' ' 354' ' ' VAL . 3.5 mt -116.22 146.21 42.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -104.94 169.67 8.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -71.46 -13.28 61.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.837 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -82.97 -45.77 13.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.3 m -84.36 150.6 57.75 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.618 0.723 . . . . 0.0 111.102 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 120.7 7.44 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.658 2.239 . . . . 0.0 112.382 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 5.9 ptt180 -93.78 -38.4 11.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -45.44 -37.59 5.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -86.25 -57.43 3.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.08 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 89.3 mt -54.2 -60.42 3.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -42.11 -64.8 0.53 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.092 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -47.79 -40.69 21.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 347' ' ' ILE . 16.6 mt -66.41 -72.42 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.13 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . 0.451 ' N ' HG22 ' A' ' 346' ' ' ILE . 22.4 mt -40.48 -38.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -67.2 -53.67 28.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 11.0 p -55.03 -36.27 65.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -80.72 11.35 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.857 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 65.96 48.83 62.64 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.536 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -122.13 160.77 16.49 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.476 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -93.57 131.11 39.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.906 0.384 . . . . 0.0 110.886 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.43 HG21 HD11 ' A' ' 334' ' ' LEU . 14.1 p -147.82 134.21 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.144 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . 0.53 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 23.1 t -137.82 158.23 44.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 29.0 p90 -130.44 168.24 17.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.938 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.534 ' CB ' HD12 ' A' ' 360' ' ' LEU . 3.1 t70 -56.57 122.03 11.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.819 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -51.7 -48.44 63.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 40.2 t -57.73 -48.48 79.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.534 HD12 ' CB ' ' A' ' 357' ' ' ASP . 32.6 mt -50.45 -51.18 49.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.93 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 4.7 m -160.23 139.23 10.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 12.6 pt -66.66 156.55 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.131 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 108.49 14.72 15.31 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.486 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -97.82 162.42 13.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.916 0.389 . . . . 0.0 111.067 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 19.5 p -116.22 -68.41 0.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.159 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' TYR . . . . . 0.53 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 9.6 p90 -99.99 147.28 25.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.906 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.97 175.86 9.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.842 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . 0.634 ' O ' HG22 ' A' ' 368' ' ' VAL . 7.9 p -75.26 3.24 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.09 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 74.6 p -112.15 27.54 9.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.121 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -104.69 101.55 11.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 9.7 m -42.66 -35.13 1.03 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.819 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -40.9 -43.68 2.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.817 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 66.1 mt -44.17 125.33 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.148 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 43.0 p -92.84 -45.05 8.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.133 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -127.41 135.84 51.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' GLN . . . . . 0.576 ' NE2' ' CE2' ' A' ' 392' ' ' TYR . 40.6 tt0 -120.33 123.84 44.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 33.0 mm -92.32 133.75 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.153 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 19.4 m -149.99 153.03 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -76.16 -28.94 57.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -134.73 80.85 48.79 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.592 0.711 . . . . 0.0 110.87 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -18.25 37.27 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.678 2.252 . . . . 0.0 112.299 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -77.52 -64.32 2.09 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.488 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -42.3 -57.72 2.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.797 0.332 . . . . 0.0 110.909 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -79.86 129.04 34.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.943 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 70.6 p -63.1 -179.85 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.121 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 25.3 p -110.98 178.87 4.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 49.0 t -125.29 137.97 55.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.107 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.0 mt -44.12 123.34 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.106 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 89.26 -44.29 3.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.561 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -82.16 137.41 34.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.827 0.346 . . . . 0.0 110.889 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 23.5 m -120.61 117.38 27.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . 0.576 ' CE2' ' NE2' ' A' ' 376' ' ' GLN . 9.7 m-85 -80.79 145.64 31.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.942 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 31.3 m -150.56 165.33 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.115 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -78.39 158.18 76.84 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.6 0.715 . . . . 0.0 110.894 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -4.36 13.91 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.675 2.25 . . . . 0.0 112.351 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -86.74 -23.85 25.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -59.82 -33.37 71.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 75.4 t -76.16 -47.2 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.138 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -58.35 -36.5 73.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.866 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.85 -27.38 60.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 40.4 m -76.13 -51.27 12.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 14.8 m -53.5 -41.98 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.157 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -69.27 -34.78 75.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -93.07 3.28 56.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 42.58 44.72 3.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.449 ' HG ' ' N ' ' A' ' 407' ' ' LEU . 18.6 tp -160.86 154.84 22.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.906 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.449 ' N ' ' HG ' ' A' ' 406' ' ' LEU . 97.3 mt -84.9 99.68 11.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.01 154.97 91.43 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.597 0.713 . . . . 0.0 110.902 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 105.73 1.54 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.711 2.274 . . . . 0.0 112.33 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.2 m -53.9 -16.62 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -58.27 -23.85 57.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.103 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -86.0 -31.65 21.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.908 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -102.6 39.85 1.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 43.2 t80 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.825 0.345 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.445 ' O ' HD13 ' A' ' 326' ' ' LEU . 1.3 tm? -54.26 -41.76 69.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -112.89 47.86 1.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -72.87 138.09 46.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.885 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 49.03 60.0 6.44 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.5 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 90.6 mt -150.17 121.39 7.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.823 0.344 . . . . 0.0 110.935 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -99.5 123.36 43.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -115.12 164.09 14.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -138.2 117.03 12.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.864 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.669 HD11 HG21 ' A' ' 354' ' ' VAL . 4.7 mt -93.02 141.38 28.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.92 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -95.81 -177.18 3.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -85.66 -20.84 28.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.831 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -78.6 -18.32 54.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 6.0 m -108.12 150.61 40.66 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.595 0.712 . . . . 0.0 111.126 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 119.22 6.2 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.685 2.257 . . . . 0.0 112.346 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 0.488 ' HG3' HD12 ' A' ' 334' ' ' LEU . 34.3 ttp180 -85.41 -56.78 3.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 340' ' ' ARG . 6.8 pt-20 -36.84 -39.58 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.909 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -79.0 -64.55 1.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.092 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . 0.411 HD21 ' CE2' ' A' ' 399' ' ' PHE . 52.6 mt -57.2 -61.67 2.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.894 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -41.54 -48.65 3.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.125 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -63.59 -48.97 75.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 16.8 mt -55.25 -64.82 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.159 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 32.7 mt -50.42 -47.66 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -64.6 -24.22 67.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 23.2 t -84.52 -29.7 25.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -83.53 -8.99 59.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 93.1 42.63 4.29 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.486 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -122.97 164.34 15.97 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.501 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -93.29 135.04 34.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 110.949 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.669 HG21 HD11 ' A' ' 334' ' ' LEU . 12.6 p -149.88 125.84 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.158 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 2.0 t -128.24 161.18 29.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 41.0 p90 -138.7 171.92 13.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.951 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -67.73 111.17 4.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -42.58 -54.26 4.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.4 t -41.47 -59.61 1.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 9.0 mt -51.65 -50.71 59.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 4.8 m -154.39 141.88 19.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 20.7 pt -73.92 -175.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.15 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 86.43 -15.39 50.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.451 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -63.73 166.3 7.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 0.0 111.105 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 41.0 p -117.32 -70.51 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.169 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -109.52 139.06 44.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.939 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.56 169.76 15.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.83 -19.48 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.153 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 62.7 p -84.44 26.3 0.8 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.14 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -115.05 121.09 42.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.7 t -58.41 -36.12 73.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -38.92 -40.42 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.928 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 49.8 mt -46.34 138.32 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 26.5 p -113.57 -22.85 10.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.15 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -150.26 155.33 39.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' GLN . . . . . 0.467 ' HG2' HG13 ' A' ' 378' ' ' VAL . 17.3 tt0 -135.79 111.88 9.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.95 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . 0.869 HD13 HG23 ' A' ' 393' ' ' VAL . 46.8 mm -82.75 113.74 22.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.155 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . 0.467 HG13 ' HG2' ' A' ' 376' ' ' GLN . 29.2 m -131.34 148.08 32.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.11 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -62.25 -42.93 99.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -131.93 82.19 60.42 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.593 0.711 . . . . 0.0 110.931 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . 0.444 ' HB3' ' CG2' ' A' ' 378' ' ' VAL . 53.5 Cg_endo -69.76 -13.86 35.26 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.686 2.257 . . . . 0.0 112.352 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -73.92 -44.83 29.25 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.522 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . 0.415 ' HG3' ' N ' ' A' ' 384' ' ' GLN . 3.1 pt20 -62.27 -37.34 85.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.737 0.303 . . . . 0.0 110.885 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.415 ' N ' ' HG3' ' A' ' 383' ' ' GLN . 7.8 pt20 -98.34 118.07 34.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 44.7 p -50.49 175.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . 0.518 ' HA ' ' CE1' ' A' ' 392' ' ' TYR . 1.9 t -104.81 178.66 4.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 74.4 t -119.56 136.23 57.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.149 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 5.9 mm -51.21 103.97 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 109.44 -28.34 11.02 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.497 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -105.96 148.77 27.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.787 0.327 . . . . 0.0 110.858 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 63.7 m -125.17 131.29 53.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . 0.518 ' CE1' ' HA ' ' A' ' 386' ' ' SER . 24.9 m-85 -91.43 131.74 36.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.869 HG23 HD13 ' A' ' 377' ' ' ILE . 11.3 m -130.0 166.99 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.107 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -86.73 161.36 47.92 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.603 0.716 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -7.42 21.01 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.684 2.256 . . . . 0.0 112.328 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -80.86 -24.4 38.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.885 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' TRP . . . . . 0.415 ' CH2' HD22 ' A' ' 407' ' ' LEU . 41.5 t90 -59.1 -42.14 89.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.617 ' O ' HG22 ' A' ' 402' ' ' VAL . 96.1 t -67.68 -58.37 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.156 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . 0.411 ' CE2' HD21 ' A' ' 343' ' ' LEU . 59.7 m-85 -52.31 -26.53 12.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.419 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 24.2 t0 -85.07 -49.97 7.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.861 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 15.4 m -56.75 -51.25 69.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.859 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 398' ' ' VAL . 27.7 m -55.53 -40.31 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.147 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . 0.409 ' N ' HG23 ' A' ' 402' ' ' VAL . 18.7 m-20 -80.21 -9.14 59.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -113.14 8.6 18.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 404' ' ' ALA . 1.3 mpt_? 34.42 42.64 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 7.5 tp -162.8 144.28 10.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.868 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 407' ' ' LEU . 12.4 mt -72.6 89.49 1.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.933 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.419 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 35.9 mt -56.62 154.34 17.86 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.569 0.699 . . . . 0.0 110.971 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 108.76 2.15 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.705 2.27 . . . . 0.0 112.348 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.3 m -57.19 -21.71 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.115 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -58.11 -12.0 3.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.105 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.39 -27.89 14.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -108.65 37.01 2.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 5.5 t80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.877 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.84 0.352 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 13.8 tp -49.23 -53.46 21.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.894 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . 0.418 ' HA ' HD12 ' A' ' 330' ' ' LEU . 16.6 m-85 -96.75 41.86 1.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -71.93 138.01 47.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 47.24 51.43 14.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.482 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 327' ' ' PHE . 58.0 mt -139.43 122.18 16.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 0.0 110.924 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -93.98 129.25 40.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.891 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -125.81 152.19 45.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.878 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -131.91 136.01 47.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.5 HD12 ' HG3' ' A' ' 340' ' ' ARG . 8.0 mt -112.46 137.53 50.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -85.7 -178.23 6.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -81.68 -23.4 36.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -77.48 -44.49 28.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.6 m -75.33 149.53 84.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.644 0.735 . . . . 0.0 111.103 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 124.74 11.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.65 2.234 . . . . 0.0 112.334 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 0.5 ' HG3' HD12 ' A' ' 334' ' ' LEU . 19.2 ttp180 -89.82 -60.12 2.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -38.07 -39.57 0.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.46 -60.11 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.084 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 49.4 mt -60.28 -63.42 1.3 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -39.84 -55.07 2.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.129 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -55.63 -44.53 77.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.868 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 18.5 mt -63.13 -67.92 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.129 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 33.5 mt -46.88 -42.42 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.108 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -68.95 -30.2 68.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 29.2 t -78.2 -34.05 49.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.892 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . 0.433 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 14.9 m-85 -83.42 7.62 16.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.857 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 76.36 63.96 2.27 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.55 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -145.42 154.75 26.13 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.516 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -92.57 125.66 37.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.879 0.371 . . . . 0.0 110.883 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.42 HG21 HD11 ' A' ' 334' ' ' LEU . 7.0 p -131.66 140.95 46.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.111 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 32.5 t -132.39 159.29 39.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.847 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' TRP . . . . . 0.434 ' CD1' ' SG ' ' A' ' 361' ' ' CYS . 48.8 p90 -149.48 165.89 30.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.921 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.554 ' HB3' HD12 ' A' ' 360' ' ' LEU . 2.4 t70 -55.06 110.01 0.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.855 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.449 ' CD ' ' HB3' ' A' ' 364' ' ' ALA . 14.2 mmmt -54.86 -35.53 64.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 5.4 t -55.73 -54.96 37.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.554 HD12 ' HB3' ' A' ' 357' ' ' ASP . 14.7 mt -56.11 -45.3 79.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' CYS . . . . . 0.434 ' SG ' ' CD1' ' A' ' 356' ' ' TRP . 0.8 OUTLIER -151.98 135.37 16.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.874 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . 0.529 HD13 ' C ' ' A' ' 362' ' ' ILE . 0.0 OUTLIER -78.89 143.26 12.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 133.06 -29.68 3.17 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.476 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.449 ' HB3' ' CD ' ' A' ' 358' ' ' LYS . . . -46.66 171.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 111.025 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 68.3 p -101.04 -69.81 0.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.138 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' TYR . . . . . 0.41 ' HB2' ' CG ' ' A' ' 370' ' ' ASP . 1.1 p90 -112.27 173.18 6.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -86.36 164.91 16.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.56 -23.44 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.147 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 42.0 p -84.03 25.07 0.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.132 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . 0.41 ' CG ' ' HB2' ' A' ' 366' ' ' TYR . 0.8 OUTLIER -96.12 100.49 12.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.835 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 372' ' ' ARG . 56.0 m -51.72 -41.03 61.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 371' ' ' SER . 23.6 mmt180 -37.7 -40.61 0.43 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.893 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 95.4 mt -41.77 121.35 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.13 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 39.2 p -81.25 -40.31 23.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.191 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -132.77 148.79 52.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' GLN . . . . . 0.485 ' OE1' ' NE ' ' A' ' 390' ' ' ARG . 56.8 tt0 -130.37 115.66 17.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.863 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . 0.55 HD13 HG23 ' A' ' 393' ' ' VAL . 47.0 mm -83.04 127.95 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.114 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 31.0 m -148.69 159.69 6.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.134 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.01 -38.73 35.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.477 ' NH2' ' NE2' ' A' ' 383' ' ' GLN . 42.8 mtp180 -130.26 80.8 69.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.632 0.729 . . . . 0.0 110.917 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -15.55 37.2 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.701 2.267 . . . . 0.0 112.349 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -64.47 -53.85 32.98 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.45 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . 0.477 ' NE2' ' NH2' ' A' ' 380' ' ' ARG . 3.3 pt20 -89.19 30.56 0.96 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.714 0.292 . . . . 0.0 110.89 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -109.05 121.98 46.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.926 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 39.8 m -58.33 87.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 53.3 p -52.22 159.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 96.1 t -129.01 141.27 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.6 mt -51.35 115.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 101.51 -46.34 1.29 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.539 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' ARG . . . . . 0.485 ' NE ' ' OE1' ' A' ' 376' ' ' GLN . 15.4 ttp180 -80.68 144.87 31.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 110.852 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 10.3 m -124.4 134.26 53.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . 0.433 ' CZ ' ' OE1' ' A' ' 376' ' ' GLN . 3.0 m-85 -96.74 116.53 29.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.918 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.55 HG23 HD13 ' A' ' 377' ' ' ILE . 21.0 m -123.93 158.69 29.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.126 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -75.99 158.28 82.5 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.602 0.715 . . . . 0.0 110.919 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -4.16 13.45 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.665 2.244 . . . . 0.0 112.345 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -84.6 -16.33 42.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.962 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 69.1 t90 -65.34 -39.21 92.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.938 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 73.6 t -72.54 -52.76 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -51.2 -37.13 44.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.481 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 1.1 m-20 -73.49 -45.61 52.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 69.2 m -56.67 -58.03 9.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.852 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.456 HG23 ' N ' ' A' ' 403' ' ' ASN . 30.9 m -47.94 -43.58 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.104 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . 0.456 ' N ' HG23 ' A' ' 402' ' ' VAL . 6.6 t30 -66.13 -43.67 86.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -86.53 10.53 15.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.086 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' A' ' 404' ' ' ALA . 3.2 mpt_? 36.56 37.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 15.1 tp -151.49 145.01 24.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.432 ' HA ' HD23 ' A' ' 407' ' ' LEU . 17.6 mt -74.91 89.37 2.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.94 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.481 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 34.8 mt -60.52 154.91 52.57 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.626 0.727 . . . . 0.0 110.913 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 113.47 3.38 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.731 2.287 . . . . 0.0 112.344 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . 0.46 ' HB ' HG11 ' A' ' 393' ' ' VAL . 19.5 m -55.17 -28.25 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.137 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -48.09 -30.33 4.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.136 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -77.76 -35.65 51.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.855 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -106.05 49.66 0.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 42.1 t80 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.838 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.824 0.345 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 12.2 tp -68.79 -50.55 49.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . 0.441 ' HA ' HD12 ' A' ' 330' ' ' LEU . 22.7 m-85 -87.49 31.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -66.09 118.22 9.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.832 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 66.28 49.32 57.94 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 327' ' ' PHE . 67.9 mt -141.21 122.14 14.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.904 0.383 . . . . 0.0 110.914 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -95.54 139.8 31.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.503 ' CD1' ' HB2' ' A' ' 375' ' ' HIS . 80.7 m-85 -133.79 153.57 51.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' PHE . . . . . 0.475 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 9.4 t80 -129.56 117.6 20.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.848 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.635 HD12 ' HG3' ' A' ' 340' ' ' ARG . 12.7 mt -94.68 132.2 39.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.926 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -90.63 165.68 13.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.55 ' HB3' HD11 ' A' ' 360' ' ' LEU . 0.1 OUTLIER -65.15 -30.07 70.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.828 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . 0.457 ' N ' ' HG2' ' A' ' 336' ' ' ARG . 9.1 pt-20 -65.56 -37.41 86.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.0 m -91.01 150.7 42.26 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.633 0.73 . . . . 0.0 111.106 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . 0.437 ' O ' HD12 ' A' ' 343' ' ' LEU . 53.4 Cg_endo -69.79 128.46 16.04 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.683 2.255 . . . . 0.0 112.324 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 0.635 ' HG3' HD12 ' A' ' 334' ' ' LEU . 31.1 ttm180 -92.0 -49.3 6.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.866 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -42.68 -39.61 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -79.97 -65.74 0.97 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.052 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . 0.505 HD13 HD22 ' A' ' 334' ' ' LEU . 68.6 mt -51.79 -62.53 1.57 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -40.74 -59.81 1.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -51.62 -49.14 62.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.843 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 349' ' ' SER . 31.1 mt -57.74 -70.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.136 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . 0.412 ' N ' HG22 ' A' ' 346' ' ' ILE . 28.0 mt -42.26 -52.19 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.105 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 26.5 mtt-85 -64.5 -25.66 68.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.882 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 346' ' ' ILE . 43.4 t -80.12 -30.21 39.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -92.04 14.0 17.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.893 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 70.93 57.47 6.31 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.508 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -135.22 161.04 24.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.512 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -94.81 135.06 36.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.874 0.368 . . . . 0.0 110.869 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.543 HG21 HD11 ' A' ' 334' ' ' LEU . 8.1 p -148.37 133.98 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.169 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 17.3 t -132.42 162.84 30.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' TRP . . . . . 0.534 ' CZ2' ' O ' ' A' ' 363' ' ' GLY . 20.2 p90 -137.4 -176.39 4.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.944 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.436 ' HB2' HD12 ' A' ' 360' ' ' LEU . 0.6 OUTLIER -75.38 118.92 18.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.822 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -58.89 -15.7 13.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 4.5 p -83.04 -27.66 30.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 336' ' ' ARG . 22.7 mt -76.94 -49.65 15.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.96 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 8.2 m -157.86 139.55 13.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 24.3 pt -56.53 155.75 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.534 ' O ' ' CZ2' ' A' ' 356' ' ' TRP . . . 100.52 38.17 3.55 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.486 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -105.47 117.23 33.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 0.0 111.079 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 45.3 p -69.65 -61.0 1.96 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.153 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -126.53 158.37 36.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.22 169.9 11.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . 0.475 ' HB ' ' CZ ' ' A' ' 333' ' ' PHE . 11.5 p -68.01 -10.6 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.106 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 73.4 p -95.6 14.16 23.85 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.12 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . 0.48 ' OD1' ' CG ' ' A' ' 372' ' ' ARG . 4.6 t70 -87.54 107.54 18.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 64.1 p -50.74 -28.47 9.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.842 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . 0.48 ' CG ' ' OD1' ' A' ' 370' ' ' ASP . 17.0 mmm180 -54.03 -30.46 47.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.872 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 87.2 mt -51.53 126.64 6.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.105 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 47.4 p -95.53 -43.0 8.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . 0.503 ' HB2' ' CD1' ' A' ' 332' ' ' PHE . 20.0 m80 -130.11 155.04 46.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' GLN . . . . . 0.577 ' CD ' ' CE2' ' A' ' 392' ' ' TYR . 59.6 tt0 -136.18 115.0 12.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.9 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . 0.411 ' O ' ' CG1' ' A' ' 378' ' ' VAL . 45.3 mm -80.65 136.43 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . 0.411 ' CG1' ' O ' ' A' ' 377' ' ' ILE . 35.4 m -158.01 142.2 7.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.125 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -60.1 -32.67 71.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -128.55 80.92 71.67 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.617 0.722 . . . . 0.0 110.882 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -3.51 12.16 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.674 2.249 . . . . 0.0 112.358 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -106.52 -49.19 0.92 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.487 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -52.93 -73.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.783 0.325 . . . . 0.0 110.915 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -55.38 130.21 41.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.894 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 20.3 p -63.55 131.28 47.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 54.7 p -85.28 149.53 25.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.828 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 388' ' ' ILE . 63.2 t -75.82 114.8 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.104 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.637 ' H ' HD12 ' A' ' 388' ' ' ILE . 2.1 mp -36.17 104.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.134 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 122.26 -45.11 1.24 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 11.1 ttm-85 -76.55 159.45 30.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.8 0.333 . . . . 0.0 110.83 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 19.0 m -122.31 134.85 54.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.937 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . 0.577 ' CE2' ' CD ' ' A' ' 376' ' ' GLN . 2.4 m-85 -112.85 147.55 36.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.944 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 20.8 m -151.25 145.69 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.135 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -61.35 158.36 38.39 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.557 0.694 . . . . 0.0 110.938 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -4.63 14.39 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.378 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -85.95 -19.0 31.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -64.63 -34.03 77.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 80.7 t -71.23 -32.82 48.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.182 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . 0.458 ' O ' HG22 ' A' ' 402' ' ' VAL . 38.4 m-85 -74.85 -60.03 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.873 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -52.93 -17.9 1.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 16.9 m -82.33 -53.21 6.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 399' ' ' PHE . 6.2 m -58.01 -37.54 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.158 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -72.56 -34.66 67.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.957 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 406' ' ' LEU . . . -94.31 9.23 38.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.095 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 404' ' ' ALA . 0.9 OUTLIER 36.95 31.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 404' ' ' ALA . 0.0 OUTLIER -147.27 130.98 16.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 98.1 mt -66.67 85.66 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.946 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 32.0 mt -51.24 155.38 2.37 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.633 0.73 . . . . 0.0 110.882 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 118.82 5.91 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.691 2.261 . . . . 0.0 112.359 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.1 m -64.74 -25.51 38.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.088 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -54.55 -15.32 1.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.103 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -94.42 -30.97 14.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -96.06 33.34 1.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.95 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 16.5 t80 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.85 0.357 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 18.8 tp -59.75 -54.92 40.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -95.18 37.5 1.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -73.03 139.35 46.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 53.72 47.98 62.91 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.493 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 71.9 mt -142.45 122.26 13.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.913 0.387 . . . . 0.0 110.878 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -96.13 126.76 41.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -119.34 152.81 36.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' PHE . . . . . 0.419 ' CD1' ' O ' ' A' ' 355' ' ' SER . 59.0 t80 -131.88 124.85 30.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.914 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.587 HD11 HG21 ' A' ' 354' ' ' VAL . 7.2 mt -101.78 133.15 46.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.969 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -88.74 163.99 15.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.765 ' HB3' HD11 ' A' ' 360' ' ' LEU . 2.0 ptp85 -65.2 -13.36 58.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -85.84 -46.76 10.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 4.1 m -77.94 151.1 78.93 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.652 0.739 . . . . 0.0 111.142 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 127.64 14.93 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.676 2.251 . . . . 0.0 112.36 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 0.565 ' HA ' HD13 ' A' ' 334' ' ' LEU . 0.5 OUTLIER -95.51 -55.05 3.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -39.15 -42.07 0.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -77.5 -51.12 11.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.121 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . 0.434 HD23 ' CE1' ' A' ' 399' ' ' PHE . 87.8 mt -65.16 -64.11 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -38.72 -53.14 1.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -57.54 -47.95 80.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' ILE . . . . . 0.437 HD12 ' HE1' ' A' ' 399' ' ' PHE . 38.0 mt -62.59 -67.95 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.117 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 32.2 mt -44.26 -37.33 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.085 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -77.99 -35.0 50.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 46.7 t -67.62 -29.65 69.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.858 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -94.99 20.45 8.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 64.46 63.56 4.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.519 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -136.72 164.48 25.18 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.512 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -104.15 129.29 51.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.884 0.374 . . . . 0.0 110.868 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.587 HG21 HD11 ' A' ' 334' ' ' LEU . 7.3 p -137.86 138.91 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.12 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . 0.419 ' O ' ' CD1' ' A' ' 333' ' ' PHE . 8.4 t -140.56 149.82 42.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' TRP . . . . . 0.457 ' O ' ' HB1' ' A' ' 364' ' ' ALA . 40.6 p90 -131.7 175.89 8.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.868 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.679 ' HB2' HD12 ' A' ' 360' ' ' LEU . 18.5 m-20 -62.17 114.95 3.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -44.88 -46.3 10.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.3 m -53.26 -51.83 60.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.855 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.765 HD11 ' HB3' ' A' ' 336' ' ' ARG . 21.4 mt -46.56 -49.84 18.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.921 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 1.8 t -168.19 153.33 6.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 36.2 pt -63.32 177.08 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.119 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 94.42 -37.22 3.47 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 356' ' ' TRP . . . -44.63 152.11 0.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.821 0.343 . . . . 0.0 111.121 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 5.1 p -116.2 -65.28 1.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.156 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -111.22 144.93 39.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.943 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -88.7 171.66 9.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.12 -17.35 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 22.6 p -79.24 12.09 2.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.166 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -101.43 140.56 35.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.854 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 372' ' ' ARG . 4.9 t -80.5 -40.52 25.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 371' ' ' SER . 9.0 ptp180 -36.69 -42.68 0.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.922 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.587 HG22 ' HG3' ' A' ' 390' ' ' ARG . 73.4 mt -40.11 136.89 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.146 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 58.1 p -115.22 -24.72 8.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -139.91 143.03 36.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.868 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' GLN . . . . . 0.5 ' OE1' ' N ' ' A' ' 377' ' ' ILE . 0.7 OUTLIER -137.13 108.98 7.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . 0.5 ' N ' ' OE1' ' A' ' 376' ' ' GLN . 5.5 mm -79.39 127.0 39.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.127 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 30.6 m -139.98 155.94 24.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.158 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -81.51 -23.34 37.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.407 ' O ' ' CG ' ' A' ' 383' ' ' GLN . 75.7 mtt180 -130.75 83.0 62.96 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.583 0.706 . . . . 0.0 110.852 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -18.41 36.99 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.651 2.234 . . . . 0.0 112.335 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -67.53 -55.25 15.67 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.468 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . 0.407 ' CG ' ' O ' ' A' ' 380' ' ' ARG . 3.7 pt20 -46.26 -33.85 4.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.763 0.316 . . . . 0.0 110.92 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -84.3 149.97 25.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.36 -70.7 0.71 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.119 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 96.7 p -175.13 164.23 3.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . 0.531 HG23 ' CE1' ' A' ' 392' ' ' TYR . 74.6 t -133.05 153.73 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.145 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.52 ' N ' HD13 ' A' ' 388' ' ' ILE . 3.5 mm -68.66 99.41 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.176 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 92.95 -35.01 4.25 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.482 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' ARG . . . . . 0.587 ' HG3' HG22 ' A' ' 373' ' ' ILE . 8.3 ttm180 -93.0 151.36 19.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.762 0.315 . . . . 0.0 110.888 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' CYS . . . . . 0.424 ' N ' ' HG2' ' A' ' 390' ' ' ARG . 83.3 m -134.18 139.6 45.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . 0.531 ' CE1' HG23 ' A' ' 387' ' ' VAL . 68.0 m-85 -81.38 140.67 34.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.416 ' CG1' ' HB ' ' A' ' 410' ' ' VAL . 12.0 m -150.62 166.66 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.115 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -89.42 159.32 44.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.596 0.712 . . . . 0.0 110.878 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.439 ' HA ' HG21 ' A' ' 377' ' ' ILE . 54.2 Cg_endo -69.7 -3.73 12.56 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.717 2.278 . . . . 0.0 112.379 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -84.91 -31.25 23.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.923 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 69.1 t90 -50.5 -38.44 44.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.08 -61.21 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.074 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . 0.437 ' HE1' HD12 ' A' ' 346' ' ' ILE . 12.3 m-30 -51.7 -29.63 19.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.405 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 19.4 m-20 -73.32 -52.03 15.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 405' ' ' ARG . 14.6 m -58.47 -47.36 84.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.844 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.533 HG23 ' N ' ' A' ' 403' ' ' ASN . 27.3 m -61.24 -46.27 96.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.119 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . 0.533 ' N ' HG23 ' A' ' 402' ' ' VAL . 41.2 t30 -70.07 -8.08 46.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -122.93 0.48 9.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.097 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' A' ' 401' ' ' SER . 0.2 OUTLIER 44.53 32.12 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.642 HD13 ' N ' ' A' ' 407' ' ' LEU . 1.0 OUTLIER -141.94 140.69 32.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.642 ' N ' HD13 ' A' ' 406' ' ' LEU . 12.4 mt -71.77 81.63 0.88 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.405 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 43.0 mt -55.22 155.64 8.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.599 0.714 . . . . 0.0 110.929 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 115.67 4.21 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.685 2.256 . . . . 0.0 112.325 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . 0.416 ' HB ' ' CG1' ' A' ' 393' ' ' VAL . 32.6 m -65.56 -21.39 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.144 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . 0.547 ' HA ' ' CE2' ' A' ' 414' ' ' PHE . . . -64.1 -33.8 76.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.171 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -75.93 1.07 16.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -126.06 41.56 3.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.967 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' PHE . . . . . 0.547 ' CE2' ' HA ' ' A' ' 411' ' ' ALA . 2.5 m-85 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.918 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.759 0.314 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 2.4 tt -59.25 -54.86 42.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.906 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . 0.432 ' HZ ' HG13 ' A' ' 398' ' ' VAL . 18.4 m-85 -91.5 39.37 1.0 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -80.96 106.7 13.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 88.08 43.54 5.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.458 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.568 HD11 HD11 ' A' ' 407' ' ' LEU . 83.5 mt -143.1 124.09 14.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.912 0.387 . . . . 0.0 110.909 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.439 ' HE3' ' CE2' ' A' ' 366' ' ' TYR . 28.3 mtpt -95.41 139.09 32.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.445 ' CD1' ' HB2' ' A' ' 375' ' ' HIS . 88.5 m-85 -135.2 147.32 49.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -130.01 115.31 16.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.655 HD11 HG21 ' A' ' 354' ' ' VAL . 2.6 mt -90.77 148.08 22.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -107.14 176.93 5.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.944 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.457 ' HB3' HD11 ' A' ' 360' ' ' LEU . 8.4 ptp85 -74.79 -22.08 58.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.879 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -72.46 -35.97 68.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.897 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.43 HG11 HG22 ' A' ' 377' ' ' ILE . 3.2 m -95.54 150.87 38.09 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.622 0.725 . . . . 0.0 111.127 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 120.94 7.66 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.664 2.243 . . . . 0.0 112.41 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 0.528 ' HG3' HD12 ' A' ' 334' ' ' LEU . 27.7 ttp85 -87.19 -49.87 6.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.863 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -42.4 -36.77 1.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -83.05 -63.83 1.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.059 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 53.3 mt -53.95 -59.45 4.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -42.74 -60.51 1.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -51.15 -43.07 61.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.842 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' ILE . . . . . 0.505 HG22 ' N ' ' A' ' 347' ' ' ILE . 11.8 mt -63.64 -72.58 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . 0.505 ' N ' HG22 ' A' ' 346' ' ' ILE . 29.8 mt -39.16 -43.6 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.15 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 67.6 mtt-85 -68.51 -36.07 78.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.863 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . 0.481 ' N ' ' O ' ' A' ' 346' ' ' ILE . 29.8 t -69.95 -43.34 71.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . 0.523 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 11.4 m-85 -73.17 -11.23 60.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 91.2 56.58 1.68 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.427 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -132.16 160.55 23.68 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -91.26 125.39 36.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.909 0.385 . . . . 0.0 110.886 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.655 HG21 HD11 ' A' ' 334' ' ' LEU . 12.4 p -137.85 139.56 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.132 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . 0.563 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 42.7 t -136.74 149.34 47.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' TRP . . . . . 0.421 ' CE3' ' HD2' ' A' ' 340' ' ' ARG . 15.1 p90 -129.39 -175.86 3.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.962 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.7 ' HB2' HD12 ' A' ' 360' ' ' LEU . 24.3 m-20 -76.97 105.76 8.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.82 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.514 ' HG2' ' HB3' ' A' ' 364' ' ' ALA . 7.1 mtpm? -38.89 -43.32 0.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.912 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 14.2 t -53.64 -58.73 6.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 357' ' ' ASP . 18.8 mt -50.53 -48.94 57.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.912 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 4.2 m -158.39 130.0 6.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.902 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 14.9 pt -61.14 176.34 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.14 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 107.37 -39.65 2.81 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.45 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.514 ' HB3' ' HG2' ' A' ' 358' ' ' LYS . . . -38.72 158.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.877 0.37 . . . . 0.0 111.084 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 1.2 p -113.46 -45.67 3.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' TYR . . . . . 0.563 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 33.4 p90 -125.43 173.92 8.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.956 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.96 169.34 8.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.863 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 14.0 p -58.85 -31.36 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.111 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 68.1 p -63.6 -16.21 60.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -65.7 99.3 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 372' ' ' ARG . 22.2 t -47.5 -42.11 22.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 371' ' ' SER . 29.9 mmt180 -35.58 -45.25 0.35 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.826 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.436 ' C ' ' O ' ' A' ' 372' ' ' ARG . 77.8 mt -34.45 120.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.131 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 26.7 p -92.32 -44.26 8.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . 0.445 ' HB2' ' CD1' ' A' ' 332' ' ' PHE . 20.1 m80 -129.8 146.25 51.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.799 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -131.1 94.57 3.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.918 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . 0.452 HD13 HG23 ' A' ' 393' ' ' VAL . 49.5 mm -58.61 132.44 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . 0.474 HG11 ' NE2' ' A' ' 384' ' ' GLN . 30.6 m -151.94 156.18 6.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.145 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -68.25 -38.74 82.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -122.71 84.17 49.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.57 0.7 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 94.46 0.53 Allowed 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.7 2.267 . . . . 0.0 112.346 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 152.44 -39.92 0.74 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.516 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -118.26 76.75 1.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.738 0.304 . . . . 0.0 110.923 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.597 ' OE1' ' CD1' ' A' ' 392' ' ' TYR . 0.0 OUTLIER -171.49 105.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . 0.466 ' C ' ' O ' ' A' ' 384' ' ' GLN . 10.5 m 32.9 46.68 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 13.7 p -41.5 149.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 53.8 t -134.14 110.05 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.3 mt -50.0 100.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.127 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 126.09 -42.75 1.45 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -80.25 157.82 26.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.849 0.357 . . . . 0.0 110.862 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 1.8 m -122.73 145.37 48.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.85 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . 0.597 ' CD1' ' OE1' ' A' ' 384' ' ' GLN . 37.7 m-85 -117.98 131.58 56.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.507 HG11 HG12 ' A' ' 410' ' ' VAL . 17.3 m -129.6 155.3 41.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.082 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -72.39 161.37 79.4 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.576 0.703 . . . . 0.0 110.922 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -4.24 13.63 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.702 2.268 . . . . 0.0 112.371 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 -86.26 -16.35 37.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 79.7 t90 -65.72 -34.86 79.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.432 HG13 ' HZ ' ' A' ' 327' ' ' PHE . 88.9 t -81.09 -49.81 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.106 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -51.13 -30.1 15.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.486 ' OD2' HD11 ' A' ' 408' ' ' LEU . 6.5 t70 -85.48 -47.3 10.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 63.7 m -56.45 -47.08 79.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.85 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.523 ' HB ' ' CZ ' ' A' ' 350' ' ' PHE . 23.5 m -50.44 -43.8 23.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.152 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . 0.444 ' N ' HG23 ' A' ' 402' ' ' VAL . 1.2 t30 -74.35 -40.34 62.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -76.86 0.72 19.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.121 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 41.96 44.74 3.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 25.4 tp -165.42 143.71 6.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.955 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.568 HD11 HD11 ' A' ' 330' ' ' LEU . 40.3 mt -69.6 93.94 0.74 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.941 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.486 HD11 ' OD2' ' A' ' 400' ' ' ASP . 65.7 mt -60.4 153.18 61.15 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.6 0.714 . . . . 0.0 110.924 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 114.48 3.72 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.677 2.251 . . . . 0.0 112.347 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . 0.507 HG12 HG11 ' A' ' 393' ' ' VAL . 18.7 m -58.89 -27.4 35.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.09 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -50.17 -29.46 9.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.125 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -78.48 -24.98 45.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -106.6 38.03 2.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.944 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 53.1 t80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 -179.969 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.824 0.345 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 22.4 tp -44.01 -54.06 5.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -98.0 36.78 1.5 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -60.94 116.85 4.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.864 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 76.17 -46.72 2.19 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 329' ' ' GLY . 24.3 mt -37.31 125.94 1.02 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.879 0.371 . . . . 0.0 110.95 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -95.24 144.76 25.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -135.06 153.26 52.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.919 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -140.17 117.11 11.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.64 HD22 HD13 ' A' ' 343' ' ' LEU . 2.8 mt -97.83 149.95 21.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.924 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -107.54 164.01 12.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.9 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.594 ' HB3' HD11 ' A' ' 360' ' ' LEU . 15.1 ptp180 -61.48 -31.1 71.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -41.59 97.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 10.1 m -91.03 150.81 42.43 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.628 0.728 . . . . 0.0 111.116 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 118.61 5.78 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.726 2.284 . . . . 0.0 112.301 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 0.517 ' HA ' HD13 ' A' ' 334' ' ' LEU . 24.3 ptt85 -89.29 -37.25 15.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.84 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -49.82 -42.75 47.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.851 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -74.8 -62.3 1.59 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.061 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . 0.64 HD13 HD22 ' A' ' 334' ' ' LEU . 30.9 mt -53.1 -60.36 3.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.908 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 343' ' ' LEU . . . -37.02 -58.9 0.75 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -53.14 -45.84 68.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 23.0 mt -59.23 -69.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.147 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 20.9 mt -40.1 -57.35 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.097 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -58.41 -45.78 87.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 40.2 t -55.04 -34.81 63.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -98.4 29.26 3.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.894 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 54.98 52.17 48.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.515 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -119.62 154.97 16.27 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.437 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -92.8 138.93 31.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.888 0.375 . . . . 0.0 110.864 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.435 HG21 HD11 ' A' ' 334' ' ' LEU . 7.3 p -154.78 140.33 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.118 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 42.0 t -140.04 144.23 36.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.815 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 40.5 p90 -121.13 174.84 6.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.727 ' HB2' HD12 ' A' ' 360' ' ' LEU . 19.9 m-20 -65.0 104.15 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 357' ' ' ASP . 12.1 ptpt -36.65 -44.87 0.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 11.3 t -51.93 -48.74 64.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.727 HD12 ' HB2' ' A' ' 357' ' ' ASP . 8.8 mt -53.03 -47.48 68.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.894 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 45.5 t -162.33 156.73 21.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 21.2 tt -73.24 160.21 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.112 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 112.8 -27.64 9.58 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.508 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -41.59 148.26 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.85 0.357 . . . . 0.0 111.118 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 26.0 p -108.76 -64.82 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.151 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -117.2 144.42 44.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.871 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.03 174.15 8.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.887 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 7.1 p -69.62 -22.38 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.094 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 82.6 p -86.14 24.52 1.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.137 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -98.36 102.3 14.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.3 t -46.54 -29.31 1.73 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.824 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -47.43 -40.11 17.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.88 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 58.5 mt -40.06 147.48 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.135 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 55.3 p -125.8 -30.71 2.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -147.59 110.22 4.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.868 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' GLN . . . . . 0.416 ' HG2' HG13 ' A' ' 378' ' ' VAL . 20.2 tt0 -96.68 100.98 12.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . 0.421 HD13 HG23 ' A' ' 393' ' ' VAL . 19.1 mm -68.79 113.48 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . 0.416 HG13 ' HG2' ' A' ' 376' ' ' GLN . 18.7 m -126.65 -178.93 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.136 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.55 -40.5 10.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -128.69 80.9 71.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.657 0.742 . . . . 0.0 110.891 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -10.84 29.55 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.657 2.238 . . . . 0.0 112.33 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -85.4 -20.06 57.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.517 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -102.68 -43.8 5.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.778 0.323 . . . . 0.0 110.898 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -44.82 163.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.937 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 71.4 p -87.4 121.52 29.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.178 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 56.2 p -70.54 151.88 44.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.801 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 87.3 t -129.82 114.38 30.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.142 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 8.8 mt -38.08 116.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.118 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 102.68 -44.79 1.44 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.474 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -77.62 158.03 29.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.819 0.343 . . . . 0.0 110.888 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 82.4 m -133.63 132.73 41.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.861 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -106.68 124.65 49.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.427 HG11 ' HB ' ' A' ' 410' ' ' VAL . 19.2 m -135.44 156.86 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.118 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -71.0 158.86 87.26 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.607 0.718 . . . . 0.0 110.898 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -7.74 21.83 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.684 2.256 . . . . 0.0 112.332 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -79.19 -25.37 42.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.936 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' TRP . . . . . 0.516 ' HB2' ' CD2' ' A' ' 413' ' ' TYR . 92.0 t90 -59.44 -28.11 66.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 39.7 t -72.09 -57.55 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.137 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -50.0 -53.8 24.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.448 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 0.8 OUTLIER -54.85 -45.56 74.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 21.5 m -56.58 -66.7 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 26.8 m -47.43 -40.48 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.101 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -69.89 -35.07 74.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -92.08 11.65 24.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 404' ' ' ALA . 2.8 mmm180 38.11 44.24 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.839 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 8.1 tp -165.07 150.59 9.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.929 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 97.1 mt -81.16 80.11 7.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.448 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 49.3 mt -46.04 156.45 0.46 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.562 0.696 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 119.01 6.02 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.653 2.235 . . . . 0.0 112.322 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . 0.427 ' HB ' HG11 ' A' ' 393' ' ' VAL . 35.3 m -64.88 -23.77 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.088 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -53.17 -18.58 2.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -88.73 -33.46 17.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.516 ' CD2' ' HB2' ' A' ' 397' ' ' TRP . 6.4 m-85 -95.3 36.03 1.27 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.902 179.983 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . 0.435 ' HD2' ' C ' ' A' ' 350' ' ' PHE . 9.9 mmtp . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.841 0.353 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 326' ' ' LEU . 0.2 OUTLIER -70.76 -40.45 72.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.933 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -118.06 40.71 3.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -56.94 114.78 2.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 75.23 -47.41 1.98 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.477 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 329' ' ' GLY . 33.0 mt -35.78 125.16 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.884 0.373 . . . . 0.0 110.929 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -101.96 151.13 22.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.928 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -141.94 154.48 45.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' PHE . . . . . 0.518 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 18.8 t80 -130.87 116.6 18.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.413 ' HG ' ' CG2' ' A' ' 354' ' ' VAL . 6.6 mt -91.09 146.76 23.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -101.72 164.49 11.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.912 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.552 ' HB3' HD22 ' A' ' 360' ' ' LEU . 8.9 ptt180 -66.58 -17.3 64.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -78.33 -47.62 17.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.892 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 2.1 m -84.32 148.98 54.16 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.615 0.722 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . 0.588 ' O ' HD12 ' A' ' 343' ' ' LEU . 54.2 Cg_endo -69.73 138.04 36.99 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.706 2.271 . . . . 0.0 112.35 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 341' ' ' GLU . 16.9 ptt85 -102.23 -48.09 4.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.865 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 340' ' ' ARG . 4.9 pt-20 -35.29 -46.71 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -75.31 -59.05 2.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.072 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . 0.588 HD12 ' O ' ' A' ' 339' ' ' PRO . 79.4 mt -55.9 -63.64 1.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.93 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -39.42 -54.35 1.91 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.1 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -55.71 -44.78 77.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 347' ' ' ILE . 21.7 mt -65.8 -67.79 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.135 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . 0.491 ' O ' ' N ' ' A' ' 352' ' ' GLY . 25.5 mt -41.4 -35.21 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 44.4 mtp85 -79.95 -45.65 18.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 32.3 t -56.08 -30.58 62.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . 0.435 ' C ' ' HD2' ' A' ' 325' ' ' LYS . 58.7 m-85 -98.58 26.67 5.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 58.91 58.96 11.8 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.479 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 347' ' ' ILE . . . -129.73 150.37 19.0 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.483 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -96.52 133.28 41.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.894 0.378 . . . . 0.0 110.914 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.413 ' CG2' ' HG ' ' A' ' 334' ' ' LEU . 7.4 p -143.49 143.39 24.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.119 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . 0.568 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 1.5 t -141.07 156.8 45.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' TRP . . . . . 0.442 ' O ' ' HB2' ' A' ' 364' ' ' ALA . 23.9 p90 -138.09 140.79 40.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.892 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.727 ' HB2' HD12 ' A' ' 360' ' ' LEU . 6.2 m-20 -42.77 115.99 0.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -44.7 -57.28 3.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.875 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 78.3 p -41.32 -47.87 3.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.853 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.727 HD12 ' HB2' ' A' ' 357' ' ' ASP . 86.7 mt -61.61 -50.92 70.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.895 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 23.3 m -154.95 140.55 17.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.3 pt -69.77 162.39 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.119 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 93.43 39.41 5.05 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.452 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 356' ' ' TRP . . . -113.56 149.47 34.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 0.0 111.109 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 41.4 p -98.59 -72.4 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.096 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' TYR . . . . . 0.568 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 18.5 p90 -103.43 161.79 13.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.911 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.01 168.62 11.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.834 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . 0.528 ' O ' HG22 ' A' ' 368' ' ' VAL . 7.6 p -70.69 -6.65 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.161 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 24.3 p -100.3 18.71 18.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -95.19 118.69 32.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.821 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.2 m -51.17 -43.78 61.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.843 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 21.4 mtt85 -38.93 -40.1 0.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.82 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 57.0 mt -48.55 115.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.103 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 74.8 p -85.25 -43.61 13.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -128.84 158.97 37.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.81 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' GLN . . . . . 0.54 ' CD ' ' CE2' ' A' ' 392' ' ' TYR . 25.9 tt0 -140.62 108.97 5.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . 0.436 HD13 HG23 ' A' ' 393' ' ' VAL . 44.6 mm -76.09 139.12 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.192 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 379' ' ' ASP . 18.7 m -154.7 139.59 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . 0.439 ' O ' ' CG ' ' A' ' 380' ' ' ARG . 5.7 t0 -35.95 -45.74 0.43 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.439 ' CG ' ' O ' ' A' ' 379' ' ' ASP . 62.7 mtt180 -161.07 121.6 1.6 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.65 0.738 . . . . 0.0 110.86 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 2.67 3.3 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.673 2.248 . . . . 0.0 112.373 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -96.89 -31.41 7.0 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.48 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -91.84 31.73 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.882 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -174.14 144.07 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.871 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 9.9 t -79.62 158.15 27.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.6 p -110.97 166.64 10.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 56.5 t -98.97 128.39 50.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.4 mt -44.22 110.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.151 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 113.67 -41.25 2.25 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.468 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' ARG . . . . . 0.509 ' HD2' ' CE1' ' A' ' 392' ' ' TYR . 13.2 ttm-85 -79.52 152.39 30.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.778 0.323 . . . . 0.0 110.9 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 40.5 m -120.27 115.67 24.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . 0.54 ' CE2' ' CD ' ' A' ' 376' ' ' GLN . 7.0 m-85 -92.51 130.4 38.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.919 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.436 HG23 HD13 ' A' ' 377' ' ' ILE . 25.1 m -134.97 167.98 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.143 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -83.78 160.56 58.2 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.576 0.703 . . . . 0.0 110.935 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -7.99 22.48 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.708 2.272 . . . . 0.0 112.328 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 12.6 tp-100 -79.18 -12.76 59.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 92.4 t90 -79.79 -13.03 59.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.475 ' O ' HG22 ' A' ' 402' ' ' VAL . 60.1 t -89.65 -33.81 6.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.163 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -76.33 -28.75 57.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.454 ' HB3' HD12 ' A' ' 408' ' ' LEU . 8.5 t0 -81.04 -53.09 6.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.875 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 39.3 m -48.74 -46.44 40.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 398' ' ' VAL . 18.9 m -64.25 -43.1 97.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.126 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . 0.433 ' N ' HG23 ' A' ' 402' ' ' VAL . 17.6 t-20 -64.28 -32.31 73.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -97.04 8.84 43.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.094 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 39.77 40.46 0.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 6.9 tp -156.93 149.41 23.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 90.7 mt -78.08 90.59 4.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 400' ' ' ASP . 84.4 mt -56.35 151.63 27.34 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.581 0.705 . . . . 0.0 110.908 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 107.44 1.86 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.635 2.223 . . . . 0.0 112.37 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.2 m -54.21 -19.03 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.147 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -58.31 -14.52 7.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.107 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -98.43 -16.63 19.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -114.57 28.34 8.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 26.1 t80 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.807 0.337 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.449 HD21 HD23 ' A' ' 407' ' ' LEU . 4.8 tp -71.47 -51.59 22.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.916 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . 0.489 ' HB2' ' CA ' ' A' ' 352' ' ' GLY . 22.8 m-85 -86.3 31.7 0.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -66.54 119.83 12.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.862 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 82.7 -53.07 4.79 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.467 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 329' ' ' GLY . 29.7 mt -36.69 124.84 0.86 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.847 0.356 . . . . 0.0 110.87 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -99.82 115.08 28.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -104.32 167.54 9.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' PHE . . . . . 0.41 ' CD1' ' O ' ' A' ' 355' ' ' SER . 34.6 t80 -152.58 115.56 4.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.59 HD13 ' HA ' ' A' ' 340' ' ' ARG . 4.1 mt -89.77 128.22 36.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.934 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' ASN . . . . . 0.44 ' O ' HG22 ' A' ' 338' ' ' VAL . 2.6 t-20 -83.23 145.99 28.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.546 ' HB3' HD13 ' A' ' 360' ' ' LEU . 0.0 OUTLIER -51.03 -20.03 1.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -78.75 -42.49 27.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 335' ' ' ASN . 13.3 m -82.39 151.21 65.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.623 0.725 . . . . 0.0 111.144 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . 0.524 ' O ' HD12 ' A' ' 343' ' ' LEU . 54.0 Cg_endo -69.71 124.82 11.47 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.715 2.277 . . . . 0.0 112.366 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 0.59 ' HA ' HD13 ' A' ' 334' ' ' LEU . 15.6 mtm105 -89.42 -55.45 3.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.875 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 340' ' ' ARG . 7.5 pt-20 -35.26 -45.85 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -71.58 -63.76 1.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.099 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . 0.685 HD11 ' HB3' ' A' ' 395' ' ' PRO . 35.3 mt -55.46 -63.59 1.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.916 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -37.07 -57.65 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -52.83 -46.21 67.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' ILE . . . . . 0.689 ' CG2' HG11 ' A' ' 402' ' ' VAL . 14.6 mt -61.18 -62.05 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.129 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 20.3 mt -48.63 -53.03 7.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.155 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -62.07 -40.32 95.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 4.5 m -60.21 -34.88 74.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.821 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -98.79 29.04 3.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 53.8 59.17 10.19 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.477 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . 0.489 ' CA ' ' HB2' ' A' ' 327' ' ' PHE . . . -125.39 156.31 19.16 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.467 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -91.27 142.47 27.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.951 0.405 . . . . 0.0 110.838 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.462 ' CG2' ' HG ' ' A' ' 334' ' ' LEU . 7.5 p -159.11 141.03 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.149 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . 0.41 ' O ' ' CD1' ' A' ' 333' ' ' PHE . 32.7 t -140.9 157.47 45.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.828 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -136.35 -177.89 4.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.673 ' HB2' HD12 ' A' ' 360' ' ' LEU . 2.9 m-20 -69.13 119.78 13.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 22.8 mttp -53.52 -55.43 25.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 26.5 t -48.18 -58.94 3.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.87 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.673 HD12 ' HB2' ' A' ' 357' ' ' ASP . 5.9 mt -49.97 -40.54 44.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 3.8 m -160.68 144.72 13.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 7.3 pt -82.27 151.33 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.1 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 109.79 26.94 4.82 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.451 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -99.98 155.87 17.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 111.139 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 23.8 p -108.12 -57.82 2.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.14 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -128.27 136.7 51.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.9 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.92 169.8 14.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.839 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . 0.46 ' HA ' ' CD1' ' A' ' 373' ' ' ILE . 11.3 p -55.54 -29.35 24.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.137 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 75.8 p -65.88 -25.6 67.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.145 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -62.21 98.88 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 60.5 p -49.49 -29.62 6.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -45.99 -40.45 10.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.859 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.46 ' CD1' ' HA ' ' A' ' 368' ' ' VAL . 60.0 mt -38.16 145.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.103 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 75.7 p -117.55 -30.81 5.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.164 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -141.75 124.37 15.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.827 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' GLN . . . . . 0.529 ' NE2' ' CG1' ' A' ' 378' ' ' VAL . 0.2 OUTLIER -106.09 95.04 5.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 48.2 mm -58.62 97.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.108 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . 0.529 ' CG1' ' NE2' ' A' ' 376' ' ' GLN . 27.4 m -118.58 163.3 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.137 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.96 -34.77 64.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -134.64 80.9 49.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.602 0.715 . . . . 0.0 110.906 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 3.05 2.99 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.665 2.244 . . . . 0.0 112.381 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -113.43 -21.56 5.78 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.484 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . 0.412 ' HG3' ' N ' ' A' ' 384' ' ' GLN . 1.0 OUTLIER -92.64 -61.07 1.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.78 0.324 . . . . 0.0 110.888 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.412 ' N ' ' HG3' ' A' ' 383' ' ' GLN . 2.4 pt20 -54.56 138.82 39.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 7.8 t -48.93 146.8 3.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.14 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 25.2 p -118.87 152.71 35.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.848 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.39 119.22 49.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.112 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.762 ' H ' HD12 ' A' ' 388' ' ' ILE . 5.0 mp -42.57 111.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.17 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 115.18 -38.58 3.07 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.52 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' ARG . . . . . 0.492 ' HD2' ' CZ ' ' A' ' 392' ' ' TYR . 6.7 ttm180 -83.55 146.81 28.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.765 0.317 . . . . 0.0 110.898 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 43.8 m -114.53 143.61 44.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . 0.492 ' CZ ' ' HD2' ' A' ' 390' ' ' ARG . 3.7 m-85 -123.29 129.33 51.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.488 HG11 ' CG1' ' A' ' 410' ' ' VAL . 33.8 m -132.99 152.21 35.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.197 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -71.05 160.91 81.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.576 0.703 . . . . 0.0 110.936 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.685 ' HB3' HD11 ' A' ' 343' ' ' LEU . 53.6 Cg_endo -69.74 -4.58 14.3 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.709 2.273 . . . . 0.0 112.315 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . 0.537 ' HA ' ' CD2' ' A' ' 399' ' ' PHE . 14.0 tt0 -85.36 -31.77 22.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -53.78 -30.32 44.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.985 ' O ' HG22 ' A' ' 402' ' ' VAL . 21.4 t -72.52 -38.33 59.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.106 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . 0.537 ' CD2' ' HA ' ' A' ' 396' ' ' GLN . 17.3 m-85 -63.19 -52.24 63.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.25 -26.92 67.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 45.8 m -75.81 -59.81 2.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.837 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.985 HG22 ' O ' ' A' ' 398' ' ' VAL . 5.8 m -55.6 -33.99 34.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.083 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -76.3 -38.74 55.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -85.37 12.34 8.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.085 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 40.04 36.07 0.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.403 HD12 ' H ' ' A' ' 407' ' ' LEU . 49.7 tp -151.48 151.39 31.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.978 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.449 HD23 HD21 ' A' ' 326' ' ' LEU . 46.9 mt -86.83 71.9 10.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.924 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 407' ' ' LEU . 43.6 mt -38.04 156.41 0.1 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.621 0.724 . . . . 0.0 110.906 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 113.6 3.42 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.345 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . 0.488 ' CG1' HG11 ' A' ' 393' ' ' VAL . 16.4 m -61.83 -31.22 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -45.21 -44.39 10.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.47 -27.16 67.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -98.35 38.33 1.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.889 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.801 0.334 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 22.7 tp -53.25 -53.07 56.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . 0.438 ' HB2' ' CA ' ' A' ' 352' ' ' GLY . 24.5 m-85 -95.24 35.52 1.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -60.68 113.08 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 80.51 -41.88 2.56 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.5 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 34.9 mt -44.8 124.75 4.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.903 0.382 . . . . 0.0 110.894 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -95.81 147.39 23.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -137.82 155.77 48.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -139.55 116.3 10.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.696 HD11 HG21 ' A' ' 354' ' ' VAL . 2.8 mt -94.64 152.65 18.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -114.54 147.88 38.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.447 ' HD2' ' N ' ' A' ' 336' ' ' ARG . 0.5 OUTLIER -46.86 -27.78 1.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -63.87 -48.59 76.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.7 m -86.89 151.14 51.73 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.675 0.75 . . . . 0.0 111.121 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . 0.618 ' O ' HD12 ' A' ' 343' ' ' LEU . 54.0 Cg_endo -69.77 116.06 4.38 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.67 2.247 . . . . 0.0 112.328 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 0.426 ' HG2' ' N ' ' A' ' 341' ' ' GLU . 0.0 OUTLIER -87.4 -29.98 21.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.884 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.426 ' N ' ' HG2' ' A' ' 340' ' ' ARG . 11.2 pt-20 -50.96 -49.75 59.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.401 ' N ' ' HG3' ' A' ' 341' ' ' GLU . . . -74.3 -57.59 3.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.089 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . 0.666 HD23 ' CE1' ' A' ' 399' ' ' PHE . 27.6 mt -53.14 -65.33 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 343' ' ' LEU . . . -35.03 -62.66 0.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.059 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . 0.603 ' N ' HH21 ' A' ' 348' ' ' ARG . 19.8 t80 -48.27 -49.73 32.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 349' ' ' SER . 44.4 mt -56.55 -71.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.16 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . 0.429 ' O ' ' N ' ' A' ' 352' ' ' GLY . 20.9 mt -37.99 -50.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.138 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . 0.603 HH21 ' N ' ' A' ' 345' ' ' PHE . 75.0 mtm180 -65.21 -37.71 88.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 346' ' ' ILE . 29.6 t -61.2 -42.83 99.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -88.54 23.05 2.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.869 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 60.67 57.2 20.12 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.452 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . 0.438 ' CA ' ' HB2' ' A' ' 327' ' ' PHE . . . -123.01 164.22 16.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.471 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -103.75 130.12 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.924 0.392 . . . . 0.0 110.893 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.696 HG21 HD11 ' A' ' 334' ' ' LEU . 5.7 p -141.51 142.76 28.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.123 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . 0.458 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 4.6 t -140.48 162.46 35.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' TRP . . . . . 0.568 ' O ' ' HB2' ' A' ' 364' ' ' ALA . 20.4 p90 -139.32 153.92 47.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.913 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 360' ' ' LEU . 3.9 t70 -45.07 104.87 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 357' ' ' ASP . 7.3 mtpm? -35.92 -36.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.2 t -64.0 -48.35 76.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 357' ' ' ASP . 36.8 mt -55.44 -39.35 70.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 3.7 t -172.23 146.7 1.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.6 pt -66.34 173.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.102 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 104.42 -38.96 3.0 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.499 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 356' ' ' TRP . . . -50.34 140.3 13.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.822 0.344 . . . . 0.0 111.13 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 23.6 p -101.49 -50.94 3.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.186 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' TYR . . . . . 0.458 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 29.9 p90 -112.49 149.64 32.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.52 167.56 19.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.86 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 12.8 p -69.73 -22.56 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.155 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 77.3 p -84.02 13.55 4.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.61 110.49 17.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 22.6 p -55.35 -23.8 25.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -60.94 -36.8 80.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.85 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.417 HG21 HH11 ' A' ' 390' ' ' ARG . 66.6 mt -40.55 130.38 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.121 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 69.6 p -97.52 -24.72 15.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.169 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -154.55 149.36 26.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' GLN . . . . . 0.541 ' OE1' ' CE2' ' A' ' 392' ' ' TYR . 52.8 tt0 -134.37 111.56 10.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 19.1 mm -80.0 115.0 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.129 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . 0.533 HG13 ' HG2' ' A' ' 376' ' ' GLN . 29.5 m -131.97 168.98 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.55 -34.59 31.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.458 ' CZ ' ' HG3' ' A' ' 383' ' ' GLN . 81.3 mtp180 -132.23 80.81 62.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.612 0.72 . . . . 0.0 110.872 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -18.6 37.04 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.689 2.259 . . . . 0.0 112.358 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -73.92 -32.45 58.84 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.526 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . 0.458 ' HG3' ' CZ ' ' A' ' 380' ' ' ARG . 21.1 mm-40 -76.12 -49.3 17.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.756 0.312 . . . . 0.0 110.898 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -53.17 178.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 72.4 p -122.2 121.93 38.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 81.3 p -56.88 157.54 5.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 97.3 t -125.43 140.16 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.131 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.1 mt -37.82 111.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.093 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 92.13 -49.07 2.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.489 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' ARG . . . . . 0.468 ' HD2' ' N ' ' A' ' 391' ' ' CYS . 6.9 tmm_? -84.43 146.28 27.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.806 0.336 . . . . 0.0 110.863 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' CYS . . . . . 0.468 ' N ' ' HD2' ' A' ' 390' ' ' ARG . 88.3 m -134.8 147.55 49.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . 0.541 ' CE2' ' OE1' ' A' ' 376' ' ' GLN . 5.2 m-85 -94.62 132.87 38.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 4.2 m -138.26 158.13 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.116 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -78.7 161.32 69.67 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.608 0.718 . . . . 0.0 110.913 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -6.19 18.02 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.643 2.229 . . . . 0.0 112.341 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -80.96 -23.74 38.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.946 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 92.5 t90 -63.73 -27.97 69.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.696 ' O ' HG22 ' A' ' 402' ' ' VAL . 48.0 t -75.0 -70.27 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . 0.666 ' CE1' HD23 ' A' ' 343' ' ' LEU . 5.4 m-30 -42.07 -36.95 1.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.88 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -72.44 -44.31 62.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 75.8 m -63.55 -54.47 35.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.81 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 398' ' ' VAL . 2.5 m -56.74 -33.88 41.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.089 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -79.48 -29.48 41.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -94.5 9.17 39.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.071 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? 40.19 32.71 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.597 HD13 ' N ' ' A' ' 407' ' ' LEU . 0.9 OUTLIER -152.62 137.4 17.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.93 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.597 ' N ' HD13 ' A' ' 406' ' ' LEU . 48.1 mt -74.1 85.37 1.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 45.5 mt -51.57 154.15 3.48 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.552 0.691 . . . . 0.0 110.977 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 107.93 1.96 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.711 2.274 . . . . 0.0 112.326 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.1 m -54.84 -16.78 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.141 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -62.16 -19.16 62.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -90.74 -24.24 20.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -104.96 38.27 1.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.905 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 6.0 t80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.813 0.34 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 15.9 tp -57.69 -52.57 64.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . 0.472 ' HA ' HD12 ' A' ' 330' ' ' LEU . 25.4 m-85 -92.41 38.39 1.01 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -71.69 141.15 49.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.919 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 45.49 43.45 10.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.451 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 327' ' ' PHE . 42.1 mt -132.23 126.81 34.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.86 0.362 . . . . 0.0 110.899 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.549 ' HE3' ' CE2' ' A' ' 366' ' ' TYR . 37.1 mtpt -99.32 141.38 32.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.909 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -133.18 156.16 47.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' PHE . . . . . 0.467 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 8.9 t80 -138.36 115.63 11.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.86 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.531 HD11 HG21 ' A' ' 354' ' ' VAL . 2.9 mt -94.47 151.96 18.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.933 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -104.45 177.12 4.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -77.48 -27.51 51.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.855 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -72.13 -26.04 61.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.1 m -102.15 148.39 35.31 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.603 0.716 . . . . 0.0 111.122 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . 0.465 ' O ' HD12 ' A' ' 343' ' ' LEU . 53.4 Cg_endo -69.83 122.31 8.97 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.633 2.222 . . . . 0.0 112.343 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 0.5 ' O ' ' HB3' ' A' ' 344' ' ' ALA . 6.3 ppt_? -95.08 -30.67 13.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.461 ' N ' ' HD2' ' A' ' 340' ' ' ARG . 8.1 pt-20 -52.07 -37.82 55.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -86.26 -60.67 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.112 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 339' ' ' PRO . 54.9 mt -52.7 -55.58 21.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 340' ' ' ARG . . . -45.35 -58.6 3.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.07 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . 0.407 ' O ' ' N ' ' A' ' 349' ' ' SER . 4.8 t80 -56.38 -46.93 79.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' ILE . . . . . 0.412 ' CD1' ' CE1' ' A' ' 399' ' ' PHE . 29.2 mt -55.83 -67.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.147 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 17.0 mt -45.77 -37.94 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.167 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -78.97 -26.72 43.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 345' ' ' PHE . 16.7 t -82.53 -21.9 35.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.837 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -101.18 15.56 28.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 72.31 73.37 0.85 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.501 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -158.1 169.03 34.69 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.455 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -106.03 143.47 34.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.832 0.349 . . . . 0.0 110.947 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.531 HG21 HD11 ' A' ' 334' ' ' LEU . 11.7 p -157.82 128.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.151 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . 0.548 ' HB2' ' CE1' ' A' ' 366' ' ' TYR . 1.9 m -133.7 154.15 51.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' TRP . . . . . 0.466 ' CD1' ' O ' ' A' ' 361' ' ' CYS . 14.3 p90 -122.16 -178.5 3.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.884 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 358' ' ' LYS . 10.9 t70 -73.83 111.75 9.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.854 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 357' ' ' ASP . 27.4 mttt -35.0 -51.47 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 7.9 t -57.97 -49.11 77.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 28.1 mt -51.31 -51.12 57.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' CYS . . . . . 0.466 ' O ' ' CD1' ' A' ' 356' ' ' TRP . 1.8 m -160.91 143.28 12.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 45.0 pt -66.22 160.08 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.41 ' O ' ' CZ2' ' A' ' 356' ' ' TRP . . . 96.91 36.21 5.08 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.464 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -117.33 147.17 42.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.816 0.341 . . . . 0.0 111.116 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 21.9 p -105.18 -71.06 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.146 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' TYR . . . . . 0.549 ' CE2' ' HE3' ' A' ' 331' ' ' LYS . 13.6 p90 -96.34 146.59 24.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.934 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.76 170.66 11.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . 0.467 ' HB ' ' CZ ' ' A' ' 333' ' ' PHE . 7.3 p -64.55 -18.05 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.134 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 70.1 p -85.37 22.85 1.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.181 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -104.73 103.83 13.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 30.0 m -50.35 -37.09 35.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 30.6 mtt180 -40.59 -39.84 1.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.86 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 70.6 mt -45.65 117.64 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.158 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 48.9 p -81.64 -44.93 16.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -126.32 138.87 53.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.861 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' GLN . . . . . 0.46 ' OE1' ' CZ ' ' A' ' 390' ' ' ARG . 37.6 tt0 -122.32 99.05 6.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.914 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . 0.424 ' N ' ' O ' ' A' ' 333' ' ' PHE . 25.8 mm -65.87 129.46 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 35.4 m -152.27 146.67 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.139 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -68.21 -34.54 76.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.827 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.404 ' HA ' ' HD2' ' A' ' 381' ' ' PRO . 20.2 mtp85 -132.7 89.86 34.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.612 0.72 . . . . 0.0 110.878 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 380' ' ' ARG . 53.6 Cg_endo -69.71 -27.06 27.17 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.668 2.245 . . . . 0.0 112.337 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -72.58 -59.2 4.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.528 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . 0.47 ' HG3' ' N ' ' A' ' 384' ' ' GLN . 12.1 pt20 -43.03 -36.96 1.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.808 0.337 . . . . 0.0 110.921 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.47 ' N ' ' HG3' ' A' ' 383' ' ' GLN . 10.4 pt20 -104.32 114.67 29.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.95 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 16.2 m -51.37 153.11 2.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.159 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 6.9 t -91.51 173.18 8.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.858 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.9 t -127.77 130.91 70.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.111 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 29.3 mm -42.37 125.95 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.143 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 94.68 -33.52 5.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.487 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' ARG . . . . . 0.46 ' CZ ' ' OE1' ' A' ' 376' ' ' GLN . 19.8 ttp180 -93.97 146.11 24.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.782 0.325 . . . . 0.0 110.881 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 62.5 m -129.22 127.8 42.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -96.61 133.64 40.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.507 HG11 ' HB ' ' A' ' 410' ' ' VAL . 17.0 m -143.21 142.76 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.123 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -57.85 158.45 12.48 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.607 0.718 . . . . 0.0 110.93 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -7.25 20.6 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.709 2.273 . . . . 0.0 112.294 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.31 -33.75 42.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' TRP . . . . . 0.457 ' CE2' HG12 ' A' ' 410' ' ' VAL . 69.1 t90 -48.49 -31.16 6.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.926 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.515 ' O ' HG22 ' A' ' 402' ' ' VAL . 65.7 t -80.22 -55.03 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . 0.433 ' CE2' HD21 ' A' ' 343' ' ' LEU . 68.1 m-85 -54.23 -22.02 10.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -85.45 -41.39 15.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 405' ' ' ARG . 20.3 m -66.53 -51.92 51.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 398' ' ' VAL . 15.3 m -49.77 -38.12 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.141 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -78.12 -44.18 26.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -83.08 8.28 13.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.138 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 404' ' ' ALA . 7.9 mmm180 35.57 46.0 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 12.6 tp -156.18 148.18 23.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.932 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 13.5 mt -80.0 84.14 5.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 33.1 mt -55.53 154.36 12.63 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.598 0.714 . . . . 0.0 110.886 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 114.13 3.61 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.707 2.271 . . . . 0.0 112.293 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . 0.507 ' HB ' HG11 ' A' ' 393' ' ' VAL . 35.2 m -60.57 -21.27 22.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.123 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -55.54 -40.05 71.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.085 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.38 -9.99 59.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -121.34 38.41 4.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.887 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 10.4 t80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 -179.976 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.795 0.331 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 11.6 tp -44.37 -50.58 9.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.866 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -93.01 42.59 1.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -74.56 133.86 42.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 52.32 55.29 22.75 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.486 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 88.0 mt -147.55 118.1 7.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.88 0.371 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -93.43 126.26 38.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.948 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.518 ' CD1' ' HB2' ' A' ' 375' ' ' HIS . 74.5 m-85 -120.29 160.36 23.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' PHE . . . . . 0.528 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 36.8 t80 -141.11 117.01 10.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.475 HD11 HG21 ' A' ' 354' ' ' VAL . 7.4 mt -93.67 142.84 26.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.904 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' ASN . . . . . 0.558 ' ND2' HG12 ' A' ' 378' ' ' VAL . 2.7 m-80 -101.22 158.25 16.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.776 ' HB3' HD13 ' A' ' 360' ' ' LEU . 12.9 ptt180 -58.78 -29.53 66.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.846 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . 0.462 ' CG ' ' OD2' ' A' ' 379' ' ' ASP . 11.6 tp10 -66.19 -48.0 72.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 5.1 m -80.82 150.64 69.66 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.582 0.706 . . . . 0.0 111.184 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 110.34 2.53 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.677 2.251 . . . . 0.0 112.3 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -86.53 -38.67 16.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -44.69 -41.33 6.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -82.42 -58.49 2.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.075 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 71.4 mt -53.99 -61.23 2.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -39.66 -55.55 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.068 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -58.81 -44.54 90.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 47.8 mt -59.65 -62.33 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.151 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 20.1 mt -51.97 -55.88 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -56.43 -40.26 74.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 29.5 t -64.92 -43.96 91.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . 0.468 ' CZ ' HG22 ' A' ' 402' ' ' VAL . 14.0 m-85 -73.44 -9.16 58.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 90.83 54.55 2.03 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.497 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -128.91 161.95 22.46 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.492 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -92.06 129.07 38.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.912 0.387 . . . . 0.0 110.851 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.475 HG21 HD11 ' A' ' 334' ' ' LEU . 10.8 p -148.06 143.2 19.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.155 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . 0.553 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 5.1 t -147.39 152.26 37.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.868 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' TRP . . . . . 0.509 ' CD1' ' HB3' ' A' ' 361' ' ' CYS . 31.7 p90 -128.45 173.15 10.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.668 ' HB2' HD12 ' A' ' 360' ' ' LEU . 1.2 m-20 -61.59 109.28 1.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.821 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -46.45 -34.34 4.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 28.4 t -69.41 -55.18 11.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.814 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.776 HD13 ' HB3' ' A' ' 336' ' ' ARG . 18.5 mt -54.91 -44.14 73.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.894 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' CYS . . . . . 0.509 ' HB3' ' CD1' ' A' ' 356' ' ' TRP . 2.1 t -147.21 159.97 43.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 15.7 tt -86.55 162.26 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.149 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 85.98 43.1 6.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.508 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -107.04 165.8 11.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.878 0.37 . . . . 0.0 111.09 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 20.9 p -129.78 -64.05 0.89 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.143 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' TYR . . . . . 0.553 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 8.3 p90 -112.31 145.91 39.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.953 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.13 167.17 22.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.88 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . 0.528 ' HB ' ' CZ ' ' A' ' 333' ' ' PHE . 7.5 p -63.62 -20.49 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.107 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 79.1 p -93.65 26.62 3.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.142 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -93.87 113.58 25.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 372' ' ' ARG . 11.9 t -53.62 -45.76 70.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.871 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 371' ' ' SER . 18.5 mmt180 -37.15 -42.42 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.917 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 34.0 mt -47.75 129.95 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.096 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 41.6 p -94.73 -43.1 8.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.106 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . 0.518 ' HB2' ' CD1' ' A' ' 332' ' ' PHE . 37.3 m80 -128.82 148.47 50.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -128.74 115.42 17.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.927 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 27.0 mm -82.72 116.17 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.167 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . 0.558 HG12 ' ND2' ' A' ' 335' ' ' ASN . 30.9 m -141.05 158.19 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . 0.462 ' OD2' ' CG ' ' A' ' 337' ' ' GLU . 2.8 m-20 -71.48 -37.7 71.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -127.69 81.98 69.19 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.578 0.704 . . . . 0.0 110.892 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -23.07 31.34 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.715 2.277 . . . . 0.0 112.373 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -68.64 -47.16 58.13 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.476 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -63.11 -48.9 76.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.775 0.321 . . . . 0.0 110.88 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -45.81 164.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.91 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 51.6 m -95.87 126.68 41.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.117 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 72.4 m -67.21 139.78 57.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 90.5 t -129.78 119.36 47.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.112 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.783 ' H ' HD12 ' A' ' 388' ' ' ILE . 5.0 mp -39.94 134.41 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 88.76 -40.8 3.05 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.455 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' ARG . . . . . 0.425 ' NH1' ' O ' ' A' ' 368' ' ' VAL . 14.5 ttp180 -95.65 145.79 25.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.756 0.312 . . . . 0.0 110.871 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 84.0 m -132.85 124.33 27.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -90.89 128.07 36.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.954 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 19.7 m -135.99 151.11 28.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.088 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -66.55 158.12 80.1 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.602 0.715 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -5.5 16.34 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.662 2.241 . . . . 0.0 112.362 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -80.68 -14.77 57.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -73.12 -49.77 26.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 51.7 t -55.5 -41.75 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.12 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -65.03 -64.53 0.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.484 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 2.4 m-20 -50.42 -33.42 20.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.836 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 69.6 m -70.49 -26.24 63.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.468 HG22 ' CZ ' ' A' ' 350' ' ' PHE . 2.2 t -89.23 -45.73 15.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.096 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -67.73 -31.68 71.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -88.08 5.99 38.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.087 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? 40.08 44.4 1.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 43.0 tp -165.13 144.24 6.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 16.4 mt -74.95 99.31 3.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.484 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 52.2 mt -71.55 153.62 93.56 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.634 0.731 . . . . 0.0 110.924 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 119.57 6.49 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.702 2.268 . . . . 0.0 112.35 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.09 -28.6 44.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.136 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -52.9 -21.82 4.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -84.52 -32.65 23.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -104.96 42.51 1.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.923 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 3.7 t80 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.88 179.966 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.809 0.338 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.443 HD11 ' HA ' ' A' ' 405' ' ' ARG . 2.5 tt -57.26 -52.6 64.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.936 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -92.15 38.54 1.0 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -77.21 124.37 27.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 69.01 49.2 42.71 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.544 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.498 HD11 HD11 ' A' ' 407' ' ' LEU . 88.9 mt -148.19 124.46 10.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.854 0.359 . . . . 0.0 110.935 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.46 ' HZ2' ' HB3' ' A' ' 372' ' ' ARG . 45.3 mttt -95.54 133.11 39.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -119.26 152.8 36.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.909 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -130.98 119.04 21.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.879 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.729 HD11 HG21 ' A' ' 354' ' ' VAL . 7.3 mt -97.95 140.89 31.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -98.34 -175.14 3.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.872 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -82.46 -33.74 28.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -69.81 -36.6 75.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.562 HG11 HG22 ' A' ' 377' ' ' ILE . 3.1 m -87.16 145.28 37.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.658 0.742 . . . . 0.0 111.107 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . 0.519 ' O ' HD12 ' A' ' 343' ' ' LEU . 53.6 Cg_endo -69.74 127.32 14.44 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.664 2.242 . . . . 0.0 112.33 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.86 -40.19 9.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -45.65 -41.36 10.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -78.9 -66.91 0.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.139 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 339' ' ' PRO . 60.2 mt -44.57 -58.26 3.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -43.3 -54.79 4.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -55.39 -40.61 71.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' ILE . . . . . 0.553 ' CG2' HG11 ' A' ' 402' ' ' VAL . 15.6 mt -68.64 -72.91 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.145 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . 0.472 ' N ' HG22 ' A' ' 346' ' ' ILE . 26.1 mt -37.33 -37.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.122 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -75.18 -47.99 25.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 47.5 t -55.52 -31.18 61.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.804 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . 0.422 ' CE2' ' HB ' ' A' ' 402' ' ' VAL . 20.7 m-85 -98.72 26.22 5.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 53.02 71.44 0.69 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.521 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -136.87 173.07 22.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.49 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -109.17 128.23 54.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 110.902 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.729 HG21 HD11 ' A' ' 334' ' ' LEU . 7.6 p -144.06 131.58 17.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.119 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . 0.579 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 10.4 t -136.2 163.86 29.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' TRP . . . . . 0.508 ' CD1' ' HB2' ' A' ' 361' ' ' CYS . 34.0 p90 -142.35 159.07 42.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.905 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.844 ' HB2' HD12 ' A' ' 360' ' ' LEU . 7.0 m-20 -55.65 120.88 7.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -45.08 -59.38 2.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 14.7 t -45.4 -48.88 13.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.824 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.844 HD12 ' HB2' ' A' ' 357' ' ' ASP . 32.3 mt -55.97 -49.62 73.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.973 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' CYS . . . . . 0.508 ' HB2' ' CD1' ' A' ' 356' ' ' TRP . 62.1 m -154.03 157.4 38.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.2 tt -84.9 158.48 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.117 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 91.73 36.38 6.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.486 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -105.52 158.2 16.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 0.0 111.087 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.434 ' OG1' ' CD2' ' A' ' 366' ' ' TYR . 22.3 p -111.99 -64.14 1.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.124 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' TYR . . . . . 0.579 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 16.0 p90 -110.18 139.43 45.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -76.74 171.46 14.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . 0.419 ' O ' HG22 ' A' ' 368' ' ' VAL . 13.6 p -64.12 -11.77 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.175 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 25.3 p -96.89 15.66 21.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.147 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . 0.442 ' CB ' ' HB2' ' A' ' 366' ' ' TYR . 0.9 OUTLIER -96.03 107.2 19.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.886 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 59.0 p -52.24 -33.34 41.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . 0.46 ' HB3' ' HZ2' ' A' ' 331' ' ' LYS . 26.1 mmm-85 -40.05 -45.14 1.88 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.877 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.446 HG12 ' CE1' ' A' ' 366' ' ' TYR . 20.7 mt -41.24 136.16 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.192 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 50.6 p -112.12 -23.87 10.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.114 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -134.47 134.16 41.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.847 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' GLN . . . . . 0.446 ' HG2' ' CE2' ' A' ' 392' ' ' TYR . 2.0 tp-100 -124.59 105.5 9.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.896 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . 0.562 HG22 HG11 ' A' ' 338' ' ' VAL . 6.0 mm -84.38 126.38 40.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.09 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 13.5 m -139.11 152.36 23.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.12 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -67.19 -42.49 84.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.426 ' HB3' ' NH1' ' A' ' 380' ' ' ARG . 0.0 OUTLIER -132.12 90.42 35.0 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 0.0 110.866 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -19.45 36.3 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.668 2.246 . . . . 0.0 112.352 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -65.48 -47.03 82.41 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.531 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -80.92 -42.22 21.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.756 0.312 . . . . 0.0 110.894 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -51.93 153.49 2.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.0 149.67 23.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.139 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 26.1 p -108.86 153.11 23.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.839 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 26.1 t -119.65 128.43 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.14 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.3 mt -40.4 117.67 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.167 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 103.88 -43.14 1.73 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.466 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -87.67 148.7 24.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 0.0 110.867 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 4.0 t -123.58 145.51 48.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . 0.446 ' CE2' ' HG2' ' A' ' 376' ' ' GLN . 2.9 m-85 -107.28 118.05 35.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.942 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.427 HG23 ' CD1' ' A' ' 377' ' ' ILE . 31.4 m -124.85 160.32 30.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.135 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -76.02 159.59 80.29 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.57 0.7 . . . . 0.0 110.887 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -6.69 19.18 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.669 2.246 . . . . 0.0 112.357 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -83.55 -15.9 47.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.947 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -66.09 -26.55 67.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.425 ' O ' HG22 ' A' ' 402' ' ' VAL . 85.9 t -76.43 -51.34 19.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.161 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -60.18 -30.67 69.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.464 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 1.0 OUTLIER -80.55 -36.45 33.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.904 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 71.8 m -69.27 -49.47 55.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.553 HG11 ' CG2' ' A' ' 346' ' ' ILE . 34.9 m -60.43 -45.29 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.117 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . 0.499 ' N ' HG23 ' A' ' 402' ' ' VAL . 20.9 t-20 -65.08 -39.04 92.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -87.16 9.49 19.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.128 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' A' ' 404' ' ' ALA . 12.6 mmm-85 34.71 45.31 0.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.646 HD13 ' N ' ' A' ' 407' ' ' LEU . 0.4 OUTLIER -165.32 136.1 3.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.646 ' N ' HD13 ' A' ' 406' ' ' LEU . 15.6 mt -66.1 95.99 0.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.955 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.464 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 45.6 mt -64.75 156.1 80.07 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.607 0.718 . . . . 0.0 110.941 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 116.04 4.37 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.701 2.267 . . . . 0.0 112.361 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.9 m -58.02 -26.15 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.133 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -50.94 -34.3 28.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.072 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -75.72 -26.12 57.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -108.77 42.67 1.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 43.4 t80 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.898 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.802 0.334 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 2.0 tt -60.91 -48.62 80.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.939 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . 0.411 ' HA ' HD12 ' A' ' 330' ' ' LEU . 14.0 m-85 -93.48 38.87 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.848 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . 0.488 ' CD ' ' N ' ' A' ' 329' ' ' GLY . 3.9 tp10 -72.41 133.12 44.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . 0.488 ' N ' ' CD ' ' A' ' 328' ' ' GLU . . . 58.31 53.19 47.78 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.484 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 327' ' ' PHE . 89.8 mt -148.14 132.6 17.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.884 0.373 . . . . 0.0 110.941 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -109.62 132.99 53.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.959 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -126.05 140.82 52.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.852 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -119.97 115.36 23.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.889 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 8.1 mt -89.08 145.57 25.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -98.87 -179.65 4.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -81.96 -17.96 45.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -79.3 -45.07 20.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.845 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 2.0 m -83.95 150.16 57.99 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.617 0.722 . . . . 0.0 111.18 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . 0.727 ' O ' HD12 ' A' ' 343' ' ' LEU . 53.4 Cg_endo -69.79 137.69 35.96 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.712 2.275 . . . . 0.0 112.342 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 344' ' ' ALA . 0.0 OUTLIER -105.62 -34.73 7.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.905 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -50.91 -41.61 58.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -81.5 -48.41 11.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.083 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 339' ' ' PRO . 75.7 mt -67.15 -65.67 0.65 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -38.09 -45.23 0.9 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.08 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -68.33 -44.77 74.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 25.8 mt -61.8 -63.03 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.104 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 28.1 mt -51.4 -43.01 29.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -67.63 -33.99 76.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 17.7 t -72.23 -44.05 63.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . 0.523 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 14.2 m-85 -72.68 1.16 8.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 81.42 54.78 3.4 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.499 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -129.19 153.42 19.83 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.461 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -91.81 126.36 36.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.926 0.393 . . . . 0.0 110.846 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 6.5 p -139.99 137.92 38.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.046 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . 0.548 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 29.4 t -136.18 160.77 37.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 31.8 p90 -135.41 -175.37 3.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.925 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.719 ' HB2' HD12 ' A' ' 360' ' ' LEU . 12.5 m-20 -78.08 113.22 15.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 357' ' ' ASP . 1.3 mppt? -38.31 -56.2 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 17.7 t -44.88 -50.11 10.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.719 HD12 ' HB2' ' A' ' 357' ' ' ASP . 29.1 mt -57.02 -35.68 69.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.944 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 1.9 t -174.64 156.61 2.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 10.6 tt -81.36 163.23 3.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 111.16 -33.57 5.79 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.467 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -40.47 147.14 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 0.0 111.143 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.479 ' HG1' ' HD2' ' A' ' 366' ' ' TYR . 42.8 p -110.92 -58.97 2.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.094 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' TYR . . . . . 0.548 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 18.7 p90 -111.51 146.36 37.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.905 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -86.47 165.51 16.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.838 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 13.7 p -56.73 -30.83 33.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.125 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 73.2 p -67.15 -25.84 66.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.211 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -56.69 103.65 0.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 53.9 m -54.7 -26.85 36.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -46.13 -40.11 10.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 68.4 mt -44.92 120.98 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 71.2 p -89.17 -50.58 6.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.142 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -120.7 146.69 46.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.829 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -131.44 102.7 6.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . 0.632 HD13 HG23 ' A' ' 393' ' ' VAL . 31.8 mm -71.59 130.18 35.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.147 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 22.1 m -143.01 164.2 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.157 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 380' ' ' ARG . 0.4 OUTLIER -57.95 -48.45 79.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.472 ' N ' ' OD1' ' A' ' 379' ' ' ASP . 53.4 mtm-85 -145.78 104.96 4.22 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.637 0.732 . . . . 0.0 110.861 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -0.05 6.31 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.694 2.262 . . . . 0.0 112.377 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -103.67 -34.78 3.71 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.528 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -71.23 -71.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.726 0.298 . . . . 0.0 110.861 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -61.85 143.6 56.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 96.5 m -69.05 128.95 38.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 9.2 p -80.9 166.02 21.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . 0.46 HG23 ' OH ' ' A' ' 392' ' ' TYR . 97.5 t -94.73 108.7 21.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.752 ' H ' HD12 ' A' ' 388' ' ' ILE . 5.3 mp -36.32 102.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.148 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 125.2 -44.84 1.22 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.463 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 11.6 ttm-85 -78.9 160.51 27.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 110.852 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 73.6 m -119.21 115.81 24.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . 0.46 ' OH ' HG23 ' A' ' 387' ' ' VAL . 7.4 m-85 -96.0 136.04 36.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.632 HG23 HD13 ' A' ' 377' ' ' ILE . 17.8 m -139.47 153.11 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.13 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -68.81 159.24 83.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.57 0.7 . . . . 0.0 110.912 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -8.02 22.54 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.677 2.251 . . . . 0.0 112.398 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -81.22 -20.8 40.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 70.3 t90 -60.55 -43.05 97.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.99 -55.9 20.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.161 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -51.8 -35.62 44.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -76.4 -38.99 54.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.829 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 36.8 m -64.3 -48.23 76.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.815 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.523 ' HB ' ' CZ ' ' A' ' 350' ' ' PHE . 22.3 m -61.11 -46.22 97.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.104 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . 0.493 ' N ' HG23 ' A' ' 402' ' ' VAL . 41.5 t30 -62.13 -42.76 99.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -83.38 0.39 46.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 44.07 41.94 4.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.565 HD13 ' N ' ' A' ' 407' ' ' LEU . 0.4 OUTLIER -163.3 131.53 3.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.565 ' N ' HD13 ' A' ' 406' ' ' LEU . 71.4 mt -61.15 103.13 0.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 35.0 mt -70.4 154.2 94.62 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.592 0.71 . . . . 0.0 110.878 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 105.28 1.45 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.711 2.274 . . . . 0.0 112.343 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 32.7 m -51.58 -23.97 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.157 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -49.41 -34.52 16.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.094 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -74.37 -40.53 62.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -91.07 40.1 1.01 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 34.2 t80 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.88 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 59.5 mmtt . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.793 0.33 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 2.4 tt -39.65 -48.08 2.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -96.87 42.0 1.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -80.53 107.12 13.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 90.31 43.82 4.85 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.493 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.45 HD11 HD11 ' A' ' 407' ' ' LEU . 96.6 mt -144.43 129.27 18.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.83 0.348 . . . . 0.0 110.959 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.417 ' CE ' ' HB3' ' A' ' 372' ' ' ARG . 19.7 mttm -96.79 143.57 27.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -134.33 144.09 48.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -129.57 116.72 19.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.542 HD11 HG21 ' A' ' 354' ' ' VAL . 5.4 mt -97.33 147.68 23.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.969 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -110.35 154.52 23.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -52.48 -36.63 55.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -56.62 -47.8 78.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.0 m -88.94 148.61 41.62 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.575 0.703 . . . . 0.0 111.142 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . 0.563 ' O ' HD12 ' A' ' 343' ' ' LEU . 54.2 Cg_endo -69.76 125.04 11.68 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.713 2.276 . . . . 0.0 112.343 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 344' ' ' ALA . 0.3 OUTLIER -95.07 -40.99 9.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.857 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' A' ' 342' ' ' ALA . 8.1 pt-20 -42.37 -42.89 3.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.431 ' N ' ' HG3' ' A' ' 341' ' ' GLU . . . -76.64 -46.7 24.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 339' ' ' PRO . 24.2 mt -71.02 -66.34 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.939 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -34.65 -46.08 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.117 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -65.2 -43.33 91.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.926 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 343' ' ' LEU . 15.9 mt -62.7 -67.23 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.121 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 17.6 mt -42.34 -40.26 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 -72.77 -41.83 64.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 33.7 t -60.28 -33.18 71.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . 0.67 ' CZ ' HG13 ' A' ' 402' ' ' VAL . 22.8 m-85 -92.55 14.85 15.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.907 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 63.61 55.81 23.0 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.439 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -120.98 179.72 16.27 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.499 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -113.8 125.01 53.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 0.0 110.913 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.542 HG21 HD11 ' A' ' 334' ' ' LEU . 6.9 p -141.79 134.18 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 16.3 t -131.26 158.44 40.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.835 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 41.3 p90 -136.13 178.46 7.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.945 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 358' ' ' LYS . 0.6 OUTLIER -72.24 106.68 4.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.869 179.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 357' ' ' ASP . 0.1 OUTLIER -37.84 -45.61 0.86 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.918 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 58.8 m -42.09 -46.39 4.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 31.4 mt -60.01 -50.7 72.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 6.2 t -166.43 161.78 16.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 34.8 pt -64.21 175.34 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 364' ' ' ALA . . . 103.51 -35.07 5.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.508 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 363' ' ' GLY . . . -35.63 139.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.364 . . . . 0.0 111.087 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 37.2 p -113.37 -52.87 2.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.16 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -128.3 145.9 50.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.947 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -74.28 172.58 11.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.879 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 14.0 p -73.36 -14.12 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.135 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 41.3 p -96.94 19.65 12.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.144 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -95.79 105.95 18.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.832 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 8.4 t -47.05 -32.98 4.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . 0.417 ' HB3' ' CE ' ' A' ' 331' ' ' LYS . 9.0 mmt180 -41.95 -43.43 3.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.862 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 94.0 mt -49.62 135.9 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.112 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 77.2 p -106.21 -39.43 5.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.123 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -128.83 122.11 29.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.81 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -105.2 112.69 25.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . 0.467 HD13 HG23 ' A' ' 393' ' ' VAL . 49.6 mm -86.13 117.56 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.121 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 29.3 m -136.29 178.2 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.195 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -82.34 -43.91 16.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -125.51 82.2 63.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.573 0.702 . . . . 0.0 110.917 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -14.83 36.71 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.648 2.232 . . . . 0.0 112.354 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -72.78 -54.19 7.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.455 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -99.04 41.48 1.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.74 0.305 . . . . 0.0 110.893 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 385' ' ' THR . 4.3 tp-100 -122.76 100.86 7.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.969 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . 0.415 ' C ' ' O ' ' A' ' 384' ' ' GLN . 31.3 m -36.59 122.77 0.79 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.114 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 34.4 p -102.73 -179.64 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 59.7 t -130.93 141.05 47.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.093 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.6 mt -42.2 113.89 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.133 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 104.27 -44.72 1.42 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.503 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 25.2 ttp180 -81.11 139.81 35.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.817 0.341 . . . . 0.0 110.861 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 61.8 m -127.38 125.6 40.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . 0.407 ' CE2' ' HG3' ' A' ' 384' ' ' GLN . 2.8 m-85 -85.86 137.19 32.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.932 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.467 HG23 HD13 ' A' ' 377' ' ' ILE . 23.4 m -142.34 164.46 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.119 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -79.04 160.79 70.49 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.567 0.699 . . . . 0.0 110.93 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 -4.83 14.79 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.669 2.246 . . . . 0.0 112.383 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -79.27 -34.22 42.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -50.7 -35.69 32.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.923 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 44.1 t -65.66 -51.57 61.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.107 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -57.27 -36.92 71.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.882 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.456 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 11.2 m-20 -73.8 -40.39 63.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.853 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 1.9 m -72.55 -23.28 60.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.831 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.67 HG13 ' CZ ' ' A' ' 350' ' ' PHE . 2.2 t -87.25 -31.13 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.14 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -85.37 -24.76 27.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -95.52 8.97 41.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.066 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 404' ' ' ALA . 10.2 mmt85 37.15 42.72 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.877 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 21.2 tp -166.69 142.22 4.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.94 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.45 HD11 HD11 ' A' ' 330' ' ' LEU . 13.0 mt -69.19 102.87 1.78 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.456 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 17.8 mt -73.68 154.29 89.42 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.593 0.711 . . . . 0.0 110.912 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 108.4 2.06 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.714 2.276 . . . . 0.0 112.319 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . 0.407 ' HB ' HG11 ' A' ' 393' ' ' VAL . 28.0 m -53.52 -25.36 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.164 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -53.45 -16.16 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.074 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -95.03 -22.4 17.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.868 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -111.81 36.0 3.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.935 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 2.2 t80 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.921 -179.977 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.786 0.327 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 7.5 tp -65.15 -38.65 91.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -105.87 30.16 6.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -54.1 113.84 1.39 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 78.73 -45.35 2.68 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.517 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.432 HD22 ' CE1' ' A' ' 375' ' ' HIS . 15.8 mt -39.6 130.34 1.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.872 0.368 . . . . 0.0 110.912 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -98.97 152.14 20.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -144.65 148.38 34.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -135.59 116.69 14.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.915 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.662 HD22 HD13 ' A' ' 343' ' ' LEU . 2.6 mt -94.42 139.97 30.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -88.97 171.15 10.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.447 ' CB ' HD11 ' A' ' 360' ' ' LEU . 28.9 ptt180 -77.47 -9.89 59.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.845 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -87.31 -42.84 12.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 5.7 m -84.92 150.97 56.86 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.637 0.732 . . . . 0.0 111.105 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . 0.572 ' O ' HD12 ' A' ' 343' ' ' LEU . 53.9 Cg_endo -69.8 115.34 4.05 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.681 2.254 . . . . 0.0 112.307 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -94.56 -39.7 10.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -40.2 -36.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -86.66 -49.22 7.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.106 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . 0.662 HD13 HD22 ' A' ' 334' ' ' LEU . 30.8 mt -60.29 -61.78 2.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.945 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -38.73 -62.64 0.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.098 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -48.85 -42.01 34.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 347' ' ' ILE . 23.3 mt -65.81 -72.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.122 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . 0.46 ' N ' HG22 ' A' ' 346' ' ' ILE . 27.5 mt -38.95 -44.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.153 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -66.78 -42.68 85.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 8.9 t -65.74 -28.48 69.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.849 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . 0.474 ' CZ ' HG12 ' A' ' 402' ' ' VAL . 18.5 m-85 -88.6 12.85 13.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.835 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 68.93 50.65 33.6 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.488 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -132.35 156.55 22.08 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.434 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -91.52 132.39 36.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.909 0.385 . . . . 0.0 110.911 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.457 HG21 HD11 ' A' ' 334' ' ' LEU . 7.1 p -140.24 142.8 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.157 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 26.3 t -137.05 159.85 40.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -139.65 174.42 10.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.5 119.13 4.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.887 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.43 -8.72 14.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 4.3 t -88.64 -23.41 23.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.836 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.447 HD11 ' CB ' ' A' ' 336' ' ' ARG . 12.5 mt -75.38 -51.02 14.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 2.7 t -162.48 164.66 26.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.865 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.6 pt -62.47 172.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.137 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 364' ' ' ALA . . . 105.95 -42.87 1.8 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.49 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 363' ' ' GLY . . . -35.3 124.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.893 0.378 . . . . 0.0 111.106 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 41.5 p -97.15 -65.17 0.98 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.152 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -109.61 158.74 17.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 370' ' ' ASP . 3.0 m-20 -83.23 167.97 17.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.914 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.08 -28.77 37.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.108 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 60.8 p -83.0 20.42 1.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.167 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 367' ' ' ASP . 2.8 m-20 -92.36 98.92 11.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 372' ' ' ARG . 16.6 t -43.16 -42.65 4.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.841 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 371' ' ' SER . 48.2 mtp180 -37.45 -41.46 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 78.4 mt -45.92 123.72 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 70.4 p -84.69 -45.1 12.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.14 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . 0.524 ' CD2' ' SG ' ' A' ' 391' ' ' CYS . 51.5 m80 -133.05 141.58 48.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.911 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -123.62 116.71 23.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 49.6 mm -82.42 127.78 39.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.144 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 15.4 m -140.24 172.65 11.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.103 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -90.47 -42.97 10.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.798 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 11.5 ptt-85 -121.22 81.2 36.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.568 0.699 . . . . 0.0 110.846 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 3.07 3.01 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.661 2.241 . . . . 0.0 112.325 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -97.3 -28.14 8.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.477 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -77.28 -71.33 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.787 0.327 . . . . 0.0 110.896 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.574 ' OE1' ' CE2' ' A' ' 392' ' ' TYR . 3.2 pp0? -57.34 120.78 8.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 66.5 p -58.85 140.67 54.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.156 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 27.8 p -68.32 161.12 28.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 388' ' ' ILE . 42.0 t -120.96 121.44 65.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.082 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.422 ' C ' ' O ' ' A' ' 387' ' ' VAL . 10.0 mt -36.17 132.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.124 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 86.48 -48.65 3.94 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.457 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -85.88 138.49 31.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.324 . . . . 0.0 110.901 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' CYS . . . . . 0.524 ' SG ' ' CD2' ' A' ' 375' ' ' HIS . 6.3 p -118.65 129.73 55.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . 0.574 ' CE2' ' OE1' ' A' ' 384' ' ' GLN . 7.8 m-85 -98.23 126.76 43.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.633 HG11 ' HB ' ' A' ' 410' ' ' VAL . 34.4 m -136.08 146.92 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.075 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -61.67 161.14 22.11 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.632 0.729 . . . . 0.0 110.859 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.459 ' HB3' HD11 ' A' ' 343' ' ' LEU . 54.2 Cg_endo -69.75 -10.47 28.66 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.705 2.27 . . . . 0.0 112.335 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -76.02 -26.42 56.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 85.6 t90 -56.82 -23.58 44.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.898 ' O ' HG22 ' A' ' 402' ' ' VAL . 3.9 t -87.83 -53.87 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -50.24 -33.54 19.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -79.56 -51.21 9.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 69.9 m -54.4 -51.45 64.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.898 HG22 ' O ' ' A' ' 398' ' ' VAL . 5.3 m -54.79 -44.24 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.13 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -69.84 -35.26 74.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.848 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -87.98 9.01 23.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 39.13 38.3 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.936 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.468 ' C ' HD23 ' A' ' 406' ' ' LEU . 1.0 OUTLIER -153.68 153.5 32.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.941 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 29.1 mt -85.78 93.59 8.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.11 152.88 76.62 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.73 . . . . 0.0 110.896 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 116.28 4.49 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.642 2.228 . . . . 0.0 112.356 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . 0.633 ' HB ' HG11 ' A' ' 393' ' ' VAL . 32.2 m -60.19 -19.74 18.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -63.01 -21.38 66.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.066 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -86.98 -17.27 33.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.937 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -115.49 42.68 2.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 41.7 t80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.812 -179.963 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.821 0.343 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.459 ' CD1' ' HA ' ' A' ' 405' ' ' ARG . 2.1 tt -53.03 -40.92 64.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.934 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -101.63 40.53 1.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -79.14 123.76 27.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.935 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 70.8 50.41 24.53 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.497 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 72.5 mt -142.91 162.28 35.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.86 0.362 . . . . 0.0 110.934 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -131.07 123.16 28.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.93 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.534 ' CD1' ' HB2' ' A' ' 375' ' ' HIS . 78.6 m-85 -119.42 147.49 44.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -132.31 119.91 21.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.817 HD22 HD13 ' A' ' 343' ' ' LEU . 3.6 mt -99.13 148.46 24.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -104.28 175.51 5.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.673 ' HB3' HD11 ' A' ' 360' ' ' LEU . 30.8 ptt180 -71.27 -31.86 68.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.842 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -63.58 -45.42 90.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 2.9 m -82.17 149.61 62.7 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.642 0.735 . . . . 0.0 111.135 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . 0.412 ' O ' HD12 ' A' ' 343' ' ' LEU . 54.1 Cg_endo -69.76 111.82 2.91 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.688 2.259 . . . . 0.0 112.363 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 0.448 ' O ' ' C ' ' A' ' 341' ' ' GLU . 26.1 ttp85 -78.45 -49.13 14.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 340' ' ' ARG . 1.2 mt-10 -33.59 -69.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.894 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -57.76 -64.04 1.04 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.128 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . 0.817 HD13 HD22 ' A' ' 334' ' ' LEU . 29.2 mt -42.08 -70.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 343' ' ' LEU . . . -36.98 -66.53 0.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.096 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -44.01 -49.18 8.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 28.7 mt -57.76 -67.67 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.123 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 29.2 mt -42.48 -44.64 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.164 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . 0.411 ' NH1' ' HB3' ' A' ' 348' ' ' ARG . 10.3 mtp-105 -65.1 -49.23 70.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 13.2 t -57.26 -21.08 31.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -102.2 22.75 12.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 55.96 50.29 62.23 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.513 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -122.39 163.12 15.91 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.523 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -101.96 126.5 48.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 110.895 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.758 HG21 HD11 ' A' ' 334' ' ' LEU . 6.7 p -138.94 138.64 41.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.119 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . 0.445 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 7.4 t -131.23 161.63 31.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -139.34 174.64 10.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.511 ' HB3' HD12 ' A' ' 360' ' ' LEU . 28.4 t0 -64.24 107.55 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.852 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -42.39 -44.21 3.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 5.4 t -53.57 -52.34 60.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.673 HD11 ' HB3' ' A' ' 336' ' ' ARG . 41.7 mt -48.63 -51.09 29.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 2.7 m -158.41 166.08 33.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 20.9 tt -80.54 151.97 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 125.41 -36.61 2.74 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -40.81 145.88 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.868 0.366 . . . . 0.0 111.097 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.501 ' OG1' ' CD2' ' A' ' 366' ' ' TYR . 80.8 p -110.16 -64.25 1.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' TYR . . . . . 0.501 ' CD2' ' OG1' ' A' ' 365' ' ' THR . 2.2 p90 -106.55 159.07 16.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.17 168.22 19.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.892 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . 0.438 ' O ' HG22 ' A' ' 368' ' ' VAL . 8.2 p -76.26 -3.17 4.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.163 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 73.7 p -108.08 19.76 19.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.17 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -92.94 105.9 17.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.84 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 372' ' ' ARG . 75.3 m -41.12 -42.3 1.98 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.814 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 371' ' ' SER . 62.4 mtt180 -35.75 -44.0 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 85.6 mt -44.54 130.66 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 33.6 p -103.6 -33.1 9.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.126 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . 0.534 ' HB2' ' CD1' ' A' ' 332' ' ' PHE . 24.7 m80 -138.58 124.13 19.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.806 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -112.73 94.6 4.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . 0.588 HD13 HG23 ' A' ' 393' ' ' VAL . 16.1 mm -63.45 120.64 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.19 164.58 31.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.158 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -77.08 -44.77 29.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 27.3 mmm-85 -124.07 82.79 56.22 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.63 0.729 . . . . 0.0 110.847 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -14.0 35.55 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.676 2.25 . . . . 0.0 112.341 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -79.58 -32.89 36.22 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.515 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 384' ' ' GLN . 7.1 mm100 -84.98 -55.22 4.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.786 0.327 . . . . 0.0 110.91 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 383' ' ' GLN . 30.5 mm-40 -37.47 140.0 0.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 23.5 m -78.0 91.07 4.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.142 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 94.1 p -44.18 156.4 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.84 127.08 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.134 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 18.7 mm -39.99 129.27 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.12 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 91.97 -40.22 2.93 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.549 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -91.27 146.53 23.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.792 0.33 . . . . 0.0 110.881 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 18.4 m -124.17 124.06 41.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -90.22 125.49 35.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.588 HG23 HD13 ' A' ' 377' ' ' ILE . 15.2 m -130.59 167.41 25.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.127 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -88.21 161.05 44.44 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.614 0.721 . . . . 0.0 110.876 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.477 ' HB3' HD11 ' A' ' 343' ' ' LEU . 53.7 Cg_endo -69.79 -5.33 15.98 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.646 2.231 . . . . 0.0 112.353 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 -81.03 -23.68 38.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -62.53 -35.65 80.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.917 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.676 ' O ' HG22 ' A' ' 402' ' ' VAL . 65.7 t -66.68 -61.6 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.132 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 7.9 m-30 -48.14 -31.64 5.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.449 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 3.0 m-20 -76.85 -41.97 41.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 50.6 m -65.9 -52.37 50.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.824 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 398' ' ' VAL . 4.5 m -54.59 -33.43 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.174 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -87.43 -18.29 30.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.849 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -102.93 9.26 38.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.108 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . 0.459 ' HA ' ' CD1' ' A' ' 326' ' ' LEU . 9.7 mpt_? 39.59 30.38 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 13.0 tp -149.19 164.2 35.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 408' ' ' LEU . 94.2 mt -97.61 68.12 2.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.449 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 27.9 mt -35.41 153.33 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.564 0.697 . . . . 0.0 110.94 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 114.84 3.83 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.701 2.267 . . . . 0.0 112.399 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.8 m -53.5 -22.17 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.124 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -54.22 -42.96 70.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.086 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -70.09 -8.15 47.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -127.32 43.91 3.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.988 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 91.6 t80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.864 -179.936 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.834 0.349 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.02 -44.12 94.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -103.46 40.0 1.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -76.06 130.32 38.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 62.84 50.46 63.62 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.502 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 82.5 mt -146.08 120.27 9.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.842 0.353 . . . . 0.0 110.905 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -95.1 120.62 35.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -112.43 159.42 18.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' PHE . . . . . 0.464 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 35.4 t80 -141.69 116.71 9.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.872 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.775 HD22 HD13 ' A' ' 343' ' ' LEU . 3.8 mt -94.05 148.77 21.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.927 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -96.16 179.25 5.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.588 ' HB3' HD11 ' A' ' 360' ' ' LEU . 18.4 ptt85 -73.69 -39.88 64.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.4 -49.3 76.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.1 m -69.24 150.39 97.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.65 0.738 . . . . 0.0 111.14 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 122.16 8.85 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.701 2.268 . . . . 0.0 112.341 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' A' ' 344' ' ' ALA . 5.5 tmm_? -89.6 -37.4 14.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -60.02 -38.55 83.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.934 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.82 -59.65 2.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.087 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . 0.775 HD13 HD22 ' A' ' 334' ' ' LEU . 51.5 mt -56.44 -59.2 5.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 340' ' ' ARG . . . -43.96 -56.89 3.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -54.11 -42.9 69.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.832 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 347' ' ' ILE . 17.1 mt -66.92 -70.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.117 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . 0.413 ' N ' HG22 ' A' ' 346' ' ' ILE . 37.7 mt -43.69 -37.25 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.153 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -73.2 -37.2 66.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 7.4 m -72.57 -30.2 64.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . 0.52 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 15.3 m-85 -85.87 7.0 25.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.858 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 72.58 59.07 4.63 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.495 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -138.85 156.36 24.24 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.513 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -92.16 133.38 35.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.92 0.39 . . . . 0.0 110.871 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.454 HG21 HD11 ' A' ' 334' ' ' LEU . 7.3 p -143.6 138.7 25.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.126 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . 0.533 ' HB2' ' CE1' ' A' ' 366' ' ' TYR . 5.1 t -134.05 157.28 46.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.863 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 22.6 p90 -141.03 177.14 8.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.39 111.31 4.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -50.33 -39.7 46.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 28.1 t -48.61 -47.96 39.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.588 HD11 ' HB3' ' A' ' 336' ' ' ARG . 76.0 mt -60.5 -47.03 87.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.904 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 1.8 m -166.64 137.37 3.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 26.1 pt -60.53 168.6 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 113.19 -36.96 3.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.501 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -45.45 166.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.853 0.358 . . . . 0.0 111.109 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.482 ' OG1' ' CD2' ' A' ' 366' ' ' TYR . 71.6 p -116.8 -68.94 0.88 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.12 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' TYR . . . . . 0.533 ' CE1' ' HB2' ' A' ' 355' ' ' SER . 0.9 OUTLIER -101.54 159.96 14.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.957 -179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -86.94 167.26 14.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.866 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . 0.464 ' HB ' ' CZ ' ' A' ' 333' ' ' PHE . 11.7 p -69.68 -30.3 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.109 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.5 p -83.49 20.61 1.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.139 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -95.06 121.76 37.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 99.0 p -69.78 -18.68 63.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 27.5 mtt-85 -57.33 -33.32 67.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.865 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 71.4 mt -54.64 144.26 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 25.7 p -104.48 -42.04 5.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.145 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -128.54 133.0 48.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.847 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' GLN . . . . . 0.41 ' CD ' ' CZ ' ' A' ' 392' ' ' TYR . 24.9 tt0 -113.56 104.71 12.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 9.2 mm -77.56 123.04 33.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 18.3 m -135.79 148.48 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.113 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -56.33 -39.01 72.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -148.14 104.98 3.59 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.591 0.71 . . . . 0.0 110.855 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.73 -6.38 18.44 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.69 2.26 . . . . 0.0 112.38 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 383' ' ' GLN . . . -83.21 -68.69 1.41 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 382' ' ' GLY . 12.3 mm100 -36.43 -49.64 0.73 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.696 0.284 . . . . 0.0 110.885 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -98.62 143.43 29.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 69.3 p -90.09 127.48 36.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.141 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . 0.453 ' HB2' ' CD1' ' A' ' 392' ' ' TYR . 90.4 p -62.81 159.25 16.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 88.0 t -90.3 148.52 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.111 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 6.4 mm -54.81 129.42 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.148 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 92.06 -42.44 2.75 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.498 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -85.59 146.04 27.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.765 0.317 . . . . 0.0 110.829 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 81.6 m -113.39 132.06 55.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . 0.453 ' CD1' ' HB2' ' A' ' 386' ' ' SER . 3.3 m-85 -104.13 125.3 50.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.59 HG11 ' HB ' ' A' ' 410' ' ' VAL . 6.0 m -131.64 149.7 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -63.49 158.91 55.29 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.656 0.741 . . . . 0.0 110.859 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -6.95 19.85 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.706 2.271 . . . . 0.0 112.342 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -81.39 -26.17 35.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' TRP . . . . . 0.508 ' CE2' HG12 ' A' ' 410' ' ' VAL . 81.8 t90 -54.13 -43.53 70.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.433 ' O ' HG22 ' A' ' 402' ' ' VAL . 85.5 t -65.24 -47.67 86.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.114 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -58.93 -33.19 70.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.538 ' CB ' ' CD1' ' A' ' 408' ' ' LEU . 61.6 m-20 -75.95 -31.24 58.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 26.2 m -72.84 -51.65 17.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.847 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.52 ' HB ' ' CZ ' ' A' ' 350' ' ' PHE . 12.5 m -56.13 -40.5 64.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.094 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -67.36 -40.78 85.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -92.15 14.32 16.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 404' ' ' ALA . 1.2 mpp_? 34.3 40.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.859 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.763 HD13 ' N ' ' A' ' 407' ' ' LEU . 0.6 OUTLIER -156.63 149.3 23.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.763 ' N ' HD13 ' A' ' 406' ' ' LEU . 50.0 mt -75.69 103.45 5.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.538 ' CD1' ' CB ' ' A' ' 400' ' ' ASP . 12.4 mt -70.8 155.35 93.51 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.587 0.708 . . . . 0.0 110.934 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 105.3 1.46 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.658 2.239 . . . . 0.0 112.362 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . 0.59 ' HB ' HG11 ' A' ' 393' ' ' VAL . 34.5 m -56.07 -16.63 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.135 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.11 93.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -71.18 -12.31 61.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.869 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -119.62 30.31 7.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.888 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 81.2 t80 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.892 179.995 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 36.8 mmtt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.824 0.345 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 2.1 tt -70.01 -49.23 53.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.982 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -106.59 37.82 2.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -57.15 116.07 3.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 77.68 -50.81 3.31 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.494 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 329' ' ' GLY . 19.3 mt -34.65 127.66 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.886 0.374 . . . . 0.0 110.943 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -104.11 146.77 28.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -138.72 155.12 48.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -137.37 116.61 12.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.855 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.65 HD13 ' HA ' ' A' ' 340' ' ' ARG . 3.0 mt -92.52 144.86 24.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.931 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -89.4 -177.67 5.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.635 ' HB3' HD11 ' A' ' 360' ' ' LEU . 14.0 ptt-85 -80.7 -34.79 34.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -67.16 -42.56 84.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.496 HG12 ' OD2' ' A' ' 379' ' ' ASP . 4.3 m -78.89 150.02 74.68 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.61 0.719 . . . . 0.0 111.145 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 110.95 2.67 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.671 2.248 . . . . 0.0 112.39 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 0.65 ' HA ' HD13 ' A' ' 334' ' ' LEU . 6.2 ppt_? -85.57 -36.11 20.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.449 ' N ' ' HD2' ' A' ' 340' ' ' ARG . 9.3 pt-20 -54.0 -39.41 66.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -79.51 -64.67 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.084 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 32.0 mt -50.07 -60.04 3.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.922 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 340' ' ' ARG . . . -42.4 -56.28 3.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.08 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -54.79 -45.98 74.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.914 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' ILE . . . . . 0.427 ' CG2' HG11 ' A' ' 402' ' ' VAL . 19.8 mt -60.63 -62.35 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.123 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 23.9 mt -51.9 -43.85 36.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.118 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 70.1 mtp85 -67.01 -32.36 73.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.859 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 26.3 t -74.41 -39.58 62.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . 0.543 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 20.5 m-85 -75.15 -5.59 45.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.905 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 89.0 55.21 2.16 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.462 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -134.34 163.64 24.61 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.512 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -95.69 126.51 41.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.91 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.428 HG11 ' HA ' ' A' ' 344' ' ' ALA . 12.0 p -142.37 141.13 28.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.15 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 18.2 t -143.99 151.95 40.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 31.7 p90 -129.04 172.92 10.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.919 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -59.29 111.26 1.29 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.447 ' HG2' ' HB3' ' A' ' 364' ' ' ALA . 40.1 mtpt -44.58 -36.77 3.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.4 t -58.1 -50.9 71.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.635 HD11 ' HB3' ' A' ' 336' ' ' ARG . 38.6 mt -48.55 -47.7 39.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.911 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 5.0 t -171.69 145.8 2.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.86 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.3 pt -59.87 166.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.091 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 114.63 -35.21 4.52 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.475 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.447 ' HB3' ' HG2' ' A' ' 358' ' ' LYS . . . -51.99 158.77 0.99 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.872 0.367 . . . . 0.0 111.101 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 6.1 p -115.14 -65.7 1.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.166 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -107.56 152.36 24.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.426 ' O ' HD11 ' A' ' 373' ' ' ILE . 64.0 m-20 -81.35 173.27 12.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.826 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 12.2 p -69.29 -21.19 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.086 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.6 p -87.34 25.22 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.095 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . 0.423 ' OD2' ' N ' ' A' ' 367' ' ' ASP . 6.6 m-20 -103.27 104.36 14.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 372' ' ' ARG . 11.8 t -39.92 -42.13 1.29 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 371' ' ' SER . 24.8 mmt180 -35.67 -45.54 0.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.873 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.426 HD11 ' O ' ' A' ' 367' ' ' ASP . 41.1 mt -46.6 124.97 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.08 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 44.3 p -97.17 -46.61 6.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.165 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -124.32 141.04 52.39 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.881 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -120.8 111.02 17.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 39.6 mm -76.27 124.9 35.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.083 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 34.5 m -145.08 152.33 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.133 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . 0.496 ' OD2' HG12 ' A' ' 338' ' ' VAL . 2.9 m-20 -73.37 -37.37 66.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -127.29 86.03 59.62 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.653 0.74 . . . . 0.0 110.891 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 3.22 2.86 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.692 2.261 . . . . 0.0 112.348 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -100.74 -42.8 2.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.52 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -55.13 -68.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.776 0.322 . . . . 0.0 110.956 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.429 ' NE2' ' CD2' ' A' ' 392' ' ' TYR . 4.2 pp0? -63.53 151.67 40.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 98.9 m -89.8 119.87 30.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.185 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 60.6 p -55.15 161.48 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.836 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 71.0 t -108.46 120.36 59.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.141 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 5.0 mt -39.31 104.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.156 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 119.07 -43.18 1.63 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.48 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' ARG . . . . . 0.412 ' NH1' ' HB ' ' A' ' 373' ' ' ILE . 11.8 ttm-85 -80.53 158.19 25.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.741 0.305 . . . . 0.0 110.907 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 55.8 m -126.06 128.88 48.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.891 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . 0.429 ' CD2' ' NE2' ' A' ' 384' ' ' GLN . 3.0 m-85 -105.65 132.47 51.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.907 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.469 HG11 ' CG1' ' A' ' 410' ' ' VAL . 14.2 m -143.39 147.38 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.127 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -55.12 156.21 7.71 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.59 0.709 . . . . 0.0 110.952 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -3.93 12.98 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.359 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 41.5 tp60 -85.13 -28.98 25.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.937 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -48.74 -28.14 3.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.865 ' O ' HG22 ' A' ' 402' ' ' VAL . 56.3 t -85.44 -29.58 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.105 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -72.73 -37.2 67.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.906 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . 0.669 ' OD1' HD12 ' A' ' 408' ' ' LEU . 0.8 OUTLIER -84.34 -23.2 30.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.927 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 3.2 m -81.09 -47.85 12.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.865 HG22 ' O ' ' A' ' 398' ' ' VAL . 13.2 m -57.5 -36.88 55.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.156 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -69.9 -34.39 73.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -95.66 15.08 20.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.081 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 404' ' ' ALA . 9.9 mmt85 35.89 39.73 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.892 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 27.5 tp -147.89 163.29 37.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 42.1 mt -95.0 81.02 3.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.669 HD12 ' OD1' ' A' ' 400' ' ' ASP . 62.7 mt -47.71 155.67 0.77 Allowed Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.605 0.716 . . . . 0.0 110.916 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 118.07 5.46 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.668 2.245 . . . . 0.0 112.326 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . 0.469 ' CG1' HG11 ' A' ' 393' ' ' VAL . 23.2 m -58.54 -31.28 43.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.144 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -42.88 -52.55 5.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.128 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -59.07 -39.68 82.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.471 ' CZ ' ' OD2' ' A' ' 400' ' ' ASP . 68.6 m-85 -95.21 45.76 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 31.8 t80 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.823 0.344 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 14.3 tp -42.4 -37.7 1.65 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.888 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -116.96 50.02 1.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -87.87 137.72 32.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 58.11 41.73 94.77 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.491 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 72.5 mt -141.38 120.22 12.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.902 0.382 . . . . 0.0 110.945 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -93.94 117.25 29.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -105.86 158.44 16.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -141.1 119.86 12.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.883 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.684 HD22 HD13 ' A' ' 343' ' ' LEU . 14.6 mt -95.53 142.67 27.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.916 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -100.9 179.32 4.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.867 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.437 ' HG2' ' N ' ' A' ' 337' ' ' GLU . 0.0 OUTLIER -78.24 -29.21 48.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.847 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . 0.437 ' N ' ' HG2' ' A' ' 336' ' ' ARG . 20.8 tt0 -72.48 -15.69 61.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 10.6 m -110.02 150.98 42.18 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.636 0.731 . . . . 0.0 111.109 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 115.49 4.11 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.695 2.263 . . . . 0.0 112.354 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 0.429 ' HB3' ' NH1' ' A' ' 340' ' ' ARG . 19.5 ttp-105 -77.04 -69.69 0.51 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 340' ' ' ARG . 8.3 pt-20 -35.07 -44.58 0.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.17 -64.14 0.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.099 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . 0.684 HD13 HD22 ' A' ' 334' ' ' LEU . 36.6 mt -59.35 -63.16 1.4 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.903 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 343' ' ' LEU . . . -36.84 -51.86 0.91 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.073 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -59.14 -40.05 84.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' ILE . . . . . 0.767 HD11 ' CE1' ' A' ' 399' ' ' PHE . 27.5 mt -67.24 -64.21 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 24.9 mt -48.08 -41.73 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -68.4 -39.25 81.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 12.1 t -68.17 -22.99 64.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -105.48 22.52 15.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 57.46 63.75 5.01 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.471 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -133.81 155.79 21.97 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.503 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -92.25 130.98 37.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.861 0.362 . . . . 0.0 110.908 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.544 HG21 HD11 ' A' ' 334' ' ' LEU . 7.4 p -146.39 132.2 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 9.6 t -130.06 163.46 26.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' TRP . . . . . 0.406 ' CD1' ' HB2' ' A' ' 364' ' ' ALA . 18.4 p90 -135.04 178.69 6.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.865 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.605 ' HB3' HD12 ' A' ' 360' ' ' LEU . 7.7 t70 -70.94 105.89 3.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 357' ' ' ASP . 70.3 mttt -35.47 -44.15 0.28 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.896 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 28.7 t -58.69 -52.95 63.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.834 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.605 HD12 ' HB3' ' A' ' 357' ' ' ASP . 18.5 mt -50.87 -49.44 59.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 3.0 m -160.35 145.35 14.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.3 pt -72.22 176.72 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 92.82 -15.85 61.7 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.48 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.406 ' HB2' ' CD1' ' A' ' 356' ' ' TRP . . . -56.75 -177.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.908 0.385 . . . . 0.0 111.099 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 72.7 p -131.47 -66.72 0.72 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -117.53 157.0 27.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.433 ' O ' HD11 ' A' ' 373' ' ' ILE . 1.1 m-20 -90.64 168.97 11.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' VAL . . . . . 0.433 ' HA ' ' CD1' ' A' ' 373' ' ' ILE . 9.9 p -66.24 -22.46 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 61.1 p -84.68 26.27 0.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -110.75 109.44 19.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 67.7 m -47.2 -38.23 11.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -40.15 -41.86 1.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' ILE . . . . . 0.433 ' CD1' ' HA ' ' A' ' 368' ' ' VAL . 86.8 mt -41.94 138.65 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.137 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 42.2 p -108.48 -26.82 10.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.15 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -153.44 133.07 13.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.853 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' GLN . . . . . 0.569 ' OE1' HG13 ' A' ' 378' ' ' VAL . 1.0 OUTLIER -112.33 94.06 4.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 30.2 mm -55.78 98.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.121 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . 0.569 HG13 ' OE1' ' A' ' 376' ' ' GLN . 26.8 m -122.02 140.32 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.138 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . 0.433 ' OD1' ' C ' ' A' ' 379' ' ' ASP . 4.3 t0 -48.04 -43.39 30.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.901 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -129.45 86.93 54.7 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.635 0.731 . . . . 0.0 110.823 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -9.74 26.83 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.687 2.258 . . . . 0.0 112.365 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -85.4 -39.41 8.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.504 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -73.31 -52.52 13.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.712 0.292 . . . . 0.0 110.91 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -45.51 142.01 2.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 57.9 m -71.15 101.17 2.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.106 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 24.9 p -53.56 167.71 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.817 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 389' ' ' GLY . 81.9 t -130.64 134.58 61.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.131 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.54 HG22 ' O ' ' A' ' 388' ' ' ILE . 15.3 mm -56.98 86.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.09 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 387' ' ' VAL . . . 135.06 -27.36 3.16 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.506 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -99.96 156.66 17.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.851 0.357 . . . . 0.0 110.855 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 72.3 m -129.73 123.87 32.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -97.37 121.58 39.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 21.8 m -126.83 164.01 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.144 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -87.49 161.36 45.66 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.606 0.717 . . . . 0.0 110.902 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -4.64 14.42 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.706 2.271 . . . . 0.0 112.348 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -82.99 -14.17 54.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -77.73 -13.77 59.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.827 ' O ' HG22 ' A' ' 402' ' ' VAL . 42.1 t -89.18 -41.15 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.154 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . 0.767 ' CE1' HD11 ' A' ' 346' ' ' ILE . 47.8 m-85 -71.8 -34.37 69.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.859 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.32 -45.7 53.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.884 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 2.6 m -62.6 -56.25 19.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.827 HG22 ' O ' ' A' ' 398' ' ' VAL . 15.4 m -50.64 -42.54 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -70.62 -37.96 73.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.928 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -89.87 10.73 22.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 404' ' ' ALA . 46.8 mmm-85 37.21 44.05 0.4 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 28.7 tp -153.69 142.68 21.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 20.4 mt -80.73 73.95 7.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 75.4 mt -40.69 152.35 0.24 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.605 0.717 . . . . 0.0 110.91 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 105.6 1.51 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.688 2.259 . . . . 0.0 112.353 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.8 m -50.78 -22.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.111 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -50.94 -35.83 35.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.122 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -69.39 -38.28 77.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.942 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -90.81 41.57 1.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.908 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 16.5 t80 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.944 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 48.0 m -128.21 138.03 52.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.812 0.339 . . . . 0.0 110.885 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 16.6 m -110.89 166.91 10.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.857 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 154.88 152.1 6.04 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.459 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 4.9 t -93.38 159.33 15.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.861 0.362 . . . . 0.0 110.873 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 96.7 p -104.94 -45.96 4.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.822 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 166.61 -70.05 0.18 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.468 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 29.6 mmtm -130.0 175.9 8.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.769 0.319 . . . . 0.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -102.73 52.07 0.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.834 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -128.33 92.1 3.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -132.38 145.94 51.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 1.9 tt -67.54 -35.14 78.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -112.94 37.28 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -59.81 112.66 1.92 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 83.61 -49.19 4.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.453 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 330' ' ' LEU . 12.5 mt -35.41 129.72 0.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 110.946 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -103.07 130.15 50.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.864 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -121.53 164.46 17.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -143.02 139.22 30.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.43 HD11 HG21 ' A' ' 354' ' ' VAL . 3.5 mt -116.22 146.21 42.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -104.94 169.67 8.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -71.46 -13.28 61.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.837 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -82.97 -45.77 13.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.3 m -84.36 150.6 57.75 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.618 0.723 . . . . 0.0 111.102 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 120.7 7.44 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.658 2.239 . . . . 0.0 112.382 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 5.9 ptt180 -93.78 -38.4 11.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -45.44 -37.59 5.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -86.25 -57.43 3.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.08 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 89.3 mt -54.2 -60.42 3.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -42.11 -64.8 0.53 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.092 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -47.79 -40.69 21.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 347' ' ' ILE . 16.6 mt -66.41 -72.42 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.13 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . 0.451 ' N ' HG22 ' A' ' 346' ' ' ILE . 22.4 mt -40.48 -38.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -67.2 -53.67 28.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 11.0 p -55.03 -36.27 65.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -80.72 11.35 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.857 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 65.96 48.83 62.64 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.536 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -122.13 160.77 16.49 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.476 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -93.57 131.11 39.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.906 0.384 . . . . 0.0 110.886 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.43 HG21 HD11 ' A' ' 334' ' ' LEU . 14.1 p -147.82 134.21 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.144 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . 0.53 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 23.1 t -137.82 158.23 44.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 29.0 p90 -130.44 168.24 17.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.938 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.534 ' CB ' HD12 ' A' ' 360' ' ' LEU . 3.1 t70 -56.57 122.03 11.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.819 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -51.7 -48.44 63.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 40.2 t -57.73 -48.48 79.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.534 HD12 ' CB ' ' A' ' 357' ' ' ASP . 32.6 mt -50.45 -51.18 49.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.93 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 4.7 m -160.23 139.23 10.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 12.6 pt -66.66 156.55 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.131 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 108.49 14.72 15.31 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.486 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -97.82 162.42 13.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.916 0.389 . . . . 0.0 111.067 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 19.5 p -116.22 -68.41 0.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.159 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' TYR . . . . . 0.53 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 9.6 p90 -99.99 147.28 25.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.906 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.97 175.86 9.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.842 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . 0.634 ' O ' HG22 ' A' ' 368' ' ' VAL . 7.9 p -75.26 3.24 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.09 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 74.6 p -112.15 27.54 9.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.121 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -104.69 101.55 11.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 9.7 m -42.66 -35.13 1.03 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.819 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -40.9 -43.68 2.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.817 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 66.1 mt -44.17 125.33 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.148 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 43.0 p -92.84 -45.05 8.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.133 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -127.41 135.84 51.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' GLN . . . . . 0.576 ' NE2' ' CE2' ' A' ' 392' ' ' TYR . 40.6 tt0 -120.33 123.84 44.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 33.0 mm -92.32 133.75 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.153 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 19.4 m -149.99 153.03 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -76.16 -28.94 57.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -134.73 80.85 48.79 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.592 0.711 . . . . 0.0 110.87 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -18.25 37.27 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.678 2.252 . . . . 0.0 112.299 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -77.52 -64.32 2.09 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.488 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -42.3 -57.72 2.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.797 0.332 . . . . 0.0 110.909 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -79.86 129.04 34.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.943 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 70.6 p -63.1 -179.85 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.121 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 25.3 p -110.98 178.87 4.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 49.0 t -125.29 137.97 55.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.107 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.0 mt -44.12 123.34 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.106 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 89.26 -44.29 3.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.561 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -82.16 137.41 34.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.827 0.346 . . . . 0.0 110.889 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 23.5 m -120.61 117.38 27.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . 0.576 ' CE2' ' NE2' ' A' ' 376' ' ' GLN . 9.7 m-85 -80.79 145.64 31.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.942 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 31.3 m -150.56 165.33 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.115 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -78.39 158.18 76.84 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.6 0.715 . . . . 0.0 110.894 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -4.36 13.91 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.675 2.25 . . . . 0.0 112.351 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -86.74 -23.85 25.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -59.82 -33.37 71.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 75.4 t -76.16 -47.2 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.138 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -58.35 -36.5 73.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.866 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.85 -27.38 60.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 40.4 m -76.13 -51.27 12.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 14.8 m -53.5 -41.98 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.157 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -69.27 -34.78 75.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -93.07 3.28 56.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 42.58 44.72 3.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.449 ' HG ' ' N ' ' A' ' 407' ' ' LEU . 18.6 tp -160.86 154.84 22.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.906 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.449 ' N ' ' HG ' ' A' ' 406' ' ' LEU . 97.3 mt -84.9 99.68 11.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.01 154.97 91.43 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.597 0.713 . . . . 0.0 110.902 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 105.73 1.54 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.711 2.274 . . . . 0.0 112.33 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.2 m -53.9 -16.62 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -58.27 -23.85 57.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.103 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -86.0 -31.65 21.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.908 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -102.6 39.85 1.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 43.2 t80 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 82.9 p -170.31 133.6 1.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.862 0.363 . . . . 0.0 110.911 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 47.5 t -88.88 160.55 17.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.888 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 125.3 134.57 4.17 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.524 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 77.2 p -42.47 143.44 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.882 0.373 . . . . 0.0 110.911 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 62.9 m -117.82 135.53 54.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.824 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -121.34 -77.43 0.46 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.535 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt -73.19 161.0 31.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.855 0.36 . . . . 0.0 110.883 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -118.43 40.85 3.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -146.17 146.05 30.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -134.53 142.9 47.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.88 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.445 ' O ' HD13 ' A' ' 326' ' ' LEU . 1.3 tm? -54.26 -41.76 69.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -112.89 47.86 1.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -72.87 138.09 46.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.885 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 49.03 60.0 6.44 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.5 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 90.6 mt -150.17 121.39 7.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.823 0.344 . . . . 0.0 110.935 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -99.5 123.36 43.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -115.12 164.09 14.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -138.2 117.03 12.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.864 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.669 HD11 HG21 ' A' ' 354' ' ' VAL . 4.7 mt -93.02 141.38 28.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.92 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -95.81 -177.18 3.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -85.66 -20.84 28.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.831 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -78.6 -18.32 54.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 6.0 m -108.12 150.61 40.66 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.595 0.712 . . . . 0.0 111.126 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 119.22 6.2 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.685 2.257 . . . . 0.0 112.346 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 0.488 ' HG3' HD12 ' A' ' 334' ' ' LEU . 34.3 ttp180 -85.41 -56.78 3.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 340' ' ' ARG . 6.8 pt-20 -36.84 -39.58 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.909 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -79.0 -64.55 1.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.092 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . 0.411 HD21 ' CE2' ' A' ' 399' ' ' PHE . 52.6 mt -57.2 -61.67 2.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.894 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -41.54 -48.65 3.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.125 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -63.59 -48.97 75.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 16.8 mt -55.25 -64.82 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.159 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 32.7 mt -50.42 -47.66 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -64.6 -24.22 67.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 23.2 t -84.52 -29.7 25.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -83.53 -8.99 59.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 93.1 42.63 4.29 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.486 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -122.97 164.34 15.97 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.501 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -93.29 135.04 34.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 110.949 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.669 HG21 HD11 ' A' ' 334' ' ' LEU . 12.6 p -149.88 125.84 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.158 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 2.0 t -128.24 161.18 29.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 41.0 p90 -138.7 171.92 13.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.951 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -67.73 111.17 4.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -42.58 -54.26 4.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.4 t -41.47 -59.61 1.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 9.0 mt -51.65 -50.71 59.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 4.8 m -154.39 141.88 19.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 20.7 pt -73.92 -175.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.15 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 86.43 -15.39 50.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.451 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -63.73 166.3 7.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 0.0 111.105 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 41.0 p -117.32 -70.51 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.169 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -109.52 139.06 44.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.939 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.56 169.76 15.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.83 -19.48 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.153 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 62.7 p -84.44 26.3 0.8 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.14 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -115.05 121.09 42.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.7 t -58.41 -36.12 73.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -38.92 -40.42 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.928 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 49.8 mt -46.34 138.32 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 26.5 p -113.57 -22.85 10.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.15 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -150.26 155.33 39.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' GLN . . . . . 0.467 ' HG2' HG13 ' A' ' 378' ' ' VAL . 17.3 tt0 -135.79 111.88 9.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.95 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . 0.869 HD13 HG23 ' A' ' 393' ' ' VAL . 46.8 mm -82.75 113.74 22.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.155 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.467 HG13 ' HG2' ' A' ' 376' ' ' GLN . 29.2 m -131.34 148.08 32.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.11 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -62.25 -42.93 99.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -131.93 82.19 60.42 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.593 0.711 . . . . 0.0 110.931 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.444 ' HB3' ' CG2' ' A' ' 378' ' ' VAL . 53.5 Cg_endo -69.76 -13.86 35.26 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.686 2.257 . . . . 0.0 112.352 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -73.92 -44.83 29.25 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.522 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . 0.415 ' HG3' ' N ' ' A' ' 384' ' ' GLN . 3.1 pt20 -62.27 -37.34 85.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.737 0.303 . . . . 0.0 110.885 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.415 ' N ' ' HG3' ' A' ' 383' ' ' GLN . 7.8 pt20 -98.34 118.07 34.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 44.7 p -50.49 175.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . 0.518 ' HA ' ' CE1' ' A' ' 392' ' ' TYR . 1.9 t -104.81 178.66 4.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 74.4 t -119.56 136.23 57.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.149 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 5.9 mm -51.21 103.97 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 109.44 -28.34 11.02 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.497 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -105.96 148.77 27.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.787 0.327 . . . . 0.0 110.858 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 63.7 m -125.17 131.29 53.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . 0.518 ' CE1' ' HA ' ' A' ' 386' ' ' SER . 24.9 m-85 -91.43 131.74 36.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.869 HG23 HD13 ' A' ' 377' ' ' ILE . 11.3 m -130.0 166.99 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.107 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -86.73 161.36 47.92 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.603 0.716 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -7.42 21.01 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.684 2.256 . . . . 0.0 112.328 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -80.86 -24.4 38.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.885 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' TRP . . . . . 0.415 ' CH2' HD22 ' A' ' 407' ' ' LEU . 41.5 t90 -59.1 -42.14 89.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.617 ' O ' HG22 ' A' ' 402' ' ' VAL . 96.1 t -67.68 -58.37 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.156 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . 0.411 ' CE2' HD21 ' A' ' 343' ' ' LEU . 59.7 m-85 -52.31 -26.53 12.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.419 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 24.2 t0 -85.07 -49.97 7.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.861 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 15.4 m -56.75 -51.25 69.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.859 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 398' ' ' VAL . 27.7 m -55.53 -40.31 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.147 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . 0.409 ' N ' HG23 ' A' ' 402' ' ' VAL . 18.7 m-20 -80.21 -9.14 59.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -113.14 8.6 18.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 404' ' ' ALA . 1.3 mpt_? 34.42 42.64 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 7.5 tp -162.8 144.28 10.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.868 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 407' ' ' LEU . 12.4 mt -72.6 89.49 1.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.933 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.419 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 35.9 mt -56.62 154.34 17.86 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.569 0.699 . . . . 0.0 110.971 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 108.76 2.15 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.705 2.27 . . . . 0.0 112.348 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.3 m -57.19 -21.71 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.115 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -58.11 -12.0 3.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.105 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.39 -27.89 14.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -108.65 37.01 2.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 5.5 t80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.877 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 68.8 m 41.69 48.29 3.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.895 0.379 . . . . 0.0 110.868 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 20.7 m -104.3 -49.97 3.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.846 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 59.36 170.59 0.37 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.468 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 1.2 t -108.97 170.67 7.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.837 0.351 . . . . 0.0 110.879 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.1 t -110.47 41.77 1.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 69.18 -100.79 0.74 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.469 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -138.87 119.6 14.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 0.0 110.908 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -125.57 171.59 10.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.869 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -125.72 115.67 20.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -110.9 129.88 55.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 13.8 tp -49.23 -53.46 21.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.894 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . 0.418 ' HA ' HD12 ' A' ' 330' ' ' LEU . 16.6 m-85 -96.75 41.86 1.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -71.93 138.01 47.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 47.24 51.43 14.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.482 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 327' ' ' PHE . 58.0 mt -139.43 122.18 16.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 0.0 110.924 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -93.98 129.25 40.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.891 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -125.81 152.19 45.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.878 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -131.91 136.01 47.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.5 HD12 ' HG3' ' A' ' 340' ' ' ARG . 8.0 mt -112.46 137.53 50.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -85.7 -178.23 6.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -81.68 -23.4 36.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -77.48 -44.49 28.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.6 m -75.33 149.53 84.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.644 0.735 . . . . 0.0 111.103 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 124.74 11.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.65 2.234 . . . . 0.0 112.334 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 0.5 ' HG3' HD12 ' A' ' 334' ' ' LEU . 19.2 ttp180 -89.82 -60.12 2.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -38.07 -39.57 0.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.46 -60.11 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.084 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 49.4 mt -60.28 -63.42 1.3 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -39.84 -55.07 2.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.129 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -55.63 -44.53 77.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.868 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 18.5 mt -63.13 -67.92 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.129 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 33.5 mt -46.88 -42.42 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.108 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -68.95 -30.2 68.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 29.2 t -78.2 -34.05 49.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.892 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . 0.433 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 14.9 m-85 -83.42 7.62 16.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.857 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 76.36 63.96 2.27 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.55 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -145.42 154.75 26.13 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.516 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -92.57 125.66 37.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.879 0.371 . . . . 0.0 110.883 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.42 HG21 HD11 ' A' ' 334' ' ' LEU . 7.0 p -131.66 140.95 46.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.111 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 32.5 t -132.39 159.29 39.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.847 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' TRP . . . . . 0.434 ' CD1' ' SG ' ' A' ' 361' ' ' CYS . 48.8 p90 -149.48 165.89 30.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.921 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.554 ' HB3' HD12 ' A' ' 360' ' ' LEU . 2.4 t70 -55.06 110.01 0.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.855 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.449 ' CD ' ' HB3' ' A' ' 364' ' ' ALA . 14.2 mmmt -54.86 -35.53 64.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 5.4 t -55.73 -54.96 37.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.554 HD12 ' HB3' ' A' ' 357' ' ' ASP . 14.7 mt -56.11 -45.3 79.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' CYS . . . . . 0.434 ' SG ' ' CD1' ' A' ' 356' ' ' TRP . 0.8 OUTLIER -151.98 135.37 16.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.874 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.529 HD13 ' C ' ' A' ' 362' ' ' ILE . 0.0 OUTLIER -78.89 143.26 12.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 133.06 -29.68 3.17 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.476 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.449 ' HB3' ' CD ' ' A' ' 358' ' ' LYS . . . -46.66 171.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 111.025 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 68.3 p -101.04 -69.81 0.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.138 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' TYR . . . . . 0.41 ' HB2' ' CG ' ' A' ' 370' ' ' ASP . 1.1 p90 -112.27 173.18 6.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -86.36 164.91 16.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.56 -23.44 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.147 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 42.0 p -84.03 25.07 0.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.132 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . 0.41 ' CG ' ' HB2' ' A' ' 366' ' ' TYR . 0.8 OUTLIER -96.12 100.49 12.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.835 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 372' ' ' ARG . 56.0 m -51.72 -41.03 61.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 371' ' ' SER . 23.6 mmt180 -37.7 -40.61 0.43 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.893 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 95.4 mt -41.77 121.35 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.13 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 39.2 p -81.25 -40.31 23.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.191 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -132.77 148.79 52.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' GLN . . . . . 0.485 ' OE1' ' NE ' ' A' ' 390' ' ' ARG . 56.8 tt0 -130.37 115.66 17.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.863 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . 0.55 HD13 HG23 ' A' ' 393' ' ' VAL . 47.0 mm -83.04 127.95 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.114 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 31.0 m -148.69 159.69 6.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.134 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.01 -38.73 35.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.477 ' NH2' ' NE2' ' A' ' 383' ' ' GLN . 42.8 mtp180 -130.26 80.8 69.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.632 0.729 . . . . 0.0 110.917 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -15.55 37.2 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.701 2.267 . . . . 0.0 112.349 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -64.47 -53.85 32.98 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.45 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . 0.477 ' NE2' ' NH2' ' A' ' 380' ' ' ARG . 3.3 pt20 -89.19 30.56 0.96 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.714 0.292 . . . . 0.0 110.89 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -109.05 121.98 46.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.926 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 39.8 m -58.33 87.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 53.3 p -52.22 159.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 96.1 t -129.01 141.27 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.6 mt -51.35 115.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 101.51 -46.34 1.29 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.539 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . 0.485 ' NE ' ' OE1' ' A' ' 376' ' ' GLN . 15.4 ttp180 -80.68 144.87 31.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 110.852 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 10.3 m -124.4 134.26 53.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . 0.433 ' CZ ' ' OE1' ' A' ' 376' ' ' GLN . 3.0 m-85 -96.74 116.53 29.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.918 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.55 HG23 HD13 ' A' ' 377' ' ' ILE . 21.0 m -123.93 158.69 29.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.126 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -75.99 158.28 82.5 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.602 0.715 . . . . 0.0 110.919 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -4.16 13.45 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.665 2.244 . . . . 0.0 112.345 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -84.6 -16.33 42.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.962 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 69.1 t90 -65.34 -39.21 92.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.938 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 73.6 t -72.54 -52.76 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -51.2 -37.13 44.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.481 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 1.1 m-20 -73.49 -45.61 52.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 69.2 m -56.67 -58.03 9.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.852 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.456 HG23 ' N ' ' A' ' 403' ' ' ASN . 30.9 m -47.94 -43.58 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.104 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . 0.456 ' N ' HG23 ' A' ' 402' ' ' VAL . 6.6 t30 -66.13 -43.67 86.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -86.53 10.53 15.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.086 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' A' ' 404' ' ' ALA . 3.2 mpt_? 36.56 37.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 15.1 tp -151.49 145.01 24.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.432 ' HA ' HD23 ' A' ' 407' ' ' LEU . 17.6 mt -74.91 89.37 2.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.94 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.481 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 34.8 mt -60.52 154.91 52.57 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.626 0.727 . . . . 0.0 110.913 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 113.47 3.38 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.731 2.287 . . . . 0.0 112.344 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.46 ' HB ' HG11 ' A' ' 393' ' ' VAL . 19.5 m -55.17 -28.25 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.137 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -48.09 -30.33 4.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.136 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -77.76 -35.65 51.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.855 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -106.05 49.66 0.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 42.1 t80 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.838 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.519 -0.233 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 1.4 t -143.16 151.85 41.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.849 0.356 . . . . 0.0 110.846 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 31.3 t -58.51 147.46 31.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.15 -73.99 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.529 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 63.2 p -147.52 134.26 20.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 110.879 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 7.4 m -88.5 102.54 15.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.831 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -81.96 89.7 1.44 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.467 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -74.1 103.3 4.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.786 0.327 . . . . 0.0 110.861 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -119.77 172.11 7.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.808 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.46 107.85 2.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -108.15 152.05 25.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.868 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 12.2 tp -68.79 -50.55 49.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . 0.441 ' HA ' HD12 ' A' ' 330' ' ' LEU . 22.7 m-85 -87.49 31.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -66.09 118.22 9.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.832 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 66.28 49.32 57.94 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 327' ' ' PHE . 67.9 mt -141.21 122.14 14.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.904 0.383 . . . . 0.0 110.914 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -95.54 139.8 31.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.503 ' CD1' ' HB2' ' A' ' 375' ' ' HIS . 80.7 m-85 -133.79 153.57 51.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' PHE . . . . . 0.475 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 9.4 t80 -129.56 117.6 20.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.848 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.635 HD12 ' HG3' ' A' ' 340' ' ' ARG . 12.7 mt -94.68 132.2 39.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.926 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -90.63 165.68 13.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.55 ' HB3' HD11 ' A' ' 360' ' ' LEU . 0.1 OUTLIER -65.15 -30.07 70.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.828 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . 0.457 ' N ' ' HG2' ' A' ' 336' ' ' ARG . 9.1 pt-20 -65.56 -37.41 86.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.0 m -91.01 150.7 42.26 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.633 0.73 . . . . 0.0 111.106 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . 0.437 ' O ' HD12 ' A' ' 343' ' ' LEU . 53.4 Cg_endo -69.79 128.46 16.04 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.683 2.255 . . . . 0.0 112.324 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 0.635 ' HG3' HD12 ' A' ' 334' ' ' LEU . 31.1 ttm180 -92.0 -49.3 6.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.866 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -42.68 -39.61 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -79.97 -65.74 0.97 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.052 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . 0.505 HD13 HD22 ' A' ' 334' ' ' LEU . 68.6 mt -51.79 -62.53 1.57 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -40.74 -59.81 1.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -51.62 -49.14 62.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.843 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 349' ' ' SER . 31.1 mt -57.74 -70.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.136 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . 0.412 ' N ' HG22 ' A' ' 346' ' ' ILE . 28.0 mt -42.26 -52.19 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.105 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 26.5 mtt-85 -64.5 -25.66 68.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.882 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 346' ' ' ILE . 43.4 t -80.12 -30.21 39.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -92.04 14.0 17.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.893 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 70.93 57.47 6.31 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.508 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -135.22 161.04 24.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.512 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -94.81 135.06 36.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.874 0.368 . . . . 0.0 110.869 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.543 HG21 HD11 ' A' ' 334' ' ' LEU . 8.1 p -148.37 133.98 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.169 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 17.3 t -132.42 162.84 30.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' TRP . . . . . 0.534 ' CZ2' ' O ' ' A' ' 363' ' ' GLY . 20.2 p90 -137.4 -176.39 4.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.944 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.436 ' HB2' HD12 ' A' ' 360' ' ' LEU . 0.6 OUTLIER -75.38 118.92 18.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.822 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -58.89 -15.7 13.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 4.5 p -83.04 -27.66 30.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 336' ' ' ARG . 22.7 mt -76.94 -49.65 15.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.96 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 8.2 m -157.86 139.55 13.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 24.3 pt -56.53 155.75 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.534 ' O ' ' CZ2' ' A' ' 356' ' ' TRP . . . 100.52 38.17 3.55 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.486 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -105.47 117.23 33.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 0.0 111.079 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 45.3 p -69.65 -61.0 1.96 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.153 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -126.53 158.37 36.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.22 169.9 11.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . 0.475 ' HB ' ' CZ ' ' A' ' 333' ' ' PHE . 11.5 p -68.01 -10.6 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.106 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 73.4 p -95.6 14.16 23.85 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.12 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . 0.48 ' OD1' ' CG ' ' A' ' 372' ' ' ARG . 4.6 t70 -87.54 107.54 18.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 64.1 p -50.74 -28.47 9.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.842 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . 0.48 ' CG ' ' OD1' ' A' ' 370' ' ' ASP . 17.0 mmm180 -54.03 -30.46 47.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.872 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 87.2 mt -51.53 126.64 6.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.105 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 47.4 p -95.53 -43.0 8.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . 0.503 ' HB2' ' CD1' ' A' ' 332' ' ' PHE . 20.0 m80 -130.11 155.04 46.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' GLN . . . . . 0.577 ' CD ' ' CE2' ' A' ' 392' ' ' TYR . 59.6 tt0 -136.18 115.0 12.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.9 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . 0.411 ' O ' ' CG1' ' A' ' 378' ' ' VAL . 45.3 mm -80.65 136.43 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.411 ' CG1' ' O ' ' A' ' 377' ' ' ILE . 35.4 m -158.01 142.2 7.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.125 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -60.1 -32.67 71.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -128.55 80.92 71.67 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.617 0.722 . . . . 0.0 110.882 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -3.51 12.16 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.674 2.249 . . . . 0.0 112.358 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -106.52 -49.19 0.92 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.487 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -52.93 -73.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.783 0.325 . . . . 0.0 110.915 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -55.38 130.21 41.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.894 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 20.3 p -63.55 131.28 47.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 54.7 p -85.28 149.53 25.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.828 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 388' ' ' ILE . 63.2 t -75.82 114.8 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.104 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.637 ' H ' HD12 ' A' ' 388' ' ' ILE . 2.1 mp -36.17 104.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.134 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 122.26 -45.11 1.24 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 11.1 ttm-85 -76.55 159.45 30.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.8 0.333 . . . . 0.0 110.83 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 19.0 m -122.31 134.85 54.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.937 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . 0.577 ' CE2' ' CD ' ' A' ' 376' ' ' GLN . 2.4 m-85 -112.85 147.55 36.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.944 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 20.8 m -151.25 145.69 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.135 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -61.35 158.36 38.39 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.557 0.694 . . . . 0.0 110.938 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -4.63 14.39 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.378 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -85.95 -19.0 31.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -64.63 -34.03 77.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 80.7 t -71.23 -32.82 48.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.182 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . 0.458 ' O ' HG22 ' A' ' 402' ' ' VAL . 38.4 m-85 -74.85 -60.03 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.873 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -52.93 -17.9 1.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 16.9 m -82.33 -53.21 6.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 399' ' ' PHE . 6.2 m -58.01 -37.54 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.158 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -72.56 -34.66 67.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.957 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 406' ' ' LEU . . . -94.31 9.23 38.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.095 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 404' ' ' ALA . 0.9 OUTLIER 36.95 31.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 404' ' ' ALA . 0.0 OUTLIER -147.27 130.98 16.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 98.1 mt -66.67 85.66 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.946 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 32.0 mt -51.24 155.38 2.37 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.633 0.73 . . . . 0.0 110.882 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 118.82 5.91 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.691 2.261 . . . . 0.0 112.359 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.1 m -64.74 -25.51 38.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.088 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -54.55 -15.32 1.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.103 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -94.42 -30.97 14.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -96.06 33.34 1.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.95 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 16.5 t80 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 33.6 p -99.29 42.07 1.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.874 0.368 . . . . 0.0 110.882 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 41.4 t -44.0 -48.66 8.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 154.95 -141.5 8.2 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.503 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 50.6 p -96.38 85.61 3.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.903 0.382 . . . . 0.0 110.88 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 45.3 t -157.02 138.33 13.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.882 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -103.9 79.86 0.31 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.488 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -80.05 -52.69 7.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.831 0.348 . . . . 0.0 110.885 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 21.3 m170 47.85 45.72 18.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.36 109.9 3.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -117.91 153.44 33.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 18.8 tp -59.75 -54.92 40.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -95.18 37.5 1.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -73.03 139.35 46.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 53.72 47.98 62.91 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.493 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 71.9 mt -142.45 122.26 13.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.913 0.387 . . . . 0.0 110.878 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -96.13 126.76 41.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -119.34 152.81 36.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' PHE . . . . . 0.419 ' CD1' ' O ' ' A' ' 355' ' ' SER . 59.0 t80 -131.88 124.85 30.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.914 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.587 HD11 HG21 ' A' ' 354' ' ' VAL . 7.2 mt -101.78 133.15 46.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.969 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -88.74 163.99 15.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.765 ' HB3' HD11 ' A' ' 360' ' ' LEU . 2.0 ptp85 -65.2 -13.36 58.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -85.84 -46.76 10.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 4.1 m -77.94 151.1 78.93 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.652 0.739 . . . . 0.0 111.142 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 127.64 14.93 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.676 2.251 . . . . 0.0 112.36 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 0.565 ' HA ' HD13 ' A' ' 334' ' ' LEU . 0.5 OUTLIER -95.51 -55.05 3.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -39.15 -42.07 0.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -77.5 -51.12 11.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.121 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . 0.434 HD23 ' CE1' ' A' ' 399' ' ' PHE . 87.8 mt -65.16 -64.11 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -38.72 -53.14 1.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -57.54 -47.95 80.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' ILE . . . . . 0.437 HD12 ' HE1' ' A' ' 399' ' ' PHE . 38.0 mt -62.59 -67.95 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.117 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 32.2 mt -44.26 -37.33 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.085 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -77.99 -35.0 50.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 46.7 t -67.62 -29.65 69.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.858 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -94.99 20.45 8.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 64.46 63.56 4.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.519 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -136.72 164.48 25.18 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.512 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -104.15 129.29 51.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.884 0.374 . . . . 0.0 110.868 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.587 HG21 HD11 ' A' ' 334' ' ' LEU . 7.3 p -137.86 138.91 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.12 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . 0.419 ' O ' ' CD1' ' A' ' 333' ' ' PHE . 8.4 t -140.56 149.82 42.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' TRP . . . . . 0.457 ' O ' ' HB1' ' A' ' 364' ' ' ALA . 40.6 p90 -131.7 175.89 8.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.868 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.679 ' HB2' HD12 ' A' ' 360' ' ' LEU . 18.5 m-20 -62.17 114.95 3.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -44.88 -46.3 10.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 3.3 m -53.26 -51.83 60.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.855 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.765 HD11 ' HB3' ' A' ' 336' ' ' ARG . 21.4 mt -46.56 -49.84 18.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.921 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 1.8 t -168.19 153.33 6.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 36.2 pt -63.32 177.08 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.119 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 94.42 -37.22 3.47 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 356' ' ' TRP . . . -44.63 152.11 0.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.821 0.343 . . . . 0.0 111.121 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 5.1 p -116.2 -65.28 1.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.156 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -111.22 144.93 39.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.943 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -88.7 171.66 9.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.12 -17.35 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 22.6 p -79.24 12.09 2.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.166 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -101.43 140.56 35.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.854 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 372' ' ' ARG . 4.9 t -80.5 -40.52 25.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 371' ' ' SER . 9.0 ptp180 -36.69 -42.68 0.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.922 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.587 HG22 ' HG3' ' A' ' 390' ' ' ARG . 73.4 mt -40.11 136.89 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.146 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 58.1 p -115.22 -24.72 8.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -139.91 143.03 36.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.868 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' GLN . . . . . 0.5 ' OE1' ' N ' ' A' ' 377' ' ' ILE . 0.7 OUTLIER -137.13 108.98 7.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . 0.5 ' N ' ' OE1' ' A' ' 376' ' ' GLN . 5.5 mm -79.39 127.0 39.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.127 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 30.6 m -139.98 155.94 24.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.158 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -81.51 -23.34 37.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.407 ' O ' ' CG ' ' A' ' 383' ' ' GLN . 75.7 mtt180 -130.75 83.0 62.96 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.583 0.706 . . . . 0.0 110.852 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -18.41 36.99 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.651 2.234 . . . . 0.0 112.335 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -67.53 -55.25 15.67 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.468 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . 0.407 ' CG ' ' O ' ' A' ' 380' ' ' ARG . 3.7 pt20 -46.26 -33.85 4.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.763 0.316 . . . . 0.0 110.92 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -84.3 149.97 25.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.36 -70.7 0.71 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.119 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 96.7 p -175.13 164.23 3.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . 0.531 HG23 ' CE1' ' A' ' 392' ' ' TYR . 74.6 t -133.05 153.73 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.145 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.52 ' N ' HD13 ' A' ' 388' ' ' ILE . 3.5 mm -68.66 99.41 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.176 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 92.95 -35.01 4.25 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.482 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . 0.587 ' HG3' HG22 ' A' ' 373' ' ' ILE . 8.3 ttm180 -93.0 151.36 19.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.762 0.315 . . . . 0.0 110.888 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' CYS . . . . . 0.424 ' N ' ' HG2' ' A' ' 390' ' ' ARG . 83.3 m -134.18 139.6 45.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . 0.531 ' CE1' HG23 ' A' ' 387' ' ' VAL . 68.0 m-85 -81.38 140.67 34.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.416 ' CG1' ' HB ' ' A' ' 410' ' ' VAL . 12.0 m -150.62 166.66 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.115 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -89.42 159.32 44.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.596 0.712 . . . . 0.0 110.878 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.439 ' HA ' HG21 ' A' ' 377' ' ' ILE . 54.2 Cg_endo -69.7 -3.73 12.56 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.717 2.278 . . . . 0.0 112.379 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -84.91 -31.25 23.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.923 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 69.1 t90 -50.5 -38.44 44.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.08 -61.21 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.074 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . 0.437 ' HE1' HD12 ' A' ' 346' ' ' ILE . 12.3 m-30 -51.7 -29.63 19.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.405 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 19.4 m-20 -73.32 -52.03 15.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 405' ' ' ARG . 14.6 m -58.47 -47.36 84.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.844 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.533 HG23 ' N ' ' A' ' 403' ' ' ASN . 27.3 m -61.24 -46.27 96.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.119 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . 0.533 ' N ' HG23 ' A' ' 402' ' ' VAL . 41.2 t30 -70.07 -8.08 46.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -122.93 0.48 9.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.097 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' A' ' 401' ' ' SER . 0.2 OUTLIER 44.53 32.12 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.642 HD13 ' N ' ' A' ' 407' ' ' LEU . 1.0 OUTLIER -141.94 140.69 32.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.642 ' N ' HD13 ' A' ' 406' ' ' LEU . 12.4 mt -71.77 81.63 0.88 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.405 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 43.0 mt -55.22 155.64 8.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.599 0.714 . . . . 0.0 110.929 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 115.67 4.21 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.685 2.256 . . . . 0.0 112.325 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.416 ' HB ' ' CG1' ' A' ' 393' ' ' VAL . 32.6 m -65.56 -21.39 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.144 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . 0.547 ' HA ' ' CE2' ' A' ' 414' ' ' PHE . . . -64.1 -33.8 76.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.171 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -75.93 1.07 16.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -126.06 41.56 3.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.967 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' PHE . . . . . 0.547 ' CE2' ' HA ' ' A' ' 411' ' ' ALA . 2.5 m-85 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.918 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.254 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 68.0 m 42.78 48.06 4.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.877 0.37 . . . . 0.0 110.888 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 33.3 t -124.6 100.65 6.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.844 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 68.75 -161.44 51.41 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.482 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 30.2 t -148.7 153.76 38.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.821 0.343 . . . . 0.0 110.865 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 14.4 t -104.91 162.51 13.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.871 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 103.74 148.57 19.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.479 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 32.1 tttp 66.06 44.42 2.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.826 0.346 . . . . 0.0 110.835 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -127.96 111.58 13.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.861 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp -101.71 155.24 18.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -131.71 144.99 51.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.937 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 2.4 tt -59.25 -54.86 42.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.906 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . 0.432 ' HZ ' HG13 ' A' ' 398' ' ' VAL . 18.4 m-85 -91.5 39.37 1.0 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -80.96 106.7 13.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 88.08 43.54 5.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.458 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.568 HD11 HD11 ' A' ' 407' ' ' LEU . 83.5 mt -143.1 124.09 14.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.912 0.387 . . . . 0.0 110.909 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.439 ' HE3' ' CE2' ' A' ' 366' ' ' TYR . 28.3 mtpt -95.41 139.09 32.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.445 ' CD1' ' HB2' ' A' ' 375' ' ' HIS . 88.5 m-85 -135.2 147.32 49.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -130.01 115.31 16.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.655 HD11 HG21 ' A' ' 354' ' ' VAL . 2.6 mt -90.77 148.08 22.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -107.14 176.93 5.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.944 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.457 ' HB3' HD11 ' A' ' 360' ' ' LEU . 8.4 ptp85 -74.79 -22.08 58.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.879 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -72.46 -35.97 68.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.897 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.43 HG11 HG22 ' A' ' 377' ' ' ILE . 3.2 m -95.54 150.87 38.09 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.622 0.725 . . . . 0.0 111.127 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 120.94 7.66 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.664 2.243 . . . . 0.0 112.41 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 0.528 ' HG3' HD12 ' A' ' 334' ' ' LEU . 27.7 ttp85 -87.19 -49.87 6.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.863 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -42.4 -36.77 1.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -83.05 -63.83 1.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.059 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 53.3 mt -53.95 -59.45 4.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -42.74 -60.51 1.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -51.15 -43.07 61.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.842 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' ILE . . . . . 0.505 HG22 ' N ' ' A' ' 347' ' ' ILE . 11.8 mt -63.64 -72.58 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . 0.505 ' N ' HG22 ' A' ' 346' ' ' ILE . 29.8 mt -39.16 -43.6 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.15 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 67.6 mtt-85 -68.51 -36.07 78.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.863 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . 0.481 ' N ' ' O ' ' A' ' 346' ' ' ILE . 29.8 t -69.95 -43.34 71.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . 0.523 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 11.4 m-85 -73.17 -11.23 60.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 91.2 56.58 1.68 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.427 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -132.16 160.55 23.68 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -91.26 125.39 36.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.909 0.385 . . . . 0.0 110.886 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.655 HG21 HD11 ' A' ' 334' ' ' LEU . 12.4 p -137.85 139.56 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.132 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . 0.563 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 42.7 t -136.74 149.34 47.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' TRP . . . . . 0.421 ' CE3' ' HD2' ' A' ' 340' ' ' ARG . 15.1 p90 -129.39 -175.86 3.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.962 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.7 ' HB2' HD12 ' A' ' 360' ' ' LEU . 24.3 m-20 -76.97 105.76 8.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.82 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.514 ' HG2' ' HB3' ' A' ' 364' ' ' ALA . 7.1 mtpm? -38.89 -43.32 0.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.912 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 14.2 t -53.64 -58.73 6.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 357' ' ' ASP . 18.8 mt -50.53 -48.94 57.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.912 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 4.2 m -158.39 130.0 6.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.902 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 14.9 pt -61.14 176.34 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.14 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 107.37 -39.65 2.81 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.45 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.514 ' HB3' ' HG2' ' A' ' 358' ' ' LYS . . . -38.72 158.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.877 0.37 . . . . 0.0 111.084 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 1.2 p -113.46 -45.67 3.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' TYR . . . . . 0.563 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 33.4 p90 -125.43 173.92 8.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.956 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.96 169.34 8.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.863 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 14.0 p -58.85 -31.36 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.111 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 68.1 p -63.6 -16.21 60.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -65.7 99.3 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 372' ' ' ARG . 22.2 t -47.5 -42.11 22.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 371' ' ' SER . 29.9 mmt180 -35.58 -45.25 0.35 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.826 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.436 ' C ' ' O ' ' A' ' 372' ' ' ARG . 77.8 mt -34.45 120.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.131 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 26.7 p -92.32 -44.26 8.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . 0.445 ' HB2' ' CD1' ' A' ' 332' ' ' PHE . 20.1 m80 -129.8 146.25 51.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.799 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -131.1 94.57 3.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.918 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . 0.452 HD13 HG23 ' A' ' 393' ' ' VAL . 49.5 mm -58.61 132.44 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.474 HG11 ' NE2' ' A' ' 384' ' ' GLN . 30.6 m -151.94 156.18 6.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.145 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -68.25 -38.74 82.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -122.71 84.17 49.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.57 0.7 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 94.46 0.53 Allowed 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.7 2.267 . . . . 0.0 112.346 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 152.44 -39.92 0.74 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.516 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -118.26 76.75 1.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.738 0.304 . . . . 0.0 110.923 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.597 ' OE1' ' CD1' ' A' ' 392' ' ' TYR . 0.0 OUTLIER -171.49 105.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . 0.466 ' C ' ' O ' ' A' ' 384' ' ' GLN . 10.5 m 32.9 46.68 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 13.7 p -41.5 149.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 53.8 t -134.14 110.05 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.3 mt -50.0 100.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.127 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 126.09 -42.75 1.45 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -80.25 157.82 26.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.849 0.357 . . . . 0.0 110.862 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 1.8 m -122.73 145.37 48.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.85 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . 0.597 ' CD1' ' OE1' ' A' ' 384' ' ' GLN . 37.7 m-85 -117.98 131.58 56.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.507 HG11 HG12 ' A' ' 410' ' ' VAL . 17.3 m -129.6 155.3 41.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.082 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -72.39 161.37 79.4 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.576 0.703 . . . . 0.0 110.922 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -4.24 13.63 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.702 2.268 . . . . 0.0 112.371 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 -86.26 -16.35 37.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 79.7 t90 -65.72 -34.86 79.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.432 HG13 ' HZ ' ' A' ' 327' ' ' PHE . 88.9 t -81.09 -49.81 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.106 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -51.13 -30.1 15.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.486 ' OD2' HD11 ' A' ' 408' ' ' LEU . 6.5 t70 -85.48 -47.3 10.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 63.7 m -56.45 -47.08 79.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.85 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.523 ' HB ' ' CZ ' ' A' ' 350' ' ' PHE . 23.5 m -50.44 -43.8 23.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.152 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . 0.444 ' N ' HG23 ' A' ' 402' ' ' VAL . 1.2 t30 -74.35 -40.34 62.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -76.86 0.72 19.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.121 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 41.96 44.74 3.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 25.4 tp -165.42 143.71 6.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.955 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.568 HD11 HD11 ' A' ' 330' ' ' LEU . 40.3 mt -69.6 93.94 0.74 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.941 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.486 HD11 ' OD2' ' A' ' 400' ' ' ASP . 65.7 mt -60.4 153.18 61.15 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.6 0.714 . . . . 0.0 110.924 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 114.48 3.72 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.677 2.251 . . . . 0.0 112.347 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.507 HG12 HG11 ' A' ' 393' ' ' VAL . 18.7 m -58.89 -27.4 35.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.09 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -50.17 -29.46 9.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.125 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -78.48 -24.98 45.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -106.6 38.03 2.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.944 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 53.1 t80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 -179.969 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 42.7 m -163.18 165.63 24.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 0.0 110.858 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 48.1 m -68.85 164.85 21.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.798 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -99.25 53.27 1.04 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.508 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 30.3 p -162.05 113.31 1.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 0.0 110.861 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 42.5 m -109.59 124.68 51.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -160.73 -70.97 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.444 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 19.0 tptp -152.1 106.53 3.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.343 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -86.15 117.43 24.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.84 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -123.42 41.76 3.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -41.84 132.35 3.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.906 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 22.4 tp -44.01 -54.06 5.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -98.0 36.78 1.5 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -60.94 116.85 4.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.864 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 76.17 -46.72 2.19 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 329' ' ' GLY . 24.3 mt -37.31 125.94 1.02 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.879 0.371 . . . . 0.0 110.95 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -95.24 144.76 25.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -135.06 153.26 52.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.919 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -140.17 117.11 11.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.64 HD22 HD13 ' A' ' 343' ' ' LEU . 2.8 mt -97.83 149.95 21.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.924 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -107.54 164.01 12.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.9 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.594 ' HB3' HD11 ' A' ' 360' ' ' LEU . 15.1 ptp180 -61.48 -31.1 71.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -41.59 97.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 10.1 m -91.03 150.81 42.43 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.628 0.728 . . . . 0.0 111.116 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 118.61 5.78 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.726 2.284 . . . . 0.0 112.301 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 0.517 ' HA ' HD13 ' A' ' 334' ' ' LEU . 24.3 ptt85 -89.29 -37.25 15.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.84 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -49.82 -42.75 47.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.851 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -74.8 -62.3 1.59 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.061 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . 0.64 HD13 HD22 ' A' ' 334' ' ' LEU . 30.9 mt -53.1 -60.36 3.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.908 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 343' ' ' LEU . . . -37.02 -58.9 0.75 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -53.14 -45.84 68.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 23.0 mt -59.23 -69.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.147 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 20.9 mt -40.1 -57.35 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.097 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -58.41 -45.78 87.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 40.2 t -55.04 -34.81 63.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -98.4 29.26 3.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.894 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 54.98 52.17 48.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.515 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -119.62 154.97 16.27 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.437 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -92.8 138.93 31.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.888 0.375 . . . . 0.0 110.864 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.435 HG21 HD11 ' A' ' 334' ' ' LEU . 7.3 p -154.78 140.33 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.118 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 42.0 t -140.04 144.23 36.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.815 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 40.5 p90 -121.13 174.84 6.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.727 ' HB2' HD12 ' A' ' 360' ' ' LEU . 19.9 m-20 -65.0 104.15 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 357' ' ' ASP . 12.1 ptpt -36.65 -44.87 0.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 11.3 t -51.93 -48.74 64.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.727 HD12 ' HB2' ' A' ' 357' ' ' ASP . 8.8 mt -53.03 -47.48 68.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.894 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 45.5 t -162.33 156.73 21.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 21.2 tt -73.24 160.21 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.112 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 112.8 -27.64 9.58 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.508 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -41.59 148.26 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.85 0.357 . . . . 0.0 111.118 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 26.0 p -108.76 -64.82 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.151 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -117.2 144.42 44.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.871 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.03 174.15 8.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.887 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 7.1 p -69.62 -22.38 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.094 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 82.6 p -86.14 24.52 1.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.137 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -98.36 102.3 14.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.3 t -46.54 -29.31 1.73 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.824 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -47.43 -40.11 17.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.88 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 58.5 mt -40.06 147.48 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.135 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 55.3 p -125.8 -30.71 2.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -147.59 110.22 4.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.868 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' GLN . . . . . 0.416 ' HG2' HG13 ' A' ' 378' ' ' VAL . 20.2 tt0 -96.68 100.98 12.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . 0.421 HD13 HG23 ' A' ' 393' ' ' VAL . 19.1 mm -68.79 113.48 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.416 HG13 ' HG2' ' A' ' 376' ' ' GLN . 18.7 m -126.65 -178.93 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.136 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.55 -40.5 10.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -128.69 80.9 71.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.657 0.742 . . . . 0.0 110.891 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -10.84 29.55 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.657 2.238 . . . . 0.0 112.33 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -85.4 -20.06 57.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.517 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -102.68 -43.8 5.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.778 0.323 . . . . 0.0 110.898 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -44.82 163.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.937 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 71.4 p -87.4 121.52 29.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.178 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 56.2 p -70.54 151.88 44.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.801 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 87.3 t -129.82 114.38 30.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.142 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 8.8 mt -38.08 116.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.118 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 102.68 -44.79 1.44 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.474 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -77.62 158.03 29.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.819 0.343 . . . . 0.0 110.888 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 82.4 m -133.63 132.73 41.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.861 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -106.68 124.65 49.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.427 HG11 ' HB ' ' A' ' 410' ' ' VAL . 19.2 m -135.44 156.86 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.118 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -71.0 158.86 87.26 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.607 0.718 . . . . 0.0 110.898 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -7.74 21.83 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.684 2.256 . . . . 0.0 112.332 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -79.19 -25.37 42.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.936 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' TRP . . . . . 0.516 ' HB2' ' CD2' ' A' ' 413' ' ' TYR . 92.0 t90 -59.44 -28.11 66.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 39.7 t -72.09 -57.55 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.137 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -50.0 -53.8 24.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.448 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 0.8 OUTLIER -54.85 -45.56 74.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 21.5 m -56.58 -66.7 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 26.8 m -47.43 -40.48 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.101 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -69.89 -35.07 74.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -92.08 11.65 24.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 404' ' ' ALA . 2.8 mmm180 38.11 44.24 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.839 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 8.1 tp -165.07 150.59 9.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.929 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 97.1 mt -81.16 80.11 7.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.448 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 49.3 mt -46.04 156.45 0.46 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.562 0.696 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 119.01 6.02 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.653 2.235 . . . . 0.0 112.322 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.427 ' HB ' HG11 ' A' ' 393' ' ' VAL . 35.3 m -64.88 -23.77 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.088 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -53.17 -18.58 2.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -88.73 -33.46 17.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.516 ' CD2' ' HB2' ' A' ' 397' ' ' TRP . 6.4 m-85 -95.3 36.03 1.27 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.902 179.983 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 7.7 t -117.49 164.95 14.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.883 0.373 . . . . 0.0 110.832 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 25.0 p -171.88 156.07 4.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.829 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -136.87 -126.27 2.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.463 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 1.9 t 48.45 46.77 20.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.888 0.375 . . . . 0.0 110.851 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 9.6 t -125.62 141.93 51.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.83 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -149.16 -159.36 8.54 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.48 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.492 ' O ' ' CG ' ' A' ' 323' ' ' HIS . 0.0 OUTLIER -157.73 141.27 15.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.85 0.357 . . . . 0.0 110.894 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.492 ' CG ' ' O ' ' A' ' 322' ' ' LYS . 18.8 m80 -167.31 161.93 14.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.823 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -59.71 91.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . 0.435 ' HD2' ' C ' ' A' ' 350' ' ' PHE . 9.9 mmtp -61.12 161.63 8.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 326' ' ' LEU . 0.2 OUTLIER -70.76 -40.45 72.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.933 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -118.06 40.71 3.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -56.94 114.78 2.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 75.23 -47.41 1.98 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.477 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 329' ' ' GLY . 33.0 mt -35.78 125.16 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.884 0.373 . . . . 0.0 110.929 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -101.96 151.13 22.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.928 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -141.94 154.48 45.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' PHE . . . . . 0.518 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 18.8 t80 -130.87 116.6 18.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.413 ' HG ' ' CG2' ' A' ' 354' ' ' VAL . 6.6 mt -91.09 146.76 23.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -101.72 164.49 11.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.912 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.552 ' HB3' HD22 ' A' ' 360' ' ' LEU . 8.9 ptt180 -66.58 -17.3 64.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -78.33 -47.62 17.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.892 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 2.1 m -84.32 148.98 54.16 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.615 0.722 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . 0.588 ' O ' HD12 ' A' ' 343' ' ' LEU . 54.2 Cg_endo -69.73 138.04 36.99 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.706 2.271 . . . . 0.0 112.35 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 341' ' ' GLU . 16.9 ptt85 -102.23 -48.09 4.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.865 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 340' ' ' ARG . 4.9 pt-20 -35.29 -46.71 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -75.31 -59.05 2.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.072 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . 0.588 HD12 ' O ' ' A' ' 339' ' ' PRO . 79.4 mt -55.9 -63.64 1.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.93 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -39.42 -54.35 1.91 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.1 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -55.71 -44.78 77.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 347' ' ' ILE . 21.7 mt -65.8 -67.79 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.135 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . 0.491 ' O ' ' N ' ' A' ' 352' ' ' GLY . 25.5 mt -41.4 -35.21 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 44.4 mtp85 -79.95 -45.65 18.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 32.3 t -56.08 -30.58 62.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . 0.435 ' C ' ' HD2' ' A' ' 325' ' ' LYS . 58.7 m-85 -98.58 26.67 5.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 58.91 58.96 11.8 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.479 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 347' ' ' ILE . . . -129.73 150.37 19.0 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.483 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -96.52 133.28 41.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.894 0.378 . . . . 0.0 110.914 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.413 ' CG2' ' HG ' ' A' ' 334' ' ' LEU . 7.4 p -143.49 143.39 24.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.119 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . 0.568 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 1.5 t -141.07 156.8 45.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' TRP . . . . . 0.442 ' O ' ' HB2' ' A' ' 364' ' ' ALA . 23.9 p90 -138.09 140.79 40.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.892 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.727 ' HB2' HD12 ' A' ' 360' ' ' LEU . 6.2 m-20 -42.77 115.99 0.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -44.7 -57.28 3.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.875 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 78.3 p -41.32 -47.87 3.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.853 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.727 HD12 ' HB2' ' A' ' 357' ' ' ASP . 86.7 mt -61.61 -50.92 70.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.895 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 23.3 m -154.95 140.55 17.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.3 pt -69.77 162.39 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.119 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 93.43 39.41 5.05 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.452 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 356' ' ' TRP . . . -113.56 149.47 34.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 0.0 111.109 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 41.4 p -98.59 -72.4 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.096 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' TYR . . . . . 0.568 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 18.5 p90 -103.43 161.79 13.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.911 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.01 168.62 11.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.834 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . 0.528 ' O ' HG22 ' A' ' 368' ' ' VAL . 7.6 p -70.69 -6.65 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.161 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 24.3 p -100.3 18.71 18.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -95.19 118.69 32.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.821 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.2 m -51.17 -43.78 61.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.843 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 21.4 mtt85 -38.93 -40.1 0.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.82 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 57.0 mt -48.55 115.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.103 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 74.8 p -85.25 -43.61 13.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -128.84 158.97 37.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.81 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' GLN . . . . . 0.54 ' CD ' ' CE2' ' A' ' 392' ' ' TYR . 25.9 tt0 -140.62 108.97 5.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . 0.436 HD13 HG23 ' A' ' 393' ' ' VAL . 44.6 mm -76.09 139.12 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.192 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 379' ' ' ASP . 18.7 m -154.7 139.59 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . 0.439 ' O ' ' CG ' ' A' ' 380' ' ' ARG . 5.7 t0 -35.95 -45.74 0.43 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.439 ' CG ' ' O ' ' A' ' 379' ' ' ASP . 62.7 mtt180 -161.07 121.6 1.6 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.65 0.738 . . . . 0.0 110.86 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 2.67 3.3 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.673 2.248 . . . . 0.0 112.373 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -96.89 -31.41 7.0 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.48 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -91.84 31.73 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.882 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -174.14 144.07 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.871 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 9.9 t -79.62 158.15 27.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.6 p -110.97 166.64 10.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 56.5 t -98.97 128.39 50.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.4 mt -44.22 110.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.151 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 113.67 -41.25 2.25 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.468 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . 0.509 ' HD2' ' CE1' ' A' ' 392' ' ' TYR . 13.2 ttm-85 -79.52 152.39 30.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.778 0.323 . . . . 0.0 110.9 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 40.5 m -120.27 115.67 24.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . 0.54 ' CE2' ' CD ' ' A' ' 376' ' ' GLN . 7.0 m-85 -92.51 130.4 38.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.919 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.436 HG23 HD13 ' A' ' 377' ' ' ILE . 25.1 m -134.97 167.98 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.143 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -83.78 160.56 58.2 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.576 0.703 . . . . 0.0 110.935 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -7.99 22.48 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.708 2.272 . . . . 0.0 112.328 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 12.6 tp-100 -79.18 -12.76 59.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 92.4 t90 -79.79 -13.03 59.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.475 ' O ' HG22 ' A' ' 402' ' ' VAL . 60.1 t -89.65 -33.81 6.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.163 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -76.33 -28.75 57.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.454 ' HB3' HD12 ' A' ' 408' ' ' LEU . 8.5 t0 -81.04 -53.09 6.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.875 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 39.3 m -48.74 -46.44 40.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 398' ' ' VAL . 18.9 m -64.25 -43.1 97.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.126 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . 0.433 ' N ' HG23 ' A' ' 402' ' ' VAL . 17.6 t-20 -64.28 -32.31 73.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -97.04 8.84 43.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.094 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 39.77 40.46 0.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 6.9 tp -156.93 149.41 23.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 90.7 mt -78.08 90.59 4.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 400' ' ' ASP . 84.4 mt -56.35 151.63 27.34 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.581 0.705 . . . . 0.0 110.908 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 107.44 1.86 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.635 2.223 . . . . 0.0 112.37 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.2 m -54.21 -19.03 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.147 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -58.31 -14.52 7.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.107 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -98.43 -16.63 19.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -114.57 28.34 8.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 26.1 t80 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 317' ' ' SER . 87.9 p 41.09 46.47 2.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.863 0.363 . . . . 0.0 110.871 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.448 ' C ' ' O ' ' A' ' 316' ' ' SER . 42.4 p 34.6 44.34 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.819 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -100.48 103.14 2.58 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.527 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 54.8 p -164.87 150.92 10.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.896 0.379 . . . . 0.0 110.848 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 3.2 t -94.11 174.77 6.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 172.1 -175.44 45.37 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.29 177.77 5.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.828 0.347 . . . . 0.0 110.87 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -129.58 78.29 1.84 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -101.94 108.14 19.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -136.84 149.07 47.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.449 HD21 HD23 ' A' ' 407' ' ' LEU . 4.8 tp -71.47 -51.59 22.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.916 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . 0.489 ' HB2' ' CA ' ' A' ' 352' ' ' GLY . 22.8 m-85 -86.3 31.7 0.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -66.54 119.83 12.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.862 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 82.7 -53.07 4.79 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.467 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 329' ' ' GLY . 29.7 mt -36.69 124.84 0.86 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.847 0.356 . . . . 0.0 110.87 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -99.82 115.08 28.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -104.32 167.54 9.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' PHE . . . . . 0.41 ' CD1' ' O ' ' A' ' 355' ' ' SER . 34.6 t80 -152.58 115.56 4.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.59 HD13 ' HA ' ' A' ' 340' ' ' ARG . 4.1 mt -89.77 128.22 36.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.934 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' ASN . . . . . 0.44 ' O ' HG22 ' A' ' 338' ' ' VAL . 2.6 t-20 -83.23 145.99 28.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.546 ' HB3' HD13 ' A' ' 360' ' ' LEU . 0.0 OUTLIER -51.03 -20.03 1.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -78.75 -42.49 27.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 335' ' ' ASN . 13.3 m -82.39 151.21 65.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.623 0.725 . . . . 0.0 111.144 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . 0.524 ' O ' HD12 ' A' ' 343' ' ' LEU . 54.0 Cg_endo -69.71 124.82 11.47 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.715 2.277 . . . . 0.0 112.366 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 0.59 ' HA ' HD13 ' A' ' 334' ' ' LEU . 15.6 mtm105 -89.42 -55.45 3.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.875 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 340' ' ' ARG . 7.5 pt-20 -35.26 -45.85 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -71.58 -63.76 1.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.099 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . 0.685 HD11 ' HB3' ' A' ' 395' ' ' PRO . 35.3 mt -55.46 -63.59 1.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.916 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -37.07 -57.65 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -52.83 -46.21 67.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' ILE . . . . . 0.689 ' CG2' HG11 ' A' ' 402' ' ' VAL . 14.6 mt -61.18 -62.05 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.129 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 20.3 mt -48.63 -53.03 7.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.155 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -62.07 -40.32 95.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 4.5 m -60.21 -34.88 74.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.821 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -98.79 29.04 3.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 53.8 59.17 10.19 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.477 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . 0.489 ' CA ' ' HB2' ' A' ' 327' ' ' PHE . . . -125.39 156.31 19.16 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.467 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -91.27 142.47 27.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.951 0.405 . . . . 0.0 110.838 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.462 ' CG2' ' HG ' ' A' ' 334' ' ' LEU . 7.5 p -159.11 141.03 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.149 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . 0.41 ' O ' ' CD1' ' A' ' 333' ' ' PHE . 32.7 t -140.9 157.47 45.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.828 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -136.35 -177.89 4.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.673 ' HB2' HD12 ' A' ' 360' ' ' LEU . 2.9 m-20 -69.13 119.78 13.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 22.8 mttp -53.52 -55.43 25.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 26.5 t -48.18 -58.94 3.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.87 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.673 HD12 ' HB2' ' A' ' 357' ' ' ASP . 5.9 mt -49.97 -40.54 44.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 3.8 m -160.68 144.72 13.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 7.3 pt -82.27 151.33 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.1 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 109.79 26.94 4.82 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.451 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -99.98 155.87 17.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 111.139 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 23.8 p -108.12 -57.82 2.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.14 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -128.27 136.7 51.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.9 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.92 169.8 14.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.839 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . 0.46 ' HA ' ' CD1' ' A' ' 373' ' ' ILE . 11.3 p -55.54 -29.35 24.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.137 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 75.8 p -65.88 -25.6 67.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.145 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -62.21 98.88 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 60.5 p -49.49 -29.62 6.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -45.99 -40.45 10.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.859 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.46 ' CD1' ' HA ' ' A' ' 368' ' ' VAL . 60.0 mt -38.16 145.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.103 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 75.7 p -117.55 -30.81 5.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.164 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -141.75 124.37 15.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.827 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' GLN . . . . . 0.529 ' NE2' ' CG1' ' A' ' 378' ' ' VAL . 0.2 OUTLIER -106.09 95.04 5.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 48.2 mm -58.62 97.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.108 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.529 ' CG1' ' NE2' ' A' ' 376' ' ' GLN . 27.4 m -118.58 163.3 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.137 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.96 -34.77 64.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -134.64 80.9 49.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.602 0.715 . . . . 0.0 110.906 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 3.05 2.99 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.665 2.244 . . . . 0.0 112.381 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -113.43 -21.56 5.78 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.484 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . 0.412 ' HG3' ' N ' ' A' ' 384' ' ' GLN . 1.0 OUTLIER -92.64 -61.07 1.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.78 0.324 . . . . 0.0 110.888 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.412 ' N ' ' HG3' ' A' ' 383' ' ' GLN . 2.4 pt20 -54.56 138.82 39.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 7.8 t -48.93 146.8 3.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.14 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 25.2 p -118.87 152.71 35.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.848 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.39 119.22 49.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.112 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.762 ' H ' HD12 ' A' ' 388' ' ' ILE . 5.0 mp -42.57 111.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.17 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 115.18 -38.58 3.07 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.52 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . 0.492 ' HD2' ' CZ ' ' A' ' 392' ' ' TYR . 6.7 ttm180 -83.55 146.81 28.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.765 0.317 . . . . 0.0 110.898 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 43.8 m -114.53 143.61 44.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . 0.492 ' CZ ' ' HD2' ' A' ' 390' ' ' ARG . 3.7 m-85 -123.29 129.33 51.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.488 HG11 ' CG1' ' A' ' 410' ' ' VAL . 33.8 m -132.99 152.21 35.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.197 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -71.05 160.91 81.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.576 0.703 . . . . 0.0 110.936 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.685 ' HB3' HD11 ' A' ' 343' ' ' LEU . 53.6 Cg_endo -69.74 -4.58 14.3 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.709 2.273 . . . . 0.0 112.315 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . 0.537 ' HA ' ' CD2' ' A' ' 399' ' ' PHE . 14.0 tt0 -85.36 -31.77 22.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -53.78 -30.32 44.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.985 ' O ' HG22 ' A' ' 402' ' ' VAL . 21.4 t -72.52 -38.33 59.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.106 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . 0.537 ' CD2' ' HA ' ' A' ' 396' ' ' GLN . 17.3 m-85 -63.19 -52.24 63.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.25 -26.92 67.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 45.8 m -75.81 -59.81 2.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.837 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.985 HG22 ' O ' ' A' ' 398' ' ' VAL . 5.8 m -55.6 -33.99 34.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.083 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -76.3 -38.74 55.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -85.37 12.34 8.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.085 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 40.04 36.07 0.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.403 HD12 ' H ' ' A' ' 407' ' ' LEU . 49.7 tp -151.48 151.39 31.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.978 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.449 HD23 HD21 ' A' ' 326' ' ' LEU . 46.9 mt -86.83 71.9 10.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.924 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 407' ' ' LEU . 43.6 mt -38.04 156.41 0.1 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.621 0.724 . . . . 0.0 110.906 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 113.6 3.42 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.345 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.488 ' CG1' HG11 ' A' ' 393' ' ' VAL . 16.4 m -61.83 -31.22 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -45.21 -44.39 10.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.47 -27.16 67.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -98.35 38.33 1.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.889 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 52.9 p -44.86 166.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.382 . . . . 0.0 110.87 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 47.5 t -130.72 119.86 22.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -39.49 104.1 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.463 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 97.4 p -91.36 90.91 7.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.853 0.359 . . . . 0.0 110.825 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 25.5 m -40.69 -44.27 2.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.86 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 134.92 109.17 1.02 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.454 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 22.3 tttm -84.63 -47.13 10.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.786 0.327 . . . . 0.0 110.899 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.457 ' O ' ' C ' ' A' ' 324' ' ' LYS . 9.0 m170 -71.45 121.86 19.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.858 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 323' ' ' HIS . 0.0 OUTLIER -33.34 141.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt -95.44 138.86 32.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 22.7 tp -53.25 -53.07 56.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . 0.438 ' HB2' ' CA ' ' A' ' 352' ' ' GLY . 24.5 m-85 -95.24 35.52 1.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -60.68 113.08 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 80.51 -41.88 2.56 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.5 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 34.9 mt -44.8 124.75 4.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.903 0.382 . . . . 0.0 110.894 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -95.81 147.39 23.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -137.82 155.77 48.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -139.55 116.3 10.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.696 HD11 HG21 ' A' ' 354' ' ' VAL . 2.8 mt -94.64 152.65 18.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -114.54 147.88 38.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.447 ' HD2' ' N ' ' A' ' 336' ' ' ARG . 0.5 OUTLIER -46.86 -27.78 1.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -63.87 -48.59 76.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.7 m -86.89 151.14 51.73 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.675 0.75 . . . . 0.0 111.121 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . 0.618 ' O ' HD12 ' A' ' 343' ' ' LEU . 54.0 Cg_endo -69.77 116.06 4.38 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.67 2.247 . . . . 0.0 112.328 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 0.426 ' HG2' ' N ' ' A' ' 341' ' ' GLU . 0.0 OUTLIER -87.4 -29.98 21.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.884 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.426 ' N ' ' HG2' ' A' ' 340' ' ' ARG . 11.2 pt-20 -50.96 -49.75 59.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.401 ' N ' ' HG3' ' A' ' 341' ' ' GLU . . . -74.3 -57.59 3.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.089 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . 0.666 HD23 ' CE1' ' A' ' 399' ' ' PHE . 27.6 mt -53.14 -65.33 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 343' ' ' LEU . . . -35.03 -62.66 0.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.059 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . 0.603 ' N ' HH21 ' A' ' 348' ' ' ARG . 19.8 t80 -48.27 -49.73 32.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 349' ' ' SER . 44.4 mt -56.55 -71.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.16 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . 0.429 ' O ' ' N ' ' A' ' 352' ' ' GLY . 20.9 mt -37.99 -50.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.138 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . 0.603 HH21 ' N ' ' A' ' 345' ' ' PHE . 75.0 mtm180 -65.21 -37.71 88.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 346' ' ' ILE . 29.6 t -61.2 -42.83 99.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -88.54 23.05 2.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.869 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 60.67 57.2 20.12 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.452 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . 0.438 ' CA ' ' HB2' ' A' ' 327' ' ' PHE . . . -123.01 164.22 16.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.471 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -103.75 130.12 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.924 0.392 . . . . 0.0 110.893 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.696 HG21 HD11 ' A' ' 334' ' ' LEU . 5.7 p -141.51 142.76 28.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.123 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . 0.458 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 4.6 t -140.48 162.46 35.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' TRP . . . . . 0.568 ' O ' ' HB2' ' A' ' 364' ' ' ALA . 20.4 p90 -139.32 153.92 47.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.913 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 360' ' ' LEU . 3.9 t70 -45.07 104.87 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 357' ' ' ASP . 7.3 mtpm? -35.92 -36.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 2.2 t -64.0 -48.35 76.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 357' ' ' ASP . 36.8 mt -55.44 -39.35 70.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 3.7 t -172.23 146.7 1.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.6 pt -66.34 173.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.102 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 104.42 -38.96 3.0 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.499 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 356' ' ' TRP . . . -50.34 140.3 13.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.822 0.344 . . . . 0.0 111.13 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 23.6 p -101.49 -50.94 3.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.186 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' TYR . . . . . 0.458 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 29.9 p90 -112.49 149.64 32.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.52 167.56 19.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.86 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 12.8 p -69.73 -22.56 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.155 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 77.3 p -84.02 13.55 4.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.61 110.49 17.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 22.6 p -55.35 -23.8 25.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -60.94 -36.8 80.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.85 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.417 HG21 HH11 ' A' ' 390' ' ' ARG . 66.6 mt -40.55 130.38 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.121 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 69.6 p -97.52 -24.72 15.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.169 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -154.55 149.36 26.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' GLN . . . . . 0.541 ' OE1' ' CE2' ' A' ' 392' ' ' TYR . 52.8 tt0 -134.37 111.56 10.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 19.1 mm -80.0 115.0 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.129 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.533 HG13 ' HG2' ' A' ' 376' ' ' GLN . 29.5 m -131.97 168.98 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.55 -34.59 31.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.458 ' CZ ' ' HG3' ' A' ' 383' ' ' GLN . 81.3 mtp180 -132.23 80.81 62.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.612 0.72 . . . . 0.0 110.872 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -18.6 37.04 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.689 2.259 . . . . 0.0 112.358 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -73.92 -32.45 58.84 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.526 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . 0.458 ' HG3' ' CZ ' ' A' ' 380' ' ' ARG . 21.1 mm-40 -76.12 -49.3 17.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.756 0.312 . . . . 0.0 110.898 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -53.17 178.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 72.4 p -122.2 121.93 38.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 81.3 p -56.88 157.54 5.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 97.3 t -125.43 140.16 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.131 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.1 mt -37.82 111.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.093 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 92.13 -49.07 2.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.489 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . 0.468 ' HD2' ' N ' ' A' ' 391' ' ' CYS . 6.9 tmm_? -84.43 146.28 27.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.806 0.336 . . . . 0.0 110.863 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' CYS . . . . . 0.468 ' N ' ' HD2' ' A' ' 390' ' ' ARG . 88.3 m -134.8 147.55 49.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . 0.541 ' CE2' ' OE1' ' A' ' 376' ' ' GLN . 5.2 m-85 -94.62 132.87 38.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 4.2 m -138.26 158.13 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.116 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -78.7 161.32 69.67 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.608 0.718 . . . . 0.0 110.913 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -6.19 18.02 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.643 2.229 . . . . 0.0 112.341 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -80.96 -23.74 38.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.946 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 92.5 t90 -63.73 -27.97 69.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.696 ' O ' HG22 ' A' ' 402' ' ' VAL . 48.0 t -75.0 -70.27 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . 0.666 ' CE1' HD23 ' A' ' 343' ' ' LEU . 5.4 m-30 -42.07 -36.95 1.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.88 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -72.44 -44.31 62.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 75.8 m -63.55 -54.47 35.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.81 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 398' ' ' VAL . 2.5 m -56.74 -33.88 41.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.089 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -79.48 -29.48 41.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -94.5 9.17 39.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.071 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? 40.19 32.71 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.597 HD13 ' N ' ' A' ' 407' ' ' LEU . 0.9 OUTLIER -152.62 137.4 17.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.93 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.597 ' N ' HD13 ' A' ' 406' ' ' LEU . 48.1 mt -74.1 85.37 1.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 45.5 mt -51.57 154.15 3.48 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.552 0.691 . . . . 0.0 110.977 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 107.93 1.96 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.711 2.274 . . . . 0.0 112.326 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.1 m -54.84 -16.78 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.141 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -62.16 -19.16 62.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -90.74 -24.24 20.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -104.96 38.27 1.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.905 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 6.0 t80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 15.6 m -86.03 153.87 21.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.913 0.387 . . . . 0.0 110.8 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 26.7 t -102.35 148.79 25.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.847 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -178.56 107.48 0.23 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.464 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 21.4 m -72.29 83.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.944 0.402 . . . . 0.0 110.872 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 30.0 p -70.96 96.54 1.31 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.866 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 159.97 147.49 4.92 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.468 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 18.5 mmtm -107.83 141.0 40.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.813 0.339 . . . . 0.0 110.884 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -134.0 170.69 15.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.828 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.32 98.88 6.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -91.03 133.89 34.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.903 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 15.9 tp -57.69 -52.57 64.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . 0.472 ' HA ' HD12 ' A' ' 330' ' ' LEU . 25.4 m-85 -92.41 38.39 1.01 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -71.69 141.15 49.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.919 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 45.49 43.45 10.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.451 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 327' ' ' PHE . 42.1 mt -132.23 126.81 34.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.86 0.362 . . . . 0.0 110.899 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.549 ' HE3' ' CE2' ' A' ' 366' ' ' TYR . 37.1 mtpt -99.32 141.38 32.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.909 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -133.18 156.16 47.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' PHE . . . . . 0.467 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 8.9 t80 -138.36 115.63 11.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.86 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.531 HD11 HG21 ' A' ' 354' ' ' VAL . 2.9 mt -94.47 151.96 18.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.933 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -104.45 177.12 4.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -77.48 -27.51 51.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.855 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -72.13 -26.04 61.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.1 m -102.15 148.39 35.31 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.603 0.716 . . . . 0.0 111.122 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . 0.465 ' O ' HD12 ' A' ' 343' ' ' LEU . 53.4 Cg_endo -69.83 122.31 8.97 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.633 2.222 . . . . 0.0 112.343 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 0.5 ' O ' ' HB3' ' A' ' 344' ' ' ALA . 6.3 ppt_? -95.08 -30.67 13.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.461 ' N ' ' HD2' ' A' ' 340' ' ' ARG . 8.1 pt-20 -52.07 -37.82 55.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -86.26 -60.67 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.112 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 339' ' ' PRO . 54.9 mt -52.7 -55.58 21.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 340' ' ' ARG . . . -45.35 -58.6 3.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.07 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . 0.407 ' O ' ' N ' ' A' ' 349' ' ' SER . 4.8 t80 -56.38 -46.93 79.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' ILE . . . . . 0.412 ' CD1' ' CE1' ' A' ' 399' ' ' PHE . 29.2 mt -55.83 -67.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.147 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 17.0 mt -45.77 -37.94 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.167 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -78.97 -26.72 43.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 345' ' ' PHE . 16.7 t -82.53 -21.9 35.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.837 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -101.18 15.56 28.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 72.31 73.37 0.85 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.501 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -158.1 169.03 34.69 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.455 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -106.03 143.47 34.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.832 0.349 . . . . 0.0 110.947 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.531 HG21 HD11 ' A' ' 334' ' ' LEU . 11.7 p -157.82 128.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.151 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . 0.548 ' HB2' ' CE1' ' A' ' 366' ' ' TYR . 1.9 m -133.7 154.15 51.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' TRP . . . . . 0.466 ' CD1' ' O ' ' A' ' 361' ' ' CYS . 14.3 p90 -122.16 -178.5 3.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.884 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 358' ' ' LYS . 10.9 t70 -73.83 111.75 9.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.854 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 357' ' ' ASP . 27.4 mttt -35.0 -51.47 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 7.9 t -57.97 -49.11 77.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 28.1 mt -51.31 -51.12 57.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' CYS . . . . . 0.466 ' O ' ' CD1' ' A' ' 356' ' ' TRP . 1.8 m -160.91 143.28 12.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 45.0 pt -66.22 160.08 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.41 ' O ' ' CZ2' ' A' ' 356' ' ' TRP . . . 96.91 36.21 5.08 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.464 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -117.33 147.17 42.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.816 0.341 . . . . 0.0 111.116 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 21.9 p -105.18 -71.06 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.146 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' TYR . . . . . 0.549 ' CE2' ' HE3' ' A' ' 331' ' ' LYS . 13.6 p90 -96.34 146.59 24.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.934 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.76 170.66 11.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . 0.467 ' HB ' ' CZ ' ' A' ' 333' ' ' PHE . 7.3 p -64.55 -18.05 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.134 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 70.1 p -85.37 22.85 1.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.181 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -104.73 103.83 13.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 30.0 m -50.35 -37.09 35.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 30.6 mtt180 -40.59 -39.84 1.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.86 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 70.6 mt -45.65 117.64 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.158 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 48.9 p -81.64 -44.93 16.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -126.32 138.87 53.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.861 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' GLN . . . . . 0.46 ' OE1' ' CZ ' ' A' ' 390' ' ' ARG . 37.6 tt0 -122.32 99.05 6.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.914 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . 0.424 ' N ' ' O ' ' A' ' 333' ' ' PHE . 25.8 mm -65.87 129.46 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 35.4 m -152.27 146.67 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.139 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -68.21 -34.54 76.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.827 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.404 ' HA ' ' HD2' ' A' ' 381' ' ' PRO . 20.2 mtp85 -132.7 89.86 34.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.612 0.72 . . . . 0.0 110.878 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 380' ' ' ARG . 53.6 Cg_endo -69.71 -27.06 27.17 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.668 2.245 . . . . 0.0 112.337 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -72.58 -59.2 4.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.528 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . 0.47 ' HG3' ' N ' ' A' ' 384' ' ' GLN . 12.1 pt20 -43.03 -36.96 1.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.808 0.337 . . . . 0.0 110.921 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.47 ' N ' ' HG3' ' A' ' 383' ' ' GLN . 10.4 pt20 -104.32 114.67 29.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.95 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 16.2 m -51.37 153.11 2.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.159 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 6.9 t -91.51 173.18 8.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.858 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.9 t -127.77 130.91 70.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.111 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 29.3 mm -42.37 125.95 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.143 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 94.68 -33.52 5.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.487 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . 0.46 ' CZ ' ' OE1' ' A' ' 376' ' ' GLN . 19.8 ttp180 -93.97 146.11 24.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.782 0.325 . . . . 0.0 110.881 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 62.5 m -129.22 127.8 42.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -96.61 133.64 40.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.507 HG11 ' HB ' ' A' ' 410' ' ' VAL . 17.0 m -143.21 142.76 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.123 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -57.85 158.45 12.48 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.607 0.718 . . . . 0.0 110.93 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -7.25 20.6 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.709 2.273 . . . . 0.0 112.294 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.31 -33.75 42.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' TRP . . . . . 0.457 ' CE2' HG12 ' A' ' 410' ' ' VAL . 69.1 t90 -48.49 -31.16 6.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.926 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.515 ' O ' HG22 ' A' ' 402' ' ' VAL . 65.7 t -80.22 -55.03 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . 0.433 ' CE2' HD21 ' A' ' 343' ' ' LEU . 68.1 m-85 -54.23 -22.02 10.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -85.45 -41.39 15.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 405' ' ' ARG . 20.3 m -66.53 -51.92 51.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 398' ' ' VAL . 15.3 m -49.77 -38.12 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.141 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -78.12 -44.18 26.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -83.08 8.28 13.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.138 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 404' ' ' ALA . 7.9 mmm180 35.57 46.0 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 12.6 tp -156.18 148.18 23.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.932 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 13.5 mt -80.0 84.14 5.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 33.1 mt -55.53 154.36 12.63 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.598 0.714 . . . . 0.0 110.886 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 114.13 3.61 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.707 2.271 . . . . 0.0 112.293 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.507 ' HB ' HG11 ' A' ' 393' ' ' VAL . 35.2 m -60.57 -21.27 22.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.123 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -55.54 -40.05 71.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.085 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.38 -9.99 59.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -121.34 38.41 4.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.887 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 10.4 t80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 -179.976 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 14.5 m -130.33 -57.26 1.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.814 0.34 . . . . 0.0 110.852 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 54.9 p -169.6 158.58 7.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.807 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -146.47 95.23 0.17 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.476 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 21.3 t -141.1 140.54 34.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.876 0.37 . . . . 0.0 110.86 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 44.3 m -128.49 114.23 16.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.872 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 152.39 142.42 3.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.485 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.26 110.81 18.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.745 0.307 . . . . 0.0 110.919 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 51.3 m170 -100.47 119.72 38.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.845 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -69.71 144.01 52.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -121.69 118.71 29.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 11.6 tp -44.37 -50.58 9.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.866 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -93.01 42.59 1.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -74.56 133.86 42.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 52.32 55.29 22.75 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.486 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 88.0 mt -147.55 118.1 7.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.88 0.371 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -93.43 126.26 38.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.948 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.518 ' CD1' ' HB2' ' A' ' 375' ' ' HIS . 74.5 m-85 -120.29 160.36 23.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' PHE . . . . . 0.528 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 36.8 t80 -141.11 117.01 10.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.475 HD11 HG21 ' A' ' 354' ' ' VAL . 7.4 mt -93.67 142.84 26.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.904 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' ASN . . . . . 0.558 ' ND2' HG12 ' A' ' 378' ' ' VAL . 2.7 m-80 -101.22 158.25 16.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.776 ' HB3' HD13 ' A' ' 360' ' ' LEU . 12.9 ptt180 -58.78 -29.53 66.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.846 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . 0.462 ' CG ' ' OD2' ' A' ' 379' ' ' ASP . 11.6 tp10 -66.19 -48.0 72.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 5.1 m -80.82 150.64 69.66 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.582 0.706 . . . . 0.0 111.184 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 110.34 2.53 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.677 2.251 . . . . 0.0 112.3 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -86.53 -38.67 16.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -44.69 -41.33 6.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -82.42 -58.49 2.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.075 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 71.4 mt -53.99 -61.23 2.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -39.66 -55.55 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.068 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -58.81 -44.54 90.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 47.8 mt -59.65 -62.33 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.151 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 20.1 mt -51.97 -55.88 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -56.43 -40.26 74.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 29.5 t -64.92 -43.96 91.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . 0.468 ' CZ ' HG22 ' A' ' 402' ' ' VAL . 14.0 m-85 -73.44 -9.16 58.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 90.83 54.55 2.03 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.497 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -128.91 161.95 22.46 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.492 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -92.06 129.07 38.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.912 0.387 . . . . 0.0 110.851 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.475 HG21 HD11 ' A' ' 334' ' ' LEU . 10.8 p -148.06 143.2 19.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.155 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . 0.553 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 5.1 t -147.39 152.26 37.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.868 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' TRP . . . . . 0.509 ' CD1' ' HB3' ' A' ' 361' ' ' CYS . 31.7 p90 -128.45 173.15 10.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.668 ' HB2' HD12 ' A' ' 360' ' ' LEU . 1.2 m-20 -61.59 109.28 1.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.821 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -46.45 -34.34 4.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 28.4 t -69.41 -55.18 11.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.814 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.776 HD13 ' HB3' ' A' ' 336' ' ' ARG . 18.5 mt -54.91 -44.14 73.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.894 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' CYS . . . . . 0.509 ' HB3' ' CD1' ' A' ' 356' ' ' TRP . 2.1 t -147.21 159.97 43.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 15.7 tt -86.55 162.26 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.149 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 85.98 43.1 6.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.508 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -107.04 165.8 11.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.878 0.37 . . . . 0.0 111.09 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 20.9 p -129.78 -64.05 0.89 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.143 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' TYR . . . . . 0.553 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 8.3 p90 -112.31 145.91 39.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.953 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.13 167.17 22.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.88 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . 0.528 ' HB ' ' CZ ' ' A' ' 333' ' ' PHE . 7.5 p -63.62 -20.49 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.107 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 79.1 p -93.65 26.62 3.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.142 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -93.87 113.58 25.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 372' ' ' ARG . 11.9 t -53.62 -45.76 70.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.871 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 371' ' ' SER . 18.5 mmt180 -37.15 -42.42 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.917 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 34.0 mt -47.75 129.95 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.096 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 41.6 p -94.73 -43.1 8.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.106 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . 0.518 ' HB2' ' CD1' ' A' ' 332' ' ' PHE . 37.3 m80 -128.82 148.47 50.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -128.74 115.42 17.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.927 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 27.0 mm -82.72 116.17 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.167 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.558 HG12 ' ND2' ' A' ' 335' ' ' ASN . 30.9 m -141.05 158.19 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . 0.462 ' OD2' ' CG ' ' A' ' 337' ' ' GLU . 2.8 m-20 -71.48 -37.7 71.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -127.69 81.98 69.19 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.578 0.704 . . . . 0.0 110.892 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -23.07 31.34 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.715 2.277 . . . . 0.0 112.373 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -68.64 -47.16 58.13 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.476 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -63.11 -48.9 76.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.775 0.321 . . . . 0.0 110.88 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -45.81 164.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.91 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 51.6 m -95.87 126.68 41.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.117 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 72.4 m -67.21 139.78 57.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 90.5 t -129.78 119.36 47.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.112 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.783 ' H ' HD12 ' A' ' 388' ' ' ILE . 5.0 mp -39.94 134.41 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 88.76 -40.8 3.05 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.455 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . 0.425 ' NH1' ' O ' ' A' ' 368' ' ' VAL . 14.5 ttp180 -95.65 145.79 25.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.756 0.312 . . . . 0.0 110.871 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 84.0 m -132.85 124.33 27.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -90.89 128.07 36.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.954 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 19.7 m -135.99 151.11 28.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.088 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -66.55 158.12 80.1 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.602 0.715 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -5.5 16.34 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.662 2.241 . . . . 0.0 112.362 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -80.68 -14.77 57.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -73.12 -49.77 26.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 51.7 t -55.5 -41.75 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.12 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -65.03 -64.53 0.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.484 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 2.4 m-20 -50.42 -33.42 20.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.836 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 69.6 m -70.49 -26.24 63.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.468 HG22 ' CZ ' ' A' ' 350' ' ' PHE . 2.2 t -89.23 -45.73 15.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.096 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -67.73 -31.68 71.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -88.08 5.99 38.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.087 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? 40.08 44.4 1.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 43.0 tp -165.13 144.24 6.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 16.4 mt -74.95 99.31 3.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.484 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 52.2 mt -71.55 153.62 93.56 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.634 0.731 . . . . 0.0 110.924 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 119.57 6.49 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.702 2.268 . . . . 0.0 112.35 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.09 -28.6 44.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.136 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -52.9 -21.82 4.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -84.52 -32.65 23.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -104.96 42.51 1.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.923 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 3.7 t80 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.88 179.966 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 316' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 315' ' ' GLY . 2.0 m -35.44 -53.88 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 0.0 110.837 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 3.1 m -57.9 136.14 56.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.847 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 61.37 141.93 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.451 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 33.1 m -85.89 170.25 12.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.918 0.389 . . . . 0.0 110.806 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 27.4 p -165.38 159.33 16.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.846 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -125.3 -111.57 1.85 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.496 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -94.59 82.04 3.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.788 0.327 . . . . 0.0 110.926 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -122.02 171.62 8.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.845 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 8.9 mtpt -138.38 161.08 37.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -139.91 146.63 39.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.443 HD11 ' HA ' ' A' ' 405' ' ' ARG . 2.5 tt -57.26 -52.6 64.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.936 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -92.15 38.54 1.0 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -77.21 124.37 27.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 69.01 49.2 42.71 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.544 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.498 HD11 HD11 ' A' ' 407' ' ' LEU . 88.9 mt -148.19 124.46 10.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.854 0.359 . . . . 0.0 110.935 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.46 ' HZ2' ' HB3' ' A' ' 372' ' ' ARG . 45.3 mttt -95.54 133.11 39.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -119.26 152.8 36.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.909 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -130.98 119.04 21.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.879 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.729 HD11 HG21 ' A' ' 354' ' ' VAL . 7.3 mt -97.95 140.89 31.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -98.34 -175.14 3.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.872 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -82.46 -33.74 28.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -69.81 -36.6 75.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.562 HG11 HG22 ' A' ' 377' ' ' ILE . 3.1 m -87.16 145.28 37.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.658 0.742 . . . . 0.0 111.107 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . 0.519 ' O ' HD12 ' A' ' 343' ' ' LEU . 53.6 Cg_endo -69.74 127.32 14.44 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.664 2.242 . . . . 0.0 112.33 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.86 -40.19 9.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -45.65 -41.36 10.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -78.9 -66.91 0.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.139 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 339' ' ' PRO . 60.2 mt -44.57 -58.26 3.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -43.3 -54.79 4.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -55.39 -40.61 71.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' ILE . . . . . 0.553 ' CG2' HG11 ' A' ' 402' ' ' VAL . 15.6 mt -68.64 -72.91 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.145 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . 0.472 ' N ' HG22 ' A' ' 346' ' ' ILE . 26.1 mt -37.33 -37.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.122 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -75.18 -47.99 25.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 47.5 t -55.52 -31.18 61.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.804 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . 0.422 ' CE2' ' HB ' ' A' ' 402' ' ' VAL . 20.7 m-85 -98.72 26.22 5.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 53.02 71.44 0.69 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.521 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -136.87 173.07 22.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.49 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -109.17 128.23 54.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 110.902 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.729 HG21 HD11 ' A' ' 334' ' ' LEU . 7.6 p -144.06 131.58 17.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.119 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . 0.579 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 10.4 t -136.2 163.86 29.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' TRP . . . . . 0.508 ' CD1' ' HB2' ' A' ' 361' ' ' CYS . 34.0 p90 -142.35 159.07 42.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.905 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.844 ' HB2' HD12 ' A' ' 360' ' ' LEU . 7.0 m-20 -55.65 120.88 7.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -45.08 -59.38 2.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 14.7 t -45.4 -48.88 13.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.824 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.844 HD12 ' HB2' ' A' ' 357' ' ' ASP . 32.3 mt -55.97 -49.62 73.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.973 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' CYS . . . . . 0.508 ' HB2' ' CD1' ' A' ' 356' ' ' TRP . 62.1 m -154.03 157.4 38.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.2 tt -84.9 158.48 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.117 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 91.73 36.38 6.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.486 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -105.52 158.2 16.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 0.0 111.087 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.434 ' OG1' ' CD2' ' A' ' 366' ' ' TYR . 22.3 p -111.99 -64.14 1.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.124 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' TYR . . . . . 0.579 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 16.0 p90 -110.18 139.43 45.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -76.74 171.46 14.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . 0.419 ' O ' HG22 ' A' ' 368' ' ' VAL . 13.6 p -64.12 -11.77 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.175 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 25.3 p -96.89 15.66 21.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.147 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . 0.442 ' CB ' ' HB2' ' A' ' 366' ' ' TYR . 0.9 OUTLIER -96.03 107.2 19.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.886 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 59.0 p -52.24 -33.34 41.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . 0.46 ' HB3' ' HZ2' ' A' ' 331' ' ' LYS . 26.1 mmm-85 -40.05 -45.14 1.88 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.877 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.446 HG12 ' CE1' ' A' ' 366' ' ' TYR . 20.7 mt -41.24 136.16 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.192 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 50.6 p -112.12 -23.87 10.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.114 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -134.47 134.16 41.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.847 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' GLN . . . . . 0.446 ' HG2' ' CE2' ' A' ' 392' ' ' TYR . 2.0 tp-100 -124.59 105.5 9.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.896 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . 0.562 HG22 HG11 ' A' ' 338' ' ' VAL . 6.0 mm -84.38 126.38 40.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.09 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 13.5 m -139.11 152.36 23.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.12 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -67.19 -42.49 84.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.426 ' HB3' ' NH1' ' A' ' 380' ' ' ARG . 0.0 OUTLIER -132.12 90.42 35.0 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 0.0 110.866 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -19.45 36.3 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.668 2.246 . . . . 0.0 112.352 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -65.48 -47.03 82.41 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.531 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -80.92 -42.22 21.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.756 0.312 . . . . 0.0 110.894 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -51.93 153.49 2.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.0 149.67 23.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.139 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 26.1 p -108.86 153.11 23.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.839 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 26.1 t -119.65 128.43 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.14 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.3 mt -40.4 117.67 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.167 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 103.88 -43.14 1.73 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.466 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -87.67 148.7 24.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 0.0 110.867 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 4.0 t -123.58 145.51 48.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . 0.446 ' CE2' ' HG2' ' A' ' 376' ' ' GLN . 2.9 m-85 -107.28 118.05 35.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.942 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.427 HG23 ' CD1' ' A' ' 377' ' ' ILE . 31.4 m -124.85 160.32 30.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.135 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -76.02 159.59 80.29 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.57 0.7 . . . . 0.0 110.887 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -6.69 19.18 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.669 2.246 . . . . 0.0 112.357 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -83.55 -15.9 47.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.947 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -66.09 -26.55 67.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.425 ' O ' HG22 ' A' ' 402' ' ' VAL . 85.9 t -76.43 -51.34 19.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.161 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -60.18 -30.67 69.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.464 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 1.0 OUTLIER -80.55 -36.45 33.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.904 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 71.8 m -69.27 -49.47 55.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.553 HG11 ' CG2' ' A' ' 346' ' ' ILE . 34.9 m -60.43 -45.29 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.117 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . 0.499 ' N ' HG23 ' A' ' 402' ' ' VAL . 20.9 t-20 -65.08 -39.04 92.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -87.16 9.49 19.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.128 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' A' ' 404' ' ' ALA . 12.6 mmm-85 34.71 45.31 0.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.646 HD13 ' N ' ' A' ' 407' ' ' LEU . 0.4 OUTLIER -165.32 136.1 3.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.646 ' N ' HD13 ' A' ' 406' ' ' LEU . 15.6 mt -66.1 95.99 0.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.955 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.464 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 45.6 mt -64.75 156.1 80.07 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.607 0.718 . . . . 0.0 110.941 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 116.04 4.37 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.701 2.267 . . . . 0.0 112.361 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.9 m -58.02 -26.15 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.133 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -50.94 -34.3 28.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.072 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -75.72 -26.12 57.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -108.77 42.67 1.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 43.4 t80 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.898 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 82.3 p -152.68 163.58 39.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 0.0 110.889 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 5.5 t -142.3 169.48 17.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.888 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -155.72 76.8 0.21 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.481 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 90.1 p -148.04 153.83 39.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.923 0.392 . . . . 0.0 110.806 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 48.3 t -128.16 87.92 2.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 64.18 53.87 33.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.493 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -111.24 84.31 1.92 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.796 0.332 . . . . 0.0 110.849 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -109.9 100.1 9.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.864 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -112.87 78.19 1.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.938 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -125.32 136.68 53.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.941 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 2.0 tt -60.91 -48.62 80.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.939 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . 0.411 ' HA ' HD12 ' A' ' 330' ' ' LEU . 14.0 m-85 -93.48 38.87 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.848 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . 0.488 ' CD ' ' N ' ' A' ' 329' ' ' GLY . 3.9 tp10 -72.41 133.12 44.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . 0.488 ' N ' ' CD ' ' A' ' 328' ' ' GLU . . . 58.31 53.19 47.78 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.484 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 327' ' ' PHE . 89.8 mt -148.14 132.6 17.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.884 0.373 . . . . 0.0 110.941 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -109.62 132.99 53.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.959 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -126.05 140.82 52.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.852 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -119.97 115.36 23.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.889 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 8.1 mt -89.08 145.57 25.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -98.87 -179.65 4.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -81.96 -17.96 45.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -79.3 -45.07 20.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.845 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 2.0 m -83.95 150.16 57.99 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.617 0.722 . . . . 0.0 111.18 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . 0.727 ' O ' HD12 ' A' ' 343' ' ' LEU . 53.4 Cg_endo -69.79 137.69 35.96 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.712 2.275 . . . . 0.0 112.342 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 344' ' ' ALA . 0.0 OUTLIER -105.62 -34.73 7.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.905 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -50.91 -41.61 58.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -81.5 -48.41 11.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.083 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 339' ' ' PRO . 75.7 mt -67.15 -65.67 0.65 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -38.09 -45.23 0.9 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.08 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -68.33 -44.77 74.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 25.8 mt -61.8 -63.03 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.104 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 28.1 mt -51.4 -43.01 29.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -67.63 -33.99 76.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 17.7 t -72.23 -44.05 63.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . 0.523 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 14.2 m-85 -72.68 1.16 8.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 81.42 54.78 3.4 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.499 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -129.19 153.42 19.83 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.461 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -91.81 126.36 36.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.926 0.393 . . . . 0.0 110.846 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 6.5 p -139.99 137.92 38.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.046 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . 0.548 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 29.4 t -136.18 160.77 37.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 31.8 p90 -135.41 -175.37 3.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.925 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.719 ' HB2' HD12 ' A' ' 360' ' ' LEU . 12.5 m-20 -78.08 113.22 15.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 357' ' ' ASP . 1.3 mppt? -38.31 -56.2 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 17.7 t -44.88 -50.11 10.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.719 HD12 ' HB2' ' A' ' 357' ' ' ASP . 29.1 mt -57.02 -35.68 69.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.944 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 1.9 t -174.64 156.61 2.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 10.6 tt -81.36 163.23 3.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 111.16 -33.57 5.79 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.467 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -40.47 147.14 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 0.0 111.143 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.479 ' HG1' ' HD2' ' A' ' 366' ' ' TYR . 42.8 p -110.92 -58.97 2.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.094 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' TYR . . . . . 0.548 ' CE1' ' HB3' ' A' ' 355' ' ' SER . 18.7 p90 -111.51 146.36 37.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.905 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -86.47 165.51 16.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.838 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 13.7 p -56.73 -30.83 33.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.125 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 73.2 p -67.15 -25.84 66.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.211 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -56.69 103.65 0.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 53.9 m -54.7 -26.85 36.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -46.13 -40.11 10.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 68.4 mt -44.92 120.98 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 71.2 p -89.17 -50.58 6.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.142 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -120.7 146.69 46.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.829 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -131.44 102.7 6.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . 0.632 HD13 HG23 ' A' ' 393' ' ' VAL . 31.8 mm -71.59 130.18 35.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.147 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 22.1 m -143.01 164.2 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.157 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 380' ' ' ARG . 0.4 OUTLIER -57.95 -48.45 79.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.472 ' N ' ' OD1' ' A' ' 379' ' ' ASP . 53.4 mtm-85 -145.78 104.96 4.22 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.637 0.732 . . . . 0.0 110.861 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -0.05 6.31 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.694 2.262 . . . . 0.0 112.377 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -103.67 -34.78 3.71 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.528 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -71.23 -71.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.726 0.298 . . . . 0.0 110.861 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -61.85 143.6 56.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 96.5 m -69.05 128.95 38.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 9.2 p -80.9 166.02 21.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . 0.46 HG23 ' OH ' ' A' ' 392' ' ' TYR . 97.5 t -94.73 108.7 21.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.752 ' H ' HD12 ' A' ' 388' ' ' ILE . 5.3 mp -36.32 102.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.148 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 125.2 -44.84 1.22 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.463 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 11.6 ttm-85 -78.9 160.51 27.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 110.852 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 73.6 m -119.21 115.81 24.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . 0.46 ' OH ' HG23 ' A' ' 387' ' ' VAL . 7.4 m-85 -96.0 136.04 36.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.632 HG23 HD13 ' A' ' 377' ' ' ILE . 17.8 m -139.47 153.11 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.13 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -68.81 159.24 83.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.57 0.7 . . . . 0.0 110.912 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -8.02 22.54 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.677 2.251 . . . . 0.0 112.398 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -81.22 -20.8 40.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 70.3 t90 -60.55 -43.05 97.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.99 -55.9 20.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.161 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -51.8 -35.62 44.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -76.4 -38.99 54.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.829 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 36.8 m -64.3 -48.23 76.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.815 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.523 ' HB ' ' CZ ' ' A' ' 350' ' ' PHE . 22.3 m -61.11 -46.22 97.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.104 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . 0.493 ' N ' HG23 ' A' ' 402' ' ' VAL . 41.5 t30 -62.13 -42.76 99.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -83.38 0.39 46.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 44.07 41.94 4.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.565 HD13 ' N ' ' A' ' 407' ' ' LEU . 0.4 OUTLIER -163.3 131.53 3.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.565 ' N ' HD13 ' A' ' 406' ' ' LEU . 71.4 mt -61.15 103.13 0.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 35.0 mt -70.4 154.2 94.62 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.592 0.71 . . . . 0.0 110.878 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 105.28 1.45 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.711 2.274 . . . . 0.0 112.343 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 32.7 m -51.58 -23.97 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.157 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -49.41 -34.52 16.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.094 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -74.37 -40.53 62.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -91.07 40.1 1.01 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 34.2 t80 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.88 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 24.8 m -141.05 135.95 31.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.394 . . . . 0.0 110.857 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 61.8 p -132.89 133.57 43.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.848 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 62.55 95.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.507 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 18.9 p -91.53 50.17 1.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.361 . . . . 0.0 110.843 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 57.1 p -167.56 121.74 0.98 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 166.94 120.75 0.53 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.479 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -62.63 130.03 43.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.459 ' O ' ' CD2' ' A' ' 323' ' ' HIS . 0.3 OUTLIER -55.26 109.19 0.5 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.843 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 39.6 tttm -171.56 125.74 0.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 59.5 mmtt -135.11 123.2 22.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.923 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 2.4 tt -39.65 -48.08 2.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -96.87 42.0 1.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -80.53 107.12 13.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 90.31 43.82 4.85 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.493 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.45 HD11 HD11 ' A' ' 407' ' ' LEU . 96.6 mt -144.43 129.27 18.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.83 0.348 . . . . 0.0 110.959 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.417 ' CE ' ' HB3' ' A' ' 372' ' ' ARG . 19.7 mttm -96.79 143.57 27.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -134.33 144.09 48.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -129.57 116.72 19.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.542 HD11 HG21 ' A' ' 354' ' ' VAL . 5.4 mt -97.33 147.68 23.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.969 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -110.35 154.52 23.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -52.48 -36.63 55.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -56.62 -47.8 78.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.0 m -88.94 148.61 41.62 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.575 0.703 . . . . 0.0 111.142 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . 0.563 ' O ' HD12 ' A' ' 343' ' ' LEU . 54.2 Cg_endo -69.76 125.04 11.68 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.713 2.276 . . . . 0.0 112.343 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 344' ' ' ALA . 0.3 OUTLIER -95.07 -40.99 9.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.857 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' A' ' 342' ' ' ALA . 8.1 pt-20 -42.37 -42.89 3.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.431 ' N ' ' HG3' ' A' ' 341' ' ' GLU . . . -76.64 -46.7 24.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 339' ' ' PRO . 24.2 mt -71.02 -66.34 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.939 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 340' ' ' ARG . . . -34.65 -46.08 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.117 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -65.2 -43.33 91.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.926 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 343' ' ' LEU . 15.9 mt -62.7 -67.23 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.121 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 17.6 mt -42.34 -40.26 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 -72.77 -41.83 64.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 33.7 t -60.28 -33.18 71.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . 0.67 ' CZ ' HG13 ' A' ' 402' ' ' VAL . 22.8 m-85 -92.55 14.85 15.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.907 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 63.61 55.81 23.0 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.439 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -120.98 179.72 16.27 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.499 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -113.8 125.01 53.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 0.0 110.913 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.542 HG21 HD11 ' A' ' 334' ' ' LEU . 6.9 p -141.79 134.18 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 16.3 t -131.26 158.44 40.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.835 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 41.3 p90 -136.13 178.46 7.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.945 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 358' ' ' LYS . 0.6 OUTLIER -72.24 106.68 4.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.869 179.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 357' ' ' ASP . 0.1 OUTLIER -37.84 -45.61 0.86 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.918 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 58.8 m -42.09 -46.39 4.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 31.4 mt -60.01 -50.7 72.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 6.2 t -166.43 161.78 16.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 34.8 pt -64.21 175.34 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 364' ' ' ALA . . . 103.51 -35.07 5.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.508 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 363' ' ' GLY . . . -35.63 139.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.364 . . . . 0.0 111.087 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 37.2 p -113.37 -52.87 2.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.16 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -128.3 145.9 50.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.947 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -74.28 172.58 11.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.879 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 14.0 p -73.36 -14.12 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.135 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 41.3 p -96.94 19.65 12.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.144 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -95.79 105.95 18.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.832 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 8.4 t -47.05 -32.98 4.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . 0.417 ' HB3' ' CE ' ' A' ' 331' ' ' LYS . 9.0 mmt180 -41.95 -43.43 3.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.862 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 94.0 mt -49.62 135.9 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.112 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 77.2 p -106.21 -39.43 5.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.123 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -128.83 122.11 29.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.81 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -105.2 112.69 25.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . 0.467 HD13 HG23 ' A' ' 393' ' ' VAL . 49.6 mm -86.13 117.56 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.121 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 29.3 m -136.29 178.2 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.195 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -82.34 -43.91 16.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -125.51 82.2 63.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.573 0.702 . . . . 0.0 110.917 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -14.83 36.71 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.648 2.232 . . . . 0.0 112.354 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -72.78 -54.19 7.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.455 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -99.04 41.48 1.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.74 0.305 . . . . 0.0 110.893 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 385' ' ' THR . 4.3 tp-100 -122.76 100.86 7.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.969 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . 0.415 ' C ' ' O ' ' A' ' 384' ' ' GLN . 31.3 m -36.59 122.77 0.79 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.114 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 34.4 p -102.73 -179.64 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 59.7 t -130.93 141.05 47.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.093 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.6 mt -42.2 113.89 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.133 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 104.27 -44.72 1.42 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.503 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 25.2 ttp180 -81.11 139.81 35.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.817 0.341 . . . . 0.0 110.861 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 61.8 m -127.38 125.6 40.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . 0.407 ' CE2' ' HG3' ' A' ' 384' ' ' GLN . 2.8 m-85 -85.86 137.19 32.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.932 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.467 HG23 HD13 ' A' ' 377' ' ' ILE . 23.4 m -142.34 164.46 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.119 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -79.04 160.79 70.49 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.567 0.699 . . . . 0.0 110.93 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 -4.83 14.79 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.669 2.246 . . . . 0.0 112.383 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -79.27 -34.22 42.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -50.7 -35.69 32.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.923 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 44.1 t -65.66 -51.57 61.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.107 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -57.27 -36.92 71.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.882 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.456 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 11.2 m-20 -73.8 -40.39 63.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.853 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 1.9 m -72.55 -23.28 60.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.831 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.67 HG13 ' CZ ' ' A' ' 350' ' ' PHE . 2.2 t -87.25 -31.13 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.14 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -85.37 -24.76 27.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -95.52 8.97 41.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.066 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 404' ' ' ALA . 10.2 mmt85 37.15 42.72 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.877 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 21.2 tp -166.69 142.22 4.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.94 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.45 HD11 HD11 ' A' ' 330' ' ' LEU . 13.0 mt -69.19 102.87 1.78 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.456 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 17.8 mt -73.68 154.29 89.42 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.593 0.711 . . . . 0.0 110.912 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 108.4 2.06 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.714 2.276 . . . . 0.0 112.319 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.407 ' HB ' HG11 ' A' ' 393' ' ' VAL . 28.0 m -53.52 -25.36 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.164 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -53.45 -16.16 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.074 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -95.03 -22.4 17.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.868 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -111.81 36.0 3.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.935 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 2.2 t80 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.921 -179.977 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 80.7 p -99.93 -58.28 1.95 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.921 0.391 . . . . 0.0 110.839 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 65.0 m -58.36 177.24 0.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.862 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 161.9 65.95 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.456 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 21.0 t -170.73 139.54 1.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.356 . . . . 0.0 110.883 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 321' ' ' GLY . 32.6 m -140.37 170.97 14.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.828 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 320' ' ' SER . . . 37.28 82.38 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.479 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.94 152.24 1.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 0.0 110.893 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -75.38 170.53 15.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -142.5 135.45 28.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.942 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -130.92 144.77 51.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.876 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 7.5 tp -65.15 -38.65 91.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -105.87 30.16 6.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -54.1 113.84 1.39 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 78.73 -45.35 2.68 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.517 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.432 HD22 ' CE1' ' A' ' 375' ' ' HIS . 15.8 mt -39.6 130.34 1.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.872 0.368 . . . . 0.0 110.912 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -98.97 152.14 20.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -144.65 148.38 34.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -135.59 116.69 14.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.915 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.662 HD22 HD13 ' A' ' 343' ' ' LEU . 2.6 mt -94.42 139.97 30.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -88.97 171.15 10.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.447 ' CB ' HD11 ' A' ' 360' ' ' LEU . 28.9 ptt180 -77.47 -9.89 59.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.845 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -87.31 -42.84 12.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 5.7 m -84.92 150.97 56.86 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.637 0.732 . . . . 0.0 111.105 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . 0.572 ' O ' HD12 ' A' ' 343' ' ' LEU . 53.9 Cg_endo -69.8 115.34 4.05 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.681 2.254 . . . . 0.0 112.307 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -94.56 -39.7 10.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -40.2 -36.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -86.66 -49.22 7.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.106 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . 0.662 HD13 HD22 ' A' ' 334' ' ' LEU . 30.8 mt -60.29 -61.78 2.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.945 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -38.73 -62.64 0.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.098 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -48.85 -42.01 34.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 347' ' ' ILE . 23.3 mt -65.81 -72.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.122 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . 0.46 ' N ' HG22 ' A' ' 346' ' ' ILE . 27.5 mt -38.95 -44.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.153 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -66.78 -42.68 85.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 8.9 t -65.74 -28.48 69.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.849 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . 0.474 ' CZ ' HG12 ' A' ' 402' ' ' VAL . 18.5 m-85 -88.6 12.85 13.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.835 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 68.93 50.65 33.6 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.488 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -132.35 156.55 22.08 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.434 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -91.52 132.39 36.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.909 0.385 . . . . 0.0 110.911 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.457 HG21 HD11 ' A' ' 334' ' ' LEU . 7.1 p -140.24 142.8 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.157 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 26.3 t -137.05 159.85 40.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -139.65 174.42 10.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.5 119.13 4.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.887 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.43 -8.72 14.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 4.3 t -88.64 -23.41 23.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.836 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.447 HD11 ' CB ' ' A' ' 336' ' ' ARG . 12.5 mt -75.38 -51.02 14.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 2.7 t -162.48 164.66 26.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.865 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.6 pt -62.47 172.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.137 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 364' ' ' ALA . . . 105.95 -42.87 1.8 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.49 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 363' ' ' GLY . . . -35.3 124.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.893 0.378 . . . . 0.0 111.106 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 41.5 p -97.15 -65.17 0.98 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.152 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -109.61 158.74 17.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 370' ' ' ASP . 3.0 m-20 -83.23 167.97 17.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.914 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.08 -28.77 37.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.108 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 60.8 p -83.0 20.42 1.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.167 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 367' ' ' ASP . 2.8 m-20 -92.36 98.92 11.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 372' ' ' ARG . 16.6 t -43.16 -42.65 4.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.841 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 371' ' ' SER . 48.2 mtp180 -37.45 -41.46 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 78.4 mt -45.92 123.72 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 70.4 p -84.69 -45.1 12.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.14 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . 0.524 ' CD2' ' SG ' ' A' ' 391' ' ' CYS . 51.5 m80 -133.05 141.58 48.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.911 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -123.62 116.71 23.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 49.6 mm -82.42 127.78 39.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.144 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 15.4 m -140.24 172.65 11.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.103 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -90.47 -42.97 10.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.798 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 11.5 ptt-85 -121.22 81.2 36.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.568 0.699 . . . . 0.0 110.846 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 3.07 3.01 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.661 2.241 . . . . 0.0 112.325 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -97.3 -28.14 8.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.477 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -77.28 -71.33 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.787 0.327 . . . . 0.0 110.896 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.574 ' OE1' ' CE2' ' A' ' 392' ' ' TYR . 3.2 pp0? -57.34 120.78 8.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 66.5 p -58.85 140.67 54.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.156 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 27.8 p -68.32 161.12 28.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 388' ' ' ILE . 42.0 t -120.96 121.44 65.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.082 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.422 ' C ' ' O ' ' A' ' 387' ' ' VAL . 10.0 mt -36.17 132.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.124 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 86.48 -48.65 3.94 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.457 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -85.88 138.49 31.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.324 . . . . 0.0 110.901 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' CYS . . . . . 0.524 ' SG ' ' CD2' ' A' ' 375' ' ' HIS . 6.3 p -118.65 129.73 55.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . 0.574 ' CE2' ' OE1' ' A' ' 384' ' ' GLN . 7.8 m-85 -98.23 126.76 43.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.633 HG11 ' HB ' ' A' ' 410' ' ' VAL . 34.4 m -136.08 146.92 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.075 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -61.67 161.14 22.11 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.632 0.729 . . . . 0.0 110.859 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.459 ' HB3' HD11 ' A' ' 343' ' ' LEU . 54.2 Cg_endo -69.75 -10.47 28.66 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.705 2.27 . . . . 0.0 112.335 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -76.02 -26.42 56.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 85.6 t90 -56.82 -23.58 44.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.898 ' O ' HG22 ' A' ' 402' ' ' VAL . 3.9 t -87.83 -53.87 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -50.24 -33.54 19.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -79.56 -51.21 9.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 69.9 m -54.4 -51.45 64.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.898 HG22 ' O ' ' A' ' 398' ' ' VAL . 5.3 m -54.79 -44.24 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.13 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -69.84 -35.26 74.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.848 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -87.98 9.01 23.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 39.13 38.3 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.936 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.468 HD23 ' C ' ' A' ' 406' ' ' LEU . 1.0 OUTLIER -153.68 153.5 32.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.941 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 29.1 mt -85.78 93.59 8.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.11 152.88 76.62 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.73 . . . . 0.0 110.896 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 116.28 4.49 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.642 2.228 . . . . 0.0 112.356 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.633 ' HB ' HG11 ' A' ' 393' ' ' VAL . 32.2 m -60.19 -19.74 18.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -63.01 -21.38 66.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.066 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -86.98 -17.27 33.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.937 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -115.49 42.68 2.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 41.7 t80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.812 -179.963 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 316' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 315' ' ' GLY . 87.4 p 34.43 41.9 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 3.5 t -163.69 160.52 22.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.858 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 164.2 55.34 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.465 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.1 m -102.95 104.14 14.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.909 0.385 . . . . 0.0 110.812 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 58.7 m -76.32 168.49 19.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -158.43 175.62 35.52 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.534 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -152.95 138.48 17.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.787 0.327 . . . . 0.0 110.898 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -147.07 162.45 38.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.851 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -103.0 118.42 36.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.929 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm -82.79 133.84 35.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.91 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.459 ' CD1' ' HA ' ' A' ' 405' ' ' ARG . 2.1 tt -53.03 -40.92 64.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.934 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -101.63 40.53 1.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -79.14 123.76 27.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.935 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 70.8 50.41 24.53 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.497 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 72.5 mt -142.91 162.28 35.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.86 0.362 . . . . 0.0 110.934 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -131.07 123.16 28.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.93 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.534 ' CD1' ' HB2' ' A' ' 375' ' ' HIS . 78.6 m-85 -119.42 147.49 44.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -132.31 119.91 21.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.817 HD22 HD13 ' A' ' 343' ' ' LEU . 3.6 mt -99.13 148.46 24.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -104.28 175.51 5.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.673 ' HB3' HD11 ' A' ' 360' ' ' LEU . 30.8 ptt180 -71.27 -31.86 68.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.842 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -63.58 -45.42 90.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 2.9 m -82.17 149.61 62.7 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.642 0.735 . . . . 0.0 111.135 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . 0.412 ' O ' HD12 ' A' ' 343' ' ' LEU . 54.1 Cg_endo -69.76 111.82 2.91 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.688 2.259 . . . . 0.0 112.363 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 0.448 ' O ' ' C ' ' A' ' 341' ' ' GLU . 26.1 ttp85 -78.45 -49.13 14.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 340' ' ' ARG . 1.2 mt-10 -33.59 -69.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.894 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -57.76 -64.04 1.04 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.128 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . 0.817 HD13 HD22 ' A' ' 334' ' ' LEU . 29.2 mt -42.08 -70.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 343' ' ' LEU . . . -36.98 -66.53 0.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.096 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -44.01 -49.18 8.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' ILE . . . . . . . . . . . . . 28.7 mt -57.76 -67.67 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.123 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 29.2 mt -42.48 -44.64 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.164 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . 0.411 ' NH1' ' HB3' ' A' ' 348' ' ' ARG . 10.3 mtp-105 -65.1 -49.23 70.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 13.2 t -57.26 -21.08 31.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -102.2 22.75 12.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 55.96 50.29 62.23 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.513 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -122.39 163.12 15.91 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.523 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -101.96 126.5 48.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 110.895 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.758 HG21 HD11 ' A' ' 334' ' ' LEU . 6.7 p -138.94 138.64 41.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.119 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . 0.445 ' HB3' ' CE1' ' A' ' 366' ' ' TYR . 7.4 t -131.23 161.63 31.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -139.34 174.64 10.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.511 ' HB3' HD12 ' A' ' 360' ' ' LEU . 28.4 t0 -64.24 107.55 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.852 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -42.39 -44.21 3.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 5.4 t -53.57 -52.34 60.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.673 HD11 ' HB3' ' A' ' 336' ' ' ARG . 41.7 mt -48.63 -51.09 29.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 2.7 m -158.41 166.08 33.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 20.9 tt -80.54 151.97 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 125.41 -36.61 2.74 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -40.81 145.88 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.868 0.366 . . . . 0.0 111.097 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.501 ' OG1' ' CD2' ' A' ' 366' ' ' TYR . 80.8 p -110.16 -64.25 1.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' TYR . . . . . 0.501 ' CD2' ' OG1' ' A' ' 365' ' ' THR . 2.2 p90 -106.55 159.07 16.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.17 168.22 19.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.892 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . 0.438 ' O ' HG22 ' A' ' 368' ' ' VAL . 8.2 p -76.26 -3.17 4.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.163 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 73.7 p -108.08 19.76 19.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.17 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -92.94 105.9 17.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.84 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 372' ' ' ARG . 75.3 m -41.12 -42.3 1.98 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.814 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 371' ' ' SER . 62.4 mtt180 -35.75 -44.0 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 85.6 mt -44.54 130.66 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 33.6 p -103.6 -33.1 9.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.126 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . 0.534 ' HB2' ' CD1' ' A' ' 332' ' ' PHE . 24.7 m80 -138.58 124.13 19.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.806 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -112.73 94.6 4.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . 0.588 HD13 HG23 ' A' ' 393' ' ' VAL . 16.1 mm -63.45 120.64 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.19 164.58 31.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.158 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -77.08 -44.77 29.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 27.3 mmm-85 -124.07 82.79 56.22 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.63 0.729 . . . . 0.0 110.847 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -14.0 35.55 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.676 2.25 . . . . 0.0 112.341 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -79.58 -32.89 36.22 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.515 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 384' ' ' GLN . 7.1 mm100 -84.98 -55.22 4.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.786 0.327 . . . . 0.0 110.91 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 383' ' ' GLN . 30.5 mm-40 -37.47 140.0 0.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 23.5 m -78.0 91.07 4.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.142 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 94.1 p -44.18 156.4 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.84 127.08 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.134 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 18.7 mm -39.99 129.27 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.12 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 91.97 -40.22 2.93 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.549 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -91.27 146.53 23.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.792 0.33 . . . . 0.0 110.881 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 18.4 m -124.17 124.06 41.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -90.22 125.49 35.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.588 HG23 HD13 ' A' ' 377' ' ' ILE . 15.2 m -130.59 167.41 25.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.127 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -88.21 161.05 44.44 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.614 0.721 . . . . 0.0 110.876 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.477 ' HB3' HD11 ' A' ' 343' ' ' LEU . 53.7 Cg_endo -69.79 -5.33 15.98 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.646 2.231 . . . . 0.0 112.353 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 -81.03 -23.68 38.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -62.53 -35.65 80.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.917 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.676 ' O ' HG22 ' A' ' 402' ' ' VAL . 65.7 t -66.68 -61.6 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.132 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 7.9 m-30 -48.14 -31.64 5.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.449 ' HB3' ' CD1' ' A' ' 408' ' ' LEU . 3.0 m-20 -76.85 -41.97 41.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 50.6 m -65.9 -52.37 50.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.824 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 398' ' ' VAL . 4.5 m -54.59 -33.43 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.174 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -87.43 -18.29 30.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.849 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -102.93 9.26 38.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.108 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . 0.459 ' HA ' ' CD1' ' A' ' 326' ' ' LEU . 9.7 mpt_? 39.59 30.38 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 13.0 tp -149.19 164.2 35.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 408' ' ' LEU . 94.2 mt -97.61 68.12 2.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.449 ' CD1' ' HB3' ' A' ' 400' ' ' ASP . 27.9 mt -35.41 153.33 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.564 0.697 . . . . 0.0 110.94 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 114.84 3.83 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.701 2.267 . . . . 0.0 112.399 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.8 m -53.5 -22.17 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.124 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -54.22 -42.96 70.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.086 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -70.09 -8.15 47.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -127.32 43.91 3.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.988 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 91.6 t80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.864 -179.936 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 49.8 m -41.99 156.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 0.0 110.899 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 8.4 t -58.06 105.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -167.5 153.05 22.18 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.518 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 26.3 m -54.53 119.15 4.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 110.873 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 98.7 p -88.51 96.68 10.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.871 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -100.51 143.73 16.43 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.497 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -87.58 131.42 34.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.767 0.318 . . . . 0.0 110.913 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -136.45 151.05 49.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.868 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -103.68 100.4 10.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -82.65 150.79 26.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.02 -44.12 94.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -103.46 40.0 1.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -76.06 130.32 38.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 62.84 50.46 63.62 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.502 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 82.5 mt -146.08 120.27 9.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.842 0.353 . . . . 0.0 110.905 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -95.1 120.62 35.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -112.43 159.42 18.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' PHE . . . . . 0.464 ' CZ ' ' HB ' ' A' ' 368' ' ' VAL . 35.4 t80 -141.69 116.71 9.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.872 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.775 HD22 HD13 ' A' ' 343' ' ' LEU . 3.8 mt -94.05 148.77 21.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.927 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -96.16 179.25 5.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.588 ' HB3' HD11 ' A' ' 360' ' ' LEU . 18.4 ptt85 -73.69 -39.88 64.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.4 -49.3 76.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 3.1 m -69.24 150.39 97.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.65 0.738 . . . . 0.0 111.14 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 122.16 8.85 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.701 2.268 . . . . 0.0 112.341 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' A' ' 344' ' ' ALA . 5.5 tmm_? -89.6 -37.4 14.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -60.02 -38.55 83.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.934 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.82 -59.65 2.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.087 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . 0.775 HD13 HD22 ' A' ' 334' ' ' LEU . 51.5 mt -56.44 -59.2 5.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 340' ' ' ARG . . . -43.96 -56.89 3.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -54.11 -42.9 69.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.832 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 347' ' ' ILE . 17.1 mt -66.92 -70.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.117 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . 0.413 ' N ' HG22 ' A' ' 346' ' ' ILE . 37.7 mt -43.69 -37.25 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.153 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -73.2 -37.2 66.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 7.4 m -72.57 -30.2 64.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . 0.52 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 15.3 m-85 -85.87 7.0 25.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.858 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 72.58 59.07 4.63 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.495 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -138.85 156.36 24.24 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.513 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -92.16 133.38 35.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.92 0.39 . . . . 0.0 110.871 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.454 HG21 HD11 ' A' ' 334' ' ' LEU . 7.3 p -143.6 138.7 25.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.126 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . 0.533 ' HB2' ' CE1' ' A' ' 366' ' ' TYR . 5.1 t -134.05 157.28 46.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.863 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 22.6 p90 -141.03 177.14 8.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.39 111.31 4.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -50.33 -39.7 46.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 28.1 t -48.61 -47.96 39.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.588 HD11 ' HB3' ' A' ' 336' ' ' ARG . 76.0 mt -60.5 -47.03 87.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.904 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 1.8 m -166.64 137.37 3.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 26.1 pt -60.53 168.6 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 113.19 -36.96 3.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.501 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -45.45 166.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.853 0.358 . . . . 0.0 111.109 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.482 ' OG1' ' CD2' ' A' ' 366' ' ' TYR . 71.6 p -116.8 -68.94 0.88 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.12 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' TYR . . . . . 0.533 ' CE1' ' HB2' ' A' ' 355' ' ' SER . 0.9 OUTLIER -101.54 159.96 14.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.957 -179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -86.94 167.26 14.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.866 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . 0.464 ' HB ' ' CZ ' ' A' ' 333' ' ' PHE . 11.7 p -69.68 -30.3 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.109 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.5 p -83.49 20.61 1.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.139 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -95.06 121.76 37.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 99.0 p -69.78 -18.68 63.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 27.5 mtt-85 -57.33 -33.32 67.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.865 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . . . . . . . . . 71.4 mt -54.64 144.26 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 25.7 p -104.48 -42.04 5.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.145 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -128.54 133.0 48.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.847 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' GLN . . . . . 0.41 ' CD ' ' CZ ' ' A' ' 392' ' ' TYR . 24.9 tt0 -113.56 104.71 12.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 9.2 mm -77.56 123.04 33.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 18.3 m -135.79 148.48 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.113 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -56.33 -39.01 72.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -148.14 104.98 3.59 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.591 0.71 . . . . 0.0 110.855 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.73 -6.38 18.44 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.69 2.26 . . . . 0.0 112.38 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 383' ' ' GLN . . . -83.21 -68.69 1.41 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 382' ' ' GLY . 12.3 mm100 -36.43 -49.64 0.73 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.696 0.284 . . . . 0.0 110.885 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -98.62 143.43 29.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 69.3 p -90.09 127.48 36.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.141 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . 0.453 ' HB2' ' CD1' ' A' ' 392' ' ' TYR . 90.4 p -62.81 159.25 16.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 88.0 t -90.3 148.52 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.111 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 6.4 mm -54.81 129.42 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.148 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 92.06 -42.44 2.75 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.498 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -85.59 146.04 27.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.765 0.317 . . . . 0.0 110.829 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 81.6 m -113.39 132.06 55.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . 0.453 ' CD1' ' HB2' ' A' ' 386' ' ' SER . 3.3 m-85 -104.13 125.3 50.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.59 HG11 ' HB ' ' A' ' 410' ' ' VAL . 6.0 m -131.64 149.7 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -63.49 158.91 55.29 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.656 0.741 . . . . 0.0 110.859 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -6.95 19.85 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.706 2.271 . . . . 0.0 112.342 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -81.39 -26.17 35.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' TRP . . . . . 0.508 ' CE2' HG12 ' A' ' 410' ' ' VAL . 81.8 t90 -54.13 -43.53 70.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.433 ' O ' HG22 ' A' ' 402' ' ' VAL . 85.5 t -65.24 -47.67 86.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.114 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -58.93 -33.19 70.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.538 ' CB ' ' CD1' ' A' ' 408' ' ' LEU . 61.6 m-20 -75.95 -31.24 58.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 26.2 m -72.84 -51.65 17.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.847 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.52 ' HB ' ' CZ ' ' A' ' 350' ' ' PHE . 12.5 m -56.13 -40.5 64.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.094 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -67.36 -40.78 85.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -92.15 14.32 16.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 404' ' ' ALA . 1.2 mpp_? 34.3 40.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.859 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.763 HD13 ' N ' ' A' ' 407' ' ' LEU . 0.6 OUTLIER -156.63 149.3 23.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.763 ' N ' HD13 ' A' ' 406' ' ' LEU . 50.0 mt -75.69 103.45 5.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.538 ' CD1' ' CB ' ' A' ' 400' ' ' ASP . 12.4 mt -70.8 155.35 93.51 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.587 0.708 . . . . 0.0 110.934 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 105.3 1.46 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.658 2.239 . . . . 0.0 112.362 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.59 ' HB ' HG11 ' A' ' 393' ' ' VAL . 34.5 m -56.07 -16.63 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.135 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.11 93.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -71.18 -12.31 61.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.869 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -119.62 30.31 7.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.888 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 81.2 t80 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.892 179.995 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.469 -0.253 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 28.6 m -151.26 107.17 3.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.893 0.378 . . . . 0.0 110.879 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 33.2 p -55.72 137.15 50.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 45.65 -147.08 2.3 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.492 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 3.6 m -163.16 139.51 7.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.895 0.378 . . . . 0.0 110.864 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 51.6 p -113.29 131.82 55.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.834 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 322' ' ' LYS . . . -135.86 -79.42 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.502 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 321' ' ' GLY . 30.8 mtmt 34.41 47.76 0.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.778 0.323 . . . . 0.0 110.865 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -160.58 134.92 7.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.855 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 39.8 mmtt -60.67 155.6 18.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 36.8 mmtt -121.29 164.32 17.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 2.1 tt -70.01 -49.23 53.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.982 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -106.59 37.82 2.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -57.15 116.07 3.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 330' ' ' LEU . . . 77.68 -50.81 3.31 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.494 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 329' ' ' GLY . 19.3 mt -34.65 127.66 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.886 0.374 . . . . 0.0 110.943 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -104.11 146.77 28.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -138.72 155.12 48.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -137.37 116.61 12.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.855 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.65 HD13 ' HA ' ' A' ' 340' ' ' ARG . 3.0 mt -92.52 144.86 24.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.931 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -89.4 -177.67 5.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.635 ' HB3' HD11 ' A' ' 360' ' ' LEU . 14.0 ptt-85 -80.7 -34.79 34.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -67.16 -42.56 84.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.496 HG12 ' OD2' ' A' ' 379' ' ' ASP . 4.3 m -78.89 150.02 74.68 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.61 0.719 . . . . 0.0 111.145 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 110.95 2.67 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.671 2.248 . . . . 0.0 112.39 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 0.65 ' HA ' HD13 ' A' ' 334' ' ' LEU . 6.2 ppt_? -85.57 -36.11 20.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.449 ' N ' ' HD2' ' A' ' 340' ' ' ARG . 9.3 pt-20 -54.0 -39.41 66.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -79.51 -64.67 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.084 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 32.0 mt -50.07 -60.04 3.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.922 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 340' ' ' ARG . . . -42.4 -56.28 3.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.08 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -54.79 -45.98 74.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.914 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' ILE . . . . . 0.427 ' CG2' HG11 ' A' ' 402' ' ' VAL . 19.8 mt -60.63 -62.35 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.123 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 23.9 mt -51.9 -43.85 36.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.118 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 70.1 mtp85 -67.01 -32.36 73.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.859 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 26.3 t -74.41 -39.58 62.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . 0.543 ' CZ ' ' HB ' ' A' ' 402' ' ' VAL . 20.5 m-85 -75.15 -5.59 45.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.905 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 89.0 55.21 2.16 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.462 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -134.34 163.64 24.61 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.512 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -95.69 126.51 41.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.91 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.428 HG11 ' HA ' ' A' ' 344' ' ' ALA . 12.0 p -142.37 141.13 28.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.15 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 18.2 t -143.99 151.95 40.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' TRP . . . . . . . . . . . . . 31.7 p90 -129.04 172.92 10.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.919 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -59.29 111.26 1.29 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.447 ' HG2' ' HB3' ' A' ' 364' ' ' ALA . 40.1 mtpt -44.58 -36.77 3.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.4 t -58.1 -50.9 71.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.635 HD11 ' HB3' ' A' ' 336' ' ' ARG . 38.6 mt -48.55 -47.7 39.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.911 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 5.0 t -171.69 145.8 2.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.86 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.3 pt -59.87 166.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.091 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 114.63 -35.21 4.52 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.475 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.447 ' HB3' ' HG2' ' A' ' 358' ' ' LYS . . . -51.99 158.77 0.99 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.872 0.367 . . . . 0.0 111.101 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 6.1 p -115.14 -65.7 1.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.166 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -107.56 152.36 24.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.426 ' O ' HD11 ' A' ' 373' ' ' ILE . 64.0 m-20 -81.35 173.27 12.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.826 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . . . . . . . . . 12.2 p -69.29 -21.19 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.086 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.6 p -87.34 25.22 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.095 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . 0.423 ' OD2' ' N ' ' A' ' 367' ' ' ASP . 6.6 m-20 -103.27 104.36 14.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 372' ' ' ARG . 11.8 t -39.92 -42.13 1.29 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 371' ' ' SER . 24.8 mmt180 -35.67 -45.54 0.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.873 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.426 HD11 ' O ' ' A' ' 367' ' ' ASP . 41.1 mt -46.6 124.97 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.08 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 44.3 p -97.17 -46.61 6.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.165 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -124.32 141.04 52.39 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.881 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -120.8 111.02 17.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 39.6 mm -76.27 124.9 35.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.083 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 34.5 m -145.08 152.33 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.133 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . 0.496 ' OD2' HG12 ' A' ' 338' ' ' VAL . 2.9 m-20 -73.37 -37.37 66.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -127.29 86.03 59.62 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.653 0.74 . . . . 0.0 110.891 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 3.22 2.86 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.692 2.261 . . . . 0.0 112.348 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -100.74 -42.8 2.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.52 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -55.13 -68.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.776 0.322 . . . . 0.0 110.956 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.429 ' NE2' ' CD2' ' A' ' 392' ' ' TYR . 4.2 pp0? -63.53 151.67 40.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 98.9 m -89.8 119.87 30.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.185 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 60.6 p -55.15 161.48 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.836 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 71.0 t -108.46 120.36 59.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.141 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 5.0 mt -39.31 104.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.156 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 119.07 -43.18 1.63 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.48 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . 0.412 ' NH1' ' HB ' ' A' ' 373' ' ' ILE . 11.8 ttm-85 -80.53 158.19 25.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.741 0.305 . . . . 0.0 110.907 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 55.8 m -126.06 128.88 48.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.891 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . 0.429 ' CD2' ' NE2' ' A' ' 384' ' ' GLN . 3.0 m-85 -105.65 132.47 51.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.907 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.469 HG11 ' CG1' ' A' ' 410' ' ' VAL . 14.2 m -143.39 147.38 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.127 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -55.12 156.21 7.71 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.59 0.709 . . . . 0.0 110.952 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -3.93 12.98 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.359 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 41.5 tp60 -85.13 -28.98 25.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.937 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -48.74 -28.14 3.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.865 ' O ' HG22 ' A' ' 402' ' ' VAL . 56.3 t -85.44 -29.58 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.105 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -72.73 -37.2 67.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.906 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.669 ' OD1' HD12 ' A' ' 408' ' ' LEU . 0.8 OUTLIER -84.34 -23.2 30.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.927 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 3.2 m -81.09 -47.85 12.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.865 HG22 ' O ' ' A' ' 398' ' ' VAL . 13.2 m -57.5 -36.88 55.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.156 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -69.9 -34.39 73.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -95.66 15.08 20.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.081 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 404' ' ' ALA . 9.9 mmt85 35.89 39.73 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.892 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 27.5 tp -147.89 163.29 37.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 42.1 mt -95.0 81.02 3.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.669 HD12 ' OD1' ' A' ' 400' ' ' ASP . 62.7 mt -47.71 155.67 0.77 Allowed Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.605 0.716 . . . . 0.0 110.916 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 118.07 5.46 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.668 2.245 . . . . 0.0 112.326 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.469 ' CG1' HG11 ' A' ' 393' ' ' VAL . 23.2 m -58.54 -31.28 43.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.144 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -42.88 -52.55 5.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.128 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -59.07 -39.68 82.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.471 ' CZ ' ' OD2' ' A' ' 400' ' ' ASP . 68.6 m-85 -95.21 45.76 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 31.8 t80 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 27.4 p -158.3 145.4 17.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.903 0.382 . . . . 0.0 110.854 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.8 t -128.83 171.87 11.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.816 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 150.79 156.99 7.6 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.488 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 31.8 t -157.34 134.9 10.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.881 0.372 . . . . 0.0 110.848 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 74.0 m -67.06 133.93 50.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.846 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -115.28 161.62 12.74 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.509 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -107.58 39.02 2.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.81 0.338 . . . . 0.0 110.854 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -153.6 122.64 6.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.858 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.95 160.9 0.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -110.91 141.92 43.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.881 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 14.3 tp -42.4 -37.7 1.65 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.888 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -116.96 50.02 1.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -87.87 137.72 32.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 58.11 41.73 94.77 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.491 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 72.5 mt -141.38 120.22 12.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.902 0.382 . . . . 0.0 110.945 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -93.94 117.25 29.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -105.86 158.44 16.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -141.1 119.86 12.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.883 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.684 HD22 HD13 ' A' ' 343' ' ' LEU . 14.6 mt -95.53 142.67 27.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.916 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -100.9 179.32 4.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.867 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.437 ' HG2' ' N ' ' A' ' 337' ' ' GLU . 0.0 OUTLIER -78.24 -29.21 48.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.847 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . 0.437 ' N ' ' HG2' ' A' ' 336' ' ' ARG . 20.8 tt0 -72.48 -15.69 61.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 10.6 m -110.02 150.98 42.18 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.636 0.731 . . . . 0.0 111.109 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 115.49 4.11 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.695 2.263 . . . . 0.0 112.354 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 0.429 ' HB3' ' NH1' ' A' ' 340' ' ' ARG . 19.5 ttp-105 -77.04 -69.69 0.51 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 340' ' ' ARG . 8.3 pt-20 -35.07 -44.58 0.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.17 -64.14 0.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.099 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . 0.684 HD13 HD22 ' A' ' 334' ' ' LEU . 36.6 mt -59.35 -63.16 1.4 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.903 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 343' ' ' LEU . . . -36.84 -51.86 0.91 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.073 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -59.14 -40.05 84.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' ILE . . . . . 0.767 HD11 ' CE1' ' A' ' 399' ' ' PHE . 27.5 mt -67.24 -64.21 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 24.9 mt -48.08 -41.73 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -68.4 -39.25 81.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 12.1 t -68.17 -22.99 64.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -105.48 22.52 15.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 57.46 63.75 5.01 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.471 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -133.81 155.79 21.97 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.503 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -92.25 130.98 37.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.861 0.362 . . . . 0.0 110.908 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.544 HG21 HD11 ' A' ' 334' ' ' LEU . 7.4 p -146.39 132.2 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 9.6 t -130.06 163.46 26.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' TRP . . . . . 0.406 ' CD1' ' HB2' ' A' ' 364' ' ' ALA . 18.4 p90 -135.04 178.69 6.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.865 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.605 ' HB3' HD12 ' A' ' 360' ' ' LEU . 7.7 t70 -70.94 105.89 3.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 357' ' ' ASP . 70.3 mttt -35.47 -44.15 0.28 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.896 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 28.7 t -58.69 -52.95 63.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.834 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.605 HD12 ' HB3' ' A' ' 357' ' ' ASP . 18.5 mt -50.87 -49.44 59.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' CYS . . . . . . . . . . . . . 3.0 m -160.35 145.35 14.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 13.3 pt -72.22 176.72 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 92.82 -15.85 61.7 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.48 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.406 ' HB2' ' CD1' ' A' ' 356' ' ' TRP . . . -56.75 -177.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.908 0.385 . . . . 0.0 111.099 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 72.7 p -131.47 -66.72 0.72 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -117.53 157.0 27.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.433 ' O ' HD11 ' A' ' 373' ' ' ILE . 1.1 m-20 -90.64 168.97 11.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' VAL . . . . . 0.433 ' HA ' ' CD1' ' A' ' 373' ' ' ILE . 9.9 p -66.24 -22.46 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 61.1 p -84.68 26.27 0.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -110.75 109.44 19.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 67.7 m -47.2 -38.23 11.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -40.15 -41.86 1.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' ILE . . . . . 0.433 ' CD1' ' HA ' ' A' ' 368' ' ' VAL . 86.8 mt -41.94 138.65 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.137 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 42.2 p -108.48 -26.82 10.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.15 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -153.44 133.07 13.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.853 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' GLN . . . . . 0.569 ' OE1' HG13 ' A' ' 378' ' ' VAL . 1.0 OUTLIER -112.33 94.06 4.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 30.2 mm -55.78 98.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.121 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.569 HG13 ' OE1' ' A' ' 376' ' ' GLN . 26.8 m -122.02 140.32 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.138 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . 0.433 ' OD1' ' C ' ' A' ' 379' ' ' ASP . 4.3 t0 -48.04 -43.39 30.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.901 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -129.45 86.93 54.7 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.635 0.731 . . . . 0.0 110.823 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -9.74 26.83 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.687 2.258 . . . . 0.0 112.365 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -85.4 -39.41 8.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.504 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -73.31 -52.52 13.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.712 0.292 . . . . 0.0 110.91 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -45.51 142.01 2.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 57.9 m -71.15 101.17 2.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.106 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 24.9 p -53.56 167.71 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.817 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 389' ' ' GLY . 81.9 t -130.64 134.58 61.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.131 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.54 HG22 ' O ' ' A' ' 388' ' ' ILE . 15.3 mm -56.98 86.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.09 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 387' ' ' VAL . . . 135.06 -27.36 3.16 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.506 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -99.96 156.66 17.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.851 0.357 . . . . 0.0 110.855 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' CYS . . . . . . . . . . . . . 72.3 m -129.73 123.87 32.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -97.37 121.58 39.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 21.8 m -126.83 164.01 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.144 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -87.49 161.36 45.66 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.606 0.717 . . . . 0.0 110.902 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -4.64 14.42 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.706 2.271 . . . . 0.0 112.348 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -82.99 -14.17 54.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -77.73 -13.77 59.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.827 ' O ' HG22 ' A' ' 402' ' ' VAL . 42.1 t -89.18 -41.15 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.154 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . 0.767 ' CE1' HD11 ' A' ' 346' ' ' ILE . 47.8 m-85 -71.8 -34.37 69.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.859 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.32 -45.7 53.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.884 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' SER . . . . . . . . . . . . . 2.6 m -62.6 -56.25 19.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.827 HG22 ' O ' ' A' ' 398' ' ' VAL . 15.4 m -50.64 -42.54 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -70.62 -37.96 73.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.928 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 405' ' ' ARG . . . -89.87 10.73 22.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 404' ' ' ALA . 46.8 mmm-85 37.21 44.05 0.4 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 28.7 tp -153.69 142.68 21.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 20.4 mt -80.73 73.95 7.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 75.4 mt -40.69 152.35 0.24 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.605 0.717 . . . . 0.0 110.91 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 105.6 1.51 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.688 2.259 . . . . 0.0 112.353 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.8 m -50.78 -22.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.111 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -50.94 -35.83 35.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.122 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -69.39 -38.28 77.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.942 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -90.81 41.57 1.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.908 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' PHE . . . . . . . . . . . . . 16.5 t80 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.944 . . . . . . . . 0 0 . 1 stop_ save_